Investigating the effect of interventional programmes in combatting inappropriate use of antibiotics in managing and treating acute gastroenteritis in children younger than five years at the Raleigh Fitkin Memorial Hospital in ESwatini by Matsebula-Myeni, Zinhle
Investigating the effect of interventional programmes in combatting 
inappropriate use of antibiotics in managing and treating acute 
gastroenteritis in children younger than five years at the Raleigh Fitkin 
Memorial Hospital in ESwatini 
By: 
Zinhle Matsebula-Myeni 
Submitted in fulfilment of the requirements for the degree of Master of Science in Pharmacology 
(MSc in Pharmacology) by Research 
Division of Clinical Pharmacology 
Faculty of Medicine and Health Science 
Stellenbosch University 
Supervisor: Prof. Bernd Rosenkranz 
(Emeritus Professor: Division of Clinical Pharmacology, Faculty of Medicine and 
Health Sciences, Stellenbosch University) 
Co-Supervisor Prof. Helmuth Reuter 
(Professor and Head: Division of Clinical Pharmacology, Faculty of Medicine and Health Sciences, 
Stellenbosch University) 
April 2019 
ii | P a g e
DECLARATION 
By submitting this thesis electronically, I declare that the entirety of the work contained therein is my own, 
original work, that I am the sole author thereof (save to the extent explicitly otherwise stated), that 
reproduction and publication thereof by Stellenbosch University will not infringe any third party rights and 
that I have not previously in its entirety or in part submitted it for obtaining any qualification. 
Zinhle Matsebula - Myeni 
------------------------------------------------------------------- 
Date: April 2019 
Stellenbosch University  https://scholar.sun.ac.za
iii | P a g e
ABSTRACT 
Patients at the Raleigh Fitkin Memorial Hospital, ESwatini, especially children diagnosed with acute 
gastroenteritis, are mostly prescribed with antibiotics. Previous data suggest that inappropriate use of 
antibiotics results in higher antibiotic resistance, extended hospitalisation and increased medication costs. 
Antibiotic stewardship programmes and clinical practice guidelines can reduce the inappropriate use of 
antibiotics and improve patient outcomes. Despite increased theoretical awareness of the benefits of 
antibiotic stewardship programmes, none have been established in ESwatini, and limited comprehensive 
studies have evaluated their effect in paediatric settings globally. The knowledge, attitude and practices on 
antibiotic use and resistance have not been determined at the Raleigh Fitkin Memorial Hospital. An 18-
month, single-centre process improvement study, comprising a six-month pre-intervention phase, a 
preparatory period of six months and a six-month intervention phase, was conducted at the Raleigh Fitkin 
Memorial Hospital to assess the effectiveness of a multifaceted intervention in combatting the inappropriate 
use of antibiotics and improving the management of acute gastroenteritis and its comorbidities in children 
aged less than five years. The intervention included the establishment of an antibiotic stewardship 
programme and the implementation of clinical practice guidelines related to the diagnosis, treatment and 
management of acute gastroenteritis and its associated comorbidities. Two hundred and thirteen patients 
participated in the study, with 87 patients in the pre-intervention phase and 126 in the intervention phase. 
Knowledge, attitude and practices of healthcare professionals were investigated by conducting a survey 
before and after the intervention phase. An improvement in the appropriateness of antibiotics use was 
observed in the intervention phase. A decrease in duration of hospitalisation, cost of antibiotics and mortality 
was observed. During the intervention phase, deaths were observed where severe acute malnutrition was 
present as comorbidity to acute gastroenteritis, whereas various causes of death were observed during the 
pre-intervention phase. Most recommendations by the antibiotic stewardship programme team were 
adopted during the intervention phase. An improvement in knowledge, attitude and practices on antibiotic 
use and resistance was observed after the intervention phase. The study demonstrates that an antibiotic 
stewardship programme can improve the appropriate use of antibiotics in children, with limited adverse 
effects. Clinical practice guidelines play a vital role in providing guidance to prescribers and harmonising 
therapies. Antibiotic stewardship programmes can improve healthcare professionals’ knowledge, attitude 
and practices on the appropriate use of antibiotics, and a decrease in antibiotic resistance. 
Keywords: Antibiotics; acute gastroenteritis; children; Raleigh Fitkin Memorial Hospital; antibiotic 
stewardship programme; ESwatini 
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OPSOMMING 
Pasiënte by die Raleigh Fitkin Memorial-hospitaal in ESwatini, veral kinders wat gediagnoseer is met akute 
gastroenteritis, ontvang meestal antibiotika as voorskrif. Vroeër ingesamelde data dui daarop dat die 
onvanpaste gebruik van antibiotika lei tot groter antibiotiese weerstandigheid, langer hospitaalverblyf en 
verhoogde medikasiekoste. Antibiotiese bestuursprogramme en kliniese riglyne kan die onvanpaste gebruik 
van antibiotika verminder en die kliniese uitkomste van pasiënte verbeter. Ten spyte van toenemende 
teoretiese bewustheid van die voordele van antibiotiese bestuursprogramme, is geen sodanige program nog 
in ESwatini ingestel nie, en min omvattende studies het nog die effek daarvan in pediatriese omgewings 
wêreldwyd ondersoek. Die kennis, ingesteldheid en praktyke oor die gebruik van antibiotika en antibiotiese 
weerstandigheid is nog nie by die Raleigh Fitkin Memorial-hospitaal bepaal nie. ’n Agtien-maandelange 
enkelsentrum-prosesverbeteringstudie, bestaande uit ’n pre-intervensie-fase van ses maande, ’n 
voorbereidende periode van ses maande en ’n intervensie-fase van ses maande, is by die Raleigh Fitkin 
Memorial-hospitaal uitgevoer om die effektiwiteit van ’n multi-faset-intervensie vir die teenkamping van 
onvanpaste antibiotikagebruik en die verbetering van die bestuur van akute gastroënteritis en sy 
medemorbiditeite in kinders van jonger as vyf jaar, te evalueer. Die intervensie het die vestiging van ’n 
antibiotiese bestuursprogram en die implementering van kliniese riglyne vir die diagnose, behandeling en 
bestuur van akute gastroenteritis en sy geassosieerde medemorbiditeite ingesluit. ’n Totaal van 213 pasiënte 
is by die studie ingesluit, met 87 pasiënte in die pre-intervensie-fase 126 in die intervensie-fase. Die kennis, 
ingesteldheid en praktyke van professionele gesondheidsorgwerkers is ondersoek deur ’n opname voor en 
na die intervensie-fase uit te voer. ’n Verbetering in die gepastheid van antibiotikagebruik is waargeneem 
gedurende die intervensie-fase. ’n Afname in hospitaalverblyf, koste van antibiotika en sterftes is 
waargeneem. Gedurende die intervensie-fase is sterftes, was ernstige akute wanvoeding as medemorbiditeit 
van akute gastroenteritis teenwoordig was, terwyl verskillende oorsake vir sterftes gedurende die pre-
intervensie-fase waargeneem is. Die meeste aanbevelings wat deur die antibiotiese bestuursprogram-span 
gemaak is, is aanvaar gedurende die intervensie-fase. ’n Verbetering in die kennis, ingesteldheid en praktyke 
oor die gebruik van antibiotika en antibiotiese weerstandigheid is waargeneem na die intervensie-fase. Die 
studie het gedemonstreer dat ’n antibiotiese bestuursprogram die gepastheid van antibiotika-gebruik in 
kinders kan verbeter, met beperkte klinies nadelige uitkomste. Kliniese riglyne speel ’n onontbeerlike rol om 
leiding aan voorskrywers te verskaf en om behandeling te harmoniseer. Antibiotiese bestuursprogramme 
kan professionele gesondheidswerkers se kennis, ingesteldheid en praktyke oor gepaste antibiotikagebruik 
verbeter en ’n afname in antibiotiese weerstandigheid tot gevolg hê. 
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DEFINITIONS 
Antibiotic: Any class of organic molecule that inhibits or kills microbes by specific interactions with bacterial 
targets, without any consideration of the source of the particular compound or class (Davies & Davies, 2010) 
Antibiotic resistance: The ability of bacteria to grow in the presence of a substance (antibiotic) that would 
normally kill it or limit its growth (NIH, 2013). 
Antibiotic stewardship programme: Coordinated interventions designed to improve and measure the 
appropriate use of [antibiotic] agents by promoting selecting the optimal [antibiotic] drug regimen including 
dosing, duration of therapy and route of administration (Fisherman, 2012) 
Antibiotic stewardship committee: A multidisciplinary team that co-ordinates antimicrobial Stewardship 
Programmes (ASP). The committee mainly comprises specialised doctors, general practitioners, nurses, 
pharmacists and laboratory technologists (IDSA, 2007). 
Diarrhoea: A passage of three or more loose or liquid stools per day, or more frequently than is normal for 
the individual. It is usually a symptom of gastrointestinal infection, which can be caused by a variety of 
bacterial, viral and parasitic organisms (WHO, 2013). 
Susceptible (s): A bacterial strain ensues to be susceptible to a provided antibiotic when it is inhibited in vitro 
by a concentration of this drug associated with an elevated likelihood of therapeutic success (Rodloff et al., 
2008). 
Intermediate (i): The sensitivity of a bacterial strain to a provided antibiotic ensues to be intermediate when 
it is inhibited in vitro by a concentration of this drug associated with an uncertain therapeutic effect (Rodloff 
et al., 2018). 
Resistant (r): A bacterial strain ensues to be resistant to a provided antibiotic when it is inhibited in vitro by 
a concentration of this drug associated with an elevated likelihood of therapeutic failure (Rodloff et al., 2008). 
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CHAPTER 1: INTRODUCTION 
1.1  Problem statement 
A study conducted by Matsebula-Myeni (2014) on the management and treatment of acute gastroenteritis 
(AGE) in children younger than five years, at the RFM Hospital, a tertiary hospital in Swaziland, indicated 
underutilisation of the ORS (Oral Rehydration Salts) therapy in managing dehydration, lack of bolus treatment 
with the correct fluids in severely dehydrated patients, overuse of intravenous therapy in dehydration 
management, inappropriate and overuse of antibiotics. Ninety-eight per cent of patients admitted, received 
at least one antibiotic throughout their admission stay, which was an average of seven days. 
The most frequently used antibiotics were Ceftriaxone injections, Gentamycin injections, Metronidazole 
injections and Cefaclor suspensions (Matsebula-Myeni, 2014). This study concluded that there was an 
elevated and inappropriate use of antibiotics on AGE diagnosed children at the RFM Hospital and that the 
prescribers did not adhere to the ‘Treating Diarrhea’, a manual for physicians and other senior health workers 
(WHO, 2005) and the WHO recommendations on the ‘Managing diarrhoea and pneumonia in HIV infected 
infants and children’ (WHO, 2010). Benyera (2013) also revealed the overuse and inappropriate use of 
antibiotics in a study conducted in a referral hospital, Mbabane Government Hospital (MGH) in ESwatini, 
where an outpatient prescription survey revealed overusing antibiotics especially in Upper Respiratory Tract 
Infections (URTIs). 
Even though, Systems for Improved Access to Pharmaceuticals and Services (SIAPS) programme in 2015, 
indicated a reduction in the percentage of prescriptions including at least one antibiotic from 59% to 52%, 
this rate remains higher than the WHO recommendation of 20-26% (SIAPS, February 2015). The results after 
implementing the STG, indicated a trend towards prescribing a higher number of antimicrobials for children 
and teenagers; prescriptions and the misuse of antibiotics was indicated. SIAPS emphasises that there was 
no intervention in-place to conflict the inappropriate use of antibiotics (SIAPS, February 2015). A small-scale 
Quality Improvement Project (QIP) conducted by the RFM Drugs and Therapeutics committee (DTC) indicated 
an elevated antibiotics resistance pattern (100% resistance to cotrimoxazole, 50% resistance to Ceftriaxone 
and 50% intermediate of Ceftriaxone) (Denhere et al., 2015). 
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The limitation of QIP, is that the specific bacteria that were resistant to the antibiotics were not analysed, 
attributable to a lack of resources. It is possible that the resistance pattern observed could be caused by 
overusing these two antibiotics in the country. 
The ample use of Ceftriaxone was discussed in various meetings at the RFM DTC’s (Mavundla et al., 2014; 
Mavundla et al., 2015). Most prescribers alluded that Ceftriaxone is a safe, effective and an easily 
administered drug. The half-life of the antibiotic compared to the 1st and 2nd generation Cephalosporins 
enables nurses to administer it twice a day, which is convenient. The paediatrician also mentioned that the 
extensive use of Ceftriaxone was compelled because there was a time where it was the only available 
antibiotic from central medical stores (CMS). The prescribers had to use it for minor infections (Mavundla et 
al., 2014). 
Even though the Ministry of Health developed STGs, these guidelines were primarily intended for primary 
healthcare circumstance where there are no doctors available to issue prescriptions and nurses must fulfil 
the function of prescribers. The national STGs do not address acute gastroenteritis or dehydration in children 
intensively. The RFM Hospital does not have institutional clinical practice guidelines in-place that clearly 
address managing and treating AGE in children. This lack of clinical guidelines resulted in prescribing 
inconsistencies between the prescribers at the RFM Hospital, with prescribers tending to use their personal 
experience in treating AGE (Mavundla et al., 2015). Principi & Esposito (2016), Berild et al. (2001) and Chandy 
et al. (2014) agree that clinical guidelines assist prescribers with appropriate decisions, improving consistency 
in prescribed medicines. 
The RFM Hospital statistics data unit revealed that acute gastroenteritis (AGE), followed by SAM and 
pneumonia are the leading causes of death in children admitted at RFM Hospital (Dlamini, 2015). These 
statistics agree with the findings of various authors, considering AGE as a main cause of child mortality in the 
Sub-Saharan region (Hung, 2006; Ester et al., 2011; Mengistie, Berhane & Worku, 2013; Brhanu, Negese & 
Gebrehiwot, 2017). 
Although WHO guidelines (WHO, 2010) clearly guide prescribers to treat HIV positive children equal to HIV-
negative children, prescribing trends at the RFM Hospital indicate that prescribers have an intense sense that 
HIV positive and HIV exposed children need to be protected with antibiotics. A study conducted by Eijk et al. 
(2009) in which the frequency and aetiology of diarrhoea in children aged less than two years in Kenya were 
compared, confirmed that there was no need to provide HIV positive children with antibiotics. 
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 Most children admitted to the RFM Hospital with AGE as a primary diagnosis are also diagnosed with 
comorbidities (Matsebula-Myeni, 2014), which could render treating diarrhoea more complex. At the RFM 
Hospital the most frequently observed comorbidities of AGE, are malnutrition and pneumonia (Matsebula-
Myeni, 2014; Dlamini, 2016). As there are currently no institutional practice guidelines for infectious diseases 
at the RFM Hospital, the frequent co-infection of AGE patients with pneumonia might lead to variable patient 
management amongst doctors and might also introduce inappropriate prescribing. This also applies to SAM. 
A national guideline on the integrated managing acute malnutrition (IMAM) was launched, printed and 
distributed by the Swaziland National Nutrition Council (SNNC) in 2013 (Vilakati et al., 2013), but deaths of 
AGE with SAM as a comorbidity are still observed (Matsebula-Myeni, 2014). 
Although this guideline is extensively available, the death rates for malnutrition in the RFM Hospital 
documented by its statistics unit (Dlamini, 2016), suggest that the guideline is not fully utilised. Similarly, 
Benyera (2013) established, at the MGH, a referral hospital in ESwatini, case fatality rates for childhood 
malnutrition remained extreme despite implementing the IMAM guideline (Vilakati et al., 2013) at the 
hospital. From the 227 children who met the study inclusion criteria, 111 children passed away during 
admission, provided a case fatality rate of 40.1% (Benyera, 2013). 
A further possible contributing factor to the inappropriate use of antibiotics is that the RFM Hospital lacks 
basic infrastructure and diagnostics tests. The hospital does not have an antibiogram; prescribers use their 
experience in selecting an empiric treatment for infectious diseases. The hospital lacks the availability of an 
infectious disease specialist and a pharmacist with an expertise in infectious diseases. Collectively these 
challenges compromised managing infection control, antibiotics use and containment of antimicrobial 
resistance in the hospital. Using antibiotics and the surveillance of antibiotic resistance in hospitals in 
ESwatini were deficiently quantified and no formal strategies were facilitated to optimise using antibiotics. 
Limited national capacity in ESwatini exists to identify and respond to urgent and emerging antibiotic 
resistance threats. Currently no systemic surveillance of antibiotic resistance threats exists in any of the 
country’s hospitals, neither at clinics nor at tertiary level. 
The lack of basic infrastructure and diagnostic tests in low and middle-income countries (LMICs) were noted 
as indicators of misdiagnosis and late diagnosis of infectious diseases (Cox et al., 2017; Peeling and Mabey, 
2010; Engel et al., 2016, Sharma et al., 2015). ESwatini has no accredited laboratory in the public sector that 
met the ISO 15189 standards that hampers the reliability of the cultures by the RFM Hospital. From personal 
observation during a meeting on appropriate use of antibiotics it appeared as if prescribers, nurses, 
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pharmacists and laboratory technologists worked in silos, with no formal and structured collaboration 
amongst the healthcare workers. 
A contributing factor to the inappropriate use of antibiotics in the RFM Hospital could also be the lack of 
formal post-prescriptions audits. According to the study, no assessment was conducted to address the 
inappropriate use of antibiotics and antimicrobial resistance at RFM Hospital. Post-prescriptions audits 
proved to increase the appropriate use of antibiotics, reduce antibiotics’ use and decrease restricted 
antibiotics (Boyles et al., 2013; Brink et al., 2016). 
There is a proven link between excessive antibiotic use and increased resistance (Ho et al., 2006; Smith & 
Coast, 2002; Ventola, 2015; Prigitano et al., 2018). In response to this crisis, the 2015 World Health Assembly 
(WHA) adopted a global action plan on antibiotic resistance containment (WHA, 2015a). The global action 
plan had five objectives; two were to: 
 Strengthen knowledge and evidence-based medicine through surveillance and research. 
 Optimise using antibiotics in humans and animals (antimicrobial stewardship). 
ESwatini does not have an official antimicrobial resistance containment strategy (ARCS); a committee is 
working on a draft National Action Plan. 
It is with no doubt that if ESwatini does not improvise strategies to combat inappropriate use of antibiotics 
and contain antimicrobial resistance; the country may enter the pre-antibiotic era. The inappropriate use of 
antibiotics costs lives of several children and renders treatment of serious infections difficult, attributable to 
resistance. Overuse of antibiotics, especially intravenous antibiotics, unnecessarily increases the medicines 
and medical supplies budget. 
1.2  Rationale of the study 
RFM is a tertiary hospital with an elevated patient volume. There were no interventions constructed to 
inverse the inappropriate use of antibiotics in depth. Development of an ASP, specifically in paediatrics, is 
therefore proposed to improve using antibiotics. Antibiotic stewardship (ASP) is a multidimensional, 
multidisciplinary team approach to optimise antibiotic prescribing (Boyles et al., 2013) and ASPs were 
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indicated to hold several benefits (Pate et al., 2012; Cairns et al., 2013; Berild et al., 2001; Cisneros et al., 
2013) 
Pate et al. (2012), facilitated an ASP at an urban hospital using a weekly post-prescriptive chart audit with 
intervention and feedback and for the fifteen first months; it demonstrated 80% acceptance of 
recommendations, a 21% reduction in use and a 28% reduction in cost per patient-day. An ASP interventional 
study by Cairns et al. (2013) yielded a 17% reduction in broad-spectrum antimicrobial use in the Intensive 
Care Unit (ICU) and a 10% reduction in broad-spectrum. Cairns et al. (2013) used the post-prescription audit, 
similar to the approach employed by Pate et al. (2012). 
Berild et al. (2001) developed and facilitated clinical guidelines for antibiotic treatment and prophylaxis at 
Aker university Hospital. For over two years, there was a reduction of 11% in using antibiotics with a 23% 
reduction for broad-spectrum antibiotics. In agreement with the impact of guidelines observed by Berild et 
al. (2001), Chandy et al. (2014), a decline in using antibiotics as soon as a booklet of guideline implementation 
on antibiotics use was disseminated, used in a tertiary hospital in South India. 
Cisneros et al. (2013) performed an educationally supported ASP, yielding a decrease of 26.4% of 
inappropriate antibiotics prescriptions and reflected a reduction in antimicrobial expenditure of 42%. 
Beardsley et al. (2012) demonstrated the monetary impact of ASPs over 11 years in the United States. It 
resulted in an average saving of $920,070 to $2,064,441 in antibiotic use outside the ICU setting, depending 
on the method of inflation adjustment. 
An improvement in using antibiotics was reported in LMICs, despite the inadequacy of resources (Boyles et 
al., 2016; Brink et al., 2013; Cox et al., 2013; Ho et al., 2006; Mendelson, 2016). The authors documented 
similar successes, alike European countries (Brink et al., 2013, Boyles et al., 2016). Boyles et al. (2013) indicate 
that patient safety was not compromised by implementing an ASP in the clinical setting. 
Brink et al. (2013), facilitated a pharmacist-compelled, prospective audit and feedback strategy for ASP based 
on a range of improvement science and behavioural principles amongst a diverse group of urban and rural 
private hospitals in South Africa. The ASP led to a reduction in mean antibiotic deﬁned daily doses per 100 
patient-days from 101·38 (95% CI 93·05-109·72) in the pre-implementation phase to 83·04 (74·87-91·22); in 
the post-implementation phase (p<0·0001) (Brink et al., 2013). 
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Boyles et al. (2016) facilitated an antibiotic prescription chart and weekly antibiotic stewardship ward rounds 
at two medical wards of an academic teaching hospital in South Africa. The patient database was analysed 
to determine inpatient mortality and 30-day readmission rates and laboratory records to determine usage of 
infection related tests. During the intervention there was a 19.6% decrease in antibiotic use with an antibiotic 
cost reduction of 35%. There was no difference in inpatient mortality or 30-day readmission rates during the 
control and intervention periods (Boyles et al., 2016). 
Based on these data and experiences, the need for a multifaceted intervention to manage and treat AGE in 
children at the RFM Hospital, was identified. The intervention should include proper diarrhoea and 
dehydration guidelines, antimicrobial prescribing guidelines and policies, restricting antibiotic use. To 
effectively overcome the inappropriate managing AGE and overusing antibiotics, close collaboration between 
doctors, pharmacists, nurses and laboratory staff was needed. The important function of a pharmacist in 
containing antimicrobial resistance, was supported in various studies performed in the United Kingdom (UK) 
(Waller & Jamieson, 2004, Knox et al., 2002). Developing an ASP, led by a pharmacist, was proposed. The 
target population for this project were children aged less than five years, diagnosed with AGE as a primary 
diagnosis, where the inappropriate and overuse of antibiotics were documented at the RFM Hospital in an 
earlier study (Matsebula-Myeni, 2014). 
Little is documented about knowledge, attitude and practice of healthcare professionals related to antibiotic 
use and resistance in ESwatini, including the RFM Hospital. It is therefore difficult to assess which type of 
behavioural intervention would best contribute to achieve the goal of appropriate use of antibiotics in the 
hospital. 
Drawing strengths from the above literature, the research had confidence, introducing an ASP to be led by a 
pharmacist in a low resource tertiary. This research provided a baseline for implementing ASPs in ESwatini. 
On a broader scale, it can also serve as example for improving antibiotic use and containment of antimicrobial 
resistance in developing countries with limited resources. 
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1.3  Objectives and specific aims 
1.3.1 Primary objective of the study 
To establish an ASP at the RFM Hospital and to determine its effectiveness in combatting the inappropriate 
use of antibiotics and managing AGE and its comorbidities, targeting children less than five years old. 
1.3.2 Specific aims 
 Specific Aim 1 
To reduce the overall and restricted antibiotic use, the proportion of inappropriate antibiotics used and to 
assess compliance with the (ASP) and patient outcomes. 
 Specific Aim 2 
To identify the bacterial cause of acute gastroenteritis, and the antibiotic sensitivity and resistance pattern 
of the bacterial isolates. 
 Specific Aim 3 
To develop and facilitate guidelines for managing SAM, antibiotic prescribing and the hydration protocol in 
children less than five years who present with acute gastroenteritis as a primary diagnosis. 
1.3.3 Outcome measures of the primary objective 
 Antibiotic utilisation: Decreased total and restricted antibiotic use per patient and decreased 
inappropriate antibiotics used. 
 Process outcomes: High numbers of antibiotic stewardship recommendations adopted. 
 Microbiological outcomes: Increased number of cultured bacteria and increased number of antibiotic 
sensitivity tests. 
 Clinical outcomes: Reduced number of deaths and decreased hospitalisation days. 
 Cost outcomes: Decreased cost of antibiotics. 
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 Adherence to clinical practice guidelines: Improved managing acute gastroenteritis and its comorbidities. 
1.3.4 Secondary objective 
To investigate the KAP of health care professionals related to antibiotic use and antibiotic resistance, to 
increase awareness and facilitate developing educational programmes and strategies for the appropriate use 
of antibiotics. 
1.3.4.1 Outcome measures of the secondary objective 
 Exploration: To investigate attitude and practices amongst health care professionals at RFM Hospital in 
prescribing and dispensing antibiotics. 
 Test a hypothesis: To test if the interventional programmes to be put in-place, will have a positive effect 
in the KAP of healthcare professionals, by assessing antibiotic related issues amongst healthcare workers 
at RFM Hospital. 
 Establish a baseline: To measure changes on antibiotics related knowledge and attitudes and to identify 
barriers to appropriate use of antibiotics. 
1.4  Conceptual framework 
The conceptual frameworks address challenges identified in the management and treatment of AGE in 
children less than five years at the RFM Hospital. The research was interested in addressing the challenges, 
causing inappropriate management of antibiotics at RFM Hospital. The research interest was also to 
construct interventions using the antimicrobial stewardship approach to address challenges faced by the 
hospital. The conceptual framework (Figure 1.1) addresses the challenge, the causes of challenges, the 
proposed intervention and the expected outcomes once the interventions are constructed. 
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Figure 1.1: Conceptual Framework, indicating management and treatment of acute gastroenteritis 
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CHAPTER 2: LITERATURE REVIEW 
2.1  Definitions and diarrhoea types 
Diarrhoea was a major public health problem in LMICs (Hung, 2006). It is amongst the leading causes of 
childhood morbidity and mortality in LMICs (Hung, 2006) and it is considered the second leading cause of 
death in children less than five years, especially in developing countries (Mengistie et al., 2012). The startling 
situation is generated by delays in treatment initiation and inadequate hydration, resulting in high morbidity 
(Banerjee, Hazra & Bandyopadhyay, 2003). 
The World Health Organisation (WHO) defines diarrhoea as the passage of three or more loose or liquid 
stools per day (or more frequent passage than is normal for the individual), (WHO, 2017), whereas they do 
not consider frequent passing of formed stools as diarrhoea. Several authors used a similar definition of 
diarrhoea (Gracey, 1995; Hung, 2006; ESwatini, 2012; Nasser, 2014; Nasser, 2015; Armon et al., 2001). Naseer 
(2014), defined it as an intestinal disorder characterised by abnormal fluidity and frequency of faecal 
evacuations, generally the result of increased motility in the colon. 
The MOH, STG, for ESwatini defines diarrhoea as a condition characterised by loose or watery stools, three 
or more times in a day (ESwatini, 2012). The STG describes acute diarrhoea in the paediatric section as a 
watery, frequently stool occurring over three times a day, with no blood and lasting not more than 14 days. 
Acute diarrhoea usually is defined by an onset within 24 hours (Gracey, 1995). Hung (2006) describes 
diarrhoea in children as an excessive daily stool volume, more than the upper limit of around 10 g/kg/day 
(Hung 2006). Hung (2006) mentions that by this definition, it is possible to have diarrhoea with stools, at least 
partially formed. Diarrhoea results from an imbalance in the absorption and secretion properties of the 
intestinal tract; if absorption decreases or secretion increases beyond normal, diarrhoea results (Hung, 2006). 
Gracey (1996) addresses the difficulty usually experienced by nursing mothers in their ability to define a 
“normal stool” in a healthy infant. It often depends on perceptions of ”normal”. Variations in infant stool 
patterns with some normal neonates passing up to six stools and some infants passing up to four stools daily, 
were observed (Gracey, 1995). Considering the history before diagnosing diarrhoea is important as breastfed 
infants pass more stools than other infants. 
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Diarrhoea may be classified into four conventional types, based on the mechanism, including osmotic 
diarrhoea, secretory diarrhoea, exudative diarrhoea and motility disorder diarrhoea (Hung 2006). Three 
clinical types of diarrhoeal disease were established, according to (WHO, 2017): Acute watery diarrhoea, 
acute bloody diarrhoea and persistent diarrhoea. 
 Acute watery diarrhoea, which lasts several hours or days, may also include cholera. This term refers to 
diarrhoea characterised by abrupt onset of frequent, watery, loose stools without blood, lasting less than 
two weeks (Hung, 2006). It may be accompanied by flatulence, malaise, abdominal pain, nausea, 
vomiting and fever may be present. 
 Acute bloody diarrhoea, also called dysentery, is defined as diarrhoea containing blood and mucus in 
faeces. Accompanying symptoms includes abdominal cramps, fever and rectal pain. The most compelling 
cause of bloody diarrhoea is Shigella (Hung, 2006). In developing countries, the main causative agents of 
dysentery are S. flexneri, S. boydii and S. dysenteriae. 
 Persistent diarrhoea (14 days or longer) is defined as diarrhoeal episodes of assumed infectious aetiology 
with a long duration and last at least 14 days (Hung, 2006). About 10% of diarrhoea cases in children from 
developing countries become persistent, especially amongst those less than three years and more so 
amongst infants. The episode may begin acutely, either as watery diarrhoea or dysentery. This diarrhoea 
causes substantial weight loss in most patients (Hung, 2006). It may be responsible for about one-third 
to half of all diarrhoea-related deaths (Hung, 2006). Since persistent diarrhoea is a major cause of 
malnutrition in the developing countries, even the milder, non-fatal episodes contribute to the high 
mortality rates, frequently associated with malnutrition in these countries (Hung, 2006). 
There are no published data on the relative probabilities of possible diagnoses in the child presenting to 
hospital with diarrhoea (Armon et al., 2001). In the article Armon et al. (2001) emphasise that it was essential 
that the prescribers recognise any life-threatening causes of diarrhoea, such as intussusception and 
haemolytic uraemic syndrome (HUS). It is recommended that prescribers should observe causes of diarrhoea 
other than acute viral gastroenteritis for a child’s diarrhoea with or without vomiting, which includes 
abdominal pain with tenderness, with or without guarding, pallor, jaundice, oligo/anuria, bloody diarrhoea, 
the patient being systemically unwell and a form proportional to the level of dehydration (Armon et al., 
2001). 
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2.2  The main causative agents of diarrhoea 
Diarrhoea is considered as the most important public health challenge connected to deficient quality of water 
and sanitation (Hung, 2006). The same sentiments were shared by the MOH and STGs that the main causative 
of AGE is deficient hygiene (ESwatini, 2012). 
Bacterial infections: In tropical and developing countries, diarrhoea is mostly caused by enteric bacterial 
infections (Gracey, 1995). It is a serious challenge amongst all ages from infancy to adults. The range of 
causative bacteria is significant and includes E. coli, Salmonella, Shigella, Campylobacter, Yersinia, vibrio’s 
and Clostridium difficile (Hung, 2006; Gracey, 1995). Most of the episodes of diarrhoeal diseases that occur 
in children under five years of age, are attributable to pathogens that can be transmitted through food; 
pathogenic strains of E. coli are major proportions of the organisms involved (Gracey, 1995). 
 Viral infections: Viral infections is considered as the main cause of acute diarrhoea. Rotavirus is one of the 
most common causes of severe diarrhoea (Hung, 2006). Data retrieved from 34 studies on the aetiology of 
childhood gastroenteritis revealed rotavirus as the main detected causative of diarrhoea (71% of children; 
median = 33%) (Gracey 1995).There are other viruses that may be important causes of diarrhoeal disease in 
humans, including Norwalk virus, Norwalk-like viruses, enteric adenoviruses, caliciviruses and astroviruses 
(Hung, 2006). 
Parasites: Parasites are considered as the leading cause of diarrhoea in developing countries with deficient 
hygiene and sanitation (Gracey, 1995; Hung, 2006). Parasites can enter the body through food or water and 
settle in the digestive system. Parasites due to diarrhoea, include Giardia lamblia, Entamoeba histolytica, 
Cyclospora cayetanensis and Cryptosporidium (Hung, 2006). 
Food intolerance: Some individuals cannot digest certain components of food, such as lactose, the sugar 
established in milk, or gluten in wheat and barley (Hung, 2006). 
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2.3  Risk factors for diarrhoea 
Children residing in rural areas were established to be more likely to be suffering from diarrhoea compared 
to those in the urban areas (Brhanu et al., 2017). Studies indicated that the prevalence of diarrhoea is higher 
in younger children (Hung, 2006; Oloruntoba et al., 2014; Kabayiza, 2014) and females experience more 
episodes of diarrhoea than males (Banerjee, Hazra & Bandyopadhyay, 2004). The prevalence is highest for 
children six to eleven months of age, remains at a high-level amongst one-year old children and decreases in 
the third and fourth years of life (Brhanu et al., 2017). The statistics regarding the age-related prevalence of 
diarrhoea is in agreement with several studies (Brhanu et al., 2017; Hung 2006; Banerjee, Hazra & 
Bandyopadhyay, 2004 and Kabayiza, 2014). Boys have a higher rate of diarrhoea compared to girls (Muhsen 
et al., 2017; Staat et al., 1991; Siziya, Muula & Rudatsikira, 2013). Contrary to what other studies revealed 
about males being the most affected by diarrhoea (Banerjee, Hazra & Bandyopadhyay, 2014 and Thiam et 
al., 2017) in Senegal it is revealed that “female children suffered more than males in all the three areas, but 
none were established to be statistically significant”. 
A study by (Maphalala et al., 2017) in two sentimental hospitals (RFM Hospital and MGH) revealed 50.5% 
males and 49.5% females below the age of five years were admitted for managing acute gastroenteritis (AGE) 
(Maphalala et al., 2017). Other important demographic factors, such as mothers’ age, level of mother's 
education, number of siblings, birth order, are significantly associated with a higher occurrence of diarrhoea 
in children less than five (Hung, 2006). Brhanu et al. (2017) agreed with Hung (2006) that children of mothers 
with a low level of education experience more episodes of diarrhoea, compared to children born from 
mothers with a higher level of education. Brhanu et al. (2017) also emphasised that maternal child care is 
important, contributing to diarrhoeal disease morbidity. This might be explained because maternal morbidity 
is considered as a sign of disease exposure in a family as mothers are the food handlers of the family and 
they are usually the main child care providers (Brhanu et al., 2017). 
Most children compared to adults, die annually from diseases directly linked to a lack of basic hygiene 
(UNICEF, 2007). Action relating to sanitation, hygiene and water supply indicated that it is possible to reduce 
the frequency, severity and economic impact of disease (WASH, 2007). Sanitation obviously partakes a crucial 
function in reducing diarrhoea morbidity (Oloruntoba et al., 2014). Some sanitation factors, like improper 
disposal of children's stool, non-existence of toilettes or unhygienic toilettes and sharing such, increased the 
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risk for diarrhoea in children (Oloruntoba et al., 2014; Brhanu et al., 2017). Some studies revealed that 
children not washing hand before meals or after defecation, mothers not washing hands before feeding 
children or preparing foods, dirty feeding bottles and utensils and unhygienic domestic places (kitchen, living 
room, yard), were associated with the risk of diarrhoea morbidity in children (Hung, 2006). 
Water-related factors are important determinants of the occurrence of diarrhoea, as diarrhoea is acquired 
through contaminated water and foods (Hung, 2006). This view agrees with Brhanu et al., 2017; Oloruntoba 
et al., 2014). Brhanu et al. (2017), in a study conducted in Ethiopia observed that drinking water treated at 
home was a forecaster of diarrhoeal morbidity. Factors that would contribute to the latter, were that 
contamination during collection, transportation and storage, which may in turn increase risk of diarrhoeal 
diseases. Their results contradicted a study in the same country by Anteneh & Kumie (2010) where they 
conclude that mere pit toilet utilisation did not contribute to the impact of the occurrence of childhood 
diarrhoea. 
In 2000, a team of WHO experts clearly established that breastfeeding protects babies against the risks of 
diarrhoeic infections. The influence of breastfeeding on the prevention of infant mortality existed, which led 
to a recommendation for a six-month period of breastfeeding (WHO, 2000). The literature on feeding 
practices and risk of diarrhoea is extensive (Hung, 2006; Brhanu et al., 2017); Botswana, 2012; Beck, 2007; 
Gizaw et al., 2017). Several studies indicated the strong protective effect of breastfeeding (Gizaw et al., 2017; 
Ogbo et al., 2017; Sharma et al., 2017). In general, the morbidity of diarrhoea is the lowest in exclusively 
breastfed children; it is higher in partially breastfed children and highest in fully-weaned children (Hung, 
2006; Bener, 2011; Acharyaa et al., 2017). The authors also indicated evidence that breastfed children with 
diarrhoea, should continue being breastfed throughout the rehydration and maintenance phases. The risk of 
dehydration is reduced; the children pass smaller volumes of stool and recover speedier (Armon et al., 2003). 
A particular risk of diarrhoea is associated with bottle-feeding (Gribble & Hausman, 2012). Ziyane (1996) 
alluded, infant mortality is high in ESwatini (98/1000). She quoted studies that contributed to the infant 
mortality. About 70% of infant deaths occur before the age of six months (UNICEF, 1994). In this age group, 
early infant death, is attributable to deficient feeding practices; that is introduction of breast milk substitutes 
at one to two months of age (Friedman, 1991). In ESwatini, exclusive breastfeeding for six months is as low 
as 8% (Ziyane, 1996); early supplements, comprising cereals, maize and sorghum gruel is widespread even in 
rural areas; diarrhoeal mortality is 15% amongst infants (Ziyane, 1996). 
Stellenbosch University  https://scholar.sun.ac.za
15 | P a g e  
 
 
 
Diarrhoea can be considered as a source and consequence of malnutrition (UNICEF, 2007). Diarrhoea 
prevents children from achieving their normal growth, whilst it increases the frequency and the duration of 
diarrhoeic events, creating a vicious circle (UNICEF, 2007). Malnutrition is the underlying cause for the 
increased susceptibility to infections and is indirectly responsible for several child deaths (Reddy et al., 2016). 
The association between diarrhoea and malnutrition is common in low-middle-income countries (Hung, 
2006; Brhanu et al., 2017; Ferdous et al., 2013). Ferdous et al. (2013) further alluded that the association 
between malnutrition and diarrheal mortality is bidirectional and was reported for decades as an association 
between diarrhoea and deficient growth and development of young children. Children whose immune 
systems were weakened by malnutrition, are the most vulnerable to diarrhoea (Hung, 2006; Brhanu, 2017, 
Ferdous et al., 2013). The same sentiment is shared by Gracey (1995). Specifically, persistent and chronic 
diarrhoea, undermines nutritional status, resulting in malabsorption of nutrients or the inability to use 
nutrients properly to maintain health (Hung, 2006; Ferdous et al., 2013). 
Several studies reported higher incidences of diarrhoea in malnourished children (Hung, 2006; Ferdous et al., 
2013; Gupta, 2014; Irena et al., 2011, Guerrant et al., 1992).These studies by Ferdous et al. (2013) and Gupta 
(2014), indicate a tendency of increased incidence of diarrhoea, also established in children with low weight-
for-age, in developing countries. Elliot (2007) mention that children with deficient nutrition are at an 
increased risk of complications and that developing parts of Australia have increased rates of admission for 
gastroenteritis, malnutrition, comorbidity and electrolyte disturbance (especially hypokalaemia) and a longer 
hospitalisation than the developed parts of Australia. This finding is coherent with Quiroga (2011), who 
established that malnutrition is the fundamental cause of 53% of all deaths amongst children under five, 
globally and established that the frequency of infectious disease as the basic cause of death was seven times 
higher when malnutrition coexisted as antecedent cause. Rice (2000) and Ahmend (2001) concur that 
children with severe malnutrition and diarrhoea have high mortality rates, some were previously attributed 
to faulty case-management. 
Immunodeficiency is not only a cause of persistent or chronic diarrhoea but also a risk factor for diarrhoea 
(Hung, 2006). Attributable to acquired immunodeficiency, patients are exposed to pathogens causing 
infectious diseases, including diarrhoea Pavlinac et al. (2015). Diarrhoeal incidence, duration, severity and 
mortality are higher in children with HIV/AIDS than in others (Pavlinac et al., 2015). 
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The incidence of diarrhoeal diseases varies with the seasons and a child’s age. The youngest children are 
most vulnerable with incidence been highest in the first two years of life although this declines as the child 
grow older (Oloruntoba et al., 2014). Seasonal patterns to childhood diarrhoea were noted in several tropical 
locations (Hung, 2006; Oloruntoba et al., 2016) where there are two definite seasonal peaks: summer 
(associated with bacterial infections) and winter, related to viruses. In some studies diarrhoea prevalence 
was established to be higher in the rainy season than in the dry season (Hung, 2006). 
The global and African burden of diarrhoeal disease in children 
Infectious diarrhoea remains one of the leading causes of childhood morbidity and mortality global (Gracey, 
1995; Brhanu, 2017) and cases of diarrhoea still occur in children despite government-oriented interventions 
(Oloruntoba et al., 2014). According to the WHO and United Nations Children Funds (UNICEF) there are about 
two billion cases of diarrhoeal diseases global annually (Brhanu, 2017), which increased from the estimation 
made by (Hung, 2006), where episodes of diarrhoea were estimated at one billion, with 2.5 million deaths 
occurring each year amongst children under five years of age (Hung, 2006) and the 1.5 million deaths annually 
in children under five years of age, estimated by Mengistie (2012). Diarrhoea kills over 5,000 under five 
children daily-more than AIDS, malaria and measles combined, one in nine under five child deaths are 
attributable to diarrhoea (Mengistie, 2012; Brhanu, 2017). Whilst diarrhoeal disease occurs global, 90% of 
diarrhoeal disease deaths in under five children occur in developing countries, of which about 80% of deaths, 
attributable to diarrhoea occur in the first two years of life (Hung, 2006). 
According to an Ethiopian Demographic and Health Survey (EDHS) conducted in 2011, the prevalence of 
diarrhoea amongst under five children is 13% (Brhanu 2017) and it is the leading cause of death in Nigeria 
(Oloruntoba et al., 2014). Approximately one million neonatal deaths annually are caused by infection, Waet 
al.et al (2011) claiming over 25% of global neonatal deaths and about 10% of all mortality in infants under 
the age of five years. 
Illness and death from childhood pneumonia and diarrhoea indicated a global walker et al, 2013) and a 
diarrhoea and pneumonia progress report by John Hopkins (2016) revealed that pneumonia and diarrhoea 
mortality in young children continued to be disproportionally concentrated in a few countries, year after year 
and the number of episodes were falling, but action is required global and at country level to accelerate the 
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reduction. In 2015, in ESwatini there were 230 deaths, attributable to diarrhoea, which contributed to 10% 
of the mortality for children under five years in ESwatini (Times of ESwatini, 2014:p3). 
Diarrhoeal disease remains a primary cause of death and ill health of children in Sub-Saharan Africa, a region 
where economic, geographic, political, personal and sociocultural factors cooperate to create ongoing 
challenges to its prevention and control (Hamer et al. 1998). Despite the measures that were put in-place in 
ESwatini a progress report by UNICEF (2017) revealed that diarrhoea contributes 10-15% to childhood deaths. 
There was an expectation that diarrhoeal diseases would decrease by 25% over a year in Sub-Saharan African 
(Hamer et al. 1998) but the change has not been seen. The same sentiment was still shared by recent study 
with indicated that the introduction of vaccination e.g. rotavirus has not changed the global burden of 
diarrhoea, Mokomane et al. (2018). 
According to the hospital statistical unit, diarrhoeal diseases remain the leading cause of hospitalisation of 
children less than five years old (RFM, 2016). In 2014 a rotavirus immunisation campaign was performed for 
all children under two years in ESwatini to decrease the incidence of diarrhoea, attributable to rotavirus but 
a significant difference has not been observed yet. In ESwatini, the prevalence of rotavirus was not known 
until a study was performed between January 2013 - December 2014. All the children that were hospitalised 
had stool samples collected and 302 (91%) were tested for rotavirus and 159 (52.6%) were positive for 
rotavirus (Maphalala et al., 2017). 
2.4 Prevention and control of diarrhoea 
The WHO, Control of Diarrheal Diseases (CDC) programme and other organisations, including UNICEF and 
USAID (United States Agency for Global Development) provided priority to the prevention of diarrhoeal 
deaths, rather than prevention of cases and focussed on promotion of oral rehydration therapy (ORT) (Hung, 
2006). Morbidity and mortality in diarrhoea is mainly attributable to severe dehydration (Banerjee, Hazra & 
Bandyopadhyay, 2004). The latter author discussed the importance of ORT in prevention and managing 
severe diarrhoea. He alluded, initiation of this therapy is crucial for its efficacy. The same managing diarrhoea 
was emphasised by Mengistie (2012) when he mentioned that ORT is a primary intervention for managing 
diarrhoea and it has an advantage of easy administration and being simple and affordable. 
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 A long-term, sustainable solution to childhood diarrhoeal disease must combine treatment with actions to 
eliminate diarrhoeal disease through prevention (Hung, 2006). A consensus developed that the crucial factors 
for the prevention of diarrhoea are sanitation, personal hygiene, availability of decent quality drinking water 
(Hung, 2006). Developing countries documented promoting breastfeeding, ORT and specific health education 
as part of national strategies, aiming to improve the quality of life and reduce the burdens caused by 
diarrhoea (Hung, 2006; Sharma et al., 2017; Bener et al., 2011). 
2.5 Treatment of diarrhoea 
Several variations in managing acute diarrhoea especially in children were observed in various countries. 
Armon et al. (2001) developed an evidence and consensus-based guideline for managing children, admitted 
to hospital with diarrhoea. The aims of the guideline were to (1) to improve the process and outcome of care 
for children attending hospital with diarrhoea; (2) to promote consistency of care, allowing patients with 
almost identical clinical challenges to be managed in the same way; and (3) to inform, educate and improve 
the clinical decision-making of the junior clinicians, consulting with most of these children initially. 
The goal of treating diarrhoea is to maintain hydration, treat the underlying causes and relieve the symptoms 
of diarrhoea (Hung, 2006). According to Armon et al. (2003), managing gastroenteritis, comprises correction 
of dehydration and maintenance of hydration; it is important to accurately estimate the level of dehydration. 
Rehydration and the correction of any electrolyte imbalance are critical in treating diarrhoea. Armon et al. 
(2001) mentioned researchers (Duggan et al., 1996; Mackenzie et al., 1989) who agreed about the proper 
diagnosis of dehydration, based on “prolonged skinfold”, “dry oral mucosa”, “sunken eyes” and “altered 
neurological status” These symptoms represented the most appropriate clinical signs correlating with 
dehydration as determined by post-rehydration weight gain. The authors also mentioned the important 
laboratory diagnostics of a urea of >6.5 mmol/l in a serum blood sample and pH<7.35 on blood gas as positive 
investigations associated with dehydration. The sensitivity and speciﬁcity of all these signs were low (Armon 
et al., 2001). Symptomatic relief is a second therapeutic goal (Hung, 2006). 
ORT was introduced in the past decades and rapidly became the gold standard of the CDD programme (Hung, 
2006; Mengistie et al., 2012). This therapy is achievable, efficient and safe in hospital treatment and at the 
primary care level in developing countries, preventing metabolic complications of diarrhoea and dehydration, 
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whilst reducing hospitalisation (Gracey, 1995). Proper utilisation of ORS can save the cost of requesting serum 
electrolytes from the laboratory, as ORS with the appropriate amounts of solutes and provided in the correct 
quantity is sufficient to correct electrolyte abnormalities (Armon et al., 2001). Armon et al. (2001) further 
mention that there was no direct evidence indicating when serum electrolytes should be measured in a child 
with diarrhoea, especially when the rehydration would be treated with ORS. They quoted a study of cohorts 
of children in the UK with gastroenteritis, indicating that derangement of electrolytes was rare with 1% of 
admissions suffering from hypernatraemia; there were no reports of hypokalaemia or hyponatraemia. 
Urea and electrolytes (U&E) should be measured in children receiving intravenous rehydration therapy, as 
hypernatraemia will alter with the rate at which intravenous rehydration ﬂuids are provided; further 
measurements of U&E should be made as rehydration progresses (Armon et al., 2001). There should also be 
a consideration for dehydrated children whose history or physical ﬁndings are inconsistent with simple 
diarrhoeal episodes and where a “doughy” sense to the skin may indicate hypernatraemia (Armon et al., 
2001). 
Even though the successes of ORT and intravenous fluid treatments were documented, and much attention 
was provided over the last decade on proper managing acute diarrhoea, this had inefficient impact on the 
prevention of deaths from diarrhoea (Banerjee, Hazra & Bandyopadhyay, 2003). The therapy is not accepted 
well in developed countries, where there may be widely-held perceptions that intravenous fluids are usually 
needed in children with acute diarrheal episodes (Mengistie et al., 2012). It is gradually becoming accepted 
in the developing countries, although it was referred to as "the under-used simple solution" because of the 
resistance of paediatricians (Gracey, 1995). 
Evidence exists from several randomised controlled trials, that anti-diarrhoeal and antimotility medicines are 
not clinically beneﬁcial in managing AGE in children. Their side-effect proﬁles are unacceptable (Armon et al., 
2003). Symptomatic anti-diarrhoeal drugs are usually not recommended for treating acute diarrhoea in 
children (Gracey, 1995; Hung, 2006). Antimicrobials are ineffective in uncomplicated acute diarrhoea and 
their use should be discouraged (Mokomane et al., 2018). In contrast, antimicrobials are indicated in 
dysentery, cholera, typhoid fever and diarrhoea caused by parasites, such as Giardia lamblia, Cyclospora and 
E. histolytic (Hung, 2006). The reasons why antibiotics are not recommended in childhood gastroenteritis, 
include some episodes (e.g. those caused by viruses) would not respond to antibiotics; several enteric 
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bacteria are antibiotic-resistant; unselective usage of antibiotics encourages developing plasmid-transmitted 
drug resistance; and antibiotic treatment can prolong carriage for some microorganisms, such as Salmonella 
(Gracey, 1995). Antibiotics are expensive and have significant side effects. Antibiotics may be indicated for 
medical reasons, such as treatment of a coexistent respiratory infection or serious infections, particularly in 
young, small or compromised infants and young children (Gracey, 1995). 
2.5.1 Global situational analysis: Antimicrobial use and antimicrobial resistance 
An initial “country situation analysis” was conducted in 2013 in Member States in each of the six WHO regions 
to determine the extent to which effective practices and structures, addressing antimicrobial resistance are 
already in-place and where divergences remain; only a few countries reported having a comprehensive 
national plan based on a multisectoral approach, with sustainable financing (WHO, 2013). 
A Global Point Prevalence Survey (Global-PPS) of a global network of 303 hospitals in 53 countries was 
established. The aim was to measure global antimicrobial prescribing and resistance, assessing antimicrobial 
prescribing and resistance in hospital inpatients, including eight lower middle-income and seventeen upper-
middle-income countries. The survey revealed that 34·4% of patients received at least one antimicrobial, of 
which 89·3% were antibacterial agents for systemic use. The top three antibiotics prescribed globally, were 
penicillin with β-lactamase inhibitors, third-generation Cephalosporins and fluoroquinolones (Versporten et 
al., 2018). 
A neonatal and paediatric antimicrobial PPS of the Antibiotic Resistance and Prescribing in a European 
children project was held. Seventy-three hospitals (European and non-European) were recruited in the study 
on a one-day PPS on antimicrobial use in hospitalised children in September 2011. The study revealed that 
antibiotic paediatric and neonatal use was significantly higher in non-European patients (43.8%; 95% 
confidence interval [CI]: 41.3-46.3% and 39.4%; 95% CI: 35.5-43.4%) compared with that in European 
hospitals (35.4; 95% CI: 33.6-37.2% and 21.8%; 95% CI: 19.4-24.2%) Versporten et al. (2013). 
A PPS assessing patterns of antibiotic use in a leading referral hospital in Western Kenya, revealed that 67.7% 
patients were on antibiotics. The most common classes of antibiotics prescribed were third-generation 
Cephalosporins (55%), imidazole derivatives like Metronidazole (41.8%) and broad-spectrum penicillin 
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(41.8%) (Okotho et al, 2018). Another PPS study by Labi et al. (2018) in a tertiary hospital in Ghana, indicated 
that of the 677 inpatients surveyed, 348 (51.4%, 95% CI, 47.6-55.2) were on treatment with antibiotics. 
Prevalence was highest amongst paediatric surgery where 20/22 patients (90.9%, 95% CI, 70.8-98.9) were 
administered antibiotics and lowest amongst obstetrics patients with 77/214 (36%, 95% CI, 29.5-42.8) (Labi 
et al., 2018). The top five antibiotics prescribed in the hospital, were Metronidazole 107 (17.5%), amoxicillin-
clavulanic acid 82 (13.4%), Ceftriaxone 17(12.1%), Cefuroxime 61 (10.0%) and cloxacillin 52 (8.5%) 
respectively. Most patients. 181 (52%) were treated with two antibiotics (Labi et al., 2018). 
Concerning antibiotic consumption, South Africa was recently emphasised as a major contributor to the 
global increase in antibiotic use (Mendelson & Matsoso, 2016). Despite the need to quantify the misuse of 
antibiotics at provincial, local, district and institutional levels, no integrated information systems linking 
Pharmacy with laboratory and clinical data are prepared (Mendelson & Matsoso, 2016). Koopmans et al. 
(2018) performed a study at hospital level, evaluating antimicrobial consumption rates, the antimicrobial 
spectrum used and the indications for therapy on a paediatric ward and at the paediatric ICU (PICU) at the 
Tygerberg Hospital, Cape Town, South Africa. From the 703 patients admitted during the six-month study 
period, 415/451 (92%) paediatric ward admissions and 233/252 (92%) PICU admissions received 
antimicrobials (Koopmans et al., (018). In the ward, 89% of prescriptions were for community-acquired 
infections. Ampicillin and third-generation Cephalosporins were the most commonly prescribed agents, 
Koopmans et al. (2018). 
2.5.2 The significance of antibiotic resistance and other adverse outcomes 
‘Antimicrobial resistance threatens the achievement of the Sustainable Development Goals and requires a 
global response’ (TIMES, 2016). This statement brought by one UN member states (Mr Thomas) indicates the 
significance of antimicrobial resistance globally. The level of threat to the health, social and economic aspects 
was signified because ‘this was for the first time, Heads of State committed to taking a broad, coordinated 
approach to address the root causes of AMR across multiple sectors, especially human health, animal health 
and agriculture’ (TIMES, 2017). This was the fourth time a health issue was considered by the UN General 
Assembly at a high-level meeting of the 71 sessions of the UN General Assembly (the others were HIV, non-
communicable diseases and Ebola) (TIMES, 2017). 
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Bacterial resistance to antibiotics became a global threat, especially in LMICs (Laxminarayan et al., 2014). 
Antibiotics are extensively used, but their value in the clinical setting is decreased by the increase in 
antibiotic- resistance bacteria (Ho et al., 2006). The United States Centers for Disease Control and Prevention 
(US CDC, 2015) estimated that about 2 million illnesses in the US were caused by antimicrobial resistance, 
which claims approximately 23 000 deaths annually (US CDC, 2015). These alarming figures of deaths, 
attributable to antimicrobial resistance are caused by the indiscriminate and overuse of antimicrobial agents 
within hospitals (Ho et al., 2006). Antibiotic resistance (ABR) is a critical threat to public health globally. If it 
would not be considered as serious, it could result in 10 million deaths annually, at a cumulative cost of USD 
100 trillion by 2050 (Brink et al., 2016). 
The true burden of bacterial infection in South Africa remains incompletely documented, attributable to a 
high-level of empiric management and a paucity of samples sent for laboratory diagnosis (Mendelson, 2016). 
This is also true for ESwatini as the burden of antibiotic resistance were not understood with the only 
documented and published instance of resistance being multi-drug-resistant tuberculosis (Sanchez-Padilla et 
al., 2012). The ESwatini National AIDS Programme, in collaboration with the Ministry of Health, adopted 
cotrimoxazole as an opportunistic disease prophylaxis (MOH, 2010). It follows, that with such an elevated 
burden of infection, an equally high burden of antimicrobial use occurs and hence, antimicrobial resistance 
(Mendelson, 2016). 
The extensive use of cotrimoxazole can be attributed to the cotrimoxazole prophylaxis introduced by the 
ESwatini Integrated HIV guidelines in 2010 (National Comprehensive HIV Care, 2010) requiring all patients 
with HIV infection, including those on anti-retroviral treatment (ART) to receive cotrimoxazole prophylaxis. 
In ESwatini, there is no published research that evaluated the benefit of the cotrimoxazole prophylaxis, but 
an observational cohort study of five-year follow-up by Badri et al. (2001), performed in adult HIV clinics in 
South Africa, evaluated the proposed WHO/UNAIDS criteria for initiating cotrimoxazole prophylaxis in adult 
HIV-infected patients in Africa. This is stipulated in the guidelines on post-exposure prophylaxis for HIV and 
using cotrimoxazole prophylaxis for HIV-related infections amongst adults, adolescents and children (WHO, 
2014). Even though it reduced mortality [adjusted hazard ratio (AHR), 0.56; 95% confidence interval (CI), 
0.33-0.85; P > 0.001] and the incidence of severe HIV-related illnesses, the authors alluded that studies are 
needed to assess the optimal time to commencement of prophylaxis, as prevalent cotrimoxazole use will 
lead to increasing antimicrobial resistance to other major pathogens in Africa (Badri et al., 2001). 
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According to Laxminarayan et al. (2012) using cotrimoxazole to treat opportunistic infections increased 
resistance to cotrimoxazole in Pneumococci and E.coli. From observations in using antibiotics, it is increased 
by the lack of stringent laws. Private pharmacies dispense antibiotics to patients without prescription from 
prescribers and even if prescribers wrongly prescribe antibiotics, the Pharmacy personnel dispense the 
medication to patients (Laxminarayan et al., 2012). 
Laxminarayan et al. (2012) state that in certain developing countries (Nigeria and Sudan), up to 90% of 
antibiotics are available over the counter without a prescription. Non-prescription transactions are common 
in almost all countries; these findings are consistent with reports (WHO, 2010) that over 50% of antibiotics 
globally, are purchased privately without a prescription, from pharmacies or street vendors in the informal 
sector. Self-medication was noted in the United States of America and Europe, particularly for colds and 
upper respiratory tract symptoms, self-limiting and mostly caused by viruses (WHO, 2010). South Africa 
initiated a national public surveillance programme for bacteria causing specific respiratory, gastrointestinal 
and central nervous system infections, but there are significant divergences in knowledge about drug 
resistance in bacteria, other than tuberculosis (hereafter termed bacterial resistance) (Mendelson, 2016). 
Whilst developing new antibiotics for gram-positive infections could persevere the emergence of resistant 
bacteria, this is not the same for antibiotics against gram-negative infections, with none expected on the 
market for the next decade (Boyles et al., 2013). The alarming increase in rates of extended spectrum beta-
lactamase (ESBL)-producing gram-negative bacteria being reported from South African hospitals (Boyles et 
al., 2013) and countrywide outbreaks of Carbapenems-Resistant Enterobacteriaceae, is a sincere concern 
(Boyles et al., 2013). Compounding the challenge is the lack of infection prevention control capacity in South 
Africa, rendering it difficult to contain the spread of resistant bacterial infections. It poses a direct threat to 
patient safety (Boyles et al., 2013). Although antimicrobial resistance data were not collected for ESwatini, a 
situation similar to that in South Africa (Boyles et al., 2013) is believed to exist in ESwatini. The two countries 
are direct neighbours and travelling between the two countries occurs regularly and without the need for a 
visa. 
Cost containment is often the overriding priority in managing patient, but with the rapid development and 
dissemination of multi-resistant organism in the hospital settings, global attention is now firmly engrossed 
on controlling antibiotic use to pause the increase and spread of such organisms (Knox et al., 2003). In a four-
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year study conducted by Boyles et al. (2017), there was an inflation-adjusted cost of antibiotics of ZAR 
2,191,594 in 2011 and lower, for each of the subsequent years. By 2015, inflation-adjusted cost was 46% 
lower than in 2011. The total savings over the four years was ZAR3 263 340 (Boyles et al., 2017). This finding 
suggests that ASPs cannot only fund themselves but can potentially be a source of revenue to provide 
infection prevention and quality improvement programmes advancing patient safety, related to infection 
(Boyles et al., 2017). 
Healthcare associated infections (HCAIs) are also progressively documented in LMICs. A recent evaluation 
revealed that the collective occurrence of HCAIs in resource-limited settings was twice the average 
prevalence of HCAIs in Europe (Laxminarayan et al., 2014). HCAIs are mainly associated with the increased 
use of antibiotics, as they may worsen a patient’s clinical outcome and prolong hospitalisation (Bebella & 
Muiruc, 2014). Equally, the necessity for antibiotics and the burden of resistance are likely to upsurge with 
the rate of HAIs in LMICs (Laxminarayan et al., 2014). The susceptibility to infections, especially in children, 
can be attributed to the poverty status encountering LMICs in the Sub-Saharan region. Impervious infections 
are costly to treat. Patients infected with resistant strains of bacteria are likely to need prolonged 
hospitalisation, which would increase costs, compared to patients infected with drug-susceptible strains, 
which need affordable and readily available first-line treatment and a shorter hospital admission 
(Laxminarayan et al., 2014). 
A previous study on children at RFMH did not quantify antibiotic resistance (Matsebula-Myeni, 2015). A 
correlation between resistance and mortality is challenging to demonstrate because the risk influences for 
infection with a resistant pathogen, including duration of hospitalisation especially in an ICU, are similar to 
those causing inferior outcomes in patients without resistant pathogens (Fortin et al., 2015). Allerberger et 
al. (2008) state that if antimicrobial agents continue with an alarming resistance rate, it is possible to establish 
the return of the pre-antibiotic era or conversely, the emergence of the post-antibiotic era. This was echoed 
by Barriere (2014) who emphasises that the possibility of the return to a pre-antibiotic era, where ill health 
and death rates could rise dramatically. Routine surgical procedures would not be performed for fear of post-
operative infections. 
The inappropriate and overuse of antibiotics have numerous negative consequences, including significantly 
increased incidences of drug-related adverse events (Principi et al., 2016) threatening public health 
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(Goossens et al., 2006). Brink et al. (2016) mention that overuse and inappropriate use of antibiotics resulted 
in the emergence of multi-drug-resistant (MDR), extensively drug-resistant (XDR) and pan-drug-resistant 
(PDR) bacteria, increasingly common in South Africa. 
Principi et al. (2016) establish that inappropriate antibiotic use causes the emergence of multi-drug 
resistance, which may lead to extended hospital admissions, augmented healthcare costs and amplified 
patient mortality. They also emphasise on related challenges, including cumulative incidence of Clostridium 
difficile Infection and the negative impression on microbiota. The under-treatment risk was also emphasised 
with under-dosing. 
2.5.2.1 Children at high-risk of adverse effects of antimicrobial resistance 
Even though the mortality rate of children under five in Africa (per 1,000 live births) declined from 163 in 
1990 to 100 in 2011, the highest rates of child mortality still occur in Sub-Saharan Africa where one from nine 
children dies before the age of five, over 16 times the average for developed regions (one from 152) (UNICEF, 
2012; Ester et al., 2011). These rates are still insufficient to achieve MDG number four of the eight MDS’s, 
stating that all 191-member states should reduce under five mortalities with 66% by 2015. The eight United 
Nations Millennium Development Goals (MDGs) form a blueprint, agreed by global countries and leading 
development institutions. They galvanised unprecedented efforts to meet the needs of the world’s poorest 
by 2015 (Ester et al., 2011). The revised MDG’s (WHO, 2017) aim at reducing deaths by 2030, end preventable 
deaths of new-borns and children under five years of age, with all countries aiming to reduce neonatal 
mortality to at least as low as 12 per 1000 live births and under-five mortalities to at least as low as 25 per 
1000 live births (WHO, 2017). 
The main causes of child mortality are well-known in the Sub-Saharan region, in order of importance: 
Neonatal causes (26%), child pneumonia (21%), malaria (18%), diarrhoea (16%), HIV/AIDS (6%), measles (5%) 
and accidents (2%) (Ester et al., 2011). A recent WHO report reveals that pneumonia (13%), followed by 
diarrhoea (8%) are the leading infectious diseases, causing of death in children less than five years old, 
globally (WHO, 2016). The same sentiments were shared by the ESwatini statistics, where diarrhoea (8.1%) 
is the second leading cause of death, following pneumonia (15.2%) (UNICEF, 2016). In Sub-Saharan Africa, 
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pneumonia improved from 36% in 2000 to 46% in 2010 for rural areas and from 49% to 52% in urban areas 
(UNICEF, 2016). 
ESwatini and South Africa hold the highest rate of mortality in children under five, associated with HIV (28% 
and 23%) respectively (UNICEF, 2012; WHO, 2011). In the World Health Statistics 2015 released by WHO, 
ESwatini failed to reduce the mortality rate of children under five during the period 1990 to 2013 (WHO, 
2015). This represents a clear call for action for the country. Ester et al. (2015) allude that achieving the fourth 
MDG, which required reducing the mortality rate of children under five years old between 1990 and 2015, is 
evident that reaching these goals will require political participation, resources and suitable strategies at an 
innovative, exclusive level. 
Gerber et al. (2010) establish that over 60% of hospitalised children received unnecessary antibiotics from 
40 hospital in the United States over a one-year period. Principi et al. (2016) concur that overusing antibiotics 
is widespread in paediatrics and that numerous of these antibiotics are used inappropriately. Bowes et al. 
(2014) concur with Gerber et al. (2010), stating that it was reported (levy et al., 2012; Pakyz et al., 2009; 
Groskopf et al., 2005) that an average percentage of 33%- 72% of hospitalised children receives at least one 
antibiotic in the United States, mostly for URTI’s. Brink et al. (2016) agrees with Gerber et al. (2013) in that 
the majority (75 - 80%) of antibiotics for systemic use in adults and children are prescribed in the community, 
with acute respiratory tract infections (ARTIs) such as bronchitis, pharyngitis and sinusitis being the most 
common indications. The author further state that 60% of patients with an ARTI receive an unnecessary 
antibiotic, unlikely to be of benefit to their condition (Brink et al., 2016). Collectively, this contributes to 
avoidable adverse events, stimulates the expansion of URTIs resulting in unnecessary costs (Gerber et al., 
2013). 
Overusing antibiotics may elevate by diagnostic uncertainty (Llor & Bjerrum, 2014). The paediatric population 
can have viral infections and non-specific syndrome presentations and is therefore prone to inappropriate 
use of antibiotics, especially when the bacterial cultures are negative (Bowes et al., 2014). At least two-third 
of infantile transience is correlated to infections and children are therefore possibly more susceptible than 
adults (Laxminarayan et al., 2014). Mendelson et al. (2015) emphasised a report by Requejo, Newby & Bryce 
(2013) in a WHO meeting in Geneva. Access to antimicrobials and inhibition measures were important factors 
in reducing maternal and child deaths by half (50%) since 1990. Globally, after two decades, the number of 
Stellenbosch University  https://scholar.sun.ac.za
27 | P a g e  
 
 
 
deaths of children younger than five years, still reached 7·6 million, regardless the increased access to 
antimicrobials, vaccination and other prevention measures against infectious diseases in countries 
encountering challenges in implementing maternal, neonatal and child health interventions (Mendelson et 
al., 2015). 
One from five emergency department visits in the US for adverse drug events in children younger than 18 
years, are caused by antibiotics (CDC, 2017). Infections are still the main origin of neonatal deaths, even if 
effective antibiotics are available, which in turn account for over a third of the universal liability of child 
mortality (Laxminarayan et al., 2014). The solution lies not only in the usage of existing knowledge to render 
antimicrobial resistance a national health priority, but also in the enactment of tailored containment 
strategies (Laxminarayan et al., 2014). Attributable to the magnitude and the seriousness of the risks of 
bacterial infections in children, the study focussed on children younger than five years old. 
Paediatric patients are at a higher risk of experiencing medication errors than adults because of the need for 
a dose calculation based on patient age, weight (mg/kg) or body surface area (mg/m2) and clinical condition 
(Aseeri, 2013). Kaushal et al. (2001) reported that medication errors with the potential to cause harm were 
three times more likely in children than in adult populations. These findings emphasise the importance of 
calculating the correct dose for the paediatric population, especially antibiotics. 
Dosing medication to adults appears easy because recommended doses are determined in clinical trials 
involving adults, which is not the same with children (Anderson & Holford 2013). These proportion of the 
incorrectly doses used, are higher than the proportion (25%) reported by Storey et al. (2012). Miscalculation 
of paediatric dosing can lead to a tenfold or greater rate of dosing errors that can have harmful consequences 
for patients (Aseeri, 2013). Antibiotics and sedatives are the medications most extensively prescribed in the 
paediatric population and are the drug classes most reported, involved in paediatric medication errors 
(Aseeri, 2013). Kaushal et al. (2007) indicated that medication errors in paediatrics were observed in 
outpatients where the caregivers administered the medicine, it is suggested that they should be educated 
on the medicine administration to avoid preventable medication errors. 
Regarding dosing of antibiotics in children, it must be considered, as for most medicines, the appropriate 
paediatric dose cannot be calculated simply from the adult dose using body weight as scaling factor (mg/kg). 
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This usually results in a dose too small for infants and children because elimination does not change in direct 
proportion to weight; a dose too large in neonates whose drug elimination pathways are immature 
(Anderson & Holford, 2013). 
Regardless of the target dose, prescribers need a simple and rapid approach to identify the appropriate dose 
for each child (Bielicki et al., 2015). Global guidance is inconsistent, with the US and much of continental 
Europe favouring exact weight-based dosing for pragmatic reasons. The UK applies age banded dosing with 
the WHO recommending weight banded dosing (Bielicki et al., 2015). A simple and rapid approach will assist 
prescribers to select the correct doses. In developing countries, the prescriber is challenged by disease 
burden and a shortage of human and other resources. 
Adherence to prescribed dosing recommendations, including dosing intervals, was listed as the most 
important modifiable factor that compromises treatment outcomes. Inadequate adherence to treatment 
recommendations was indicated to negatively impact patient outcomes (Bhoi et al., 2017). 
Lansky et al. (2007) assessed the consequences for antibiotic efficacy of various types of deficient adherence 
to a short-term dosing regimen. Four patterns of non-adherence were investigated: Dosage omission, 
irregular dosing intervals, delayed dosing and treatment discontinuation. Errors in timing of doses with a 
standard deviation less than two hours, had a minor effect on antibiotic efficacy, whereas dosage omission 
had a significant negative effect. Since non-adherence patterns are difficult to detect, recommended dosing 
regimens should be sufficiently robust against most doses (Lansky et al., 2007). 
Currently, children under the age of five, die from a lack of access to antibiotics for pneumonia, others die 
from antibiotic-resistant infections (Mendelson & Laxminarayan, 2016). Although more deaths can also be 
caused by resistance when antibiotics are too readily accessible, access to quality-assured antibiotics to all 
who need them is an ultimate human right, which was compromised in several regions. The innovative 
approaches of ASPs are designed to reverse the inequity of access versus excess (Mendelson & Laxminarayan, 
2016). 
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2.5.3 Approaches and commitments for addressing antimicrobial resistance 
It is recognised that global collaborative action is needed across all resource settings to confront the 
challenge of ABR (Cox et al., 2017; UN 2017). Several LMICs are in the process of developing stewardship 
policies and programmes (Cox et al., 2017), as countries endorsed their commitment to develop national 
action plans on AMR (UN, 2017). Policymakers realised that if left unattended, AMR will have significant 
social, health security and economic repercussions that will seriously undermine developing countries (UN, 
2017). The critical function of national politicians in influencing laws that will enforce appropriate use of 
antibiotics to mitigate antibiotic resistance in developed and developing countries, was recognised 
(Laxminarayan et al., 2012; Saam et al., 2016). The challenge of AMR is that its impact cannot be easily 
quantified alike other conditions, such as HIV/AIDS and competing with other public health priorities 
(Laxminarayan et al., 2012).More education and collaborative awareness-raising campaigns are required 
(WHO, 2015) by all affected sectors, including agriculture and environmental and natural resources sectors, 
ensuring appropriate regulations and standards will be legislated and facilitated effectively (WHO, 2015) 
In ESwatini the burden of antimicrobial resistance is inadequately quantified; there is no comprehensive 
indication on the attributed mortality of resistance infections at a country level. This represents a crucial 
disadvantage, as it is difficult to prove the impact of antimicrobial resistance to policymakers, which is urgent 
but not as obvious as HIV/AIDS. Mendelson (2015) emphasises three fundamental pillars that need to be 
strengthened to combat ABR as follows: 
“Firstly, through strengthened surveillance and reporting, as health care professionals and especially 
clinicians we should understand that the resistance profile of bacteria in our local environment or hospital is 
important as it ensures appropriate choice of an antibiotic that will be active against cultured bacteria” 
(Mendelson 2015, page:414). Secondly, “optimization of using the antibiotics to maximise its action 
(Antibiotic Stewardship) when a bacterium that requires treatment is identified or an empiric antibiotic(s) is 
needed before its identification” (Mendelson 2015, page: 415). Lastly, “we need to maximize infection 
control: prevent infection before it occurs by attending to social factors or drivers of infectious diseases, such 
as water supply and sanitation, and increase access to and coverage with vaccines” (Mendelson 2015, page 
415). 
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The IDSA issued a policy statement titled “Combating Antimicrobial Resistance: Policy Recommendations to 
Save Lives,” provides clear suggestions for addressing the “synergistic crises” of increasing antimicrobial 
resistance and decreasing availability of new antimicrobial therapies (Barriere, 2014). South Africa took major 
steps in combatting antimicrobial resistance through its National Strategic Plan for AMR and implementing a 
clear plan for change (Mendelson, 2015). The National Strategic Plan includes national core standards for 
antimicrobial stewardship (and for infection prevention and control) that will be examined by the Office of 
Health Standards and Compliance. These standards include the requirement for stewardship committees and 
teams in all South African hospitals and at district level (Mendelson, 2015). 
The WHO issued an endorsement for countries to develop an antimicrobial resistance containment strategic 
plan (WHO, 2015). ESwatini is drafting its National Strategic Plan on the containment of antimicrobial 
resistance in the country. 
2.5.4 Developing ASPs 
Mendelson et al. (2015) discussed the advantages and disadvantages of access, and excess to antibiotics. 
Principles and measures to promote rational antimicrobial use, are required to improve access to quality-
assured antimicrobials, health services, prevention measures, diagnostics (preferably at the point-of-care), 
prescribing guidelines and education (Mendelson et al., 2015). They allude that an integrated approach is 
needed to confront antimicrobial resistance, ensuring appropriate antimicrobial use, especially against 
bacterial infections (Mendelson et al., 2015). 
The IDSA, the Society for Healthcare Epidemiology of America (SHEA) and the Paediatric Infectious Disease 
Society (PIDS) define antibiotic stewardship as coordinated interferences intended to improve and measure 
the appropriate use of antibiotics by promoting selecting the optimal drug regimen (Barlam et al., 2016). Ho 
et al. (2006) clearly articulate antibiotic stewardship as “the optimal selection, dosage and duration of 
antimicrobial treatment that results in the best clinical outcome for the treatment or prevention of infection, 
with minimal toxicity to the patient and minimal impact on subsequent resistance’’. Strategies that improve 
antibiotic use are essential to combat microbial threat (Ho et al., 2006). 
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The National Action Plan for containing antibiotic-resistant bacteria delivered in the White House in March 
2015, recognised the need for antibiotic stewardship across all fields of healthcare (WHO, 2015). The 
antibiotic stewardship interventions aim at various players: Prescribers, patients, drug providers, 
policymakers and the public (Cox et al., 2017). Institutions and hospitals recognised the inappropriate use of 
antibiotics and various countries developed action plans (Goff et al., 2017). Most countries in the first world 
realised the importance of antibiotic stewardship (Goff et al., 2017). Evidence indicates the effectiveness of 
antibiotic stewardship interventions at hospital level, including reduced hospitalisation, shorter treatment 
duration without an increase in mortality, and a reduction in colonisation and infection with resistant bacteria 
(Cox et al., 2017). 
In South Africa, alike other countries, antibiotic stewardship programmes successfully reduced antibiotic 
consumption (Boyles et al., 2017). The existing antibiotic stewardship infrastructure in South Africa has 
important limitations. First, formal stewardship programmes mainly target postgraduate clinicians in hospital 
settings and have not reached outpatient and community settings, where most antibiotic prescribing occur 
(Boyles et al., 2016). Secondly, programmes are usually led by infectious diseases physicians, who are a scarce 
resource in South Africa and unavailable in healthcare settings. Effecting sustained behavioural change 
concerning antibiotic prescriptions, requires an insight into and an appreciation of the factors leading to ABR 
(Boyles et al., 2016). 
The IDSA considers preauthorisation or prospective audit and reaction interventions as a robust strategy with 
moderate evidence in rendering ASPs successful (Barlam et al., 2016). The society recommends the 
optimisation of therapy in ASPs. It is alluded that any antibiotic stewardship intervention must be customised, 
based on local needs, prescriber behaviours, barriers and resources (Barlam et al., 2016). Restricted 
formularies were also identified as a crucial strategy for effective ASPs (Buising, 2011). Establishing formulary 
restriction and approval systems that include restricting broad-spectrum and later generation antimicrobials 
to patients where the use is clinically justified, can be effective in optimising antimicrobial use in a hospital 
setting in Australian hospitals (Buising, 2011). Buising (2011) findings are consistent with a study by Po, 
Nguyen and Carling (2012), where a significant decrease in linezolid use was observed in the 16-month 
follow-up period after implementing restricted formulary. 
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 Rahal et al. (1998) facilitated extensive restrictions on using Cephalosporins. A significant decrease in 
ceftazidime-resistant Klebsiella infections and colonisation was achieved one-year later (Rahal et al., 1998). 
Lewis et al. (2012) achieved comparable results where restriction of ciprofloxacin use led to increases in 
carbapenems use, associated with a significant decrease in the rate of resistance of Pseudomonas aeruginosa 
to ciprofloxacin and carbapenems. Restricting third-generation Cephalosporins antibiotics is recommended 
in ASPs as these are the force behind resistance in gram-negative bacteria (Paterson, 2006); their restriction 
is valuable in ASPs. Paterson (2006) indicates that a restriction of Ceftriaxone use in combination with ASPs 
result in increased efficiency and decreased duration of stay. 
Barlam et al. (2006) conducted two surveys, directed to ASP directors and teaching and community hospitals. 
The goal “was to determine whether certain antibiotic stewardship interventions were universally instituted 
and accepted at top US academic centres and to document what interventions, if any, are used at both 
teaching and community hospitals within a geographic area” (Barlam & DiVall, 2006). They established that 
the hospitals instituted interventions to improve antibiotic prescribing, but none of the interventions were 
collectively accepted as essential or effective (Barlam & DiVall, 2006). Ninety-five per cent teaching hospitals 
had a restricted formulary, compared to 49% community hospitals; 89% teaching hospitals had an antibiotic 
approval process, compared to 29% community hospitals (Barlam & DiVall, 2006). ASP interventions 
therefore need to be customised rather than generalised. 
Another intervention that was constructed to combat inappropriate use of antibiotics, is the conversion from 
intravenous (IV) to oral therapy (PO). Cyriac & James (2014) appraised the conversion from IV to PO, 
mentioning that short intravenous therapy for two to three days, followed by oral treatment for the 
remainder of the course, is beneficial to several patients. This is extensively practised in developing countries. 
Other previous studies have also commented on the positive influence of ASP on duration of hospital stay, 
readmission rate and mortality (Akpan et al., 2015). 
A prospective observational study accomplished for a period of six months in the Dr Pinnamaneni Siddhartha 
Institute of Medical Sciences and Research (Tejaswin et al., 2018), indicated that only 43.68% of antibiotics 
were converted from IV-to-oral formulation. Duration of hospitalisation significantly (p<0.05) decreased 
following IV-to-oral conversion of antibiotics in comparison with patients with non-conversion of antibiotics 
from IV-to-oral formulation (Tejaswin et al., 2018). 
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Gums et al. (1999) describe shorter duration of hospital stays in the intervention group than the control 
group (9.0 vs. 5.7; p = 0.0001) and decreased mortality, namely 6.3% mortality in the intervention group 
compared to 12.0% in the control group. Ng et al. (2008), reported a noteworthy difference in duration of 
hospitalisation (7.46 and 6.97 respectively; p<0.001) between the periods before and after ASP 
implementation with no difference in mortality. 
Fischer et al. (2003) mention that several hospitalised patients continue to receive unnecessary prolonged 
intravenous medications. Another study by (Lee & Lindstrom, 2007) also emphasised that the major cost of 
managing community-acquired pneumonia (CAP) relates to the duration IV antibiotic use and duration of 
hospitalisation. They introduced guidelines on early switch to oral antibiotics and early discharge from 
hospital which may assist to achieve a unified approach to managing CAP (Lee & Lindstrom, 2007). Switching 
from IV to PO therapy as soon as patients are clinically stable can therefore reduce the duration of 
hospitalisation and lower associated costs without compromising clinical care (Fischer et al., 2003; Tejaswini 
et al., 2018; McLaughlin et al., 2005). 
Prescribing the recommended dose is important when prescribing antibiotics (Rello, 2007; Dryden et al., 
2011, Ghosh et al., 2014 and Bielicki et al. 2015). Rello (2007) mentioned that optimal initial therapy 
comprises a broad-spectrum antibiotic, started in a punctual manner and administered at the correct dose 
and through the correct route. Ghosh et al. (2014) agree, mentioning that other contributing factors for 
emergence of resistance and treatment failure include, inappropriate use of antimicrobials concerning dose, 
frequency and duration, not considering compatibility and drug interaction effect of co-administered drugs. 
Bielicki et al., (2015) emphasise that correct antibiotic doses must be prescribed to achieve optimal bacteria 
disposal with minimal undesirable effects, such as drug toxicity or selecting resistant pathogens. Provided 
challenges associated with increasing antibiotic resistance, optimal use of antibiotics for children is important 
for global antimicrobial stewardship. 
Some countries in Asia, including Singapore, Taiwan, Japan, South Korea and Thailand, have investigated 
methods to combat inappropriate use of antibiotics and documented challenges encountered with these 
strategies (Hsu et al., 2012), including: 
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 Education programmes for the proper use of antimicrobials. 
 Providing consultations from clinical microbiology or infectious disease specialists and trained 
pharmacists. 
 Restriction of hospital formulary. 
 Utilisation review based on guidelines and treatment algorithms for rational and appropriate usage. 
 Monitoring and analysis of antimicrobial usage. 
 Surveillance of antimicrobial susceptibility. 
 Monitoring compliance to advise on choices of antimicrobial agents. 
 Feedback to physicians. 
 Conducting hospital infection control. 
Exploring the most suitable approach for implementing an ASP is important as various interventions have a 
different influence, resulting in diverse patient outcomes (Barlam et al., 2016). The primary goals of ASPs are 
improved clinical outcomes and reduced antimicrobial resistance (James et al., 2012; Boyles et al., 
2013).There was immense inconsistency amongst the approaches towards overseeing antibiotic prescribing 
at hospitals and interventions for managing antibiotics were lacking (Allerberger & Mittermayer, 2008). It 
was concluded that further research was needed to define the best antibiotic stewardship approach for 
various hospital settings. Numerous authors (Dellit et al., 2007; MacKenzie et al., 2006; Madaras et al., 2003; 
Struelens et al., 2003; Ho et al., 2006) emphasised the importance of formulating programmes to address 
AMR and the appropriate use of antibiotics, providing the best patient outcomes and reducing the risks of 
adverse effects. They emphasise the importance of formulating antibiotic stewardship guidelines. Barriere et 
al. (2014) insist that the onus of control of resistance is an ethical authoritative that is each person’s 
responsibility. 
The current practice in low resource countries is not conducive to combatting antibiotics resistance 
(Sprenger, 2017) and antibiotics are prescribed when it may not be beneficial to patients without directing 
therapy to the anticipated pathogens and often not using the suitable drug, dosage and duration (Bell, 2001; 
Knobler, 2003). At an individual patient level, an ultimate question needs to be directed before any antibiotic 
is prescribed, “Does this patient have a bacterial infection that requires an antibiotic?” (Mendelson 2015; 
page 415). Most often this question is relevant to primary care prescribers where inappropriate use of 
antibiotics was observed for viral URTI’s, it applies equally to febrile patients admitted to hospitals at all levels 
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(Mendelson, 2015). The aforementioned author makes this statement, based on a study, exposing that 
patients are provided with up to 10 different antibiotics concurrently in both the private and public sectors 
in South Africa. 
Ho et al. (2006) state that an ASP should not be observed as a programme to directly cut pharmaceutical and 
medical cost but should rather be observed as a strategy to enhance patient safety. He defined ASP as a 
multidisciplinary, programmatic, prospective, interventional approach to optimising using antimicrobial 
agents” (Ho et al., 2006). Principi et al. (2016) agree with the definition provided by Ho et al. (2006), stating 
that multidisciplinary teams are considered essential to ensure adequate development of ASPs. The authors 
mentioned crucial members as drivers of an ASP, such as clinical microbiologists, infectious diseases 
specialists, infection control practitioners and clinical pharmacists. Several authors (Barlam et al., 2016) 
recommended that commitment by hospital leadership and administrators, treating an ASP as a priority 
programme to improve and enhance antibiotic use, is essential to render it successful. The IDSA and SHEA 
strongly believe that ASPs are best led by infectious disease physicians with additional stewardship training, 
Barlam (2016). 
In 2007, the IDSA published Guidelines for Developing an Institutional Program to Enhance Antimicrobial 
Stewardship, identifying paediatrics as a priority area for further research on the effectiveness of stewardship 
activities (Hersh et al., 2015). The number of ASPs grew substantially in children’s hospitals after the release 
of these guidelines (Hersh et al., 2015). Studies indicate that paediatric ASPs signified favourable outcomes, 
including reductions in antibiotic prescribing and lower costs. A shortcoming identified, is the limitation of 
research to a small number of single-centred studies, instead of multi-centred studies (Hersh et al., 2015). 
Hersh et al. (2015) reported that after publication of the IDSA in 2007, antibiotic use decreased in the children 
hospitals, with a more pronounced change in those hospitals that established formal ASPs. Despite the 
growing evidence of the importance of ASP, several well-recognised obstacles hinder their growth and 
development. ASPs require substantial funding and education of prescribers (Principi et al., 2016) and 
therefore, the development and the sustainability of ASPs are less likely in low resource hospitals. 
Prospective audits with feedback and previous approval of prescriptions belong to the core strategies for 
ASPs; these require dedicated personnel who may not be available in a paediatric setting with limited 
resources (Smith et al., 2012). 
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Bowes et al. (2014) indicated that less than 20% of the staff held the appropriate knowledge on local 
resistance patterns for common bacteria. This evidence indicates that educational programmes are essential 
in ASP, but the challenge is that educational interventions require dedicated personnel and the educational 
material requires funding (Bowes et al., 2014). 
2.5.4.1 Antimicrobial stewardship programmes in the African context 
Most studies on antibiotic stewardship were performed in high-income settings in Europe, the US and 
Australia (Cox et al., 2017). A systematic review on the effectiveness of antibiotic stewardship in hospitals in 
LMICs is in preparation (Cox et al., 2017). Limited studies provided data, identifying crucial interventional 
components and the effectiveness of ASPs in resource-limited settings (Brink et al., 2017). A global survey of 
stewardship activities revealed that only 14% of respondents in Africa had an ASP established (Brink et al., 
2016). Several antimicrobial stewardship studies were conducted in South Africa (Boyles et al., 2013; 
Mendelson, 2015; Mendelson, 2016; Brink et al., 2016), but there is inadequate published information about 
the rest of the Southern African Development Community (SADC) region. 
In South Africa, the South African Antibiotic Stewardship Programme (SAASP) was formed under the auspices 
of the Federation of Infectious Diseases Societies of Southern Africa (FIDSSA) (Mendelson, 2016). The SAASP 
comprises members from public and private sectors, comprehending the necessary skill sets of infectious 
disease physicians and paediatricians, veterinarians, microbiologists, infection and prevention control (IPC) 
practitioners, pharmacists, pharmacologists, intensivists, surgeons, epidemiologists and quality 
improvement experts (Mendelson, 2016). 
2.5.4.2 Challenges of inappropriate antibiotic use, antibiotic resistance and barriers to antibiotic stewardship 
in weak health care systems 
Antibiotics are essential in managing high-risk patients, including septic shock and other intensive care 
patients or those who are immunosuppressed (Mendelson, 2015; Mendelson, 2016). Although antimicrobial 
resistance is a natural occurrence, its spread is accelerated by misuse of antimicrobial medicine, deficient 
quality medicine, weak laboratory capacity and surveillance, insufficient regulation of using these medicines 
and inadequate or inexistent programmes for IPC (Mendelson 2015). Mortality is higher in antibiotic-resistant 
infections, as is morbidity and duration of hospitalisation (Cosgrove, 2006). 
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Antibiotic resistance causes a considerable financial burden in LMICs, because second- and third-line 
antibiotics will be required, and they are more expensive (Mendelson, 2015). Antibiotic stewardship is 
challenging in general and is even more so when human resources in the health care system, laboratory 
equipment, unavailability of drugs, limited or no policies exist or lack (WHO, 2015). It is difficult for 
governments to fund studies in LMICs, improving clinical outcomes (Laxminarayan et al., 2014). In ESwatini, 
there are limited funds allocated for health research (MOH, 2017). This challenge extends attributable to the 
National Health Research office not recognised. Presently, members who review a protocol, do it voluntarily. 
The lack of research (Laxminarayan et al., 2014), overuse and misuse of antibiotics, deficient sanitation, low 
vaccination rates and deficient infection control and practices (Cox et al., 2017) lead to the misuse of 
antibiotics. Limited studies amongst several health care professionals, demonstrated the extent of the 
burden of inappropriate use and antimicrobial resistance in LMICs to convince policymakers of the urgent 
need to react emerging antimicrobial resistance (Laxminarayan et al., 2014). In LMICs with weak health 
systems, the consequences of antibiotic resistance on health and economics are mainly undervalued and 
unstated (Laxminarayan et al., 2014). 
In South Africa, the main obstacles implementing ASPs in most public and private hospitals, were insufficient 
infectious diseases expertise and resources; additionally, in large hospital networks, the geographical 
distribution of these institutions also hindered implementation (Brink et al., 2016). In the study by Brink et 
al. (2016) it was concluded that a multicentre antibiotic stewardship initiative, led by non-specialised 
pharmacists, decreased antibiotic prescribing across a large network of urban and rural hospitals in an 
infectious diseases resource-limited setting (Brink et al., 2016).Messina et al. (2015) performed studies, 
indicating that ASPs led by non- infections disease experts, had impressive results. Messina et al. (2015), 
another pharmacist-compelled process enhancement intervention in the same hospitals, resulted in a 
signiﬁcant change in the timing of administration (“hang time”) of intravenous antimicrobials in over 32 000 
patients. ASPs centred on nurses, still have to be documented; the success of task-shifting ART management 
from doctors to nurses suggests that nurses could be an important addition to stewardship programmes 
within and external from South Africa (Boyles et al., 2017). 
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2.5.4.3 Diagnostic challenges 
Antimicrobial use contributes significantly to most hospital budgets; with 30 to 50% of patients receiving 
antibiotics in several circumstances in the US (Know et al., 2003). The overuse of antibiotic is attributed by 
missed opportunities to reduce the burden of infections, especially in public hospitals (Laxminarayan et al., 
2012). Steps to reduce the burden of infections include the proper diagnosis of infections (Collins, 2005). In 
some situations, physicians might miss infections, because they have no access to diagnostic devices 
(Mendelson, 2015). 
According to research published in 2017, childhood deaths occurred in Sub-Saharan Africa at the time (Feikin 
et al., 2017). Most of these deaths are attributable to infectious diseases (Cox et al., 2017; Feikin et al., 2017). 
The burden of infectious diseases was significant in developing countries (Cox et al., 2017). Countries with 
high rates of HIV (Cox et al., 2017), malnutrition (UNICEF, 2007; Cox et al., 2017) and malaria (Cox et al., 2017) 
may render patients more susceptible to invasive bacterial infections. 
Although there is evidence that there is a burden of infection in developing countries, the availability of 
clinical microbiology laboratories is limited in hospitals (Cox et al., 2017). Currently, in South Africa, it is 
impossible to identify patterns of community compared to hospital-acquired bacterial resistance, 
attributable to a lack of linkage between laboratory and clinical data systems (Mendelson et al., 2016). In 
Sub-Saharan Africa there are several deaths, attributable to infections not quantified, attributable to the 
absence of laboratory confirmations (Feikin et al., 2017). The relevance of clinical bacteriology laboratories 
in low resource settings is increasingly documented as the increase in antimicrobial resistance is recognised 
as alarming (Barbe et al., 2017) 
 Accurate, reliable and punctual laboratory testing is important for confirming clinical diagnoses, conducting 
precise infectious disease surveillance and directing public health care policy (Feikin et al., 2017). An 
assessment of medical laboratories in Sub-Saharan Africa performed 10 years ago, revealed a system failure 
with unreliable analyses, leading to compromised patient care, unnecessary expenditures and a lack of trust 
from clinicians and health authorities (Barbe et al., 2017). This dysfunctional system was declared a barrier 
to healthcare in Africa (Barbe et al., 2017). 
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In developing countries, the laboratory and health care infrastructures are sometimes inadequate to meet 
the countries’ needs, attributable to limited funds (Feikin et al., 2017). The AMR crisis casts a new urgency 
on the need to improve performance levels as reference laboratories in Sub-Saharan Africa revealed severe 
shortcomings in bacterial identification and antimicrobial susceptibility (Barbe et al., 2017). Limited access to 
reliable diagnostic testing, misdiagnosis occurs, resulting in inadequate treatment, increased mortality and 
an inability to determine the true prevalence of diseases (Feikin et al., 2017). Inadequate access to laboratory 
testing led to clinicians finding alternative means of diagnosing disease, which causes uncertainty (Feikin et 
al., 2017). As an example, it was indicated that access to rapid tests for diagnosing malaria in Zambia led to 
a four-fold reduction in inappropriate antimalarial prescribing and a five-fold increase in the appropriate use 
of antibiotics for pneumonia (Mendelson, 2015). 
Barriers to laboratory testing in Sub-Saharan Africa are protean, are unique between and within countries 
and extend beyond economic constraints (Feikin et al., 2017). Health care policymakers and clinical 
investigators need to promote rational, cost-effective diagnostic methods for infectious disease, with an 
emphasis on improvement (Feikin et al., 2017). Although the life-threatening need for diagnosis of bacterial 
infections is recognised, clinical bacteriology only recently achieved eminence with policymakers, prompted 
by the increasing recognition of the looming crisis of AMR (Barbe et al., 2017). 
The World Health Organisation Regional Office for Africa (WHO AFRO) launched the Stepwise Laboratory 
Quality Improvement Process Towards Accreditation (SLIPTA) programme, which prepared clinical 
laboratories for ISO 15189 accreditation and also developed the Strengthening Laboratory Management 
Towards Accreditation (SLMTA) toolkit to support implementing SLIPTA (Barbe et al., 2017). These measures 
introduced by WHO AFRO, yielded reliable results. There was an increase in accredited laboratories in the 
past years through the WHO AFRO initiative in producing quality laboratories in low resource settings (Barbe 
et al., 2017). 
2.5.4.4 Knowledge and awareness of healthcare professionals on antimicrobial use and resistance 
Behaviour change is a main factor in correcting deficient prescribing practice (Mendelson, 2015). 
Inappropriate prescribing is compelled by a complex set of prescriber and patient behaviours (Mendelson 
2015). In the WHO (2015) report, in a survey conducted in the six regions and 133-member states, revealed 
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that public awareness of antimicrobial resistance was generally low in all regions. This challenge was also 
observed in countries where national public awareness campaigns had been conducted (WHO, 2015). The 
low level of awareness on antimicrobial resistance was observed in sectors of health care, politics, the media 
and academia. ABR became an established threat to global health and inappropriate prescribing behaviours 
by clinicians, were identified as a major contributing factor (Boyles et al., 2017). At community level, 
prescribing is often influenced by prescribers perceiving that their patients will be dissatisfied should they 
not receive an antibiotic, particularly for ARIs (Mendelson, 2015). 
Inappropriate use of antibiotics contributes to several factors, including doctors' lack of knowledge, 
inexperience and a lack of health care professionals’ education (Ghadeer, 2012). Ghadeer (2012) quoted 
earlier studies, indicating inappropriate prescribing and dispensing patterns, caused by prescribers and 
dispensers. Inadequate studies explicitly assessed paediatric prescribers’ knowledge and clinical approach to 
scenarios illustrating contemporary principles of antimicrobial stewardship (Bowes et al., 2014). 
Containment of antimicrobial resistance requires changes in the antimicrobial prescribing behaviour of 
changes in antimicrobial prescribing patterns, (Abera, Kibret & Mulu, 2014). He emphasised that changes in 
antimicrobial prescribing patterns will demand changes in prescribers’ behaviour towards the magnitude of 
the AMR challenge. He also emphasised that information on prescribers and nurses’ knowledge and belief 
on AMR will permit developing more effective interventions on containment of AMR. 
Ling et al. (2011), Mohamed et al. (2014), Barakh et al. (2016) conducted studies on public perspective on 
knowledge and attitude towards antibiotics, which partake a dynamic function in the achievement of 
treatment development. Results indicate that the public holds inadequate knowledge on antibiotics use and 
resistance. 
2.5.4.5 Health care facilities 
Health care facilities in LMIC’s have are significantly challenged with a basic lack of infrastructure, large 
patient numbers and shortage of health care personnel with high turnovers and deficient job satisfaction 
(Cox et al., 2017). Gaede and Versteeg (2011) agree with Cox et al. (2017) where they conclude that South 
Africa has deficient health outcomes, especially in rural areas, despite spending significantly more on health 
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than other middle-income and developing countries that produce advanced outcomes. A review of the state 
of health in SA, established insufficient progress in combatting HIV AIDS and malaria, no progress in 
improving maternal health and a deterioration in the mortality of children less than five years of age (Gaede 
& Versteeg, 2011). 
2.5.4.6 Adherence to clinical practise guidelines 
Clinical guidelines aim at assisting prescribers to render appropriate decisions concerning treatments for 
specific clinical conditions, comprising systematically developed reports (Principi et al., 2016). For these 
guidelines to be effective, they need to be shared with all health care professionals involved in prescribing 
antibiotics, including infectious disease specialists, microbiologists and pharmacists (Principi et al., 2016). 
Evidence-based clinical guidelines are also emphasised as an important device in promoting rational medicine 
use. They provide a benchmark of satisfactory diagnosis and treatment against which comparison of actual 
treatments can be made (WHO, 2002). 
Rebbeck et al. (2013) allude to the importance of implementation approaches for clinical guidelines and 
indicated modest effects in changing health professionals’ knowledge and practice. Targeted 
implementations are recommended as they suggest achieving proficient improvements. It was established 
that the patients attending training and later measured their compliance, significantly indicated a knowledge 
increase and were more likely to comply with the guidelines at follow-up (compliant at baseline 58%, follow-
up 79%, p = 0.002) (Rebbeck et al., 2013). It was concluded that a targeted implementation strategy improved 
health professionals’ knowledge and clinical practice, enabling them more compliant with clinical guidelines. 
The importance of developing and implementing facility-specific clinical practice guidelines is also 
recommended. The two associations recommend using the clinical guidelines where feasible (IDSA 2007; 
SHEA 2012). 
Barth et al. (2016) discuss the main barriers for clinicians to adhere to CPG, based on a review of adherence 
to clinical guidelines. The main factors were firstly identified as a lack of awareness, familiarity and agreement 
with the contents. Secondly, clinicians must sense that they have the skills to deliver on the CPG, able to 
overcome the inertia of “normal practice” and understand the need for change. Thirdly, the goals of clinicians 
and patients are not always the same. “Finally, there are a multitude of external barriers including 
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equipment, space, educational materials, time, staff, and financial resource” (Barth et al., 2016, p.1133). In 
the UK, inadequate physician adherence to clinical practice guidelines was indicated, leading to deficient 
medical care quality (New England Healthcare Institute, 2008). 
Ellodrt et al. (1995) determined factors that may led physicians not to comply with clinical practice guidelines 
in a large community teaching hospital. A retrospective analysis of patients whose physicians were not 
compliant with discharge recommendations from a prospective, controlled interventional trial of a guideline 
to reduce hospitalisation duration for patients admitted for chest pain (Ellodrt et al., 1995). Physician refusal 
accounts for a small percentage (16%) of non-compliance. Implementation issues, such as health care system 
inefficiency and severity of illness were the predominant reasons why physicians did not comply with 
guidelines. The study further supported the principle that clinical practice guidelines should complement 
rather than be a substitute for physician judgement (Ellodrt et al., 1995). 
Gould (1999) identifies a need for hospitals to develop guidelines to combat the increasing bacterial 
resistance and to promote the adequate use of antibiotics. Smith et al. (2012) share the same sentiments, 
establishing that there were no adverse events associated with implementing the developed guidelines. Oh 
et al. (2011) indicate that adherence to guidelines for managing CAP, increased patients’ clinical outcomes. 
Even though the need for developing guidelines is identified, Halm et al. (2000) and Van De Beek et al. (2002) 
emphasised the challenge of low to moderate adherence to guidelines. Grol (1997) postulates that, for 
guideline implementation to improve, the magnitude to which prescribers observe the necessity for a 
guideline and support implementing that specific guideline before the guidelines are developed and 
facilitated, must be recognised. 
Peter et al. (2004) conclude that a comprehensive enactment approach is required for prescribers to render 
their prescribing practices consistent with guideline recommendations. According to Peter et al. (2004), the 
reasons for barriers in appropriate use of antibiotics, using the prescribing practice guidelines, are as follows: 
A lack of dissemination of guidelines, uncertainty about the credibility of the content, an attitude that there 
is no need for guidelines, a lack of autonomy, insufficient knowledge, overestimation of the feasibility of an 
intervention and social and institutional context. The reasons for not implementing guidelines, varied 
extensively (Almatar, 2015). He acknowledged that several obstacles affect prescribers’ adherence, including 
the influence of senior doctors, were crucial in the non-compliance of guidelines, lack of awareness, the 
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requirement to do a calculation to assess the severity of the disease, existence of other conflicting guidelines 
and not expected to follow the guidelines. 
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CHAPTER 3: RESEARCH DESIGN AND METHODOLOGY 
3.1 Study design and setting 
3.1.1 Design 
This was a single-centre process improvement study with a pre-intervention phase. During this phase, a 
baseline was established. This was followed by a preparatory period. Thereafter a multifaceted intervention, 
aimed at achieving the primary objective of the study, was facilitated to achieve the establishment and 
evaluation of an ASP, aimed at combatting the inappropriate use of antibiotics and managing AGE in children 
< five years of age. The term intervention phase is used to represent the period following the intervention. 
The secondary objective, indicating investigating the KAP of healthcare professionals on antibiotics use and 
antibiotics resistance, was addressed by assessing the KAP of healthcare professionals involved in managing 
acute gastroenteritis in children before and after the intervention phase. The methodology for the primary 
objective is discussed first, followed by the methodology for the secondary objective. 
3.1.2 Setting 
The study was conducted at the RFM Hospital, one of the four high volume tertiary hospitals in ESwatini. The 
RFM Hospital is a 350-bed regional referral and teaching hospital situated in Manzini, the capital of ESwatini. 
The hospital occupies approximately 7,000 square metres of clinic buildings and 2,300 square metres of 
support buildings. The hospital is in the centre of ESwatini and is located in the most populated region. 
3.1.3 Duration 
The total duration of the study was 18 months. The research related to developing the ASP and its associated 
interventions, commenced with a six-month pre-intervention phase. Baseline data were collected between 
September 2015 and March 2016. This was followed by a preparatory period of six months. This period 
included developing the relevant clinical guidelines, developing the ASP terms of reference and research 
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training at the Tygerberg Hospital. This was followed by a six-month intervention phase, which occurred 
between September 2016 and March 2017. 
Investigating the KAP of healthcare professionals working at the RFM, was conducted between September 
2016 and March 2017, with an assessment before the intervention phase and another assessment at the 
conclusion of the phase. 
3.2 Ethics approval 
The Health Research Ethics Committee (HREC) at the Stellenbosch University (Ethics Reference number: 
S16/02/026) and the National Health Research Review Board (NHRRB) in ESwatini approved the study. RFM 
Hospital granted permission to conduct the study. 
The primary objective did not involve any invasive procedures. The interventions introduced, created a 
standard of care in the hospital, therefore a waiver was obtained from the Ethics Committees (HREC and 
NHRRB) not to require informed consent by the children’s guardians. Data was anonymously collected from 
patient records; study numbers were allocated, and no patient identifiers were collected. 
A structured questionnaire (Annexure 2) was used for the secondary objectives. The participants were 
provided information on the purpose of the study, using the questionnaires to collect data, and the benefits 
of being part of the study; the participants were requested to sign an informed consent form (Annexure 3) if 
they were interested. Participants were assured that they had the right to decide to be part of the study with 
no repercussions. 
3.3 Methodology for the primary objective: Developing and implementing an antibiotic stewardship 
programme 
3.3.1 Study population 
The following inclusion and exclusion criteria were used to define the patient population included in the pre-
intervention phase and the intervention phase. 
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3.3.1.1 Inclusion criteria 
The medical charts of children younger than five years of age, presented with AGE as a diagnosis during the 
six-month period of each phase, were included in the study. The following inclusion criteria were used: 
 Children younger than five years of age. 
 Children diagnosed with AGE as their primary diagnosis. 
 For inclusion in the intervention phase, children had to be admitted within 24 hours of presenting and 
being diagnosed with AGE. 
 For inclusion in the intervention phase, children had to be prescribed an antibiotic. 
3.3.1.2 Exclusion criteria 
Medical charts of children that met any of the following exclusion criteria, were excluded from the study: 
 Children who were severely dehydrated, attributable to an underlying disease that could affect the 
assessment of hydration. 
 Children with underlying chronic diseases, such as malignancy, gastroesophageal reflux, renal failure and 
liver disease. 
3.3.2 Collection of baseline data 
3.3.2.1 Selection of cases for inclusion 
To identify cases of AGE for establishing baseline data for the pre-intervention phase, the entries in the 
admission book in the children’s ward of all patients who were admitted between September 2015 and 
March 2016, were reviewed. All patients who were admitted with any form of diarrhoea during this period, 
were selected. This strategy was based on experience gained from a previous study, conducted at the same 
hospital, to assess the management and treatment of children less than five years, presented with diarrhoea 
in 2013 (Matsebula-Myeni, 2013). These include cases of wrong diagnoses by doctors. To anonymise patient 
data, anonymous participant codes were assigned to each case, identified from the list of admissions. 
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3.3.2.2 Data extraction 
A structured data extraction form (Annexure 4) was used to collect relevant demographic and clinical features 
from the medical charts for each patient. This would establish a baseline against which the interventions 
could be evaluated. Basic demographic data, including age, gender and source of diarrhoea (community vs 
hospital-acquired diarrhoea) were captured in the data extraction form. Extracted data included 
comorbidities, names and duration of the antibiotic used, total duration of stay (hospital days) and drug 
allergy history. Clinical notes by the prescribers in the daily rounds, were perused and interpreted with 
prescribers’ assistance. 
During the pre-intervention phase, there were no antibiotics prescribing guidelines, antibiotics prescription 
forms and restricted antibiotics prescription forms; these sections of the antibiotic stewardship form were 
therefore not completed. Chemistry tests were available before the intervention phase. Cultures (stool and 
blood) were not routinely performed in the laboratory; the sections on cultures could not be completed on 
the data extraction device for all cases. 
During the pre-intervention phase, there were no ward rounds where the laboratory technician and the 
research were involved. Prescribers made therapeutic decisions or alterations without involving other 
healthcare professionals; there were no documented recommendations from other healthcare professionals. 
Decisions to continue with a certain therapy or the addition of other laboratory investigations, depended 
solely upon the ward doctor. From the review of the files, follow-up on laboratory results and the availability 
of required medication from the Pharmacy, appeared inadequate. 
3.3.2.3 Review of baseline data 
The baseline data was reviewed to identify issues in managing AGE in children < five years of age. The issues 
and concerns identified during this review were used to inform the preparation of the multifaceted 
intervention to address the identified inappropriate managing AGE management. 
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3.3.3 Training at Stellenbosch University and Tygerberg Academic Hospital 
In preparation for the study, one month was spent at Stellenbosch University and the Tygerberg Academic 
Hospital for training. The hospital pharmacist at Tygerberg Academic Hospital were consulted and all 
documents used by the hospital concerning the ASP and managing acute gastroenteritis, were reviewed. The 
purpose of the training was to expose the research to the ASP established at the hospital and to be 
familiarised with materials used during ward rounds. During this training, the research was exposed to the 
prescriptions that were sent to the Pharmacy, indicating the antibiotic prescribing form, the restricted 
antibiotics prescribing form and the contributions by the pharmacist before dispensing the medication. The 
research conducted observed the ward rounds by the paediatrician in the gastro-enterology ward. Access to 
the clinical guidelines (AGE guidelines, hydration guidelines and antibiotic prescribing guidelines) was 
allowed. These were used in the paediatrics’ ward and processes followed by nurses in taking patient history 
and managing patients in the ward, were observed. 
3.3.4 Preparatory activities for antibiotic stewardship programme implementation 
3.3.4.1 Establishment of an antibiotic stewardship committee 
The research developed the terms of reference (TOR) of the antibiotic stewardship committee (ASC) 
(Annexure 5). The Senior Medical Officer at RFM Hospital approved the TOR. Members of the ASC were then 
appointed and tasked with establishing an ASP. The members of the ASC were identified, based on their 
individual expertise and included a pharmacist (the researcher), a paediatrician or the ward doctor and a 
laboratory technician (Annexure 5). Core members of the ASC were tasked to perform ward rounds 
concurrently, according to their functions indicated in the TOR, daily between Monday and Friday for the six-
months intervention period. The ASC core objectives are described in Annexure 5. 
3.3.4.2 Establishment of a steering committee 
A steering committee was established, comprising the members of the paediatrics department. The 
paediatrics department comprised a paediatrician, general practitioners and family nurse practitioners. The 
steering committee was responsible for developing the relevant clinical practice guidelines (Section 3.3.5). 
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The recommendation of the National Institute for Health and Care Excellence informed the rationale for the 
composition of the steering committee (NICE, 2014). When developing guidelines, it is crucial to involve the 
individuals who might be affected by the guideline recommendations in a collaborative and transparent way. 
The practitioners managing childhood diseases, were the stakeholders involved in developing and 
implementing the guidelines. Their function was to contribute to the draft initial guidelines developed 
according to their relevant expertise. Their contribution ensured that the guidelines addressed issues 
relevant to them and met patients’ health needs. It was ensured that the guidelines included medicines 
readily available in the hospital, procured with ease when required. The microbiologists ensured that all the 
laboratory tests that could be requested during the intervention, were in order. 
3.3.4.3 Development of prescription forms 
The steering committee reviewed the new prescription forms, adopted from Tygerberg Hospital. The forms 
were as follows: 
 Antibiotic prescribing form (Annexure 6). 
 Restricted antibiotic prescribing form (Annexure 7). 
Seven antibiotics were restricted in treating AGE and its comorbidities in the hospital. These included: 
Ceftriaxone, which was previously established to be inappropriately used in children diagnosed with AGE 
(Matsebula-Myeni, 2014) Ciprofloxacin, which is not indicated for children under 12 years or with a body 
weight, less than 40 kg; Piperacillin; Meropenum; Clindamycin; Tazobactam and Vancomycin; these five 
antibiotics are not included in the ESwatini national general patient’s formulary, since they are reserved for 
ICU or renal hospital patients. 
3.3.5 Development of clinical practice guidelines 
The steering committee was responsible for developing the following clinical practice guidelines: 
 Diagnosis, treatment and managing AGE and its comorbidities - namely pneumonia, bronchitis, 
pharyngitis, otitis media and tonsillitis (Annexure 9). 
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 Antibiotic prescribing guideline (Annexure 8). 
 SAM guideline (Annexure 10). 
Guidelines that were developed by the Tygerberg Academic Hospital in Stellenbosch (an antibiotic prescribing 
guideline and an acute gastroenteritis guideline accompanied by a hydration protocol) were used as a basis 
for developing an empirical clinical practice treatment guideline for common AGE comorbidities for the RFM 
Hospital. The practice guidelines that were used at Tygerberg Academic Hospital were modified. The 
prescribers at the RFM Hospital were consulted through the steering committee, regarding the modification 
of the guidelines to encourage the latter to ‘own’ the guidelines and fully facilitate them. The steering 
committee discussed these guidelines at the RFM Hospital during weekly meetings held every Tuesday from 
February 2016 to April 2016. The head of the paediatrics’ department chaired the meetings, coordinated 
through the research. All comments and feedback were documented, and relevant issues were discussed 
with the research supervisors at the Tygerberg Academic Hospital and the paediatrician at Tygerberg 
Hospital. 
These guidelines were developed primarily to achieve the best patient outcomes, with a secondary aim to 
encourage prescribers’ adherence to the guidelines. Multidisciplinary teams from the RFM Hospital, which 
included the Antibiotic ASC and the hospital guidelines and policy team, consulted Tygerberg Academic 
Hospital. These teams included critical care doctors, a surgical specialist, paediatricians, pharmacists, a 
microbiologist and nurses. The main goal was to involve specialists or departments, involved in treating 
patients in the children’s ward. Although the study did not include children with surgical conditions, all 
children at RFM Hospital use the same ward but children are admitted in various cubicles. It was also 
considered advantageous for all prescribers to be aware of the standard of care being introduced in the 
hospital. 
The Ministry of Health (MOH) disseminated a SAM guideline document in use at RFM during the study. The 
existing MOH guideline was compared with the SAM guideline from Tygerberg Hospital. The two guidelines 
agreed but the Tygerberg guideline was easier to read and follow. The research collaborated with the steering 
committee, facilitating the Tygerberg Academic Hospital guideline document. 
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3.3.6 Implementing the antibiotic stewardship programme and associated interventions 
Before implementing the ASP, the study was explained to all the children’s ward staff, which included the 
sisters in charge, staff nurses and nursing assistants, ensuring that they understood the new procedures 
established during the intervention study period. 
3.3.6.1 Implementing clinical practice guidelines 
Printed copies of the clinical practice guideline were distributed in the children’s outpatient department, 
emergency department, laboratory department, special care unit department and the Pharmacy 
department. During the intervention phase, implementing the newly established clinical guideline was 
assessed, including the acute gastroenteritis guideline (accompanied by the hydration protocol), the 
antibiotic prescribing guideline and the SAM guideline. The hydration protocol included six checklist 
questions and the antibiotic prescribing guideline, and the SAM guideline included 10 checklist questions 
each. Each guideline data extraction form had a compliant and a non-compliant field or section at the end. A 
prescription was considered compliant when it comprised over five correct responses in the AGE or hydration 
protocol section, and over eight correct responses in the antibiotic prescribing guideline and the SAM 
guideline. 
3.3.6.2 Identification of cases for inclusion in the antibiotic stewardship programme 
The ASP was facilitated in the 2nd week of September 2016 by the following process. The researcher identified 
medical charts of eligible participants each morning before the ward round. Patients who met the inclusion 
criteria, none of the exclusion criteria and who had received antibiotics for less than 24 hours were eligible 
to be included in the ASP. Medical records were reviewed prospectively by the research in the ASP team, 
with the assistance of the ward doctor and the nursing sister in charge (where necessary). 
3.3.6.3 Accompanied ward rounds 
The main activity of the antibiotic stewardship programme was the accompanied ward rounds as per the TOR 
(Annexure 5) of the ASC members. These ward rounds commenced in the second week of September 2016, 
when the ward doctor could be accompanied during each ward round. A dedicated laboratory technician, 
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assigned to the microbiology bench in the laboratory, was expected to be present. The department was short 
staffed; therefore, the research was discussed with the laboratory technician. Any information that needed 
his attention after the ward round was discussed with him. He could also be called in during the ward round. 
During the intervention phase, the children’s ward was visited every morning between Monday and Friday 
to see if there were any AGE admissions. All patients diagnosed with AGE’s files were retrieved from the filing 
cabin in the children’s ward. 
The ward round comprised a review of clinical notes and the results of laboratory and X-ray investigations. 
These were collected and analysed to establish the indication, planned duration and appropriateness of 
antibiotic therapy. Depending on each patient’s case, the cases were followed up as needed. Patients with 
severe acute malnutrition were followed up daily, as SAM with diarrhoea have high fatality rates. 
All relevant information needed, were followed up from the medical charts, contained in the data extraction 
form. Before the physical ward round, the following aspects were checked: 
 The diagnosis matched the clinical presentation of the patient. 
 The hydration guideline on admission was followed. 
 The presence of any diagnosed comorbidities. 
 Adherence to the antibiotic prescribing guideline. 
A course of antibiotic therapy was considered inappropriate and was eligible for ASP enrolment, if any of the 
following criteria were met: 
 Inappropriate dosage, defined as errors in dosage (under-dosing and over-dosing), frequency or 
formulations of antibiotics based on dose ranges suggested by the South African Medicine Formulary 
(SAMF), considering specific conditions, such as renal or liver dysfunction. 
 Antibiotic-bacteria mismatching (bacteria/drug mismatching), defined as use of a requested or current 
antibiotic with suboptimal activity against the bacteria according to culture or susceptibility results. 
 Inappropriate antibiotic selection for documented infection, which included susceptibility to a narrower-
spectrum agent, such as use of a gram-positive antibiotic for a gram-negative bacillus. The definition of 
inappropriate selection also included inappropriate route of administration, such as use of intravenous 
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therapy if the oral form of therapy was considered acceptable (guideline followed to determine 
acceptability, Annexure 8). 
 Inappropriate spectrum of coverage, which included therapeutic duplication (double coverage). This 
involves the prescription of two or more antibiotics with the same antibiotic activity, which is 
unnecessary (such as Piperacillin/Tazobactam and Metronidazole for treating anaerobic infections). 
 Inappropriate indication, indicating no evidence of infection or the infection was a viral infection for 
which antibiotics were unnecessary. There was absence of clinical, laboratory or radiographic evidence 
of infection or the presence of documented or suspected viral infection. 
 Contraindication based on the patient‘s drug allergy history, defined as the prescription of an antibiotic 
to patients with known allergies to a particular antibiotic or antibiotic class. 
 Prolonged duration of therapy, defined as unnecessarily prolonged therapy for the indicated infection 
based upon standards established by the SAMF. 
Patients who needed immediate attention were discussed with the ward doctor, including: 
 Severely dehydrated patients. 
 Patients with SAM. 
 Patients with SAM accompanied by severe dehydration. 
 Patients with SAM and kidney function tests that indicated infection. 
 Patients who had no or pending chemistry results but were initially diagnosed with moderate to severe 
dehydration. 
Each case was reviewed by the ward doctor and laboratory technician, considering local resistance patterns 
and then decided if the antibiotic use was appropriate. Decisions regarding inappropriateness, reasons why 
the use was inappropriate and recommendations for changes in antibiotic use, were collected on the 
standardised data extraction form (Annexure 4). 
Patients admitted on weekends or holidays were not enrolled in the ASP, unless enrolled in the study less 
than 24 hours after the start of antibiotic use; patients admitted after 12:00 pm on Sunday were enrolled in 
the study as the ward rounds are conducted between 08:00 am and 12:00 pm each weekday. The prescriber 
who admitted the patient, was contacted telephonically or a physical meeting was arranged in cases where 
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there was inappropriate management of the diagnosed disease and if a lack of correction could cause a 
serious adverse reaction. These cases included the following instances: 
 Patients who were eligible for bolus infusion, who did not receive it. 
 Patients who received wrong intravenous fluids by bolus administration. 
 Patients who received wrong maintenance intravenous fluids. 
 Patients who received a higher dose of antibiotics with ambiguous chemistry results. 
 Patients who were severely dehydrated and prescribed gentamycin without kidney function tests. 
 Patients showing impaired renal function. 
Prescriber’s on-call between 5:00 pm and 8:00 am were eligible to order restricted antibiotics without 
approval. In such cases, prescribers were not allowed to order over three doses without the restricted order 
form. During ward rounds, the ASC core members discussed cases where restricted drugs were used and 
decided whether to continue with the antibiotic. Use of restricted antibiotics was approved up to a specified 
‘stop date‘, but the research was allowed to dispense the restricted antibiotics after this date to prevent 
lapses in dosing for critically ill patients. The prescribing doctor or the laboratory was consulted for the 
relevant results. Once the information was collected and a prolonged treatment required, the patient could 
continue to receive the antibiotics until the treating doctor decided on a discontinuation. Resubmission of 
requests for restricted antibiotics before the approval stop date was encouraged. 
3.3.6.4 Recommendations 
Following the assessment of using all antibiotics and restricted antibiotics, all recommendations were 
recorded in the structured data extraction form. A change in using antibiotics or other related 
recommendations were suggested; the final decisions regarding antibiotic choices were left to the ward 
doctor, who was a member of the ASP team, or to the paediatrician. Documented recommendations were 
the following: 
 Discontinue antibiotics: elimination of duplicate therapy or unnecessary therapy. 
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 Modifying therapy: Adding an antibiotic, prescribing an antibiotic with a narrower or broadened 
spectrum, adjusting antibiotic dose or duration, changing the route of administration, or recommending 
an alternative therapy because of patient allergy. 
 Specialist consultations: When the antibiotic choice was complex, attributable to the complicated nature 
of the patient’s condition and a specialist consultation was considered necessary. 
 Other recommendations: Monitoring laboratory parameters, recommending sterile site cultures, 
removal of an infected source (the removal of a potentially infected device, for example, the intravenous 
cannulas). 
The recommendations were deliberated with the ASC, documented and kept in the relevant patient’s file. In 
the absence of an infectious disease specialist at the RFM Hospital, cases of complex diseases or treatments 
were referred to the paediatrician. For each patient, more than one type of recommendation could be 
recorded; in this instance, all recommendations were captured on the data extraction form. 
The research conductor and the ward doctor were responsible for discharging patients. Thereafter, 
complicated cases were discussed in the following regular ASC meeting, including: 
 Severe dehydration with SAM. 
 Re-admissions of SAM with dehydration and oedema. 
3.3.6.5 Control of restricted antibiotic use 
Use of restricted antibiotics required prior approval by the research, with close supervision by the 
paediatrician, especially in complicated cases (Annexure 7). 
3.3.6.6 Laboratory investigations 
The Laboratory Standard Operation Procedure (SOP) was adopted and the following tests were performed 
during the intervention. 
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3.3.6.7 Plasma glucose test 
Finger prick plasma glucose tests were performed in every child admitted with moderate to severe 
dehydration before the child was sent to the ward (Annexure 11). 
3.3.6.8 Liver and kidney function tests 
All patients with moderate to severe dehydration were tested for U&E before hydration with the appropriate 
intravenous fluids. For patients who presented with malnutrition as a comorbidity, kidney function tests were 
performed. The COBAS INTEGRA 400 PLUS test was used to analyse blood, cerebrospinal fluid (CSF) and urine 
chemistry estimations. A volume of 4 ml of blood was collected for the testing of all chemistry parameters in 
a Serum Separator Tube (SST) (yellow top) or plain container (red top). Each sample tube was labelled with 
the sample identification (ID) and Patient identification (PTID) number. The calibration, quality control, 
results processing and reporting and chemistry reference ranges are detailed in Annexure 14. 
3.3.6.9 Stool culture 
Fresh stool samples were collected on admission or during admission from patients to whom antibiotics were 
prescribed, preferably before administration of the antibiotics. The stool specimens were collected in a 
screw-capped sterile container and transported to the laboratory within two hours of collection. 
Upon reception at the laboratory, the specimens were provided unique bar codes for identification and then 
sent to the microbiology department for analysis. The stool specimens were macroscopically examined 
before culture and then inoculated onto Xylose Lysine Deoxycholate (XLD) agar, Sorbitol MacConkey, 
MacConkey and Salmonella Shigella Agar by spreading a pea sized portion of the stool on the culture plate 
using an applicator stick. An inoculating wire loop was then used to streak the stool with flaming in between 
streaking to obtain single colonies. Selenite broth was also used for enriching the stool specimens. A pea 
sized portion of the stool was inoculated into selenite broth using an applicator stick. The plates and broth 
were incubated at 37 °C aerobically for 16-24 hours after which the plates were observed for growth. The 
selenite broth was sub-cultured onto XLD and incubated for a further 16-24 hours at 37 °C. 
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All plates with growth were observed for colonial morphology and distinct features on each media used. 
Gram staining was accomplished to classify the bacterial isolates and further identification of the organisms 
with biochemical tests was conducted. The biochemical tests conducted included indole test, Kligler iron 
agar, motility, urease production and oxidase and citrate utilisation test (Annexure12) 
3.3.6.10 Antibiotic sensitivity testing 
Antibiotic sensitivity testing was conducted using the Kirby-Bauer disc diffusion method. An inoculum of the 
test organism was prepared by adding 3 to 5 colonies into 3 ml of normal saline. The turbidity of the inoculum 
was adjusted to match 0.5 McFarland standard solution. The inoculum was streaked onto Mueller Hinton 
agar using the lawn streaking technique. Antibiotics were then seeded onto the streaked plates within 10 
minutes. The plates were incubated at 37 °C for 18 hours after which they were checked for antibiotic 
sensitivity (Annexure 13) 
3.3.6.11 Radiographic investigations 
X-ray investigations were performed in patients with comorbidities like bronchitis and pneumonia or with 
SAM. The severe acute gastroenteritis guideline required that both the chest X-ray-AP and lateral were taken 
in each patient. The chest X-rays were read and interpreted by the doctor. 
3.3.7 Collection of intervention data 
The structured data extraction form (Annexure 4) was used to collect the relevant demographic and clinical 
features from the medical charts for each patient to compare any improvement in managing AGE when 
interventions for appropriate managing AGE were put in-place. The data extraction form was completed 
using data from medical charts and discussions made during the ward rounds. Basic demographic data 
including age, gender and source of diarrhoea (community vs hospital-acquired diarrhoea) were captured in 
the data extraction form. Clinical and other data included comorbidities, name and duration of the antibiotic 
used, total duration hospitalisation (hospital days) and history of drug allergy were also collected. The 
recommendations made during the ward rounds were recorded. 
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3.3.8 Measures of effectiveness of the antibiotic stewardship programme 
The following measures were used to assess the effectiveness of the ASP. 
 Days of therapy (DOS). 
 Cost of antibiotic therapy. 
 Duration of hospitalisation. 
 Targeted antibiotics consumption. 
 Appropriateness of antibiotic therapy. 
 Patient outcomes. 
3.3.8.1 Days of therapy 
The days of therapy (DOT) for each patient, were measured. The DOT was recorded for each antibiotic 
administered, regardless the dose and the frequency. For example, a patient who received amoxicillin 250mg, 
eight-hourly for three days had three DOT, whereas a patient receiving both amoxicillin 250mg, eight-hourly 
for three days and Metronidazole 100mg, eight-hourly for three days would have six DOT. 
3.3.8.2 Cost of antibiotic therapy 
The cost of antibiotic therapy was determined from the cost of each dose of the antibiotic used, obtained 
from the electronic system of the hospital Pharmacy and the duration of treatment. 
3.3.8.3 Duration of hospitalisation 
The duration of hospitalisation was calculated for each patient. The number of hospitalisation days were 
calculated from the time the patient was admitted. 
3.3.8.4 Targeted antibiotic consumption 
The proportion of restricted antibiotic versus unrestricted antibiotics used in the study were recorded. The 
restricted antibiotics were the targeted antibiotics, monitored in the study. 
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3.3.8.5 Proportion of inappropriate antibiotic courses and compliance with ASP team recommendations 
The proportions of antibiotic courses that were inappropriate and needed review by the ASP team were 
determined on admission and the rate of compliance with ASP team recommendations were determined 
during the ward rounds or on Day 3 by examining patients’ medical records to determine whether: (i) the 
antibiotic course was still inappropriate; and (ii) the ward doctor had accepted the ASP team’s 
recommendation. The compliance rate was defined as the proportion of all changes made by the ward 
doctor/ nurses in compliance with the ASP recommendations (treatment providers made changes after the 
communication with the ASP team in the intervention group) divided by all recommendations recorded in 
the data collection form by the ASP team. 
3.3.8.6 Antibiotic stewardship programme team recommendation at variance with culture results 
For cases in which alternative therapy (broadened or narrowed empirically) was recommended, it was 
determined whether any of recommended therapies were inconsistent with the antibiotic susceptibilities of 
any cultured organisms. 
3.3.9 Measures of patient outcomes 
3.3.9.1 Development of subsequent infection 
For cases in which it was recommended to stop therapy, it was determined whether the patients developed 
subsequent laboratory-confirmed infections, or any infections defined by the ward doctor. Patients who 
were discharged were followed up to see if they developed a subsequent infection (suspected nosocomial 
infection) within 72 hours following the ASP recommendation to discontinue antibiotic therapy. A nosocomial 
infection can be suspected in cases occurring within 48 hours of hospital admission, three DOS discharge or 
30 DOS an operation (Revelas, 2012). 
3.3.9.2 Readmission for AGE 
The researcher identified patients who were re-admitted for AGE within a week after discharge. 
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3.3.9.3 Mortality 
 Patients who died, had cause of death recorded. Mortality was calculated as number of deaths/ total number 
of patients enrolled in the study. 
3.4 Methodology for secondary objective: Investigation of the knowledge, attitude and practices of 
health care professionals on antibiotic use and antibiotic resistance 
3.4.1 Study population 
The following inclusion and exclusion criteria were used to define the participants population included in the 
pre-intervention phase and the intervention phase. 
3.4.1.1 Inclusion criteria 
 Healthcare professionals including doctors, pharmacists, Pharmacy technicians and laboratory 
technologists, who were managing children admitted at the children’s ward 
 Agreement to participate in the study. 
3.4.1.2 Exclusion criteria 
Healthcare workers that were not considered technical for the study; phlebologists, Pharmacy assistants and 
nursing assistants. 
3.4.2 Procedure 
To increase awareness and facilitate developing educational programmes and strategies for the appropriate 
use of antibiotics by the health care professionals working at the RFM Hospital, their KAP related to antibiotic 
use and antibiotic resistance was assessed. A quantitative research method was followed using a survey 
instrument developed for this purpose. To determine whether the ASP and its associated interventions 
resulted in any changes in the KAP of healthcare professionals the assessment was conducted at two time 
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points. The first assessment was performed before the intervention phase of the study and the second at the 
end of the intervention phase. A non-experimental, descriptive-correlational research design was used for 
the assessment. 
3.4.3  Survey instrument 
3.4.3.1 Development and validation of the KAP questionnaire 
A literature review was conducted of studies with performed similar surveys. The survey instrument was 
developed based on two studies by Awad t al. (2015) and Thriemmer et al (2013). The original questionnaire 
of Awad et al. (2015) focussed on the knowledge, attitudes and practices towards antibiotic use amongst the 
public in Kuwait. The second study by Thriemmer et al. (2013) investigated the knowledge, attitudes and 
practices amongst medical doctors and students in the Democratic Republic of Congo. A pilot study was 
conducted by four various healthcare professionals from the target participants. The participants in the pilot 
study were not included in the study. The questionnaire was then modified by the research, using feedback 
received from the professionals. To test the reliability of the instrument, a pilot test of the survey instrument 
was conducted using two modes of data collection (paper and electronic). The questionnaire was distributed 
to 30 individuals with a medicine or health sciences background. 
Revisions of the KAP questionnaire was made based on feedback from the pilot and included re-wording, re-
ordering and removal of some questions. 
3.4.3.2 Structure and content of the survey instrument 
The final version of the questionnaire (Annexure 2) comprised four sections that addressed the aims of the 
secondary objective. The four sections are described below. 
 Section A: Demographic profile of the healthcare professionals 
Demographic questions were included at the beginning of the questionnaire to establish the characteristics 
of the participants. As the purpose of the secondary objective was to investigate the perspectives of 
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healthcare professionals, the first demographic question sought to define the sample by asking participants 
to mention their professional background. Additional demographic questions sought to identify the highest 
level of education of each participant, the number of years since graduation, gender and age. The 
participant’s professional background was particularly important to address the research questions and 
provide a basis for comparison between variables. 
 Sections B to D: KAP of the health care professionals 
Section B comprised 27 questions that assessed the knowledge of the health care professionals. Section C 
comprised nine questions on attitudes. Section D comprised 12 questions related to behaviour. 
All the sections used a five-point Likert scale (Strongly Agree, Agree, Neutral, Disagree and Strongly Disagree) 
designed to capture the knowledge, attitudes and practices of healthcare professionals using scaled 
responses. A Likert scale is a rating scale in which the attitude of the respondent is measured on a continuum 
from one extreme to another with an equal number of positive and negative response possibilities and one 
middle or neutral category (Rea & Parker, 2005). As a framework for data analysis and presentation, five 
health care dimensions were developed: 
 Antibiotic resistance. 
 Antibiotic use. 
 Antibiotics misuse. 
 Healthcare professionals’ beliefs. 
 Health care practices. 
Each dimension comprised a response scale and the health care professionals were asked to indicate their 
perceptions across the five dimensions. The following conceptual definitions and number of items for the 
five health care dimensions were used: 
 Antibiotic Resistance: Health care professional’s knowledge and beliefs regarding antibiotic resistance. 
 Antibiotic Use: Knowledge and beliefs regarding antibiotic use. 
 Antibiotics misuse: Healthcare professionals’ knowledge and perception of antibiotics misuse. 
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 HCP’s beliefs: HCP’s beliefs pertaining to antibiotic use and antibiotic resistance. 
 Health care professionals Practices: Practices by HCPs regarding antibiotic use and antibiotic resistance. 
3.4.4 Recruitment 
 Healthcare professionals were approached during their meetings and provided information on the study. 
They also had an opportunity read the information leaflet and to ask questions where they were not clear. 
Informed written and signed consent was obtained from participants who voluntarily agreed to participate 
in the study. The participants were not provided any incentive for participating in the survey. 
3.4.5 Conduct of the survey 
Paper-based, self-administered structured questionnaires were distributed to staff members who had 
provided informed consent to participate in the KAP assessment. The informed consent forms were signed 
before the participants completed the questionnaire. The participants completed the questionnaire in the 
meeting room and submitted the completed questionnaire to the research. The participants completed the 
questionnaires without any use of reference material. During completion of the questionnaire, the research 
was available for providing clarifications on any of the questions if necessary. The researcher captured the 
data provided by the participants and submitted the raw data to the statistician. 
The pre-intervention KAP survey was conducted between the 3rd and the 7th of September 2016. The post-
intervention survey was conducted between the 20th and the 24th of March 2017. Nurses who were 
unavailable during the day shift, who were on night shift were missed in this exercise 
3.5 Statistical method 
3.5.1 Sample size and power calculation 
For the evaluation of the primary objective a sample size of 200 patients, 100 in each arm, was used. The 
sample size was calculated as follows: 
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A study conducted in 2014 by Huttner et al. (2014), demonstrated a 10% to 25% decrease in antibiotic use. 
In a study conducted by Cairns et al (2013), total broad-spectrum antibiotic use decreased immediately by 
16.6% (p < 0.001) when the intervention commenced in the ICU. The assumption was made that the 
intervention would reduce the number of children for whom antibiotics were incorrectly prescribed by 15%, 
with 80% power and a significance level set at 0.05, leading to a required sample size of 200, with 100 in the 
pre-intervention and 100 in the post-intervention phases. 
There are approximately 1500 admissions of children between 0 to 12 years presenting with all conditions 
annually in the children’s ward at RFM Hospital. The hospitalisation records for the period of January 2012 
and December 2012 were retrieved and the following information was derived: 80% of the 1500 admitted 
children were between 0 - five years; meaning that an average of 1200 children between the ages of 0 - five 
years were admitted per year. Of these approximately 240 children (20%) had AGE as the main diagnosis. If 
this number is halved, it means that in six months 120 children presented with and were admitted for AGE. 
It was estimated that it would be possible to identify approximately 120 children for inclusion in the study 
during each of the 6-month periods of the pre-intervention and intervention phases. The researcher 
identified 87 cases for inclusion in the pre-intervention phase and 126 for the intervention phase (sections 
3.3.2.1 and 3.3.6.2above). The realised sample was slightly different from the calculated sample size, with 
less than the 100 required cases identified in the pre-intervention and more identified in the post-
intervention phase. There was enough power to achieve the primary objective, as described later in the 
results section. 
3.5.2 Statistical analysis 
The analysis was conducted using STATA software version 14 (Stata corporation, 2016), as described below. 
P-values below 0.05 were used for statistical significance and 95%Cis reported for estimates were 
appropriate. 
3.5.2.1 Analysis for the primary objective 
The Shapiro-Wilk test was performed to test measured data for normal distribution. Normally distributed 
measured variables were presented as means and standard deviations; whilst medians and interquartile 
Stellenbosch University  https://scholar.sun.ac.za
65 | P a g e  
 
 
 
ranges (IQR) were described for non-normally distributed data. Frequencies and percentages were calculated 
to describe basic demographic and clinical data in the pre-intervention and intervention groups for 
categorical variables. Student’s t-test for continuous variables (or Wilcoxon sum rank test, if data were not 
normally distributed) and Pearson’s chi-squared test for categorical variables were used to determine 
whether there were significant demographic or clinical differences between pre-intervention and during 
intervention use of antibiotics, proportion of antibiotics used and compliance to ASP recommendations. If a 
categorical variable had a cell with fewer than five cases, Fisher’s exact test was performed for normally 
distributed variables. 
To understand using antibiotics, DOT per 100 patient-days, cost of antibiotic therapy and duration of 
hospitalisation for the six months of the pre-intervention phase were compared with those for the six months 
of the intervention phase. Causative agents (from stool samples) and sensitivity patterns (from blood 
samples) of the bacteria were analysed and presented as frequencies. Proportions of inappropriately 
prescribed antibiotics i.e. the incorrect antibiotic was prescribed for the causative agent, were also reported. 
The chi-square test was used to determine statistically significant differences in antibiotic prescribing, 
managing acute malnutrition and appropriate hydration between the pre-intervention and intervention 
phases. 
3.5.2.2 Analysis for the secondary objective 
For the comparison of the KAPs of various groups of healthcare professionals (doctors, pharmacists, 
Pharmacy technicians, nurses and laboratory technologists) at the RFM Hospital, the knowledge, attitudes 
and practices were summarised as scores and expressed as percentages. A knowledge score above or equal 
to 80% was considered as good knowledge, attitude and practice and a score below 80% considered as 
deficient knowledge, attitude and practice. The Kruskal Wallis test was used to compare KAP scores between 
various groups of healthcare professionals; and a chi-squared test was used to compare the good or deficient 
knowledge, attitudes and practices categories in the questionnaire. Additional analyses tested the 
association between demographic variables (professional background, level of education, age, gender and 
years of experience) and KAP scores. 
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CHAPTER 4: RESULTS 
4.1  Introduction 
This chapter outlines the results of both the pre-intervention and the post-intervention phase of the study. 
The results related to implementing the antibiotic stewardship programme (and the associated 
interventions) are presented first, followed by the results for investigating the KAP of healthcare workers. 
4.2 Results: Antibiotic Stewardship programme and associated interventions 
4.2.1 Demographic and clinical data of the patients 
There were 150 admissions that were initially identified and coded in this way. Of these, 30 cases were 
subsequently identified as deaths, four as re-admissions (one patient was re-admitted twice and two patients 
were each re-admitted once; the initial admission and re-admissions were consolidated as a single case for 
each patient, thus three cases in total), four cases of chronic diarrhoea and seven cases of bloody diarrhoea. 
The remaining 106 admissions were confirmed as cases with AGE as primary diagnosis. When the research 
went to the chart room to retrieve the patient files only 94 files could be located although the electronic 
system identified their physical location. Of the 94 files retrieved, two files were of patients with bloody 
diarrhoea and information was missing from five of the patient files. The total number of patient files 
available for review was therefore 87. 
In the six months after implementing the intervention, 153 patients were admitted with AGE. Of these, 18 
patients were excluded from the study as they had been admitted more than 48 hours before. Three patients 
passed away before being enrolled into the study, four patients had bloody diarrhoea and two patients had 
chronic diarrhoea. A total number of 126 patients were therefore identified for inclusion in the intervention 
phase. 
The demographic characteristics of the patients were the similar in the pre-intervention and intervention 
phases of the study (Table 4.1). The median age of patients included in the study was 10 months, with an 
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interquartile range of 5-15 months. The median age of patients whose files were included for collecting 
baseline data during the pre-intervention phase was 9 (5-14) months whereas the median age (IQ range) of 
children included study during the intervention phase was 10 (5-15) months, (Table 4.1). The difference 
between the median ages for the two phases was not statistically significant (P= 0.4882). Most the patients 
were male in both phases of the study and there was no statistically significant difference in gender. 
DEMOGRAPHIC AND 
CLINICAL 
CHARACTERISTICS 
UNITS OVERALL, N= 213 PRE-
INTERVENTION 
(N = 87) 
DURING 
INTERVENTION 
(N = 126) 
P-VALUE 
AGE MEDIAN (IQR) 
N=213 
 
Months  
 
10(5-15) 
 
9(5-14) 
 
10(5-15) 
 
0.4882 
GENDER N(%), N=212 Females 101(47.9) 42(48.8)  59(47.2) 0.815 
 Males 110 (52.1) 44 (51.2) 66 (52.8)  
WEIGHT, MEDIAN 
(IQR), N=213 
 
Kg 
 
7.3 (5.8-9) 
 
7(5.2-8.5) 
 
7.43(6-9) 
 
0.1064 
BODY 
TEMPERATURE, 
MEDIAN (IQR) N=213 
 
°C 
 
37.9 (37.9-38.7) 
 
38 (37.2-39) 
 
37.8(36.7-38.5) 
 
0.170 
 
Table 4.1: Demographics and clinical characteristics of children included in the study 
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Figure 4.1: Comorbidities diagnosed in all patients and during the pre-intervention phase and during the 
intervention phase separately 
 
Malnutrition was the most common comorbidity observed in the two phases of the study, followed by 
pneumonia and bronchitis (Figure 4.1). In the intervention phase, the number of pneumonia cases was lower, 
and the number of bronchitis cases was higher than in the pre-intervention phase. A few patients were 
diagnosed with otitis media and laryngitis during intervention phase. There were rare cases, 2(1.58%), where 
patients had more than one comorbidity. Of the 140 patients who were diagnosed with comorbidities in the 
study, 47 (34.8%) had severe acute malnutrition as one of the comorbidities, the percentages were almost 
the same in the pre-intervention and post-intervention (Figure 4.1). 
4.2.2 Effectiveness of the antimicrobial stewardship programme 
Of the 126 patients who were included in the intervention phase, 70 patients presented with cases that were 
eligible for ASP review. These were patients who needed modification of their antibiotics therapy. The 
antibiotics measures that decreased in the intervention phase were the antibiotics used, restricted antibiotics 
used, duration of therapy, DOT and the cost of antibiotics used. A statistically significant difference was 
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observed in the restricted antibiotics used (P<0.001), DOT (P=0.003) and the cost of antibiotics used 
(P=0.0024). 
4.2.2.1 Targeted antibiotic consumption 
 Antibiotic use 
All patients who were admitted for AGE and its comorbidities received antibiotics. The number of antibiotics 
used per patient remained at two in both phases of the study. There was no statistically significant difference 
observed in the antibiotic use between the two phases of the study. 
 Restricted antibiotic use 
From the total of 212 patients who received antibiotics in the study, there were 124 patients who received 
restricted antibiotics, including 69 patients (79.31%) in the pre-intervention phase and 55 patients (43.65%) 
in the intervention phase respectively. This difference was statistically significant (P<0.001). 
 Days of therapy and duration of hospitalisation 
A statistically significant difference was observed in the duration of therapy and duration of hospitalisation 
between the two phases of the study, with P=0.0003 and P=0.001 respectively (Table 4.2). 
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ANTIBIOTICS 
MEASURE 
VARIABLES 
UNIT OVERALL PRE- INTERVENTION DURING 
INTERVENTION 
P-VALUE 
DURATION OF 
THERAPY, 
MEDIAN (IQR) 
N=213 
Days  5(3-5) 5(5-5) 4(3-5) 0.0003 
DURATION OF 
HOSPITAL STAY, 
MEDIAN (IQR) 
N=213 
5(3-6) 5(5-7) 4(5-7) 0.0001 
Table 4.2: Duration of antibiotic therapy and duration of hospitalisation during the pre-intervention and 
intervention phase   
4.2.2.2 Cost of antibiotic therapy 
The average cost of the antibiotics used per patient in the intervention phase was E43.40 (E27.00-E109.00) 
compared to the pre-intervention phase E81.50 (E54.50-E121.70). A statistically significant difference of 
P=0.0024 was observed. 
4.2.2.3 Proportion of inappropriate antibiotic courses 
A decline in the number of inappropriate antibiotic courses was observed in the intervention phase and a 
statistically significant difference was observed (p<0.001) for all the variables listed in Table 4.3, except for 
the recommended doses prescribed (p=0.891). 
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Variable  Overall (%) 
N=212 
Pre-
intervention 
(%), (N=87) 
During 
intervention (%), 
(N=125) 
P-value 
Decision appropriate for 
prescribing an antibiotic on 
admission, n (%) 
No 122(57.55) 65(74.71) 57(45.60) <0.001 
Appropriate empirical 
antibiotics prescribed 
before microbial testing, n 
(%) 
No  124(58.49) 77(88.51) 47(37.60) <0.001 
Definite treatment 
prescribed after microbial 
testing, n (%) 
No  106(72.60) 78(73.58) 28(26.42) <0.001 
Doses prescribed as 
recommended by the 
clinical practice guidelines, 
n (%) 
No  35(16.43) 14(16.1) 21(16.8) 0.891 
Doses administered at 
correct dosing interval 
during admission, n (%) 
No  95(44.81) 53(60.92) 42(33.60) <0.001 
Table 4.3: Inappropriate antibiotics courses in the pre-intervention and during the Intervention 
4.2.2.4 Antibiotic stewardship recommendations 
There were 150 recommendations made by the ASP core team during the intervention phase. The 
recommendations most frequently made were “Change dosing interval”, “Convert from IV to oral” and “Stop 
antibiotics”. Two recommendations were adopted fully in all cases, i.e. “Increase dose” and “Initiate 
antibiotics”. Recommendations for changing the dosing interval were not adopted. The other 
recommendations were partially adopted (“Stop antibiotics”, “Change antibiotics” and “Decrease dose”). 
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 Antibiotic stewardship recommendations adopted 
Out of the total of 150 recommendations made by the ASP core team during the intervention 85(56%) were 
adopted. “Increase of dose” and “Initiate antibiotics” were the fully adopted. None of the antibiotic 
stewardship recommendations of “Change dosing interval” were adopted. 
Figure 4.2: Antimicrobial stewardship recommendations made and adopted during the intervention 
 
 Proportion of antibiotic stewardship recommendations at variance with culture results 
From the total of 150 recommendations made, 35 recommendations informed by culture results and 
sensitivity results, which were “Stop antibiotics” (21, 14%) and “Change antibiotics” (14, 9.33%). The 
proportion of recommendations proposed informed by culture results was 23% and the proportions of 
recommendations adopted at variance with culture was 17.1% 
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4.2.2.5 Patient outcomes 
 Development of subsequent infections 
There were no patients who developed subsequent infections during the intervention phase. 
  Re-admissions for AGE 
There were four cases of re-admissions in the pre-intervention phase compared to the intervention phase 
where one readmission was observed. 
  Mortality 
During the intervention phase two patients passed away within an hour of admission, before they were 
enrolled in the ASP and were excluded from the number of deaths observed during the intervention phase. 
There were 30 (22.1%) deaths observed in the pre-intervention phase compared to the 15(11.9%) deaths 
during the intervention phase. The causes of death during the pre-intervention phase were as follows: 14 
deaths caused by SAM, seven deaths, attributable to AGE, four deaths, attributable to sepsis, pneumonia or 
bronchitis and five deaths, attributable to severe dehydration. 
4.2.3 Bacterial cause of acute gastroenteritis 
4.2.3.1 Culture results 
No culture or antibiotic sensitivity tests were performed in the hospital during the pre-intervention phase. 
During the intervention phase, 59 laboratory requisition forms were completed by prescribers for stool 
culture, one for blood culture and one for CSF. 
The positive cultures of organisms were divided into four groups, namely: Enteropathogenic Escherichia coli 
(E. coli), Gram- positive bacilli, gram-negative bacilli and Klebsiella. For Enteropathogenic Escherichia coli (E. 
coli) there were 20 positive cultures (32.79%) and two (3.28%) positive cultures were reported as gram-
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positive bacilli, with no specific organism mentioned. There were also seven positive cultures (11.58%), which 
were reported as gram-negative bacilli, with no specific organism mentioned. There were two positive 
cultures (3.28%) of Klebsiella. Nineteen samples (31.15%) did not yield significant growth and 11 samples 
(18.03%) were not analysed by the laboratory department. 
4.2.3.2 Sensitivity results 
Drug sensitivity tests were performed for all samples that had positive cultures (31 cultured samples, 100%). 
E.coli was resistant to Ceftriaxone (13 samples), cotrimoxazole (5 samples), chloramphenicol (5 samples) and 
amoxicillin (8 samples). E.coli was sensitive to gentamycin (6 samples), nalidixic acid (9 samples) and 
ciprofloxacin (5 samples). Gram-positive bacilli (one cultured from blood) were resistant to Ceftriaxone (2 
samples), Metronidazole (2 samples), gentamycin (1 sample), nalidixic acid (2 samples) and amoxicillin (2 
samples). Gram-negative bacilli were resistant to Ceftriaxone (4 samples), cotrimoxazole (4 samples) and 
chloramphenicol (3 samples). Both Klebsiella samples tested were resistant to Ceftriaxone, gentamycin and 
cotrimoxazole, but sensitive to nalidixic acid. 
4.2.4 Compliance with clinical practice guidelines 
4.2.4.1  Antibiotics prescribing guideline 
A statistical significance (<0.001) difference in antibiotic prescribing in the pre-intervention and during 
intervention was observed, except the doses prescribed variable, which indicated no statistical significance 
difference (0.891) between the two phases of the study (Table 4.4). 
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Variable  Pre-
intervention, n 
(%) 
During 
Intervention, n 
(%) 
P-value 
Decision appropriate for prescribing 
an antibiotic, n (%) 
Yes  22(25.29) 68(54.40) <0.001 
No 65(74.71) 57(45.60) 
Culture conducted before 
administration of antibiotics, n (%) 
Yes  2(2.30) 35(28.00) <0.001 
No  85(97.70) 90(72.00) 
Appropriate empirical antibiotics 
prescribed, n (%) 
Yes  10(11.49) 78(62.40) <0.001 
No  77(88.51) 47(37.60) 
Definite treatment prescribed after 
relevant assessment  
Yes 5(12.5) 35(87.5) <0.001 
No  78(73.58) 28(26.42) 
Not 
appli
cable 
4(4.60) 62(49.60) 
Practised infection control, n (%) Yes  3(3.45) 100(80.00) <0.001 
No  84(96.55) 25(20.00) 
Were antibiotics evaluated 
appropriately, n (%) 
Yes  31(35.63) 110(88.00) <0.001 
No  56(64.37) 15(12.00) 
Use of microbiology and other 
relevant tests for informing managing 
infection, n (%) 
Yes  32(36.78) 73(58.40) <0.001 
No  55(63.22) 46(36.80) 
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Variable  Pre-
intervention, n 
(%) 
During 
Intervention, n 
(%) 
P-value 
Not 
appli
cable 
0(0.00) 6(4.80) 
Doses prescribed as recommended in 
clinical practice guidelines, n (%) 
Yes  73(83.9) 102(81.6) 0.891 
No  14(16.1) 23(18.4) 
Switching from intravenous therapy 
to oral therapy, n (%) 
Yes  5(5.75) 39(31.20) <0.001 
No  80(91.90) 37(29.60)  
Not 
appli
cable 
2(2.35) 49(39.20)  
Doses administered at right correct 
dosing interval, n (%) 
Yes  34(39.08) 81(64.80) <0.001 
No  53(60.92) 42(33.60)  
Table 4.4: Statistically significant differences in antibiotic prescribing in the pre-intervention and during 
intervention 
4.2.4.2 Guideline for the diagnosis, treatment and managing AGE and its co-morbidities 
In the following sections, the guideline for the diagnosis, treatment and managing AGE and its comorbidities 
will be referred to as the AGE guideline. 
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 Severe acute malnutrition 
After an assessment of every child admitted for AGE at RFM Hospital during the study period, a total of 44 
patients were diagnosed with SAM. In the pre-intervention phase, there were 17 patients diagnosed with 
SAM and 27 patients in the intervention phase. Improvements to the diagnostic measures required by SAM 
guideline for the proper diagnosis and managing SAM are indicated in Figure 4.3. There was a statistically 
significant difference in the number of appropriate diagnostic measures (plasma glucose measure, 
appropriate blood tests, urine Microscopy Culture and Sensitivity and chest X-ray) that were performed 
during the intervention phase compared to the pre-intervention phase (p < 0.001). Most (41/44) of the 
patients’ urine was not cultured. Only one urine test was performed in the pre-intervention phase and only 
two urine tests were performed during the intervention. 
Out of the total of 44 patients who were diagnosed with SAM in the study overall, 41 patients where checked 
for plasma glucose on admission. During the intervention phase, plasma glucose tests were performed for all 
27 patients on admission and in the pre-intervention, only three patients were not checked for plasma 
glucose. 
Most patients in the intervention phase (21/27) underwent appropriate blood tests (albumin, renal function 
test). In the pre-intervention phase only two of the 17 patients underwent appropriate blood tests. There 
was a statistically significant difference between the two phases of study (P<0.001) for the performance of 
appropriate blood tests. In cases where the results indicated an infection, urine MCS (Microbiology, Culture 
& Sensitivity) was conducted and it was conducted for three patients in the study. In the pre-intervention 
phase, the urine MCS could not be performed as the albumin and renal tests were not performed in majority 
of the patients. During the intervention phase, eight patients were eligible for urine MCS but only two 
patients had urine cultures performed. 
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Figure 4.3: Number of patients (%) with severe acute malnutrition in whom appropriate diagnostic tests 
were performed during the pre-intervention phase 
 
For the study, 39 of the patients were provided appropriate nutritional feeds, 14 patients in the pre-
intervention phase and 25 patients in the intervention phase. The number of patients who were provided 
the appropriate fluids were higher in the intervention phase 19 patients, in comparison to the pre-
intervention phase where nine patients were provided appropriate fluids, but the increase was not 
statistically significant (P = 0.072). Chest X-rays were performed in 27 patients diagnosed with SAM in the 
study overall, mainly to determine the presence of tuberculosis (TB) co-infection, amongst other possible 
infections. A statistically significant difference between the pre-intervention and the intervention phases was 
observed for the number of chest X-rays (P<0.001). Most patients, namely 24 patients, had a chest X-ray 
taken in the intervention phase. 
A total of 21 of 44 patients diagnosed with SAM were checked and their electrolytes corrected where needed 
and there was a statistically significant difference between the two phases of the study (P<0.001). Twenty-
four patients of the 27 patients diagnosed with SAM in the intervention phase were provided micronutrient 
supplements and three patients of the 17 patients were provided micronutrient supplements in the pre-
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intervention phase. Out of the 44 patients admitted with SAM in the study overall, there were 30 patients 
who had an appropriate follow-up planned and most them (23 patients) were in the intervention phase. 
VARIABLE   OVERALL  PRE-
INTERVENTION  
DURING 
INTERVENTION 
P-VALUE 
NUTRITIONAL FEEDS, 
N 
Yes  39 14 25 0.297 
No  5 3 2 
HYDRATION 
APPROPRIATE, N 
Yes  28 9 19 0.072 
No  13 8 5 
Not 
applicable 
3 0 3 
ELECTROLYTES 
CORRECTED, N 
Yes  21 1  20 <0.001 
No  23 16  7  
MICRONUTRIENTS 
SUPPLEMENTED, N  
Yes  27  3  24  <0.001 
No  17  14 3  
FOLLOW-UP 
PLANNED 
APPROPRIATELY, N  
Yes 
No  
30 
14 
9 
8 
21 
6 
0.002 
Table 4.5: Statistically significant difference in treating severe acute malnutrition in the pre-intervention 
and during the intervention 
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 Acute gastroenteritis guideline (Hydration protocol) 
There was a statistically significant difference (P<0.001) between the pre-intervention phase (43.7%) and 
during the intervention phase (70.6%), in prescribers mentioning if there was dehydration or no dehydration 
accompanying the diarrhoea. Fifty-nine per cent of the patients had some dehydration, followed by those 
who were severely dehydrated (43%). A statistically significant difference between the two phases in the 
categorised degree of hydration was not indicated (P=0.734). 
Sixty-one patients in the study was eligible to receive rehydration through a short-term infusion, of these 
patients 46 (75.41%) received the rehydration through a short-term infusion and 15 (24.59%) did not receive 
through a short-term infusion. All the patients who received the rehydration through a short-term infusion 
was established in the intervention phase of the study. There was a statistically significant difference 
(P<0.001) between the number of patients who received rehydration through a short-term infusion during 
the pre-intervention and intervention phases of the study. 
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Figure 4.4: Degree of dehydration observed in the pre-intervention and during the intervention 
  
 
Most of the patients who received short-term infusion in the study, namely 45 (78.95%), received an 
appropriate fluid replacement. In 12 patients (21.05%) the type of intravenous fluid was not mentioned. 
There was a statistically significant difference in the appropriateness of the intravenous fluid used (P< 0.001) 
between the pre-intervention and intervention phases. 
Most patients, namely 170 (79.81%) received appropriate fluid maintenance replacement in the study and a 
statistically significant difference between the pre-intervention and intervention phases (P<0.001) was 
observed (Table 4.6). There was no statistically significant difference between the two phases in the correct 
rate and appropriate volume of rehydration fluid administered in the study. Most of the patients, namely 
172 (80.75%) received fluids at a correct rate and the appropriate volume was used in the study (Table 4.6). 
There were 111 (52.86%) biochemical investigations (renal function tests and plasma glucose) that were 
conducted appropriately in the intervention phase, whilst 98 (77.78%) biochemical investigations were 
conducted in the pre-intervention phase (Table 4.6). 
Appropriate routine medication (vitamin A and zinc sulphate) was provided to 161 patients (77.40%) in the 
study, whilst 34 patients (16.35%) were not provided the appropriate routine medication (Table 4.6) and a 
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statistically significant difference (P<0.001) between the two phases was observed. Most of the patients in 
the intervention phase, namely 111 (88.10%), were provided the appropriate medication, compared to the 
pre-intervention phase, in which 50 (60.98%) were provided the appropriate medication (Table 4.6). 
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Variable  Overall, N 
(%) 
Pre-
intervention, 
N (%) 
Intervention, 
N (%) 
P- value 
Appropriate fluid for 
bolus infusion, n (%) 
 
Yes  45(78.95) 0(0.00) 45(78.95) <0.001 
No  12(21.05) 0(0.00) 12(21.05) 
Method of 
rehydration 
appropriate, n (%) 
Yes 166(77.93) 49(56.32) 117(92.85) <0.001 
No 47(22.06) 38(43.68) 9(7.14) 
Appropriate fluid 
used, n (%)  
Yes  170(79.81) 50(57.47) 120(95.24) <0.001 
No  43(20.19) 37(42.53) 6(4.76) 
Correct rate and 
volume of fluid used, 
n (%) 
Yes  172(80.75) 50(57.47) 122(96.83) <0.001 
No  41(19.25) 37(42.53) 4(3.17) 
Investigations 
conducted 
appropriately, n (%) 
Yes  111(52.86) 13(15.48) 98(77.78) <0.001 
No 76(36.19) 69(82.14) 7(5.56) 
Not 
applicable 
23(10.95) 2(2.38) 21(16.67) 
Routine medication 
provided, n (%) 
Yes 161(77.40) 50(60.98) 111(88.10) <0.001 
No 34(16.35) 30(36.59) 4(3.17) 
Not 
applicable 
13(6.25) 2(2.44) 11(8.73) 
Table 4.6: Hydration management in acute gastroenteritis cases in the pre- intervention phase and during 
the intervention 
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4.3 Results: Knowledge, attitude and practices of health care professionals on antibiotics use and 
antibiotics resistance 
4.3.1 Demographic characteristics of the participants 
A statistically significant difference (P<0.001) concerning the professional background of the participants 
during the pre-intervention and the intervention phases of the study was observed (Table 4.7). Gender and 
highest education level did not indicate any statistical significance difference (P=0.951) and (P=0.207) 
respectively. 
A total of 34 healthcare professionals were recruited during the pre-intervention phase and included medical 
doctors (9), nursing staff (11), Pharmacy technical staff (10) and laboratory technicians (4). Some nurses were 
recruited in the paediatrics doctors’ meeting, as they are family nurse prescribers and some nurses were 
recruited in the children’s ward. 
A total of 41 healthcare professionals were recruited for the post-intervention survey namely: Nine medical 
doctors, 14 nursing staff, 12 Pharmacy technicians and six laboratory technicians. 
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Table 4.7: Demographic characteristics of the participants in the study 
4.3.2 Knowledge, attitude and practice of health care professionals from various professional 
backgrounds in the pre-intervention phase 
A statistically significant difference was observed in the knowledge of healthcare professionals from various 
professional backgrounds in both the Likert scale and multiple-choice assessments (Table 4.9). For the 
assessment by Likert scale, a statistically significant difference was observed between Pharmacy 
technicians/pharmacists and laboratory technologists (p=0.034) and between nurses and laboratory 
technologist (p=0.029). In the assessment using multiple-choice questions, a statistically significant 
difference was observed between medical doctors and pharmacists (p=0.004) and between nurses and 
laboratory technologist (p=0.041). 
  
Demographic and 
clinical characteristics 
 
Overall, 
N= 75 
Pre-
intervention 
N= 34 
During 
intervention 
N= 41 
 
P-value 
Gender N (%) Males  40(53.33) 18(52.94) 22(53.66)  
 Females 35(46.67) 16(47.06) 19(46.34) 0.951 
Professional 
Background N (%) 
Medical Doctor 18 (38.66) 9(26.47) 
 
9(21.95)  
 
Nurse  22 (24.00) 11(32.35) 11(24.83)  
Pharmacy 
Professional staff 
26 (34.67) 10(11.76) 16(29.27) <0.001 
Laboratory 
professional staff 
9(12.00) 4(11.76) 5(23.20)  
Highest Education 
level N (%) 
Diploma 
 
30(40.00) 11(32.35) 19(46.34) 
 
 
 
 
Bachelor’s Degree  
23(30.67) 11(32.35) 12(29.27)  
Post Graduate 
Diploma 
 
19(25.33) 12(35.29) 7(17.07) 0.207 
BSC Honours Degree 1(1.33) 0(0.00) 1(2.44)  
Master’s Degree 2(1.33) 0(0.00) 2(4.88)  
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Table 4.8: Knowledge, attitude and practice of health care professionals from various professional 
backgrounds in the pre- intervention phase 
 
Characteristics  Medical 
doctors 
Pharmacists/ 
Pharmacy 
Technicians  
Nurses Laboratory 
Technologist 
P-Value 
Knowledge, 
Mean (SD) 
Likert 
Scale 
score 
 82.4(7.13) 
 
75.3(7.8) 75.63(7.46) 86.6(3.13) 0.0074 
 Multiple-
choice 
score 
8.4 (7.1) 5.1(2.74) 5.4(2.06) 8.4(1.34) 0.005 
Attitude, 
Median (IQR) 
Likert 
Scale 
score 
44(43-45) 39(34-43) 41.5(40.5-45) 43(41-45) 0.0502 
Practice, Mean 
(SD) 
Likert 
Scale 
score 
40(5.9) 47.2(7.83) 41.06(6.07) 44.8(8.67) 0.0772 
4.3.3 Knowledge, attitude and practice of healthcare professionals during the pre-intervention and post-
intervention phases of the study 
The healthcare professionals Likert scale results between the pre-intervention and during the intervention 
did not indicate any significant statistical difference in the knowledge on antibiotics use and resistance (Table 
4.10). An improvement concerning percentages was observed in most of the 17 questions that were included 
in the questionnaire to assess the healthcare professional’s knowledge. Only one question had a 100% 
Characteristic  Medical 
doctors 
Pharmacists/ 
Pharmacy 
Technicians 
Nurses Laboratory 
Technologist 
P-Value 
Knowledge, 
Mean (SD) 
Likert 
Scale 
score 
 70.56(6.19) 
 
67.82(6.34) 71.1(5.9) 71(1.4) 0.567 
 Multiple-
choice 
score 
5.33(1.11) 4.1(1.0) 5.1(1.29) 2(2.25) 0.007 
Attitude, 
Median (IQR) 
Likert 
Scale 
score 
38(36-43) 40(37-43) 41.5(37-42) 44.5(41-45) 0.3925 
Practice, Mean 
(SD) 
Likert 
Scale 
score 
37(33-39) 40(38-41) 37(5.16) 36.5(35-43.5) 0.6236 
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correct response in the study, and it was observed during the intervention, the question was “Humans can 
be resistant to antibiotics” (Table 4.10). 
Healthcare professional’s knowledge on antibiotics use (Likert scale) Pre-
intervention 
During 
intervention 
P-Value 
Question    
1. Different antibiotics are needed to cure various diseases, correct 
response n (%) 
27(79) 36(88) 0.158 
2. Antibiotics are effective against bacteria, correct response n (%) 32(94) 40(98) 0.934 
3. Antibiotics are effective against viruses, correct response n (%) 27(79) 32(78) 0.531 
4. Antibiotics will speed up the recovery of colds and cough, correct 
response n (%) 
23(67) 27(78) 0.355 
5. Antibiotics should be used to acute diarrhoea, correct response n (%)  15(44) 26(63) 0.532 
6. Antibiotics shortens the duration of acute diarrhoea, correct response 
n (%) 
14(41) 25(61) 0.324 
7. If you get side effects during a course of antibiotics treatment you 
should stop taking them as soon as possible, correct response n (%) 
16(47) 31(76) 0.222 
8. If you get skin reaction when using antibiotics, you should not use the 
same antibiotic again, correct response n (%) 
16(47) 19(46) 0.551 
9. Is amoxicillin sensitive to E.coli bacteria? Correct response n (%)  13(38) 18(44) 0.427 
10. Is gentamycin indicated for chronic diarrhoea, correct response n 
(%?)? 
16(47) 28(68) 0.041 
11. Is Metronidazole the best drug for acute diarrhoea? Correct response 
n (%) 
20(59) 28(68) 0.223 
12. Ceftriaxone is the golden treatment for treating bacterial pneumonia, 
correct response n (%) 
18(53) 24(59) 0.138 
13. Antibiotics can cause imbalance in the body’s own bacterial flora, 
correct response n (%) 
28(82) 38(93) 0.102 
14. The unnecessary use of antibiotics can increase the resistance of 
bacteria to them, correct response n (%) 
32(94) 38(93) 0.390 
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15. Resistance of antibiotics is a global challenge, correct response n (%) 31(44) 37(90) 0.417 
16. Using antibiotics amongst animals can reduce the effect of antibiotics 
amongst humans, correct response n (%) 
15(44) 30(73) 0.307 
17. Humans can be resistant to antibiotics, correct response n (%) 30(88) 41(100) 0.100 
Table 4.10: Healthcare professional’s knowledge as assessed by Likert scale during the pre- and the post-
intervention phases of the study 
Ten multiple-choice questions were assessed on knowledge on all the healthcare professionals in the pre-
intervention and during the intervention (Table 4.11). Out of the 10 questions, three questions indicated a 
significance statistical difference, namely: 
“A 6-year-old child has a fever of 38 °C, purulent rhinitis and angina for two days. At inspection, the throat is 
reddish. Which treatment do you recommend”? (P<0.001) 
“During your ward round, you see two patients with severe renal failure. Patient A is a 4-year-old suffering 
from serious cellulitis at the leg, she is treated with clindamycin. Patient B is five years old with a juvenile 
diabetes which is empirically treated for septicaemia with ceftriaxone. Dosage reduction is needed for”? 
(P=0.003). 
“Methicillin resistant - Staphylococcus aureus is susceptible to”? (P=0.004), (Table 4.11). 
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Healthcare professional’s knowledge on antibiotics use (Multiple-
choice) 
Pre- 
intervention 
During 
intervention 
P-value 
Question  
 
 
30(88) 
 
 
 
38(93) 
 
 
 
0.510 
1. A 4-year-old girl has diarrhoea for 4 days (3 stools/day). She has 
no fever at examination nor during the last few days. Which 
treatment do you propose? Correct response n (%) 
2. A 6-year-old child has a fever of 38 °C, purulent rhinitis and 
angina for two days. At inspection, the throat is reddish. Which 
treatment do you recommend? Correct response n (%) 
 
 
3(9) 
 
 
20(49) 
 
 
0.00 
3. During your ward round, you see two patients with severe renal 
failure. Patient A is a 4-year-old suffering from serious cellulitis 
at the leg, she is treated with clindamycin. Patient B is five years 
old with a juvenile diabetes which is empirically treated for 
septicaemia with Ceftriaxone. Dosage reduction is needed for? 
Correct response n (%) 
 
 
 
 
 
4(12) 
 
 
 
 
 
17(41) 
 
 
 
 
 
0.003 
4. Which one of the following antibiotics is safe in neonates? 
Correct response n (%) 
 
26(76) 
 
32(78) 
 
0.871 
5. Which one of the following antibiotics has the best activity 
against anaerobes? Correct response n (%) 
 
28(82) 
 
30(73) 
 
0.344 
6. Methicillin-resistant - Staphylococcus aureus is susceptible to: 
Correct response n (%) 
 
7(21) 
 
23(56) 
 
0.004 
7. Which one of the following antibiotics most effectively crosses 
the blood-brain barrier? Correct response n (%) 
 
18(53) 
 
25(61) 
 
0.926 
8. Aminoglycosides such as gentamicin are active if they are 
administered as follows: Correct response n (%) 
 
21(62) 
 
31(76) 
 
0.135 
9. At RFM Hospital, what is according to your information the 
estimated resistance rate of Salmonella Typhi to Cotrimoxazole 
(Bactrim)? Correct response n (%) 
 
 
8(24) 
 
 
18(44) 
 
 
0.193 
10. At RFM Hospital, what is according to your information the 
estimated resistance rate of Klebsiella to Ceftriaxone? Correct 
response n (%) 
 
 
8(24) 
 
 
22(54) 
 
 
0.122 
Table 4.11: Healthcare professional’s knowledge as assessed by multiple-choice questions during the pre-
intervention and the post-intervention phases of the study 
Nine questions were directed to assess the healthcare professional’s attitude on antibiotics. Even though an 
improvement was observed in all the questions during the intervention, there was no statistical significance 
difference observed between the two phases of the study, (Table 4.12. There were also eleven questions that 
assessed the healthcare professionals’ practices and a statistical significance difference (P= 0.004) was 
observed in one question. 
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Healthcare professionals’ attitude on antibiotics use Pre-
intervention  
During 
intervention  
P-value 
Question    
1. There is abuse on antibiotics at present, correct response n 
(%) 
30(88) 38(93) 0.378 
2. Antibiotics resistance became a challenge in ESwatini, correct 
n (%) 
28(82) 38(93) 0.017 
3. Abuse of antibiotics became the main cause leading to 
bacterial resistance, correct response n (%) 
31(91) 37(90) 0.256 
4. Antibiotics resistance affects the livelihood of the 
community, correct response n (%) 
29(85) 38(93) 0.375 
5. It is necessary to get more education about antibiotics, 
correct response n (%) 
33(97) 41(100) 0.015 
6. There is a need to establish course on ‘rational use of 
antibiotics’ at university level, correct response n (%) 
32(94) 39(95) 0.569 
7. It is necessary to conduct evidence base research on 
antibiotics use, correct response n (%) 
33(97) 40(98) 0.159 
8. It is necessary to formulate an antimicrobial stewardship 
committee in the hospital, correct response n (%) 
31(91) 37(90) 0.218 
9. It is necessary to have continuous profession education about 
antibiotics, correct response n (%) 
32(94) 41(100) 0.917 
Healthcare professionals’ practice towards antibiotics use     
10. Doctors prescribe antibiotics when having fever (>38.5°C), 
correct response n (%) 
3(9) 21(51) 0.004 
11. Doctors prescribe antibiotics for coughing, correct response 
n (%) 
6(18) 20(49) 0.138 
12. Doctors often tell patients/caregivers on how antibiotics 
works, correct response n (%) 
10(29) 22(54) 0.954 
13. Pharmacists often tell patients how antibiotics should be 
used, correct response n (%) 
20(59) 25(61) 0.478 
14. Pharmacists often ensure the right dose of antibiotic is 
provided to the patient, correct response n (%) 
23(68) 29(71) 0.463 
15. Pharmacists often give patient education on antibiotics, 
correct response n (%) 
10(29) 18(44) 0.804 
16. Doctors often prescribe antibiotics because the patient 
expect it, correct response n (%) 
15(44) 24(59) 0.753 
17. Doctors often consider carefully whether antibiotics are 
needed or not, correct response n (%) 
16(47) 23(56) 0.050 
18. Pharmacists trust doctors’ decision when she or he prescribe 
antibiotics, correct response n (%) 
14(41) 16(39) 0.302 
19. Doctors trust pharmacists that they will dispense and advise 
patients on using antibiotics, correct response n (%) 
25(74) 26(63) 0.993 
20. Doctors’ advice that antibiotics can be used when cough last 
up to two weeks or more, correct response n (%) 
9(26) 20(49) 0.344 
21. Patients can be provided antibiotics when they ask them, 
correct response n (%) 
28(82) 33(80) 0.598 
Table 4.12: Healthcare professional’s attitude and practice during the pre- and the post-intervention phase 
measured using the Likert Scale 
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CHAPTER 5: DISCUSSION 
5.1  Antibiotic stewardship programme 
5.1.1 Demographic and clinical characteristics of the patients 
In this study, diarrhoea was observed most frequently in children between the ages of 6-11 months, with the 
median age of 10 months and an interquartile range of 5-15 months as indicated in Table 4.1. This result is 
consistent with other studies in finding that diarrhoea prevalence is higher in younger children (Hung, 2006; 
Oloruntoba et al., 2014; Kabayiza, 2014) and that the prevalence is highest for children 6-11 months of age, 
remaining at a high-level amongst one-year old children and decreasing in the third and fourth years of life 
(Brhanu et al., 2017). In contrary to the current study findings, Thiam et al., 2017, reported the highest 
prevalence of diarrhoea in children between the ages of 24-59 months. 
In the current study there were more males (52.13%) hospitalised than females (47.87%). This finding is 
consistent with the previous research by Matsebula-Myeni (2014) in the same institution. In several other 
studies more boys were diagnosed with AGE than girls (Muhsen et al., 2017, Staat et al., 1991; Siziya, Muula 
& Rudatsikira, 2013). In a study by Banerjee (2004) more girls than boys were diagnosed with AGE. 
The establishment of an ASP is inadequate to curb the emerging antibiotics resistance but putting prepared 
interventions in-line with the current practices/challenges for that particular setting and then measurement 
of the effectiveness of the ASP is critical. 
5.1.1.1 Targeted antibiotic consumption (overall use and restricted antibiotics) 
The expected reduction of the antibiotic consumption during the intervention phase was not achieved. This 
can be attributed to the fact that during the pre-intervention phase, Ceftriaxone was commonly used, and it 
was the only antibiotic prescribed per patient during the course of the therapy. Overusing Ceftriaxone at RFM 
Hospital especially in children was discussed in several DTC meetings (January, March and June) (RFM, 2015). 
During DTC meetings, prescribers defended their choice of antibiotic since Ceftriaxone covers both gram-
Stellenbosch University  https://scholar.sun.ac.za
92 | P a g e  
 
 
 
positive and gram-negative bacteria, so for them that was crucial as the child might present with an infection 
which was missed by the prescriber and the factor that it is provided twice daily (DTC, 2015). 
The prescribers also mentioned that the administration of Ceftriaxone is easy and convenient for the nurses 
and they are confident that when prescribed, administration in admitted patients is definite, compared to 
cefazolin which should be provided eight-hourly. The prescribers’ preferred choice of antibiotic is contrary 
to the current STG of the Kingdom of ESwatini (MOH, 2012), as Ceftriaxone is not recommended as first-line 
antibiotic for the most frequently observed comorbidities in patients in this particular study. The prescribers’ 
preferences are, however, in agreement with the results of study by Friedman (2013) in which it was 
established that a prescribing pattern is influenced by several factors, one of which is the ease and practicality 
of administration of a treatment. Friedman’s (2013) findings are consistent with those of Medved (2013) who 
identified the medication factors, environmental factors and patient factors, predicting the occurrence of 
medication administration time errors by registered nurses in an acute care setting in Canada. The results of 
his study indicated that time criticality was one of the independent predictors of medication administration 
delivery time errors in the research setting (Medved, 2016). 
In the current study, a significant decrease in the consumption of antibiotics was expected because the 
prescribers were availed of the antibiotic prescribing guidelines, stipulating clear criteria on when to use an 
antibiotic. No significant decrease in the total number of antibiotics prescribed was observed. This finding is 
contrary to various studies, indicating a decrease in antibiotic use after implementing ASP programmes 
(Cairns et al., 2013; Mercer et al., 1999; Bassetti et al., 2000; Berlid et al., 2001; Ansari et al., 2003; Siddiqui 
et al., 2007; Cheng et al., 2009; Teo et al., 2012; Michaels et al., 2012; Hagert et al., 2012; Storey et al., 2012; 
Vettese et al., 2013 and Principi et al., 2016). A change towards a reduced use of Ceftriaxone was observed; 
it was restricted in AGE during the intervention phase and there was a shift towards the overuse of 
gentamycin and Metronidazole in the intervention phase. 
When implementing the ASP during the intervention phase, patients received a combination of at least two 
antibiotics per admission, which were mainly a combination of Metronidazole and Gentamycin. These two 
antibiotics were not restricted for AGE in the intervention phase of the study and prescribers were not limited 
to them concerning prescribing. Although the prescribing guideline facilitated during the intervention phase, 
explained that antibiotics were not recommended for acute diarrhoea but only in persistent and chronic 
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diarrhoea, or when accompanied by sepsis (RFM, 2016), doctors prescribed antibiotics for all patients eligible 
for hospitalisation. The research established that prescribers relied on the laboratory investigation to 
determine if antibiotics can be excluded from the treatment and all were patients put on antibiotics awaiting 
laboratory bacterial culture investigations. Despite the growing evidence that most bacterial AGE infection 
are EPEC and using antibiotics is not recommended, as in most cases, EPEC-induced diarrhoea is self-limiting 
and can be effectively treated with ORT (Ochoea, 2011; Pawlowski, Warren & Guerrant(2011). Ochoea et al. 
(2011) report that EPEC may rarely produce persistent infections, which may require antibiotics. 
A statistically significant reduction (P<0.001) was observed in using restricted antibiotics. Using Ceftriaxone 
decreased during the intervention phase, as it was a restricted antibiotic, which required approval from the 
pharmacist after the prescriber had completed the restricted antibiotic form. The significant decrease in 
using Ceftriaxone suggests that restricting some antibiotics could be an effective intervention in preventing 
abuse of some antibiotics. This result also suggests that the abuse of Ceftriaxone was since there was no 
proper managing antibiotics and that close monitoring of antibiotics use can limit inappropriate use of 
antibiotics. Restricted antibiotics were identified as a crucial strategy for effective ASPs in other studies (Rahal 
et al., 1998; Paterson, 2006; Buising, 2011; Carling, 2012). 
In the current study, there were only six patients for whom antibiotics were not prescribed on admission, but 
these were later recommended by the ward doctor who based his recommendation on the persistence of 
the diarrhoea, which continued despite the rehydration conducted and using medication like the zinc tablets 
and other supplements. All six patients to whom antibiotics were not prescribed were admitted by the same 
doctor. During the steering committee meetings that were held every Thursday, the prescriber who did not 
prescribe the antibiotics on admission, criticised the stewardship team on adding antibiotics to the patient’s 
therapy. Most of the prescribers indicated that in their opinion it was crucial to treat the patients with 
antibiotics, but they were not specific on which antibiotic should be used. 
The high percentage of antibiotic use was not influenced by implementing the ASP, attributable to the 
prescribing doctors’ reluctance to not use antibiotics in the children admitted with AGE. They did, however, 
stop antibiotics in response to antibiotic stewardship recommendations and this resulted in a decrease in 
DOS intravenous therapy. The researcher had expected implementing the ASP to bring about a decrease in 
the total number of antibiotics prescribed to patients (whether restricted or not), in keeping with the 
Stellenbosch University  https://scholar.sun.ac.za
94 | P a g e  
 
 
 
literature, but it failed to change the prescribing habits of the prescribing doctors. It is possible that the 
unavailability of an infectious disease (ID) physician and a microbiologist in the team contributed to this 
pattern. The researcher supports the notion that an effective ASP requires a multidisciplinary team including 
an ID physician, a microbiologist and a clinical pharmacist with infectious diseases training. Putting together 
such a multidisciplinary team is not always feasible in low-income countries like ESwatini. There were 
measures that were successful, however, as discussed below. 
5.1.1.2 Days of therapy and duration of hospitalisation 
A statistically significant decrease in the duration of hospitalisation was observed during the intervention 
phase compared to the pre-intervention phase. There are several factors that could have contributed to the 
decreased DOT and duration of hospitalisation. It was provided by instances where conversion from 
intravenous to oral therapy was introduced during the intervention phase, proper hydration of dehydrated 
patients and appropriate managing SAM. Elliot (2010), indicated that increased rates of admission of children 
with gastroenteritis is exacerbated by malnutrition as a comorbidity and electrolytes disturbances. The 
results and the outcomes of implementing the SAM guidelines will be discussed later in this chapter. 
Bruzzese, Giannattasio & Guarino (2018), also indicate that hospitalisation was associated with antibiotics 
prescriptions. 
The shortened DOS IV therapy in the intervention phase enabled ward doctors to discharge patients after 
the two to three days and ward doctors had an option to discharge patients with an oral therapy. The 
researcher observed that the doctors did not see a need of continuing the patients with oral therapy for over 
three days in several cases, as the patients responded well to the therapy and there were no signs of 
infections. 
These results are consistent with other studies that indicated a decrease in days of hospitalisation and DOT 
in cases where conversion from IV to PO therapy was facilitated and when adherence to treatment guidelines 
were demonstrated (Cyriac & James (2014); Akpan et al., 2015; Tejaswin et al., 2018; Ng et al., 2008). The 
conclusion that can be drawn from this, suggests that days of hospitalisation are influenced by the DOT, in 
turn influenced by the drugs formulation received by the patients. Patients who are on oral therapy have a 
possibility of an early discharge compared to patients on IV therapy, because oral therapy can be provided 
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at home. In the past there has also been the conventional way of prescribing antibiotics for a specific number 
of days, for example for 5 days or 7 days, explaining why several patient admissions lasted for five or seven 
days. Eliminating antibiotics therapy, as suggested in the AGE guidelines, can decrease the days of 
hospitalisation. The socio-economic factors associated with AGE and SAM was studied in LMICs (Hamer et 
al., 1998; Hugh, 2006; UNICEF, 2007). 
5.1.1.3 Cost of antibiotic therapy 
Although a statistically significant difference was not observed between the two phases of the study, a cost 
decrease was observed. The researcher measured the cost of the antibiotic provided, but other costs such as 
the cost of medical supplies and professional costs were not measured. In the pre-intervention phase, most 
patients received intravenous therapy throughout the period of hospitalisation which had a minimum of 5 
days. They received Ceftriaxone injections which come in a powder form and require sterile water for 
reconstitution, intravenous administration sets, syringes, needles and a compactible intravenous fluid. If the 
cost of these supplies had been taken into consideration when calculating the cost of antibiotic therapy, the 
difference in cost would were even higher. 
The ethical aspect of considering cost versus the best interest of the patient when rendering decisions about 
treatment consider was argued informally in the hospital DTC meeting (RFM, 2016). Early switch of the 
patients from IV therapy to PO therapy, contributed to the considerable decrease in the cost of the antibiotics 
therapy. Besides lower drug cost, costs of medical supplies and staff support are higher for IV than oral 
therapy, although these have not been assessed in the present study. 
Although cost saving was not initially the main aim of the antibiotic stewardship programme, high cost 
savings related to antimicrobial use are often used to justify ASPs (Dodds Ashley et al., 2014). The budget of 
pharmaceuticals and medical supplies is ESwatini was decreasing after several years. The ESwatini MOH and 
politicians are considering measures that can be put in-place to decrease the budget of medicine without 
compromising patients’ clinical outcomes. In view of the results and the literature on the benefits of switching 
from IV therapy in ASP (Fischer et al., 2003; McLaughlin et al., 2005; Lee & Lindstrom 2007 and Tejaswini et 
al., 2018), the RFM Hospital administrator and Senior Medical Officer is advised to support establishing ASP 
in the hospital and expand the programme the entire hospital and to the 20 associated community clinics. 
Stellenbosch University  https://scholar.sun.ac.za
96 | P a g e  
 
 
 
Since antibiotic stewardship needs a lot of funding (mainly for laboratory tests and trained personnel) proving 
that they can save costs might render hospital managers support that establishment and implementing ASPs. 
Other studies reported signiﬁcant cost savings brought about by ASPs demonstrating the importance of ASPs 
in LMICs (Mercer et al., 1999; Bassetti et al., 2000; Berlid et al., 2001; Ansari et al., 2003; Siddiqui et al., 2007; 
Cheng et al., 2009; Teo et al., 2012; Michaels et al., 2012; Hagert et al., 2012; Vettese et al., 2013 and Principi 
et al., 2016). 
5.1.1.4 Proportion of inappropriate antibiotic courses 
The patients that were eligible for the ASP enrolment, had one of the following variables. 
 Inappropriate indication 
The appropriateness of the indication of the antibiotics was measured using the four variables, fever; 
leucocytosis with neutrophilia and left shift, toxic granulation; raised inflammatory markers and specific 
organ dysfunction. More than half of the patients in the pre-intervention phase were inappropriately 
provided an antibiotic on admission. An improvement in the appropriateness courses of antibiotics during 
the intervention phase was observed, which was a statistically significant. More than half of the patients in 
the intervention were eligible to be provided an antibiotic compared to only 35% in the pre-intervention who 
had been were eligible to be provided an antibiotic. The improvement in the intervention phase could be 
attributable to the quality of the patient history available during the intervention phase compared to the pre-
intervention phase. For example, the prescribers in the intervention phase, diagnosed more comorbidities in 
the pre-intervention phase. The variable that could have misled the prescribers in prescribing antibiotics in 
the intervention phase is the presence of fever. 
In the DTC’s meeting at RFM Hospital (RFM, 2014), a paediatrician mentioned that children who come in with 
temperatures above 38 °C needs antibiotics as part of their treatment as fever can indicate a bacterial 
infection. This statement might have caused the inappropriate decision to prescribe antibiotics in the study, 
because most patients had fever. Fleisher & Matson (2017), indicated that bacterial infection is sometimes 
hard to distinguish from viral infection. Bruzzese, Giannattasio & Guarino (2018), alluded that fever is not 
necessarily a strong indication for bacteria, but more clinical evaluation needs to be conducted. In diarrhoea, 
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bacterial infections are more common in locations where there is unsafe drinking water and deficient 
handling of sewage (Fleisher & Matson 2017). This might be true in the region were the study was conducted, 
as the hospital is situated in a highly populated area, which is close to the Matsapha Industrial site (Swaziland 
Population, 2018; UN, 2017). 
The 2nd variable used to determine appropriateness of antibiotic indication was increased white blood cells. 
This variable was measured in all patients who were diagnosed and hospitalised for AGE. Although the 
increased number of white blood cell did not confirm whether the infection was bacterial or viral, it at least 
provided the research the idea of a presence of infection. This variable also tends to mislead prescribers in 
shifting their minds towards bacterial infections. 
The 3rd variable considered in establishing the rationale of initiating empirical antibiotic therapy was 
measuring raised inflammatory markers C - reactive protein (CRP). Although, Adelstein and Baker (2014) and 
Bruzzese, Giannattasio and Guarino (2018) consider measuring CRP as the most practical way to detect and 
monitor the presence and progress of a systemic inflammatory response, in our current study, our laboratory 
could not measure CRP, attributable to a lack of modern equipment that can measure the CRP. The 
researcher considered to measure this variable in the intervention phase, as she was misled by the laboratory 
technologist that there is a laboratory machine that could measure CRP. The researcher believes that if CRP 
measurements were conducted in the hospital, it could have assisted the ASP in better recommendations of 
modification of therapy. Considering the importance of the CRP measurement, the research has motivated 
the need for measuring CRP with the laboratory and the management motivated in the MOH and currently, 
even though it was after the study, the hospital have a new machine that can measure the CRP. 
The 4th variable considered, was organ dysfunction. The main organ taken into consideration in the context 
of the thesis was the kidney. The kidney function tests were performed in every patient diagnosed with AGE 
on admission. This test and a liver function test were mandatory if the patient had SAM as a comorbidity. 
 Inappropriate dosage 
The correct dose was appropriately conducted in both phases of the study. In the study only 16.43% cases 
had an inappropriate dose prescribed. There were no significant differences observed in the two phases of 
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the study. The importance of prescribing the correct dose was discussed by several authors (Rello, 2007; 
Dryden et al., 2011; Ghosh et al., 2014 and Bielicki et al., 2015). A challenge experienced during the 
intervention phase was the administration of the antibiotics at the correct dosing interval. Although there 
was an improvement and a statistically significant difference observed during the intervention phase, the 
number of cases (42/125, 33.60%) in whom the correct dosing interval was not adhered to is still considered 
too high. An intervention is needed to improve adherence to the appropriate dosing interval. The antibiotics 
that were not administered at the correct dosing interval were mainly those that were prescribed three times 
daily. During the intervention phase, when nurses were asked and advised about the dosing interval, most 
of them had no idea of their wrong doing. They thought three times a day mean morning, afternoon and 
night versus eight-hourly dosing. 
Another dosing interval challenge was managing the first dose time provided at the point of admission 
(Outpatient department or emergency room). The nurses at the wards did not consider the time of the first 
antibiotic dose, for example, a patient admitted at 16:00hrs would also get another dose at 20:00hrs as a 
standard time for administration of medicines in the wards. 
Non-adherence to the dosing intervals of antibiotics prescribed three times daily could also be attributed to 
the nurses’ standard shifts in the hospital. The four standard shifts have an hour of reporting exercise and 
then administration of medicines. Two from the four shifts start at 07:00hrs which renders and the standard 
first dose is at 08:00hrs after the reporting section. The staff will be more during the day and at second dosing 
is 14:00hrs, the third dose is at 20:00hrs after the evening shift report. 
The researcher reported the challenge regarding adherence to the correct dosing intervals and made a formal 
request from the Chief Nursing Matron to change the nurse’s shift to correctly dose the patients, but during 
the study period, the nurses’ day and night shifts could not be changed. The medication errors arising from 
nursing care was appraised by Smeulers et al. (2015), where he mentioned that one-third of all medication 
errors causing harm to hospitalised patients occur in the medication preparation and administration phase, 
which is predominantly a nursing activity. 
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 Antibiotic-bacteria mismatching (bacteria/drug mismatching) 
In the current study, there were less cases where their antibiotic-bacteria mismatching was observed. The 
researcher established it challenging to ensure that the bacteria/drug mismatching was appropriately 
evaluated in this study, because there was a limitation of blood culture from the laboratory department. 
With the data and the analysis done, the research could not determine the inappropriateness of the 
antibiotic/documented infection. 
 Inappropriate antibiotic selection for documented infection 
The researcher could not measure the appropriateness of antibiotics for documented infection as it lacks an 
institutional antibiogram. An antibiotic recommended primarily (acute gastroenteritis guideline) for 
treatment of bacterial diarrhoea is cotrimoxazole. The researcher did not expect the prescribers to prescribe 
cotrimoxazole, as sensitivity studies in this hospital have indicated 100% resistance in E.coli cultured form 
the stools of hospitalised patients that were treated with AGE in this hospital, in a quality improvement study. 
Although cotrimoxazole is a safe drug to use in paediatrics and covers a lot of bacteria and may treat several 
conditions, its value in treating other conditions, except as prophylaxis for HIV/AIDS, has declined. Overusing 
cotrimoxazole in the hospital could have caused the high resistance observed. 
In the current study, appropriateness concerning antibiotic treatment in managing SAM was observed. The 
clinical guidelines stipulate empirical treatment with Ceftriaxone for cases of AGE with SAM as comorbidity. 
In AGE cases with SAM as a comorbidity, Ceftriaxone was not considered as a restricted antibiotic. All patients 
that were diagnosed with SAM were provided Ceftriaxone therapy at the maximum dose. 
The researcher was challenged with using Ceftriaxone in pneumonia during the intervention phase. The 
prescribers filled the restricted antibiotic prescribing forms in cases of Ceftriaxone prescription for 
pneumonia, but the reason they offered was the unavailability of blood culture to determine the bacteria 
that caused the pneumonia. The hospital also lacks an antibiogram that can inform the common bacteria 
established in pneumonia. An unresolved argument in the hospital and amongst members of the ASP 
committee was using amoxicillin and amoxicillin-clavulanic acid in treatment of pneumonia in children that 
had AGE as a primary diagnosis. Because of the side-effect of penicillin to cause diarrhoea prescribers had 
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reservations regarding using the amoxicillin and amoxicillin- clavulanic acid for these cases. Another reason 
offered by prescribers was the fact that amoxicillin is extensively used for URTIs and its overuse is thought 
be to link to resistance that was indicated in a quality improvement study by the DTC. 
 Prolonged duration of therapy 
During the intervention, prescribers adhered to the prescribing a 3-day course of antibiotics and prescribed 
them for longer periods in cases where there was a comorbidity, i.e. SAM or pneumonia. The researcher 
together with the ward doctor made recommendations when the antibiotics therapy was prolonged 
unnecessarily. 
5.1.1.5 Antibiotics stewardship recommendations 
During the intervention phase, recommendations aimed at ensuring the appropriate use of antibiotics during 
accompanied ward rounds (section 3.3.6.3). There were 150 recommendations made for 94 of the 126 
patients who were included in the intervention phase. In some cases, more than one recommendation was 
made in a patient. The higher percentage of recommendations made during ward rounds suggests an 
intensive commitment of the healthcare professionals during the ward rounds and it may also reflect that 
the admitting doctors did not do due diligence in appropriately prescribing and assessing the antibiotic 
therapy. The researcher introduced and measured interventions that were realistic and easier to transmit 
and easier for physicians to adopt, as previously facilitated by Pasquau et al. (2015). 
The percentage (74.6%) of antibiotic stewardship recommendations made in this study was higher than the 
45% recommendations made, reported by Metjian et al. (2008), who performed a prospective observational 
study to describe the use and impact of a paediatric ASP. They assessed the outcomes and compliance on 
empiric antimicrobial therapy decisions and recommendations to discontinue antimicrobial therapy and it 
was also higher than the percentage observed by Cairns et al (2013) (35%), who introduced ASP in inpatients 
hospitalised in three metropolitan hospitals in Melbourne. The documentation of recommendations in the 
intervention phase allowed the ASP core team (ward doctor, pharmacists and laboratory technologist) to 
analyse the divergences on the managements of conditions requiring antibiotics in their therapy. 
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Decisions about altering antibiotic therapy were informed by microbiology results and other clinical findings. 
The ward doctor, pharmacist and laboratory technologist made these decisions together. There were 
instances where one antibiotic was changed to another depending on the drug sensitivity and other instances 
where the antibiotics were stopped because there was no bacterial growth. When the results were available, 
it was easier for doctors to accept the alteration of the therapy than when the decision had to be taken solely 
based on the patient’s clinical status. There were cases where the patients stayed in hospital longer because 
there were no laboratory results obtained from the laboratory departments, so patients had to continue 
treatment. 
5.1.1.6 Stopping antibiotics 
During the intervention, 14% of the recommendations made in the ASP were to stop antibiotic courses and 
the ward doctor approved 85.71% of these recommendations. The researcher recommended that the 
antibiotics should be stopped because there was no indication for the antibiotics. The prescribers were 
reluctant to stop antibiotics in cases where the patients were still having loose stools. Other cases that made 
the recommendation to stop antibiotic therapy a challenge were cases where there were comorbidities. The 
ward doctor argued that it would be too risky to stop antibiotics when there were no negative blood cultures 
available to confirm the absence of the bacterial infection. 
5.1.1.7 Modifying therapy 
 Changing dosing interval 
The most frequently made recommendation was “Change dosing interval” (28%), which is consistent with 
the results of a study by Principi et al. (2016), who also established the most frequent recommendation was 
related to changing of dosing interval. This recommendation was not adopted at all, as the hospital stipulated 
times for administration of injectable doses. The nursing department provided the nurses a schedule of three 
times daily which is 08:00, 14:00 and 20:00. As can be seen, the time between the first two scheduled times 
is 6 hours and 12 hours between 20:00 and 08:00. This was discussed earlier in the discussion. 
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 Conversion from IV therapy to Oral therapy 
During the intervention phase, 26% of recommendations were related to the conversion from IV therapy to 
oral therapy. This recommendation was usually made between ‘Day 2’ and ‘Day 3’ of admission and it was 
made for patients who were supposed to continue with antibiotics therapy. The ward doctors adopted this 
recommendation in 71.79% of all cases. The most common reason for not adopting the recommendation 
was that the doctors were not sure that the patients would not vomit again. 
In some instances, the recommendation to convert from IV-to-oral therapy in patients who were due for 
discharge was not made, an explanation provided by the ward doctor using an oral therapy for a period as 
short as one-day would be a waste of the drug and lead to an unnecessary increase in the cost of antibiotics. 
Most of the oral suspensions are 100 ml and a separate bottle is assigned for each patient. The 100 ml is 
usually for a treatment period of seven days and using the 100 ml bottle for a day and discard the bottle was 
not considered cost-effective. Whether implementing ASP interventions should increase using oral 
antibiotics as a strategy to improve outcomes and decrease costs, were deliberated in studies (Cyriac & 
James, 2014; Pasquau et al., 2015 and Barlam et al., 2015). 
During the intervention phase of the study, the convenience of the conversion from IV-to-oral therapy was 
observed as the nurses prefer oral therapy compared to IV therapy which needed cannula insertion 
techniques. Even though, prescribers preferred IV therapy (measured because all inpatients were prescribed 
IV antibiotics therapy), the safety of conversion from IV-to-oral therapy was demonstrated by the reduction 
in re-admissions and improvement in clinical outcomes were observed. There was no therapeutic difference 
observed between the IV and the oral route. The ASP core team took into consideration the availability of 
antibiotic suspensions during the intervention period. This was important to ensure that a switch from IV-to-
oral therapy was possible. 
Based on the results of this research, it is recommended that ASPs should be facilitated to increase both 
appropriate use of oral antibiotics for initial therapy and the punctual transition of patients from IV-to-oral 
antibiotics. From discussions with ward doctors it was determined that they preferred prescribing antibiotics 
through IV because it ensures that patients receive the correct oral dose administration whereas accuracy of 
oral administration is dependent on individual nurses. The study indicated that conversion from IV-to-oral 
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therapy decreases the cost of the antibiotics and reduces the duration of hospitalisation and revealed that 
there was an overuse of IV antibiotics compared to oral antibiotics. Patients were seemingly receiving 
intravenous therapy just because they were inpatients. 
According to Cyriac and James (2014), the overuse of injections, when oral formulations would be more 
appropriate, is one of the crucial factors for the irrational use of medicines. They also alluded to the fact that 
prescribers believe that chances of reinfection will be less if they give a complete IV course of antibiotics. As 
a result, prescribers usually tend to prefer IV medications during admission and continue them until patients 
are discharged. This behaviour was observed in the pre-intervention phase where no IV-to-oral therapy 
conversions were observed. 
Recommendations for changing IV-to-oral administration were not made in cases where it was impossible to 
do so. These were cases where the clinical practice guidelines did not specify how the change should be 
made, for example, where there was a use of gentamycin. IV-to-oral conversion of the same antibiotic is less 
complicated than other strategies and is applicable to several healthcare settings (Barlam et al., 2016). The 
authors specified that these programmes should be integrated into routine Pharmacy activities and ASPs 
should facilitate strategies to assess patients who can safely complete therapy with an oral regimen to reduce 
the need for IV catheters. Using IV catheters in administrating IV injectables may cause bloodstreams 
infections, so converting patients to oral therapy may also assist in controlling infection. The association of 
IV catheters with bloodstream infections was qualified by (Grady et al., 2011; Hadaway 2012). 
According to Cyriac and James (2014) the main obstacle limiting intravenous to oral conversion is the belief 
that oral medications do not achieve the same bioavailability as that of intravenous medications and that the 
same agent must be used both intravenously and orally. 
 Shorten the duration 
During the intervention, recommendations to shorten the duration of antibiotic treatment constituted 4.67% 
of the recommendations and these were readily accepted by ward doctors. From discussions with ward 
doctors during ward rounds, the research observed that they were comfortable to shorten the therapy when 
Stellenbosch University  https://scholar.sun.ac.za
104 | P a g e  
 
 
 
there were formed stools. In cases where there was a de-escalation of antibiotics, there was no evidence of 
untoward effect. 
Although prescribers were guided to prescribe antibiotics for three days during admission and that the ward 
doctor would recommend whether there was a need to continue treatment, most prescriptions were for at 
least five days and seven days at most. The rationale for the prescribed DOT could not be established. 
The study findings are in agreement with other studies (Masterton, 2011; Camargo, 2013) that shortened 
antibiotic treatment of three to four days could be adequate for most bacterial infections. It is acknowledged 
that there are exceptions though. It was impossible to assess possible reduction in resistance, attributable to 
the limited duration of the intervention phase when discussing the limitations of the study. A suggestion for 
future studies could be to evaluate the effectiveness of the ASP over a longer period, whilst at the same time 
expanding it to more cover IDs. 
Despite the evidence that shortened duration of antibiotics in otitis media, acute bacterial rhinosinusitis, 
prescribers were prescribing antibiotics for seven days at the RFM Hospital when these conditions were 
diagnosed as comorbidities to AGE (Matsebula-Myeni, 2014). There were no side effects observed in patients 
for whom the recommendation to shorten or stop antibiotic treatment was made and adopted. According 
to Hayashi & Paterson (2011) the extent to which knowledge of the efﬁcacy of shortened durations of 
antibiotics for common infections was translated into changes in clinical practice is completely unknown. 
There is a need to determine the effectiveness of shortening the duration of antibiotic therapy. There is also 
a need of a quality standard laboratory for microbiology to assist prescribers by confirming the presence or 
absence of bacteria. 
 Alteration of dose 
During the intervention phase, recommendations to alter the prescribed antibiotic dose were also made. The 
pharmacist calculated the dose based on the weight of the child on admission. There were 14% of cases 
where the dose needed alteration, of those 14% cases, 8% were to increase dose and 6% were to decrease 
dose. The small percentage of incorrect doses on prescriptions suggest that the prescribers are vigilant on 
dosing children in accordance with their weight. 
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Incorrect doses were a challenge in children at RFM Hospital. The researcher, who is a pharmacist by 
profession, has encountered several outpatient prescriptions where there were wrong doses prescribed. An 
improvement in the doses per weight was observed, however and was confirmed by the relatively small 
percentage of incorrect doses observed during the intervention phase. 
 Special consults 
During the intervention phase, there were no cases that needed a special consult from the paediatrician. 
 Other recommendations 
During the intervention, the ASP core team followed the hand washing procedure stipulated by the hospital 
infection prevention and control department. The ward doctors washed their hands with water and soap 
after each ward cubicle and after each patient, they used the alcohol hand sanitiser produced in the hospital 
by the Pharmacy department. During the intervention, in 80% of cases, the ward doctors, documented the 
instruction to nurses to discontinue treatment and removal of the IV catheter, thereafter. 
5.1.1.8 Patient outcomes 
 Development of subsequent infections 
No subsequently developed infections were observed during the intervention phase. The researcher took 
cognisance of prescribers’ fears about altering antibiotics therapy from the doses and durations prescribed 
in the clinical practice guidelines. Developing subsequent infection was measured, especially in patients for 
whom there was an alteration of therapy, i.e. dosing alterations, stopping the therapy, conversion from IV-
to-oral therapy and changing of antibiotics. 
Although not several studies measured developing subsequent infection after altering of antibiotics therapy 
from the conventional therapy, some studies, articulated below, have proved that exposure-reducing 
strategies do not compromise patients’ clinical outcomes. In a study by Metjian et al. (2008), only three of 
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the 84 (3.5%) patients for whom alternative therapy was recommended, developed an infection not covered 
by the ASP recommendations or the antibiotic initially requested by the clinician. 
Contrary to the above findings, a study by Lee & Lindstrom (2007), where a guideline of IV-to-oral conversion 
was introduced, and an early discharge was performed, led to a thirty-day readmission rate of 6%. These 
findings suggest that there should be a close monitoring in patients where the dosages are altered. Although 
in the current study there was no development of subsequent infections, a study should be conducted to 
measure developing subsequent infections in confirmed bacterial IDs. 
 Readmission for acute gastroenteritis 
During the intervention phase the number of re-admissions for AGE decreased compared to the pre-
intervention phase. A statistically significant difference was observed between the two phases of the study. 
This were possibly caused by the improved managing AGE provided by implementing the clinical guideline 
for the diagnosis, treatment and managing AGE and its comorbidities during the intervention phase. This was 
a positive outcome of the study as there was only one readmission during the intervention phase which 
suggests that there was proper managing AGE and its comorbidities. In the current study, patients that were 
re-admitted were those that had SAM as a comorbidity. This could be explained by Gupta (2014), as he 
mentions that each episode of diarrhoea deteriorates the nutritional status of the body necessary for growth 
and development children. 
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 Mortality 
Fewer deaths (15 deaths; 11.9%) were observed during the intervention phase than during the pre-
intervention phase (30 deaths; 21.6%). This is an important and significant emphasise of the study, as 
reducing child mortality is one of the MDGs (Siziya, Muula & Rudatsikira, 2013). The proper utilisation of ORS 
during the intervention phase and managing adequate hydration could possibly have contributed to the 
decrease in the number of deaths. Our study mortality results are comparable with results published by 
Thiam et al in 2017. 
The major cause of death in the pre- intervention phase was SAM (21 deaths), followed by AGE (13 deaths). 
There were no good records on the hydration status of these patients. There were also nine deaths of 
patients who had comorbidities of sepsis, pneumonia and bronchitis and seven deaths in patients with severe 
dehydration. Interestingly, during the intervention phase, all the patients who passed away were those who 
presented with SAM and most of them were re-admissions of malnutrition cases. 
Gupta (2014) indicate the link of several episodes of diarrhoea, malnutrition and mortality. The patients who 
passed away of SAM in the pre-intervention phase, were not assessed whether they were re-admissions or 
not. Two patients passed away within an hour of admission and these were excluded from the number of 
deaths as the patients were not included in the intervention phase of the study. The current study results are 
consistent with Bruzzese, Giannattasio, Guarino (2018) that indicated the association of SAM and increased 
mortality. The author also mentioned that patient with AGE were significantly more likely with malnutrition 
and the status of the malnutrition is the only independent factor associated with an infection. 
The decrease in mortality observed during the intervention phase was a positive outcome of the intervention 
and was probably related to better managing children with AGE, an increased awareness and implementing 
unique treatment requirements of severely malnourished children, as Bruzzese, Giannattasio, Guarino 
(2018), recommended that patients with SAM should be treated differently and the antimicrobial therapy 
should be aggressive. 
Although the intervention resulted in a decrease in the percentage of deaths, the deaths attributable to 
diarrhoea and malnutrition observed in the study was higher than that recommended by (Sphere project, 
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2003) (less than 10%). It also fell short of WHO suggestions of less than 5% (WHO, 2013). These findings 
suggest that SAM is the major cause of death in patients that present with AGE as a primary diagnosis. It also 
suggests that proper managing dehydration in AGE has positive clinical outcomes. 
5.2 Conclusion: Effectiveness of the ASP 
Implementing the multifaceted ASP interventions improved the diagnosis and treatment of infections during 
the intervention phase. The study also reduced child mortality during the intervention phase, which is one of 
the MDG’s (Siziya, Muula & Rudatsikira, 2013). The successful implementing AS strategies had a significant 
impact on reducing targeted antibiotics use, improving quality of care of hospitalised patients and preventing 
the emergence of resistance. Not all challenges related to implementing AS programmes in paediatric 
settings are solved. The most important remaining challenges involves educating prescribers on the 
unnecessarily prescribing on the non-targeted antibiotics as decreasing the use of antibiotics was not 
achieved. 
Prior approval of using restricted antibiotics by the pharmacists for AGE and its comorbidities, combined with 
the daily ward rounds that were by the ASP core team resulted in a better managing patient admitted for 
AGE and received antibiotics as part of their therapy. Prescribers adopted recommendations that were made 
by the pharmacist and the laboratory technologist during the ward round. Some resistance to change therapy 
was documented for younger patients. Prescribers did not change their belief that antibiotics should be 
prescribed to children requiring hospitalisation for acute gastroenteritis, which is not recommended in the 
AGE guidelines and other global guidelines on treatment of AGE presenting with or without dehydration. In 
spite of an ASP intervention, there was high use of antibiotics in children presenting with AGE, which is not 
in keeping with other studies. Our findings provide a useful baseline for ASP intervention and comparison 
with other future national, regional and global studies. 
5.3 Recommendations: Effectiveness of the ASP 
The interventions that were facilitated are labour intensive, so it is recommended that the hospital should 
have a full-time pharmacist to do antibiotic stewardship activities and participate in wards rounds full-time. 
A sustainable audit and feedback mechanism should be put in-place. There is also a need of implementing 
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an ASP in other hospitals in the country and intervention results should be documented, monitored and 
compared. Expansion of postgraduate programmes for prescribers, pharmacists/Pharmacy technicians, 
laboratory technologists and nurses in paediatrics IDs. 
Successful antibiotics stewardship interventions need to be further identified and facilitated in hospitals. The 
recently finalised “National Action Plan for Combating Antibiotic-Resistant Bacteria” should encourage the 
formation of ASPs and strongly encourages these programmes to include paediatric patients, in the interest 
of decreasing the incidence of antibiotic-resistant bacteria and improving health care for children. We further 
recommend that hospital administrations support these programmes and agree with legislative and 
reimbursement initiatives for ensuring their presence. 
5.4 Bacterial causes of acute gastroenteritis and antibiotic sensitivity 
The current study revealed that most the patients presented with E.coli as the bacterial cause of AGE. It could 
not be established whether the other causes of AGE were viral. The reason for determining whether the 
major cause of AGE was bacterial, was that antibiotics were prescribed for almost all patients diagnosed with 
AGE with or without comorbidities. Although (Elliot, 2010) indicated that it is not necessary and practical to 
perform stool specimen for children presenting with acute gastroenteritis, the research required all stool 
specimen of children prescribed antibiotics to be tested for the presence of bacteria. The researcher wanted 
to use these results as a motivation to prescribers not to prescribe antibiotics in children with AGE, when the 
results have proved so. 
Although it is known that most gastrointestinal illnesses are self-limited and managing dehydration in AGE is 
the golden treatment, certain risk factors such as malnutrition, immunosuppression and young age rises 
developing diarrhoea and can complicate managing AGE (Elliot, 2010). In the current study, Enteropathogenic 
E.coli was the most diagnosed bacterial cause of AGE in the intervention phase. Our results are consistent 
with Bruzzese, Giannattasio & Guarino (2018), where he established that four agents (rotavirus, 
Cryptosporidium, enter toxigenic Escherichia coli (ETEC) producing heat-stable toxin and Shigella) account 
for most cases of infectious diarrhoea in African and Asian children younger than five years old. There was 
study was running concurrent with our study and revealed that rotavirus was established in 42% of the 
patient presenting with AGE. 
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The most frequently observed clinical features were vomiting and fever in the current study. Bruzzese, 
Giannattasio & Guarino (2018), mentioned that bacterial infections may be associated with the presence of 
specific clinical features, notably fever, abdominal pain, blood in the stool and faecal leukocytes, which was 
not observed in the current study and most importantly in the pre-intervention phase, when patient 
examination was properly conducted. The presence of faecal leukocytes was not measured in the stool. None 
of these features are reliable to support a bacterial aetiology, although it is known that faecal leukocytes are 
not commonly observed in diarrhoea caused by virus and parasite Bruzzese, Giannattasio & Guarino (2018). 
In the current study, the infection rate was higher amongst children of age 5-15 months and slightly higher 
amongst males compared to females. It is extensively documented that contact with diarrhoeal pathogens 
in developing countries is related to the age of the child (Fletcher, McLaws, Ellis (2013), Mekonnen, 2015 and 
Bruzzese, Giannattasio & Guarino, 2018). There was no association observed between age and gender of the 
child with the isolated enteric bacterial pathogens. The findings of the current study are consistent with the 
findings obtained by (Mekonnen, 2015) who established the predominant age bracket to be 6-24 months 
and male predominance. This was also established in a study conducted in Nepal, in which the infection rate 
was highest in the age group of 6-24 months and the 78.3 % of diarrhoea cases were observed in boys (Ansari 
et al., 2012). 
The European Society for Paediatrics Gastroenterology, Hepatology and Nutrition/European Society for 
Paediatrics IDs evidence-based guidelines for managing acute gastroenteritis in children support the use 
antibiotics in patients less than six months of age, although there is no good evidence (Guarino et al., 2014). 
The guidelines stipulate that for infants under three months of age, microbiology should always be obtained, 
and antibiotics treatment should be considered. The guidelines recommend that if diarrhoea is severe or 
there are signs or clinical symptoms of general infection, or if symptoms are worsening after three or more 
days from their onset, antibiotic therapy should be started. Although there were few children below the age 
of six months in our study, the ones that were enrolled were covered with antibiotics as Dr Getahun, the 
paediatric specialist from our hospital once articulated that the condition of younger children can change 
drastically, so the cover with antibiotics is important (Mavundla et al., 2015). 
In the current study, most isolated bacteria were EPEC, which is consistent with other studies with also 
indicated that EPEC is the main cause of diarrhoea identified in developing countries (Qadri et al., 2005, 
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Ochoa et al., 2011 and Taru Singh et al., 2017). In South Africa, it was indicated that 40% of infantile diarrhoea 
could be accredited to EPEC (Aslani, 2009). 
The author agrees and can relate to the conclusion by Fletcher, McLaws & Ellis (2013) that there is a need for 
developing inexpensive sensitive and specific diagnostic methods to improve pathogen detection in clinical 
laboratories. Global support is necessary for equitable access to rotavirus vaccines in developing settings and 
for continued research and development of cost-effective interventions to prevent and control diarrhoeal 
illnesses global. 
The prescribers at RFM Hospital prescribed antibiotics in acute diarrhoea even in cases where there were no 
comorbidities present in both phases of the study. Using fluids in managing AGE is supported by the evidence 
that most non-bloody diarrhoeal episodes in children under five years of age in low-income settings are self-
limiting and are caused by viral pathogens (rotavirus, norovirus, astrovirus and enteric adenovirus) or 
pathogens for which antibiotics are likely of limited efficacy or even dangerous (e.g. Salmonellae and 
Campylobacter). These findings are also supported by the study performed at RFM Hospital. 
5.5 Microbiology results 
The most frequently isolated bacteria in this study were E. coli, Klebsiella and other gram-negative bacilli, two 
cultures yielded gram-positive bacilli, one of which was a CSF culture. Positive stool cultures were interpreted 
as being indicative of enteropathogenic organisms. Although EPEC are of public health significance, they are 
not routinely diagnosed as enteric pathogens in clinical laboratories (Garcia et al., 2009). Their incidence in 
children under 2 years of age and importance in community-acquired diarrhoea is generally unknown (Garcia 
et al., 2009). Lanata et al., (2013) and Ochoa et al., (2011) claim that EPEC is a substantial cause of infectious 
watery diarrhoea often accompanied by fever, vomiting and dehydration in children under 2 years of age. In 
the current study positive E. coli cultures were interpreted as EPEC. 
The stool culture results are comparable to studies by Akingbade et al., (2014) where (54%) yielded growth 
of E. coli and another study by Galadima & Kolo (2014), where E. coli bacteria was identified in 84 cases 
(47.734%). Other studies by Behiry et al., (2011) and Mekonnen (2015) E.coli was also the most commonly 
cultured organism (5.6% and 12.8%, respectively), but the percentage was lower than in the current study. 
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The prevalence rate of E.coli infection was higher than in most studies from low-to-middle-income countries: 
Iraq (25.9%; Alrifai et al., 2009), Nepal (22.8%; Jeevan et al., 2009) and Ethiopia (12.8%; Mekonnen, 2015). 
These findings suggest that E.coli is the most cultured bacteria in AGE patients. Although the presence of 
E.coli does not suggest that the bacteria is infectious and there is a need of antibiotics, but these results will 
assist the hospital in informing the empirical treatment of bacterial diarrhoea. 
Bacterial culture and surveillance of viral infections were considered to be the most important step leading 
to diagnostic certainty in the RFM Hospital. Although the research perceived viral infection to be the most 
possible cause of AGE, most prescribers believe that bacteria were a cause of the diarrhoea, hence the 
prescribing of antibiotics for all AGE patients. The researcher concentrated on bacterial culture to stop using 
antibiotics where it was necessary. The researcher is of the opinion that if a clinician can lead the ASP core 
team, the greater decrease in using antibiotics could be brought about than from an intervention lead by a 
pharmacist as was the case in this study. More details on the perception on antibiotics use will be discussed 
in the later sections. Principi et al. (2016) emphasised that the challenge of selection of the correct antibiotic 
regimen for a child is related to the lack of bacterial evidence. In the current study the research’s results were 
limited by the lack of rapid diagnostic tests and the prescriber waited for 24 hours before confirming the 
presence of the bacteria in the stools. 
5.6 Sensitivity results 
In the current study, intervention phase, the E.coli resistance rate to Ceftriaxone was 76.5%, cotrimoxazole 
(83.3%), chloramphenicol (62.5%) and amoxicillin (88.9%). Cultured E.coli isolates were sensitive to 
gentamycin (54.6%), nalidixic acid (50%) and ciprofloxacin (55.6%). These results were expected to be slight 
less than the observed as these drugs are not extensively used in the hospital and they are sensitive to gram-
negative bacilli. These results indicate lower sensitivity to nalidixic acid than in a Nigerian study, in which 
73.3% of E. coli cases were sensitive to nalidixic acid (Kandakai-Olukemi, 2009). The results suggest that 
antibiotic resistance is a challenge in the hospital and if major interventions are not put in-place, antibiotics 
in the hospital will be of no use and we would not have any antibiotics for severe infections and ICU cases. 
Bruzzese, Giannattasio & Guarino (2018), mentioned the recommendation of shortened duration of 
antibiotics therapy in severe cases of AG, but also indicated the emerging challenge of antibiotics resistance 
also observed in the current study results. 
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No bacterial cultures were performed during the pre-intervention phase, which made it difficult to compare 
the relevance of using antibiotics during the pre-intervention phase to their use during the intervention 
phase. The inclusion of routine stool cultures as part of the multifaceted intervention assisted prescribers 
and the ASP core team in appropriate diagnosis and treatment of the AGE and its comorbidities. 
The Infectious Disease Society of America (IDSA) suggests rapid infection diagnostic testing to conventional 
culture and routine reporting in infectious diseases (IDSA, 2006). Although this might be possible in 
developed countries, the limited resources in developing countries renders it difficult to have rapid infection 
diagnostic tools. The RFM Hospital has inconsistent availability of laboratory diagnostics and in ESwatini out 
of stock of laboratory diagnostic devices are considered to be less important than out of stock of medicines 
and medical supplies. This was confirmed by a task team appointed by the Prime Minister to look into the 
issues of medicines out of stock, during the same period that the country was not performing CD4 counts in 
patients diagnosed with HIV. 
Our study results as also consistent with Theren (1988), that most gram-negative bacteria, including EPEC are 
sensitive to gentamycin and nalidixic acid and for that reason it may be a better choice than Ceftriaxone, as 
Ugwu et al. (2017) observed a low susceptibility of diarrhoeal organisms with third-generation cephalosporin 
(Cefuroxime and Ceftriaxone). The same result was indicated by Kibret et al. (2011) who concluded that 
nitrofurantoin, gentamicin and ciprofloxacin are considered appropriate for empirical treatment of E. coli. 
Regular monitoring of antibiotic susceptibility was recommended. 
The sensitivity testing results obtained during the intervention phase suggest that bacterial gastroenteritis at 
the RFM Hospital can be treated with nitrofurantoin. Nalidixic acid had the highest level of susceptibility of 
all the antibiotics tested in positive E.coli cultures followed by nitrofurantoin, followed by ampicillin, 
amoxicillin, cotrimoxazole, Ceftriaxone, gentamycin and Metronidazole. Nalidixic acid and nitrofurantoin are 
currently not included in the ESwatini standard treatment guidelines and essential medicines list. 
Nitrofurantoin is a broad-spectrum bactericidal antibiotic that, through a complex mode of action which is 
not completely understood, affects both gram-negative and gram-positive bacteria (Munoz-Davila, 2014). In 
studies that were reviewed by Munoz-Davila (2014) activity against E. coli non-ESBL is excellent 
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A six-month study, in a private practice set-up, 109 children with a mean age of 2.61 years, who were 
admitted to the hospital with acute bacterial diarrhoea diagnosed on the basis of clinical findings and faecal 
leucocytes over 10/high power field, were treated with nalidixic acid, established that nalidixic acid was an 
effective and safe antibiotics in acute infectious diarrhoea. It cut down the days of hospitalisation and cost. 
It was well tolerated even in children less than 3 months (Paramesh 1990). 
Diniz-Santos et al. (2006), share the sentiments with Paramesh (1990). He alluded that nalidixic acid is the 
only non-fluorinated quinolone available initially considered the best option to replace ampicillin and TMP-
SMX in treating acute bacterial diarrhoea. 
5.7 Conclusion: Bacterial causes of AGE and antibiotic sensitivity 
The study revealed that the EPEC was the commonly isolated bacteria and the causative agent for acute 
bacteria gastroenteritis in children less than five years at RFM Hospital and most these were established 
amongst children less than 24 months of age. The study also revealed that there is an elevated antibiotics 
resistance to EPEC at RFM Hospital. An elevated resistance was observed in antibiotics that were commonly 
used in the hospital mainly amoxicillin, cotrimoxazole, Ceftriaxone, cotrimoxazole and chloramphenicol. 
Surprisingly, there was a resistance in nalidixic acid which was not used in the hospital and other public 
hospitals. Drug susceptibility testing revealed that gentamicin, nalidixic acid and ciprofloxacin were more 
likely to be effective against EPEC than Ceftriaxone, cotrimoxazole and amoxicillin, respectively. 
Metronidazole was established to be intermediate. 
Nalidixic acid is available in private pharmacies but the research is not aware of the magnitude of use of the 
antibiotic. Childhood diarrhoea caused by enteric bacteria remains an important health concern in the study 
community. These findings provide useful information to the hospital laboratory in its endeavours to have 
an institutional antibiogram. 
5.8 Recommendations; bacterial causes of AGE and antibiotic sensitivity 
Gentamicin and nalidixic acid may be prescribed as effective antibiotics to treat diarrhoea. Although 
gentamycin therapeutic drug monitoring (TDM) is a recommendation, the RFM Hospital is not equipped to 
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perform TDM of aminoglycosides and therefore, this recommendation could not be facilitated, but may be 
considered for future studies. Care giver should be educated on the bacterial causes of diarrhoea and proper 
sanitation should be encouraged. Children should always be provided clean water. The hospital laboratory 
needs to improve its microbiology desk, as the technicians were unable to classify a significant number of the 
gram-positive and gram-negative bacteria. It would be helpful to recruit a microbiologist or a pathologist. 
EPEC should be considered the next priority for vaccine development for paediatric diarrhoeal disease, 
attributable to its high morbidity and mortality rates. 
5.9 Compliance with clinical practice guidelines 
This section discusses in depth the adherence of the clinical practice guidelines that were developed and 
facilitated during the intervention phase. The guidelines are as follows; antibiotic prescribing guideline, acute 
gastroenteritis guideline accompanied by the hydration protocol and the SAM guideline. 
5.10 Antibiotic prescribing guideline 
 Appropriateness of decision to prescribe antibiotic 
The appropriateness of the antibiotic was determined by the diagnosis and the presence of any comorbidities 
and the suggested empirical treatment and the clinical history of the patient. The variables to determine the 
presence of infection was measured appropriately during the intervention compared to the pre-intervention 
as there were instances where relevant information was not available. 
In the pre-intervention phase, 25.29% of prescriptions were deemed appropriate compared to the 54% of 
prescription in the intervention phase (p <0.001) thus reflecting a statistically significant improvement with 
regard to the appropriateness of decisions to prescribe antibiotics during the intervention phase. Bruzzese, 
Giannattasio & Guarino (2018), established 78% cases of inappropriate antibiotics use in children with 
gastroenteritis, which were deviations from the WHO protocol for AGE. 
The presence of comorbidities had an influence in the appropriateness of the decision to prescribe 
antibiotics, a good example was the presence of pneumonia, as it was difficult to determine the bacteria that 
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could have caused the pneumonia as there was no blood culture conducted during the intervention. The 
limitation of culturing blood rose from the fact that the laboratory with inconsistencies in availability of 
culture bottles, therefore an antibiotic sensitivity test was not performed for all cases of pneumonia. The 
diagnosis of pneumonia was only confirmed by X-ray. 
 Culture performed to confirm the presence of bacteria 
Although a statistically significant increase was observed in with regard to the number of stool cultures 
performed to confirm the presence of bacteria before prescribing an antibiotic, it was still low during the 
intervention phase (28%). The possible reasons for not requesting stool cultures, e.g. challenges experienced 
regarding the prescribers’ apparent resistance to request cultures because the laboratory. In the research’s 
observation, prescribers were not keen in requesting the stool cultures, they complained that the laboratory 
is unreliable and most of the time the prescribers did not trust the results from the laboratory. They also 
complained about the cumbersomeness of filling the microbiology stool culture forms. The other challenge 
experienced regarding the stool culture was the delay of nurses sending the stools to the laboratory and the 
laboratory technologist bring back the results of the cultured specimens. 
Most of the patients in the intervention phase cultured their stool after administration of the antibiotics. 
Those were the patients whose stools were requested by the ward doctor. At RFM Hospital, the patients get 
their first dose during admission, therefore most of the time the laboratory tests will be performed in the 
wards. Prescribers would always blame the laboratory department of delaying results, hence admitting the 
patient and then request for investigation is the most comfortable route for both the prescriber and the 
patient. 
The inadequate human resource in the laboratory was the main challenge identified as cause of the un-
analysed specimens. Initially the laboratory functioned with only one laboratory technician who had the 
required knowledge to do bacteria cultures and sensitivity testing, but he was later joined by another 
laboratory technician who was passionate about microbiology. During weekends the microbiology bench was 
not working, and specimens taken on Fridays could therefore not be analysed in time to inform decisions 
about the need for antibiotic treatment. 
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 Empirical antibiotic treatment 
There was a statistically significant difference (p<0.001) in appropriateness of empirical treatment between 
the intervention phase (62.40%) and the pre-intervention phase (11.49%). Most patients were prescribed 
appropriate empirical treatment during the intervention phase. Patients that were considered to be provided 
antibiotics empirically, were severely sick patient and or with specific risk factors (i.e. immunocompromised). 
In the intervention phase, depending on the severity of patients, empirical treatment was started whilst 
awaiting the results of the microbiological investigated as indicated by (Bruzzese, Giannattasio & Guarino, 
2018) 
The main drug restricted because of abuse was Ceftriaxone, but it was only allowed to be prescribed as first-
line treatment for patients with malnutrition. Using Ceftriaxone as an empiric treatment in the pre-
intervention phase was observed, hence it was restricted in the intervention phase. Bruzzese, Giannattasio 
& Guarino (2018), indicated using cotrimoxazole and Metronidazole oral, but does consider using parenteral 
Ceftriaxone in severe cases. 
The RFM Hospital does not have any local rates of resistance to various pathogens as suggested by the IDSA 
and SHEA (2006) that every institution should develop stratified antibiograms to assist ASPs. 
Appropriate empirical treatment was observed in all patients who were diagnosed with AGE and malnutrition 
concurrently. The antibiotics prescribing guideline recommended using amoxicillin for pneumonia and an 
addition of gentamycin in children less than six months, but it was not conducted in the current study. The 
AGE and its comorbidities guidelines suggest that bronchitis, Laryngitis are mostly viral and there is no need 
for antibiotics, but in the current study, the antibiotics that were used were not the prescribed empirical 
treatment. In the intervention phase, there were cases of otitis media that were observed and using 
penicillins antibiotics as per the antibiotic prescribing guideline was not aligned to. 
The researcher could not find the reason for the underutilisation of penicillin for pneumonia and otitis media, 
but from the quality improvement study by the DTC, the research can conclude that prescribers do not trust 
using penicillin for confirmed cases of pneumonia and otitis media as there was a resistance of penicillin to 
the cultures bacteria, although there bacteria isolated were not identifies in the quality improvement study. 
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According to the statistics unit, pneumonia is the second leading cause of deaths for children less 12 years at 
RFM Hospital (RFM, 2017), therefore prescribers tend to over prescribe antibiotics, ensuring that they do not 
miss an infection. Although, otitis media is not a common comorbidity but if left untreated can cause serious 
side effects, even in this case, prescriber tend to over prescribe antibiotics. 
 Definitive treatment after laboratory culture results 
Most prescriptions were definitive treatments in the intervention phase, namely (87.5%), whilst 12.5% of 
patients were provided definitive treatment in the pre-intervention phase. In the pre-intervention phase, 
treatment was considered definitive in cases where the comorbidities diagnosed were confirmed using 
diagnostic devices other than culture, for example, the presence of kidney infections was confirmed through 
kidney function tests which were conducted in patients which had malnutrition as a comorbidity. 
The researcher concentrated mainly on stool culture results as blood culture could not be conducted in most 
cases as there were no blood culture bottles in the laboratory department. Murray & Masur (2012) argued 
that the value of blood cultures for confirming the clinical diagnosis of disseminated infection (such as 
meningitis, pneumonia, abdomen, urinary tract, or febrile neutropenia) from a localised focus as suboptimal. 
Although most untreated patients with bacterial meningitis have positive blood cultures, only 30% of patients 
with bacterial pneumonia and intra-abdominal infections have positive cultures. This may lead to infections 
not treated when definite treatment is based solely on blood culture results. 
 Evaluation of appropriateness of antibiotic treatment 
During the intervention phase, the ASP core team was mandated to evaluate the appropriateness of 
antibiotic treatment at ‘Day 3’ of the antibiotic course and the prescriber was expected to have written notes 
on the patient chart whether the antibiotic was still necessary, attributable to clinical diagnostics, bedside 
tests and laboratory tests. Using antibiotics can change, attributable to changes of the patient condition. 
Evaluating the patient’s condition throughout hospitalisation is important especially when the patients 
present with multiple morbidities. 
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During the intervention phase, 88% of prescriptions were deemed appropriately evaluated throughout 
hospitalisation. Most often, the presence of persistent fever in patients influenced prescribers in favour of 
prescribing antibiotics as clinically, the presence of an infection raises the body temperature. This indicator 
is not, however, unique to bacterial infections, as body temperature can also rise in the presence of viral 
infections. During the ward rounds, the prescriber noted the basis of continuing the antibiotics other than 
the presence of one variable which cannot determine using antibiotics. Attributable to the absence of 
computed tomography scanning in the RFM it was impossible to diagnose whether pneumonia was bacterial 
or viral and the ASP core team had to rely on blood cultures which were not consistently available from the 
laboratory department. 
 Recommended dose prescribed 
The doctors prescribed the recommended dose in most cases. In the pre-intervention phase only 16.43 % 
had wrong doses prescribed. The researcher expected an improvement in the cases of correct doses but 
almost the same percentage on cases existed in both phases of the study. It was observed that the antibiotic 
doses prescribed, were either too small or too big and it could not be established how the prescribers had 
calculated the doses they prescribed. The doses were then adjusted during the intervention phase and the 
adjustments were recorded as ASP recommendations. 
 Correct dosing intervals for administration 
In the study overall, antibiotics were administered to half of the patients at the correct dosing intervals. Most 
of the patients (64.8%) were administered at the correct dosing interval in the intervention phase compared 
to the pre-intervention (39%). 
 Infection prevention and control 
Most patients that were eligible for the IV to PO switch, were converted from the IV-to-oral switch, as per 
the antibiotic prescribing guideline. Some patients that were eligible for the switch could not be switched 
because of unavailability of the oral alternative, i.e. switching from Ceftriaxone IV to Cefuroxime PO. The 
IDSA and SHEA (2006) strongly recommend punctual conversion from IV to PO therapy where an oral 
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alternative exists. The punctual conversion of the IV therapy was associated with the reduced cost of 
antibiotics and decreased hospitalisation days. 
The conversion from IV to PO was probably the most accepted recommendation; if only the oral drugs were 
available and there were integrated Pharmacy activities to ensure that this recommendation is fully 
facilitated. The IV-to-oral switch was the accepted principle of antibiotic prescribing. The same sentiments 
are shared by; Storey et al. (2012), where he obtained a 100% implementation rate of the IV-to-oral therapy. 
The prescribers self-initiated the IV-to-oral therapy without waiting for a recommendation from the research. 
Some patients that were not switched were those that were left with few doses before discharge, to limit 
the waste of the suspension. Initiating oral therapy will be the best therapy to avoid cost in eligible admission 
cases. The IDSA emphasised a important aspect of PO therapy being less complicated and it could be this 
reason that most patients eligible with being switched, were switched. The researcher fully agrees with the 
association. Most nurses prefer the IV route during admission in AGE because some patient especially the 
children turn to vomit when they have diarrhoea, so it is difficult to decide to give a second dose after 
vomiting especially when the vomiting did not occur immediately after provided the patient the PO dose. 
 Infection prevention and control 
The ASP intervention to control infection though removal of IV catheter right after discontinuation of IV 
therapy succeeded in the intervention phase compared to the intervention phase. In the pre-intervention 
phase, no prescriber documented or provided the order to remove the IV cannulas after discontinuation of 
IV therapy, compared to the intervention phase where there were 80 cases prescribers documented the 
instruction for the removal of the IV cannulas. The researcher established cases where the IV cannulas were 
not removed and when the ward doctor was approached on why the IV cannulas were not removed, the 
ward doctor alluded to the fact that, in most cases where the cannulas were not removed was attributable 
to the ward doctor not feeling confident that the patients will not need the IV cannula during the admission. 
 Infection prevention and control is an important characteristic for combatting the inappropriate use of 
antibiotics and containment of antibiotic resistance. The hospital infection prevention and control unit has 
not made intervention in considering the removal of IV cannula as a way of preventing and controlling 
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hospital-acquired infections. A lot of studies have not studied the impact of early removal of IV cannulas as 
an integral antibiotic stewardship intervention. In our current study, even though the observations were not 
documented, prescribers were compiling with the hospital hand washing campaign of washing hands every 
after three patients, but the ward doctor had the alcohol hand rub that he used to spray every after each 
patient. 
5.11 Guideline on the Diagnosis, treatment and managing AGE (accompanied by the hydration protocol) 
and its comorbidities 
Diarrhoea remains the most common cause of admissions at the RFM Hospital amongst children under five. 
This was observed in the comparable number of admissions in the pre-intervention and during the 
intervention phase. This is similar what was observed globally, as diarrhoea is said to be the second most 
common cause of death (UNICEF/WHO, 2009) and is the cause of admissions in developing countries (Elliot, 
2010). 
In the study, pre-intervention phase, managing hydration was inadequately performed, compared to the 
intervention phase, when the clinical practice guidelines were available. Most of the variables that were 
measured during the intervention phase, were followed by the prescribers accordingly. The managing AGE 
improved during the intervention phase and resulted in no child dying from dehydration compared to the 
pre-intervention phase, where deaths were observed in children with AGE, without SAM as a comorbidity. 
Gupta (2014), indicated that diarrhoea dehydrates the body and weakness that body immune system, which 
may cause malnutrition and enhances their body susceptibility to infections. Elliot (2010), alluded that 
optimal management with fluids minimise the risk of dehydration and its adverse outcomes. The clinical 
practice guidelines that were out in-place, encourage using rehydration in managing AGE, particularly using 
oral rehydration. Improved health outcomes, amongst them reduced death, through adherence to 
prescribed guidelines was appraised by (Grimshaw JM, 1993; Perlstein et al., 2000; Walker, 1998). 
 Classification of dehydration 
In the intervention phase, dehydration was classified accordingly (severe, moderate, mild) and if there was 
no dehydration, the prescribers mentioned it as part of the diagnosis (i.e. AGE with severe dehydration). A 
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statistically significant difference was observed between the two phases of the study, improving from the 
(30%) observed in the pre-intervention phase to (70.8%) in the intervention phase. The importance of 
assessing hydration in gastroenteritis is important, to determine the immediate managing the dehydration, 
as indicated by Elliot (2010). 
The researcher observed that most cases where the dehydration was not mentioned, were the cases where 
there was no dehydration observed. The prescribers were not keen in mentioning that there was no 
dehydration observed in the patients file. The researcher also noted that those cases were only prescribed 
the ORS. Surprisingly, children with no dehydration mild dehydration, in some instances with no presence of 
comorbidities were hospitalised, which is not supported by Elliot (2010). 
These results are in-line with the results obtained by Weru (2014), who reported that approximately a third 
(31.1%) of the patients were not classified using terms consistent with the Kenyan MOH’s paediatric 
protocols. This is also comparable to a study conducted in a tertiary hospital in Kenya where 19.74% of the 
patients admitted with acute diarrhoea had no dehydration classification consistent with the clinical practice 
guidelines. This may be attributable to a lack of crucial performance indicators of prescribers’ initiation from 
management. 
 Method of rehydration appropriate 
An improvement in the appropriateness in the rehydration method was observed. During the intervention 
phase, (93%) of patients were rehydrated with the correct method. The researcher observed that prescribers 
adhered to the hydration protocol on severely dehydrated patients. All the patients who were severely 
hydrated were treated with boluses of fluid received rehydration through short-term infusion during the 
intervention. A statistically significant difference (<0.01) between the numbers of patients who were maned 
with fluid boluses in the pre-intervention phase and during the intervention phase. In the pre-intervention 
phase, there were no patients treated with boluses, despite 13 patients that had been described as being 
severely dehydrated. Some of the severely dehydrated patients received rehydration through short-term 
infusion. 
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Our study revealed that, despite the increasing evidence supporting the safety and efficacy of ORS, they 
remain underutilised as a sole rehydration method for managing acute gastroenteritis at our hospital. 
Common management errors including using ORS in children with little or no dehydration, administering 
intravenous rehydration therapy to children with only moderate dehydration and inappropriately 
withholding ORS or other feeding in children with vomiting were observed in the intervention phase. 
Although, underutilisation of ORS was observed in the study, an improved use of the ORS was observed 
during the intervention phase. The prescribers motivated the caregivers to give the patients ORS despite the 
concurrent use with the short-term infusion. These results are consistent with the results obtained by Weru 
(2014), were twelve (19.7%) of patients with a diagnosis of severe dehydration did not receive intravenous 
fluids. 
A mismanagement in the method of dehydration was observed in the pre-intervention phase in some 
patients that were diagnosed with some dehydration. Some patients diagnosed with some dehydration 
without vomiting were prescribed IV therapy in the pre-intervention phase, but a major improvement was 
observed during the intervention where IV fluid therapy was only provided to vomiting patients. It was also 
of note that during the pre-intervention phase, patients without dehydration were not provided ORS at all, 
whilst the hydration protocol stipulates that even when there is no clinically detectable dehydration, ORS 
should be provided. 
 Appropriate fluid used 
During the intervention phase, there was an improvement in the correct fluid used, from (57%) in the pre-
intervention phase to (95%) during the intervention phase. The plasma glucose level was important to 
determine the correct fluid for rehydration in the study. It was observed that in the pre-intervention, most 
patients received half strength of Darrows, dextrose despite their plasma glucose levels. The same 
observations in the pre-intervention phase were observed in patients when bolus fluid was due, there were 
cases where prescribers prescribed ringers lactate instead of sodium chloride. 
 Correct rate and volume of fluid used 
An improvement in the correct rate and volume of fluid was observed during the intervention phase. Most 
patients (97%) were provided the correct rate and volume of the IV fluid therapy compared to the pre-
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intervention phase where only (57%) of the patients were provided the correct rate and volume. The 
challenge in the adherence in the pre-intervention phase in this variable might be were attributable to 
prescriber’s unawareness on how to calculate the rate and the volume, as the AGE was unavailable during 
the pre-intervention phase. This was observed during developing the guideline when there were 
misunderstandings and differences indicated on how the calculations are conducted. During the pre-
intervention phase, the prescribers wrote the method and name of the fluid without specifying the rate and 
the volume of the fluid. This was a challenge as it can possibly cause fluid overload. 
 
 Investigations conducted appropriately 
Although, supplementary laboratory studies, including serum electrolytes to assess patients with acute 
diarrhoea usually are unnecessary (Teach, Yates & Feld, 1997; Nager & Wang, 2002; Elliot, 2010) however 
our guidelines serum electrolytes in some instances, as alluded by Elliot (2010). There were (52.86%) 
laboratory investigations that were conducted appropriately in the pre-intervention phase, which improved 
to (77.78%) during the intervention phase. 
Although stool cultures are indicated in cases of dysentery but are not usually indicated in acute watery 
diarrhoea for the immune-competent patient (King et al., 2003). Certain laboratory studies might be 
important when the underlying diagnosis is unclear or when diagnoses other than acute gastroenteritis is 
possible. Important investigations that were conducted included plasma glucose level, which was measured 
when the patients were provided the IV fluid therapy, to determine the correct fluid to be administered. The 
other relevant investigation important in the study was the kidney function tests especially in cases of 
severely dehydrated patients. The chemistry tests were also measured to ensure that the acceptable level of 
salts is maintained during the dehydration status of the patients. Prescribers ordered the relevant laboratory 
investigations, but the research observed that the nurses and the laboratory department were not availing 
the results to the prescriber for further diagnosis and treatment management. There were instances where 
laboratory order requested never came back to the wards would come after the patient is discharged. 
 Routine medication 
Most of the patients with acute watery diarrhoea in the intervention phase (88.10%), were prescribed the 
appropriate routine medication, which was zinc sulphate at the correct dose and duration compared to the 
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pre-intervention phase, in which only 50 (60.98%) patients were prescribed the appropriate medication. The 
results of the intervention phase are comparable to the results observed by Weru (2014) in his study where 
92% of patients (345/376) were provided with appropriate routine medication for diarrhoea. The zinc 
sulphate was available throughout the duration of the study and patients received the routine medication as 
prescribed. 
5.12 Conclusion: Compliance with the acute gastroenteritis accompanied by the hydration protocol 
The intervention phase demonstrated moderate to high adherence to the clinical guidelines for managing 
acute diarrhoea in children under five years at RFM Hospital, ESwatini. Despite the good adherence observed, 
treatment practices are still improper at RFM Hospital and there is a room for improvements. The prescribers 
are commanded for not using anti-diarrhoeal and antiemetic drugs as they have no therapeutic value in 
children with AGE, as several authors their use (Elliot, 2010). 
There was an improved managing dehydration in patients who presented with AGE during the intervention 
compared to the pre-intervention phase. An increase in the proper classification of dehydration during the 
intervention phase was observed compared to the pre-intervention phase and an improvement in all aspects 
of managing dehydration was observed. There was improved use of oral rehydration fluid therapy during the 
intervention phase compared to the pre-intervention phase, but for proper, adequate and frequent use of 
ORS, the mother of the child is the crucial person. Her knowledge, practices and attitude are of immense 
importance. A major public health concern is using antibiotics in treating AGE accompanied by dehydration 
especially in the absence of comorbidities. The findings of the study will contribute to the understanding of 
the most current managing childhood diarrhoea and identify the divergences justifying the need to develop 
alternative approach to continue reducing the impact of diarrhoea and improve the management and 
treatment of AGE in children. 
It is evident that rehydration improves the success of clinical outcomes and compliance of ORT, decreases 
the rate of intravenous therapy and improves the dehydration status of the patient efficiently and decrease 
the rate and duration of hospitalisation. Even though there is no formal economic study, judging from the 
excessive cost of hospitalisation and the decreasing cost of the medication, it is likely that immediate use of 
ORS and use of IV therapy when necessary can reduce the health care costs in patients presenting with acute 
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gastroenteritis. Prescribers and nurses are aware of the importance of ORS and the positive function in acute 
gastroenteritis. They do not follow optimum recommendations from nutrition, laboratory examinations and 
drug prescriptions. Consequently, this poses significant financial losses and economic burden. 
5.13 Recommendations; compliance with the acute gastroenteritis accompanied by the hydration 
protocol 
A much more detailed prescription sheet should be designed to provide for information to be presented by 
the prescriber to ensure proper informed diagnosis. The prescribing sheet should include a detailed history 
and clearly describe the severity of the dehydration status of the patient. The cause of diarrhoea should be 
determined before treatment is begun and specific therapy be chosen for each of the causes. There should 
be a study to evaluate parents/caregivers’ satisfaction on the success of ORT so that patients can be managed 
at home; which is more comfortable for both the patients and parents. 
5.14 Severe acute malnutrition guideline 
This section discusses the crucial findings about compliance with the SAM guideline during the intervention 
phase and also discusses findings on managing SAM during the intervention phase. The researcher looked 
into the impact of the SAM guidelines and compared managing SAM in the pre-intervention phase and during 
the intervention. Managing SAM is important when managing patients with AGE, as children with deficient 
malnutrition is at risk of complications (Elliot, 2010). Gupta (2014), also indicated an association between 
diarrhoea and malnutrition, thus substantiating the presence study in putting in-place SAM guideline in the 
management and treatment of AGE. In the current study, SAM was the most common comorbidity in all the 
phases of the study, accounting for 38.6% of comorbidities in the study. The observation of diarrhoea and 
SAM was documented by several authors, namely (Brown, 2003; Rice, 2000; Ochea et al., 2011; Ferdous et 
al., 2013; Gupta, 2014). The link between diarrhoea and malnutrition was observed in our study. In both the 
pre- intervention and intervention phases, malnutrition was the most observed comorbidity and all deaths 
that were observed during the intervention phase were in patients with malnutrition as a comorbidity. This 
observation is consistent with Rice (2000). 
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Appropriate managing patients with SAM following the 10 steps that were incorporated resulted in 
substantial improvement in morbidity and mortality in children during the intervention phase. The patients 
included in the intervention phase had a higher prevalence of SAM with dehydration and oedema at 
admission, compared to patient with SAM and dehydration without oedema. An interesting observation was 
that all the patients admitted with SAM during the intervention presented with diarrhoea. These factors 
(diarrhoea with severe dehydration and oedema) were established to increase their risk of mortality during 
subsequent treatment at the ward as markers of hyponatraemia, hypokalaemia or high creatinine were more 
common in fatal cases and increased the risk of death. Bacteraemia detected by the kidney function tests 
was also a major risk factor for death in those admitted with diarrhoea. For children admitted with SAM and 
diarrhoea there was no difference of dying associated with HIV status amongst those tested? Deficiencies in 
adherence to the SAM guideline were observed in some areas during the intervention phase, namely the 
treatment and prevention of hypoglycaemia and checking for the presence of infections during the 
intervention phase. 
The SAM guideline recommendations are consistent with (Mbugua, 2015; Bruzzese, Giannattasio & Guarino, 
2018), where they mentioned that all acute severely malnourished children should be treated with antibiotic 
upon admission, regardless of whether they have clinical signs and symptoms of systemic infection or not. 
Rice (2000) has furthermore emphasised the well-known synergistic relationship between malnutrition and 
infection and nutritional interventions have thus been recognised as an important approach for reducing 
mortality from diarrhoea. In the current study, all SAM patients (100%) were treated with broad-spectrum 
antibiotics as recommended in the guidelines and this practice is in-line with other studies and reviews (Rice, 
2000; Nzioki et al., 2008, Mbugua, 2015; Bruzzese, Giannattasio & Guarino, 2018), in which SAM patients 
were provided broad-spectrum antibiotics. 
During the intervention phase there were 27 children admitted with SAM as comorbidity to AGE resulting in 
14 deaths (51.8%). This finding is comparable to the findings of a study by Benyera (2013), which was 
conducted in a referral hospital in Mbabane, ESwatini and in which 111 (40.1%) of 277 children passed away 
in hospital, under the care of SAM clinical guidelines. Benyera (2013) concluded that case fatality rates for 
childhood malnutrition remain high in MGH in ESwatini, despite implementing the WHO treatment 
guidelines. 
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Step 1: Treatment and prevention of hypoglycaemia 
During the intervention phase plasma glucose level were determined for most patients during admission. 
This was retrieved from the nurse’s sheet. It was observed during the intervention phase, that nurses did not 
document the plasma glucose level when it was normal. There was, however, an improvement in the plasma 
glucose testing in the intervention phase compared to the pre-intervention phase. A guideline adherence 
during the intervention phase was observed. There was an improvement in the determining of plasma 
glucose levels (from 82% pre-intervention, to 100% during intervention). No p-value was calculated. The 
current study results are better compared with two Kenyan studies, in which only 29.9% of the patients were 
tested for random blood sugar levels Nzioki et al. (2008) and 16.7% Mbugua (2015), respectively. 
It was furthermore encouraging to note that during the intervention phase that all hypoglycaemic patients 
were provided the correct fluids for hydration. The hospital had challenges with the inconsistent availability 
of plasma glucose strips as the hospital is a parastatal and receives most of its laboratory commodities from 
the National laboratory, but the plasma glucose machines used by RFM Hospital are not the same as those 
used by the other government hospitals which forces the hospital to buy plasma glucose strips with the 
limited budget the institution has. 
Step 2: Treatment and prevention of hypothermia 
The average temperature of patients admitted to the wards was 38.0 °C in the pre-intervention phase and 
37.8 °C average temperature of in the intervention phase. There were a few patients (3/27, 11.11%), who 
presented with body temperatures of less than 35°C and were considered hypothermic. Although the current 
guidelines prescribe the necessity of availing heaters and warm blankets for patients, the RFM children’s 
ward does not have those. Other studies do reveal a small percentage of patients presenting with 
hypothermia, but nursing staff fail to adhere to the guidelines of keeping the patients warm (Warfa et al., 
2014; Mbugua, 2015). The need of procuring the hypothermia blankets and or heaters for the children' ward 
is important. 
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Step 3: Treat or prevent dehydration 
Taking into consideration that in the current study, only patients who presented with AGE as a primary 
diagnosis and then assessed for SAM were enrolled in the study. Those patients who did not present 
diarrhoea, were excluded from the study. Treating and preventing of dehydration is important in managing 
SAM especially with patients with oedema. Assessment of hydration status and appropriate rehydration 
demonstrated that a total of 27 patients (63.64%) were appropriately rehydrated in the intervention phase. 
A statistically significant difference between the two phases of the status concerning rehydration was 
observed. 
The change in prescribers’ managing SAM during the intervention phase may be attributed to the availability 
of the SAM guidelines and the associated monitoring of AGE and SAM during the intervention phase. The 
interaction between the research and the clinical team during this phase of the study improved hydration 
management as the research was able explain the importance of managing hydration and the emphasising 
using the correct rehydration fluid in SAM patients. During the intervention phase ward rounds, the most 
difficult assessment was to differentiate between oedema and a well-hydrated patient. One of challenges 
associated with treating oedema, SAM and severe dehydration in patients with AGE is using intravenous 
rehydration versus ORS. In most cases patients with AGE will be vomiting and then a Nasogastric (NG) tube 
has to be used. During the intervention phase, most of the needed medication, intravenous fluids and 
medical supplies were available, which made implementing the guideline possible. 
The managing patients with shock, severe dehydration and SAM with oedema proved challenging during the 
intervention phase as the ward doctors and the nursing staff had difficulty in treating the dehydration during 
shock. The managing shock in children with severe malnutrition remains controversial (Obonyo & Maitland, 
2014). Current WHO guidelines for treating children with severe malnutrition reserve intravenous fluids for 
those with decompensated (hypotensive) shock, advocating hypo-osmotic solutions and limiting fluid 
volumes, attributable to concerns about the risk of precipitating heart failure in children with severe 
malnutrition (WHO, 2000). For both non-malnourished and severely malnourished children the guidelines do 
not distinguish treating hypovolemic shock, secondary to dehydrating diarrhoea or septic shock (Obonyo & 
Maitland, 2014). 
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During the intervention phase the treatment and prevention of dehydration was adequately monitored and 
correctly recorded (including relevant vital signs) in all patients on ReSoMal or IV fluids to check for over-
hydration and thereby decreasing the risk of cardiac failure. Only five patients (38.46%) of patients with 
dehydration were not appropriately rehydrated, attributable to nurses failing to adhere to doctors’ orders. 
During the pre-intervention phase, eight patients (61.54%) were inappropriately treated for dehydration 
receiving IV fluids although they were not clinically shocked. 
Step 4: Correction of electrolyte imbalance 
All patients admitted with SAM as a comorbidity to AGE during the current study were investigated for 
electrolyte imbalance and 21 patients (47.73%) of the 44 patients were supplemented with potassium or 
provided F75. Twenty of these patients (95.24%), who had their electrolytes corrected, were in the 
intervention phase, compared to only one patient (4.76%) in the pre-intervention phase. 
Children presenting with SAM often have a serious electrolyte imbalance which may be apparent at any time 
during treatment Mbugua (2015). Although the SAM guideline mentioned the importance of the chemistry 
baseline and follow-up results, it was observed that the follow-up chemistry was not consistently conducted 
in all patients, especially those that were responding well clinically. It was also noted that children who were 
re-admitted for the SAM were provided more care compared to those who were presenting with the 
condition for the first time. Treatment of electrolyte imbalance includes using F75, which contains macro- 
and micronutrients in quantities adequate to correct the imbalance. During the intervention phase there was 
a period during which F75 was unavailable in the country, but the research managed to report the F75 out 
of stock and the Nutrition Council in collaboration with the MOH assisted the institution with the F75. 
Mbugua (2015) reported a study conducted in Pakistan, in which 93 (63.3%) of children were investigated for 
electrolyte imbalance, whereas Younas et al (2012) reported a study in which only five (5.2%) patients with 
SAM were investigated for electrolytes and only three patients (3.1%) were supplemented with potassium. 
In both phases of the study, most patients (88.64%) were appropriately treated with F75 without 
supplementation of magnesium, as some patients presented with oedema. This indicates an improved 
utilisation of guidelines when compared to Kenyatta National Hospital where approximately 56 (55%) of 
patients were provided commercially prepared F75 (Nzioki et al., 2008). 
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Step 5: Treat or prevent infections 
During the intervention phase, all the patients were provided treatment for presumed bacterial infection, in 
accordance with the SAM guideline and in accordance to Bruzzese, Giannattasio & Guarino (2018). 
Gentamycin and Metronidazole were initially prescribed for several patients on admission in the pre-
intervention phase, although the number of patients were not quantified, but during the intervention phase 
antibiotics were changed to Ceftriaxone in accordance with the SAM guideline and Bruzzese, Giannattasio & 
Guarino (2018), where broad-spectrum antibiotics are indicated, but the author alluded that there is little 
evidence of efficacy in using broad-spectrum antibiotics in the absence of overt infection in malnutrition. 
Ceftriaxone was prescribed as a first-line treatment for all SAM patients. The ASP core team preferred using 
Ceftriaxone as it covers both the gram-positive and gram-negative bacteria whereas gentamycin only covers 
the gram-negative bacteria, has a low therapeutics index and is nephrotoxic. Confirmation of kidney infection 
was observed in all the patients for whom kidney function tests were performed during the intervention 
phase, where other patients indicated severe kidney infections compared to other patients. Patients who 
indicated serious infection were provided the maximum Ceftriaxone dose. 
Step 6: Correct micronutrient deficiencies 
A large proportion of patients with SAM (88.89%) were provided micronutrient supplements during the 
intervention phase compared to the (11.11%) patients in the pre-intervention phase. The patients received 
F75 or F100 and the nurses provided the nutritional feeds following the prescribed SAM guidelines and 
consequently all patients with a slight deficiency of vitamin A were received vitamin A supplementation. The 
prescribers and or the nurses requested the child care card from the caregiver to confirm if the child has not 
recently been provided vitamin A. 
Some patients were provided zinc supplementation in combination with the F75 according to the SAM 
guideline used by the facility, which is contrary to WHO guidelines, which state that zinc supplements should 
not be used when these feeds are available. These disparities in using vitamin A and zinc at our hospital may 
be attributed to the fact that the hospital in the past had irregular supplies of F75/F100 and prescribers might 
be enticed to prescribe those supplements with the history of deficient supply in mind. 
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F75 and F100 combined with a mineral vitamin mixture (CMV) provides an adequate amount of vitamin A to 
manage mild vitamin A deficiency and to replace low liver stores of vitamin A during treatment (Mbugua, 
2015). Higher doses of vitamin A should, however, be administered to patients who have signs of severe 
deficiency. 
Step 7: Initiating nutritional feeds 
In total 39 SAM patients, (88.64%) were prescribed the nutritional feeds, 25 SAM patients (64.10%) were in 
the intervention phase and 14 SAM patients (35.90%) in the pre-intervention. All 39 SAM patients received 
the correct amount of F75 and at the right frequency as per the SAM guideline. The feeds were monitored 
daily for the 39 SAM patients (88.64%). The route of feeding was specified as oral for patients who were not 
in shock and NGT tube for patients in shock, respectively. 
 Step 8: Catch-up growth and follow-up 
From the 39 SAM patients who received F75, 30 SAM patients were appropriately transited from F75 to F100 
at the correct prescribed volume and had an appropriate follow-up for monitoring thereof. During the 
intervention phase, 23 SAM patients (76.67%) planned follow-up, compared to only seven SAM patients 
(23.33%) with a planned follow-up in the pre-intervention phase and this difference was statistically 
significant (P<0.001). Based on the above findings, there was thus a significant improvement in the follow-
up during the ASP in the children’s ward of RFM Hospital. 
5.15 Conclusion: Compliance with the severe acute malnutrition clinical practice guideline 
Treatment outcome of SAM in this study was not good, especially when the diarrhoea with hydration was 
also present. It indicates that over half of the patients were not cured. Guidelines for managing SAM were 
adequately utilised at the RFM Hospital during the stewardship programme, although it did not decrease the 
case fatality rates for childhood malnutrition according to the WHO standards at RFM Hospital. Some nurses 
in the children ward were not adequately trained in managing severe acute malnutrition at RFM Hospital and 
there is an elevated staff turnover which is a burden to the hospital as each nurse joining the ward need 
training for SAM. During the stewardship, training for prescribers and nursing sisters was conducted. The 
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severity of malnutrition was associated with the age of the participants, as there was a significantly higher 
proportion of children with amongst 6 to 12 months compared to those aged 12 to 59 months. 
5.16 Recommendation: Compliance with the severe acute malnutrition clinical practice guidelines 
To improve treatment outcome for children with SAM, continuous supervision has to be conducted for all 
healthcare professionals to avoid irrational provision of routine medication and attention should be provided 
for improving the capacity of healthcare professionals on proper managing SAM. This comorbid disease, they 
have to be treated appropriately to increase cure rate. Constant medical education for all health workers on 
case-managing SAM is recommended and the Pharmacy department should maintain a reliable supply of 
commodities needed for managing SAM. A narrower study should be conducted to evaluate the effectiveness 
of utilisation of guidelines for managing SAM. 
5.17 Knowledge, attitudes and practices of healthcare professionals before and after the intervention 
5.18 Demographic characteristics of the participants before and after the intervention 
The KAP of healthcare professionals (doctors, pharmacists & pharmacy technicians, nurses and laboratory 
technicians) related to antibiotic use and antibiotic resistance was evaluated and compared before and after 
the intervention phase. The four groups of healthcare professional’s background indicated a statistically 
significant difference, where the pharmacists/pharmacy personnel had the greatest number of participants 
in the study. The Pharmacy technicians’ posts were filled during the intervention phase and the newly 
appointed Pharmacy technicians only answered the questionnaire after the intervention phase 
The gender and the educational background indicated no statistically significant difference, with males 
having the most participants in the study. Most of the participant’s highest level of education was a diploma 
and only a few (2) participants has a master’s degree. 
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5.19 Knowledge, attitude and practice of health care professionals from various professional 
backgrounds before the intervention 
The results of the survey conducted before the intervention phase, indicated no statistically significant 
difference between the four different groups of healthcare professionals’ KAP related to antibiotics use and 
antimicrobial resistance. The only significant difference was observed in the knowledge (multiple-choice) and 
medical doctors were more knowledgeable on antibiotic use and antimicrobial resistance. The researcher 
expected doctors and pharmacists to be more knowledgeable on the subject compared to the other cadres 
because these two professionals are crucial in the management and treatment of ID. The questions that were 
in the questionnaire were not clinical, there were more on public health issues and doctors from RFM 
Hospital have not conducted research and there are not aware of public health issues. 
Pharmacy personnel (pharmacists and Pharmacy technicians) and laboratory technicians were leading the 
QIP on antimicrobial resistance surveillance conducted over six months in the hospital. There were lot of 
issues that were raised in the DTC concerning antibiotics use and resistance in the hospital and the two latter 
professionals were the engineers of the project. The pharmacists are the custodians of antibiotics; therefore, 
they are expected to be more knowledgeable over any other healthcare cadre. In the current study, the 
pharmacists were combined with the Pharmacy technicians, therefore the results are not a true presentation 
of the pharmacist’s opinion. In future research, pharmacists will be segregated from Pharmacy technician to 
get the true reflection of their opinions. 
In the current study, in the pre-intervention phase, the laboratory technicians were at 20% knowledge on 
antibiotics use and antimicrobial resistance in the multiple-choice knowledge section. These results were 
expected as laboratory technicians are not involved in antimicrobial use public health. The hospital only 
involves the laboratory in availing laboratory results and there is no analysis conducted thereof. The 
researcher, then educated the laboratory technicians on issues of antibiotics use and antimicrobial 
resistance. 
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5.20 Knowledge, Attitude and Practice of Health Care Professionals from various professional 
backgrounds after the intervention 
During the intervention phase, a statistically significant difference was observed between the four healthcare 
professionals. The laboratory technician had a better knowledge compared to the other healthcare 
professionals. There are several factors that might have contributed in the laboratory technicians to be more 
knowledgeable in the intervention phase. During the study, there were three new laboratory technicians that 
were fresh from university, therefore they studied the public health issues around antibiotics use and 
antimicrobial resistance. The researcher was having a frequent contact session with the laboratory staff on 
the issues around the problem study of the research and interventions that was put in-place to curb the 
inappropriate use and antimicrobial resistance. 
The laboratory department is a small department and it is easy to co-ordinate/collect them and explain on 
issues on antimicrobial resistance. The doctors improved their attitude towards antimicrobial resistance 
during the intervention and laboratory technicians’ good attitude decreased. The improved attitude in the 
doctors were caused by the positive outcomes of the antibiotic’s stewardship programme. Another factor 
could be that the doctors were the only healthcare professionals that maintained the same doctors from the 
pre-intervention phase. The doctors also improved in the KAP on antibiotics use and antimicrobial resistance. 
 Knowledge, attitude and practice of healthcare professionals before and after the intervention 
The mean score on the knowledge questions (4.84) in the pre-intervention phase are comparable to the 
result from the similar survey conducted in DR Congo (Thriemer et al., 2013). The low mean score was in 
large part, attributable to the three questions with flawed replies. The questions concern AB use in URTI, 
cross-resistance of MRSA to beta-lactam and AB dose reduction in renal failure. These question replies were 
also flawed in the survey conducted in DR Congo (Thriemer et al., 2013). Taking cognisance of the high 
proportion of incorrect answer concerning URTI, this topic on the inappropriate use of antibiotics was of 
target during the intervention phase of the study. Most of the respondents did not know about the cross-
resistance of MRSA to beta-lactam AB. The reason for the outcome could be explained by the non-
functionality of microbiological facilities at RFM, disqualifying estimates of MRSA incidence. There was 
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insufficient knowledge about local AB resistance rates in the facility. The laboratory and the Pharmacy 
department answered the local AB resistance rates better than doctors and nurses. 
In the current study, implementing the ASP improved the knowledge in the health care professionals 
especially in the questions that were improperly answered in the intervention phase. The improvement in 
this question was expected especially between the doctors and nurses as the research did a lot of informal 
education on when to decreases dose and the factors that were considered when altering a dose. The third 
question that improved during the intervention phase was, “Methicillin resistant - Staphylococcus aureus is 
susceptible to”? (P=0.004), (Table 4.11). This question was deliberated during the intervention phase 
especially with the laboratory department and during our ASC meetings. Most of the questions were not 
answered satisfactory in the pre-intervention phase and an improvement was observed in the intervention 
phase. 
The Likert scale questions were satisfactory answered in both phases of the study, but an improvement was 
observed during the intervention phase. The difference in the outcome in the knowledge between the 
multiple-choice and the Likert scale was observed, which suggest that education can improve knowledge of 
healthcare professional and the multiple-choice indicated a gap in knowledge on antibiotics use and 
antimicrobial resistance. There were questions in the intervention phase in the Likert scale that were 100% 
answered correctly. 
The KAP-surveys provided the insights in the driving forces of antibiotics use and are corresponding to 
surveillance of AB resistance and AB consumption which together establish baseline information to design 
interventions about AB prescribing. This is the first known study to be conducted in the Manzini region and 
probably in the Kingdom of ESwatini to systematically demonstrate knowledge, attitudes and practice 
towards antibiotic use amongst healthcare professionals. These findings would be the first step in providing 
a baseline quantitative data of patterns of antibiotics use, knowledge and attitudes regarding antibiotics 
amongst healthcare professionals in this hospital. This will aid in the assessment of the adequacy of the 
present continuous medical educational meeting that happens every Friday in the hospital on therapeutics 
and provide further insight in designing future multifaceted interventions targeting specific are as to promote 
rational antibiotic use and replenish the knowledge and attitude divergences as an effort against antibiotic 
resistance. 
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High rates of antibiotic prescribing were identified by the present study. This high rate of prescribing could 
partly be explained by the respondents thinking that antibiotics does cure virus and that antibiotics will speed 
up the recovery of colds and flu. The baseline survey also identifies using antibiotics in acute diarrhoea and 
this could be partly explained by the most respondents who believed that antibiotics should be used to cure 
acute diarrhoea and that it shortness the duration of diarrhoea. The inappropriate use of antibiotics by 
doctors was revealed by the practice determined by all the healthcare professional in the baseline survey, 
where majority of the respondents agreed that doctors prescribe antibiotics for fever and coughing and that 
doctors do not do due diligence in prescribing antibiotics. 
The baseline survey also revealed that managing diarrhoea from acute to chronic is not well understood. This 
was explained by the latter sentence and the incorrect answers obtained from the question that asked if 
gentamycin was indicated for chronic diarrhoea. The survey baseline also indicated that the knowledge about 
antimicrobial resistance is limited. This was evident when the survey revealed that most respondents were 
not in agreement that antimicrobials resistance is a global challenge and they did not associate using 
antibiotics in animals and increased resistance thereof. Surprisingly, the respondents in the baseline it and 
disagreement that doctors often take time to consider carefully whether antibiotics are needed or not. 
The study revealed that pharmacist do not give patient education on antibiotics use, but the respondents 
believed that the pharmacist dispensed the antibiotics correctly with a proper advice and ensured the correct 
dose. Interestingly, the doctors trusted pharmacists that they will dispense the antibiotics as prescribed and 
conversely the healthcare professionals did not trust the doctor’s antibiotics prescriptions. 
The study baseline survey revealed that the healthcare professionals have a good attitude towards rational 
use of antibiotics and have a positive attitude towards initiation of programmes to combat the irrational use 
of antibiotics and the alarming rates of antimicrobial resistance. This was evident in the respondent’s 
agreement that it is necessary to get more education about antibiotics and that there is a need to establish 
a course on ‘rational use of antibiotics’ at university level and the necessity to conduct evidence base research 
on antibiotics use. It was of the research surprise that the respondents established the need to formulate an 
antimicrobial stewardship committee in the hospital and the necessity to have continuous profession 
education about antibiotics. 
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From the present survey, potential fields of intervention are the following: improvement of knowledge about 
AB properties and usage targeting medical students during their university curriculum, the provision of 
unbiased and evidence-based information about AB and local AB resistance rates to all prescribers and 
implementing quality assurance for drugs to improve confidence amongst the general public and 
professionals. Educational measures such as trainings are highly welcomed and implementing AB committees 
should be studied at national pilot settings. 
The significant association between overuse of antibiotics and antibiotic knowledge suggests that 
educational campaigns that emphasise knowledge may be effective to inverse the inappropriate use of 
antibiotics. This finding is crucial in developing comprehensive and multifaceted interventions. Respondents’ 
inadequate knowledge of antibiotics was identified to not correlate positively with attitude, therefore, in this 
baseline survey, inappropriate knowledge of antibiotics was identified to be a predictor for negative practice 
towards antibiotic use. 
KAP-surveys however have characteristic limitations: respondents may be elicited to the topic and this - in 
combination with the multiple-choice format of the questionnaire - may direct them to socially desirable 
answers. Respondents with no interest in the topic in question can just answer to fill the survey but not a 
true reflection of the respondents especially respondents in a remote and busy health centres. The 
completion of the questionnaire anonymously and assurance of confidentiality provided to the respondents 
would minimise the over- and under-reporting. This survey has a strength of addressing medical doctors, 
pharmacists, Pharmacy technicians, nurses and laboratory technicians. The researcher could not find any 
comparable study with conducted a study on KAP towards antibiotics use and antimicrobial resistance on the 
four healthcare professionals, but studies were conducted on medical doctors, students and the public. A 
further strength is the intervention phase data that represented that reflected the changes in respondents’ 
knowledge and attitude after the ASP intervention in relation to antibiotics use. 
To inverse these limitations, the present survey was adopted from Thriemer et al. (2013), which have 
validated by a team of local professionals and took into account limitation in time and concentration of the 
respondents. The present study emphasised on the KAP of medical doctors, pharmacists, Pharmacy 
technicians, nurses and laboratory technology in an elevated volume, resource-limited setting in the Kingdom 
of ESwatini. To fully understand the whole extent of inappropriate AB prescribing and usage, further research 
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is needed amongst the other aspects of interventions that can be used to curb inappropriate use of AB for 
example, the importance of ASP and knowing the perceptions of healthcare professionals towards the ASP’s 
in healthcare professionals. The KAP can also be conducted in all other healthcare facilities in the country. 
Differences between the results of other health facilities may advise for interventions to address the national 
challenge of antibiotic resistance. Despite these limitations, the present findings provide valuable 
information for evaluating and improving knowledge, attitude and practice towards antibiotics use. 
5.21 Conclusion 
Differences in perspective exist between the four groups of health care professionals regarding the various 
aspects of antibiotic use and antibiotic resistance. The development and implementing the ASP improved the 
KAP of all the health care professionals. The present findings allow for important relative work with existing 
(although might be limited) and future investigations at RFM Hospital and in the Kingdom of ESwatini. Given 
the rapid growth rate of antibiotic resistance at RFM Hospital and recognised health issues related to 
inappropriate use of antibiotics, the present findings emphasise important concerns regarding antibiotics 
amongst healthcare professionals at RFM Hospital. The crucial findings of this study will assist the DTC at 
RFM Hospital to plan and establish future effective multifaceted interventions to improve the appropriate 
use of antibiotics. 
5.22 Recommendations 
Qualitative and quantitative studies need to be conducted at institutional, regional and national level to 
identify the determinants of attitudes, behaviour, expectations and motivation that lead people to use and 
misuse antibiotics. Healthcare institutions should improve communication about antibiotic appropriateness 
between healthcare professionals and patients. 
The Swazi Government should support and commit to investing in public health education programmes for 
both public and healthcare professionals, including policymakers, doctors, nurses, pharmacists and patients. 
The public education programmes should be in all media meaning that should be targeted more efficiently 
at those who have low knowledge, negative attitude and inappropriate practice towards antibiotic use. These 
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campaigns should use behavioural and influencing theories and repetition to target modifications in health 
risk attitudes. An evaluation of its effectiveness should follow each campaign 
The ESwatini government should require its healthcare system to urgently facilitate the proper regulations 
and prescribing policies and controls for antibiotics. Policies of auditing antibiotic prescriptions in the 
healthcare facilities and investigating the consultation behaviour and other behavioural components 
engaged in patients’ expectations for antibiotics. Pharmacist’s should be authorised the function in raising 
awareness in using antibiotics and antibiotic resistance, emphasising pharmacists’ function in health 
education and promotion and responsibility in elimination antibiotic dispensing without prescription from an 
authorised prescriber and monitoring sources of obtaining antibiotics through enforcing the strict 
regulations. 
Finally, public health strategies should be developed, to curb areas of misconception and misuse of 
antibiotics. Further research to investigate knowledge, attitude and practice towards antibiotic use amongst 
expatriates will assist in the adoption and implementing successful future policies to promote rational 
antibiotic use amongst the public in Kuwait. 
5.23 Study limitations 
The study was single-centred to RFM Hospital. This can lead to multiple biases, a failure to deliberate 
developments in antibiotic use and absence of assessments with antibiotic use in other health facilities 
without ASP. Using convenience sampling limited the study because to generalise conclusions about a 
population, a random sample, or scientifically selected subset of that population must be drawn (Rea & 
Parker, 2005). In the pre-intervention phase, the medical records were incomplete, leading to 
misclassification of the accuracy of the submitted data, the missing data comprised the minimum number of 
cases that were supposed to be enrolled in the study to inform better comparison between the two phases 
of the study. The study was accomplished over a limited period. 
 
In the current study, antibiotics use intervention was only based on all children that were diagnosed with 
AGE as a primary diagnosis, this meant that the ASP core team was unable to triage other complex cases 
which needed robust interventions, which should assist to avoid overestimation of the intervention effects. 
Stellenbosch University  https://scholar.sun.ac.za
141 | P a g e  
 
 
 
We excluded children admitted in ICU from our intervention as these patients might receive the most 
restricted antibiotics. This special population is especially vulnerable to infections and the empiric therapy 
for them may tend to be broader spectrum antibiotics. 
 
The study was also limited to prescribers and nurses working in the children’s ward during the duration of 
the study and excluded those prescribers working in other departments. The perceptions, beliefs, attitudes 
and practices of the health care professionals may change over time, but the findings of this study were 
limited to what the participants believed and perceived about antibiotic use and antibiotic resistance at the 
time in which participants completed the survey. 
 
The study assumed that all heath care professionals working in the paediatrics’ department were aware of 
the guidelines provided by the research. The study assumed that the prescribers treated patient without 
oppression to please the research or the hospital management. The study assumed that the results produced 
by the laboratory microbiology were a true reflection of the microbiology results. The study assumed that 
research participants completed the KAP questionnaire independently and provided honest responses to the 
questions to the best of their knowledge and ability. It was also assumed that responses to questionnaire 
were based on each individual health care professional’s perceptions and not based on what others might 
believe. 
5.24 Conclusion 
There is an evidence that ASPs are successful at increasing appropriate antibiotics use and limiting the 
development and spread of antibiotic resistance. The nature of ASP interventions and the outcomes of 
importance to patients can determine study design selection and methodology. Well-designed ASPs aimed 
at evaluating ASP impact on antibiotics use. Patient outcomes are critical for maintaining efficient, high 
quality patient care, promoting essential antibiotic use. 
The ability to assess the effect of an ASP intervention is often limited by external factors, beyond the control 
of the research. Health commodities such as antibiotics shortages, availability of microbiology and chemistry 
reagents, high personnel turnover and expansion of services, can have a major influence on intervention 
outcomes. It can therefore be difficult to isolate the true effect of an intervention from these external 
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influences. It is also important to recognise that several ASPs do not have adequate funding to support their 
activities. Thus, the lack of these resources can be a major barrier to the conduct of effective evaluations of 
ASPs. 
There is an explicit need to appraise various ASP interventions in a broad range of clinical settings from 
primary health care to tertiary hospitals; from general clinics to specialised clinics. Although the predominant 
goals of essential antibiotic prescribing are the same across various healthcare settings, the approach to 
supporting essential prescribing should be tailored to each setting. Interventions should for instance be 
customised concerning age (children vs adults), or conditions (acute infections vs chronic infections). 
The conduct of methodologically comprehensive evaluations of ASP interventions can inform best practice 
and policy. The findings of several recent studies (Pate et al., 2012; Cairns et al., 2013; Cisneros et al., 2013, 
Mendelson et al., 2016; Brink et al., 2013 and Boyles et al., 2016) have indicated the positive impact that 
ASPs can have on antimicrobial resistance and patient outcomes; however, more work is needed to further 
inform the field by identifying effective and efficient stewardship interventions. To identify the most effective 
interventions and implementation strategies, studies evaluating ASP interventions should be essentially 
planned and directed to minimise bias and maximise internal validity. Continued effort is needed to indicate 
the value of ASPs to increase the evidence base that informs best practices for stewardship in all healthcare 
settings. 
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Knowledge, attitude and knowledge of antibiotics use in children among 
healthcare workers at the Raleigh Fitkin Memorial hospital 
SECTION A 
Demographic characters 
Tick in correct box () 
Age: 20-29 Sex: M F 
30-39
40-49
50-59
 60
Profession background: Paediatrician : 
  Medical doctor: 
  Family nurse practitioner: 
  Staff nurse: 
  Pharmacist: 
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  Pharmacy technician: 
  Laboratory technologist: 
  Laboratory technician 
Highest Education level: Diploma 
  Degree  
  Post graduate diploma 
  Honours 
  Masters 
  Doctor of philosophy 
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SECTION B 
Healthcare professional’s knowledge on antibiotics use 
Question Strongly 
agree 
Agree Neutral Strongly 
disagree Disagree 
Different antibiotics are needed to cure 
different diseases 
Antibiotics are effective against bacteria 
Antibiotics are effective against viruses 
Antibiotics will speed up the recovery of colds, 
cough 
Antibiotics should be used to acute diarrhoea 
Antibiotics shortens the duration of acute 
diarrhoea  
If you get side effects during a course of 
antibiotics treatment you should stop taking 
them as soon as possible 
If you get some kind of skin reaction when using 
antibiotics, you should not use the same 
antibiotic again 
Is amoxicillin sensitive to E.coli bacteria 
Is gentamycin indicated for chronic diarrhoea 
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Is Metronidazole the best drug for acute 
diarrhoea 
Ceftriaxone is the golden treatment for treating 
bacterial pneumonia  
Antibiotics can cause imbalance in the body’s 
own bacterial flora 
The unnecessary use of antibiotics can increase 
the resistance of bacteria to them 
Resistance of antibiotics is a world-wide 
problem 
The use of antibiotics amongst animals can 
reduce the effect of antibiotics amongst 
humans 
Humans can be resistance to antibiotics 
1 A 4-year-old girl has diarrhoea for 4 days (3 stools/day). She has no fever at examination nor during 
the last few days. Which treatment do you propose? 
a) Amoxicillin p.o.
b) cotrimoxazole p. o.
c) amoxicillin -clavulanic acid p.o.
d) no antibiotic treatment, only oral rehydration
2 A 6-year-old child has a fever of 38 °C, purulent rhinitis and angina for two days. At inspection, 
the throat is reddish. Which treatment do you recommend? 
a) cotrimoxazole p. o.
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b) amoxicillin p.o.
c) amoxicillin -clavulanic acid p.o.
d) no antibiotic
3 During your ward round, you see two patients with severe renal failure. Patient A is a 4 year old 
suffering from serious cellulitis at the leg, she is treated with clindamycin. Patient B is a 5 years old 
with a juvenile 
diabetes which is empirically treated for septicaemia with Ceftriaxone. Dosage reduction 
is needed for: 
a ) Patient A  
b ) Patient B  
c) both patients
d) in neither patient A nor patient B
4 Which one of the following antibiotics is safe in neonates? 
a) Amoxicillin 
b) ciprofloxacin 
c) gentamicin
5 Which one of the following antibiotics has the best activity against anaerobes? 
a) Ciprofloxacin
b) Metronidazole
c) cotrimoxazole
6 Methicillin-resistant - Staphylococcus aureus is susceptible to: 
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a) amoxicillin-clavulanic acid  
b) cefotaxime  
c) Ceftriaxone 
d) none of those antibiotics 
 
7 Which one of the following antibiotics most effectively crosses the blood-brain barrier? 
a) Clindamycin  
b) Ceftriaxone  
c) vancomycin 
 
8 Aminoglycosides such as gentamicin are very active if they are administered as follows:  
a) orally three times daily  
b) parenteral once daily  
c) parenteral three times daily 
 
9 At Raleigh Fitkin Memorial Hospital, what is according to your information the estimated 
resistance rate of Salmonella Typhi to 
Cotrimoxazole (Bactrim)? 
a) 0-10%  
b) 10-20%  
c) 25-50% 
d) 50-75% 
 
10 At Raleigh Fitkin Memorial Hospital, what is according to your information the estimated 
resistance rate of Klebsiella to Ceftriaxone? 
a) 0-10% 
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b) 10-20% 
c) 25-50% 
d) 50-75% 
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SECTION C 
Healthcare professionals’ attitude and awareness on antibiotics use 
Questions Strongly 
agree 
Agree  Neutral  Strongly 
disagree 
Disagree  
There is abuse on antibiotics at present      
Antibiotics resistance has become a problem in 
Swaziland 
     
Abuse of antibiotics has become the main 
cause leading to bacterial resistance  
     
Antibiotics resistance affects the livelihood of 
the community 
     
It is necessary to get more education about 
antibiotics 
     
There is a need to establish a course on 
‘rational use of antibiotics’ at university level 
     
It is necessary to carry out evidence base 
research on antibiotics use 
     
It is necessary to formulate an antimicrobial 
stewardship committee in the hospital 
     
It is necessary to have continuous profession 
education about antibiotics  
     
 
  
Stellenbosch University  https://scholar.sun.ac.za
174 | P a g e  
 
 
 
Section D 
Healthcare professional’s behaviour on using antibiotics 
Questions  Strongly  
Agree  
Agree  Neutral Strongly 
disagree 
Disagree  
Doctors prescribe antibiotics when having fever (>38.5°C)      
Doctors prescribe antibiotics for coughing       
Doctors often tell patients/caregivers on how antibiotics works      
Pharmacists often tell patients how antibiotics should be used      
Pharmacists often ensure the right dose of antibiotic is given to the patient      
Pharmacists often give patient education on antibiotics      
Doctors often prescribe antibiotics because the patient expect it      
Doctors often consider carefully whether antibiotics are needed or not      
Pharmacists trust doctors’ decisions when they prescribe antibiotics      
Doctors trust pharmacists that they will dispense and advise patients on 
the use of antibiotics 
     
Doctors advise that antibiotics can be used when cough last up to two 
weeks or more 
     
Patients can be given antibiotics when they ask them      
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ANNEXURE C: PARTICIPANT CONSENT FORM 
TITLE OF THE RESEARCH PROJECT: 
INVESTIGATING THE EFFECT OF INTERVENTIONAL ANTIMICROBIAL PROGRAMMES ON THE APPROPRIATE 
PRESCRIBING OF ANTIBIOTICS FOR ACUTE GASTROENTERITIS AND ITS CO-INFECTIONS FOR CHILDREN LESS 
THAN FIVE YEARS AT THE RALEIGH FITKIN MEMORIAL HOSPITAL, SWAZILAND 
REFERENCE NUMBER : S16/02/026 
PRINCIPAL INVESTIGATOR : Zinhle Matsebula-Myeni 
ADDRESS : P. O. Box 2108 Matsapha, 
  Fairview North, Manzini 
  Swaziland 
CONTACT NUMBER :  
You are being invited to take part in a research project. Please take some time to read the information 
presented here, which will explain the details of this project. Please ask the Principal Investigator any 
questions about any part of this project that you do not fully understand. It is very important that you are 
fully satisfied that you clearly understand what this research entails and how you could be involved.  
This study has been approved by the HREC at Stellenbosch University and will be conducted according to 
the ethical guidelines and principles of the international Declaration of Helsinki, South African Guidelines for 
Good Clinical Practice and the Medical Research Council (MRC) Ethical Guidelines for Research. 
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What is this research study all about? 
Study setting 
The study will be conducted at Raleigh Fitkin Memorial Hospital, there will be 100 participants that will be 
recruited in the prospective arm. 
Aims of the study 
The aim of this research is to assess prescribers’ antibiotics prescribing patterns; knowledge, attitudes and 
practices before and after an interventional antimicrobial programme, established by the principal 
investigator through the antimicrobial stewardship committee to achieve appropriate prescribing of 
antibiotics in AGE and associated co-infections. This research will also contribute to global initiatives to 
address and combat the inappropriate use of antimicrobials, particularly in the public sector in developing 
countries. 
Purpose of the study 
To determine the number /cases of prescribers correctly prescribing antibiotics: Optimising the duration of 
choice and dose of empiric therapy: antimicrobial stewardship. 
To determine the implementation of the protocols for management of AGE, pneumonia, malnutrition, URTIs 
and otitis media, and an antibiotic policy. 
To determine the improvement of prescribers’ knowledge, attitude and practice. 
Methodology 
There will be a prospective audit of the ASP established at Raleigh Fitkin Memorial Hospital after obtaining 
approval by the hospital administration and support by the medical staff. The ASC with the paediatrician 
team will monitor the management and treatment of AGE and its co-infections, two (2) calendar days after 
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treatment is initiated by the clinician. The committee will use the TOR, developed by the Principal 
Investigator. Patients to be reviewed by the ASC will be identiﬁed by the nursing sisters in the special care 
unit and the children ward. The ASC will approve the new protocols on AGE, pneumonia, Otitis media, 
malnutrition, bronchitis and URTIs. The pharmacist will review the medical records of the patients receiving 
one or more antibiotics for medical history and physical ﬁndings necessitating initiation of antibiotics, 
including culture data, radiographic ﬁndings, and signiﬁcant laboratory values, as well as dosing and intended 
duration. Recommendations will then be communicated to the clinician caring for the child. Interventions 
will be categorised by type of recommendation and the prescribing antibiotic policy which will include the 
following: discontinue the antibiotic; narrow or broaden antimicrobial therapy based on culture and 
susceptibility data; convert the administration method from parenteral to oral route; narrow or broaden 
empirically; increase or decrease the dose; shorten or lengthen the planned duration of therapy, consolidate 
to fewer antimicrobials, or obtain an IDs consult. IDs consultation will be reserved for cases with multiple 
complex issues and/or where the diagnosis meets the criteria for IDs consultation in the institution. 
All prescriptions of children that will be diagnosed and admitted in the institution with AGE as a primary 
diagnosis between 1 April 2016 and 31 September 2016 will be selected. A separate prescription form will be 
filled for antibiotics. Using a newly developed prescription form for inpatients. The diagnosis of AGE will be 
confirmed either according to the International Classification of Disease and Related Health Problems, 10th 
revision (ICD 10) or based on the results from a rapid RV (Retroviral) diagnostic test. Medical history will be 
collected from the medical charts or the hospital database, and the duration of hospitalisation/ and or 
consultation for AGE, defined as the number of days between the date of admission and the date of 
discharge, will be automatically calculated in the medical chart database. A questionnaire will be completed 
on demographic data, diagnosis, and treatment of AGE and co-infections. Before and after the intervention 
are put in-place, a questionnaire designed by the researcher will be used to determine the knowledge, 
attitude and practices of prescribers on antibiotics at RFM Hospital. 
Randomisation process 
During statistical analysis, one hundred participants will be randomly selected from the participants that 
were in the study. Their chart numbers will be arranged from the smallest number to the largest number and 
the 1st hundred participants will be selected and analysed. 
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Why have you been invited to participate? 
Your participation as a prescriber will contribute positively to the research. The study is on children less than 
5 years and you are working under that children department. 
What will your responsibilities be? 
Diagnosing, prescribing and management of children with acute gastroenteritis and its co-infections namely 
pneumonia, Otitis media, malnutrition, bronchitis and upper URTIs according to the approved protocol. 
Participant in the wards rounds that will include the antimicrobial stewardship committee 
Will you benefit from taking part in this research? 
The study will benefit you in gaining knowledge on antimicrobial stewardship and learning more on 
antibiotics use. 
You will gain more knowledge on how to give the best optimal treatment of the five conditions namely: Acute 
gastroenteritis, pneumonia, Otitis Media, Bronchitis, Malnutrition and URTIs. 
Gain more knowledge in procedures on culture and sensitivity 
Gain insight on optimising antibiotics use 
Are there in risks involved in your taking part in this research? 
There are no potential risks to your participation; however, you may feel uncomfortable participating in the 
study. You do not have to participate. The information will not be used for appraisal purposes. 
If you do not agree to take part, what alternatives do you have? 
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If you do not agree to participant in the study, you will continue with your own management of the patients 
with AGE and its co-infections. 
Who will have access to your medical records? 
The data will be stored in the Principal Investigators office and stored privately. The statistician will have 
access to the coded information of the patient. There will be no names published for public consumption. 
The data will be stored for a minimum of five years at Stellenbosch University in their research archives. The 
data will also be stored in the Principal Investigator password protected computer and in a locked cupboard 
file during the study. Upon completion of the data collection and data entry, all hard copies (consent 
documents, survey instruments, etc.) will be destroyed. The remaining data will be maintained indefinitely; 
however, the data may be used in future research studies of the Principal Investigator and or the supervisor. 
The results will not be shared with the management, to prevent victimisation. 
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Will you be paid to take part in this study and are there any costs involved? 
  There will be no costs involved for you, if you do take part. 
Is there anything else that you should know or do? 
You can contact the institution Research Chairperson, Dr xxxxx, if you have any further queries or 
encounter any problems. 
You can contact the Principal Researcher if you have any technical queries, or anything to do with 
research project at xxxx 
You can contact the HREC at 021-938 9207 if you have any concerns or complaints that have not been 
adequately addressed by Principal Investigator and the Research Chairperson. 
You will receive a copy of this information and consent form for your own records. 
Declaration by participant 
By signing below, I …………………………………..…………. agree to take part in a research study entitled 
(INVESTIGATING THE EFFECT OF INTERVENTIONAL ANTIMICROBIAL PROGRAMMES ON THE APPROPRIATE PRESCRIBING OF 
ANTIBIOTICS FOR ACUTE GASTROENTERITIS AND IT’S CO-INFECTIONS FOR CHILDREN LESS THAN FIVE YEARS AT RALEIGH FITKIN 
MEMORIAL HOSPITAL, SWAZILAND) 
I declare that: 
I have read or had read to me this information and consent form and it is written in a language with which I 
am fluent and comfortable. 
I have had a chance to ask questions and all my questions have been adequately answered. 
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I understand that taking part in this study is voluntary and I have not been pressurised to take part. 
I may choose to leave the study at any time and will not be penalised or prejudiced in any way. 
Signed at......................…........…………….. on…………....………………………………………………………………… 2016. 
Signature of participant  Signature of witness 
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Declaration by the investigator 
I…………….……………………………………………..………………………………………… declare that: 
I explained the information in this document to ……………………………………………………………. 
I encouraged him/her to ask questions and took adequate time to answer them. 
I am satisfied that he/she adequately understands all aspects of the research, as discussed above 
I did/did not use an interpreter. 
Signed at………........................…........…………….. on………………………....………………………………………… 2016. 
Signature of investigator  Signature of witness 
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INVESTIGATING THE EFFECT OF INTERVENTIONAL ANTIMICROBIAL PROGRAMMES ON THE APPROPRIATE 
PRESCRIBING OF ANTIBIOTICS FOR ACUTE GASTROENTERITIS AND IT IS CO-INFECTIONS FOR CHILDREN LESS THAN 
FIVE YEARS AT RALEIGH FITKIN MEMORIAL HOSPITAL, SWAZILAND 
Demographics 
Name of hospital: ____________________________________________ 
Region:…………………………………………………………………………………. 
1.1 PRESCRIBER’S INFORMATION: 
Qualifications: 
Tick in the correct box 
Paediatrician Medical Doctor Family Nurse Practitioner Nurse Other 
Work experience: 
years 2-4 years 4-6 years 6-8 years 8-10 years > 10 years 
1.2 PATEINT INFORMATION: 
Age: Gender: Male Female: Weight: 
Admission details: First attendance RE- attendance 
Residential address 
Region: Manzini; Hhohho; Shiselweni; Lubombo 
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1.3 CAREGIVER’S INFORMATION: 
Age: <18 years: 18-25 years:25-30 years: 30-35 years: 35-40 years :>40 years 
 Gender: Male female: 
Education background: No formal education Primary education: Secondary education: University level: 
Relationship with patient: Mother; Father; Sister; Aunt; Helper 
PATIENT’S HISTORY 
Signs and symptoms of diarrhoea : 
Temperature: _______ Capillary Refill: _____ 
Time elapsed between onset of diarrhoea and attending health centre in days: ____________ 
Frequency of passing stool per day: _______ 
Consistency and nature of stool: ________ 
Complaints of patients: 1. ___________________________ 2. ……………………………………………………………. 
3……………………………………………………. 
Patient level (Circle one): Level 1 Level 2 level 3 
Point of admission: General OPD emergency room: Baylor clinic: 
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Place of admission: Special care unit children’s ward ICU: 
Prescriber’s recommendation: admission monitored at emergency room: 
2.2 Other condition at admission: 
HIV: Exposed not exposed: 
Pneumonia: acute malnutrition: severe malnutrition: bronchiolitis: otitis media: 
Coughing: allergic rhinitis: tonsillitis: 
Any other chronic condition: please 
specify………………………………………………………………………………………………………………………………………………… 
Doctors’ orders: 
Laboratory (Please attach) 
X-ray (Please attach)
Final prescriber’s diagnosis: 
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2.3 Medication history (last 6 months) 
Antibiotics used: 
1. 
2. 
3. 
Indication: 
1. 
2. 
3. 
Facility level: Clinic/PHU/Hospital 
1. 
2. 
3. 
Other Medication used: 
1. 
2. 
3. 
Indication: 
1. 
2. 
3. 
Facility level: Clinic/PHU/Hospital 
1. 
2. 
3. 
Chronic medication: 
1. 
2. 
3. 
Indication: 
1. 
2. 
3. 
Facility level: Clinic/PHU/Hospital 
1. 
2. 
3. 
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2.4 Prescribed medications and fluids on and during admission 
List of medication (Generic) 
dose/strength/duration 
 D1 D2 D3 D4 List of medication (Generic) 
dose/strength/duration 
D5 D6 D7 D8 D9 D10 D11 D12 D13 D14 
Antibiotics : Antibiotics: 
1. 1. 
2. 2. 
3. 3. 
Fluids: Fluids: 
1. 1. 
2. 2. 
3. 3. 
Any other medication: Any other medication: 
1. 1. 
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
188 | P a g e
List of medication (Generic) 
dose/strength/duration 
 D1 D2 D3 D4 List of medication (Generic) 
dose/strength/duration 
D5 D6 D7 D8 D9 D10 D11 D12 D13 D14 
2. 2. 
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2.5 Laboratory results 
Were laboratory tests used before prescribing antibiotics: YES NO 
Were antibiotics continued after laboratory results: YES NO 
Culture done Bacterium cultured Sensitive drugs Intermediate drug Resistance drug 
Blood 
Pus 
Urine 
Stool 
CSF 
Synovial fluid 
Vomitus 
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Culture done Bacterium cultured Sensitive drugs Intermediate drug Resistance drug 
Are the sensitive drug available: YES NO 
Which is the cheapest available drug: YES NO 
Which drug was dispensed and why?.................................................................................................................................................................................................................... 
  ……………………………………………………………………………………………………………………………………………………………………………………………………………… 
  ……………………………………………………………………………………………………………………………………………………………………………………………………………….. 
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Full medication cost stay: 
PLEASE ATTACH RESULTS: 
  Total cost: 
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INTERVENTION: 
Description of intervention Tick the relevant 
intervention 
Any further comments 
Discontinue the antibiotic 
 
  
Narrow or broaden antimicrobial therapy 
 
  
Convert from parenteral to oral route 
 
  
Narrow or broaden empirically 
 
  
Increase or decrease the dose 
 
  
shorten or lengthen the planned duration of therapy 
 
  
Consolidate to fewer antimicrobials 
 
  
Obtain an ID consult   
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2.6 List of discontinued medication due to side effects or Laboratory results: 
1……………………………………………………………… 
2……………………………………………………………… 
3……………………………………………………………… 
4……………………………………………………………… 
Any comments on medication 
given:……………………………………………………………………………………………………………………………………………………………………………………
………………………………………………………………………….. 
………………………………………………………………………………………………………………………………………………………………………………………………
…………………………………………………………………………. 
2.7 List of added medications after laboratory results 
1……………………………………………………………………………….. 
2………………………………………………………………………………… 
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3………………………………………………………………………………... 
4……………………………………………………………………………….. 
5……………………………………………………………………………….. 
2.8 Symptoms on discharge 
1………………………………………………………………………………… 
2…………………………………………………………………………………. 
3………………………………………………………………………………….. 
2.9 Medication on discharge 
……………………………………………………………………. 
……………………………………………………………………. 
…………………………………………………………………….. 
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ALIGNMENT TO antimicrobial stewardship committee 
Did the prescriber align to the antimicrobial stewardship committee recommendations? Yes No Partially comply 
Did the prescriber align to the Standard Treatment Guideline or Protocol? Yes No Partially Comply 
Terms of reference 
The antimicrobial stewardship committee 
Accountability: 
The antimicrobial stewardship committee (ASC) is accountable to the hospital DTC. 
Purpose: 
The Raleigh Fitkin Memorial Hospital (RFMH) Antimicrobial Stewardship (AMS) Committee will provide oversight 
and input into the development, implementation and ongoing review of the AMS programme at RFM Hospital. 
The AMS programme will involve a systematic approach to optimising the use of antimicrobials in RFM Hospital 
to improve patient outcomes, reduce inappropriate antimicrobial use, and reduce adverse consequences of 
antimicrobial use (including antimicrobial resistance, toxicity and unnecessary costs). 
  
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
196 | P a g e  
 
 
 
Primary objectives: 
Advisory: The ASC recommends the development and adoption of professional policies regarding antimicrobial 
agents within RFM, including the evaluation, selection, procurement, distribution, use, safe practices, control, 
and clinical protocols of antimicrobials 
Education: The ASC recommends the development of programmes and educational tools designed to meet the 
needs of AHS staff for complete and current knowledge on matters related to antimicrobials and their 
appropriate use. 
Research: The ASC encourages and supports research on antimicrobials, antimicrobials use, and antimicrobials 
Pharmacoeconomics. 
Secondary objectives: 
1. AMS Rounds 
The antimicrobial stewardship (AMS) team will carry out AMS rounds at RFM Hospital every Friday of each week. 
The purpose of these rounds will be to review antimicrobial prescribing in targeted clinical areas (e.g. critical 
care, respiratory, and surgical wards). The AMS team is authorised to make point-of-care interventions (such as 
adjusting antimicrobial therapy based on allergy mismatch, microbiology results or organ dysfunction), and/or 
discuss their recommendations with treating teams. 
2. Monitoring of Antimicrobial Usage and Resistance 
The AMS program incorporates a range of data collection methodologies to monitor both the quantity and 
quality of antimicrobial usage and examine processes associated with antimicrobial prescribing and supply. These 
methods include (but are not limited to): 
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Analysis of Antimicrobial Utilisation Surveillance Program (NAUSP) reports for RFM every 3 months; 
Analysis of carbapenem antibiotic usage at RFM every 3 months; 
Review of audits of compliance with antimicrobial prescribing guidelines at RFM Hospital. 
The AMS committee also works closely with the Management Sciences for Health to extract and evaluate data 
on local antimicrobial resistance rates and changes or trends that emerge over time. This includes: 
Review of multi-resistant organism (MRO) surveillance data every 3 months in liaison with a representative from 
the Infection Prevention and Control Committee; 
Review of cumulative hospital level antibiogram for RFM Hospital every 12 months. 
The core objectives of the committee includes: 
1. To develop, implement, maintain and evaluate policies, protocols, and programmes to promote safe, 
optimised, and cost-effective antimicrobial use. 
2. To regularly collect and evaluate process and outcome measures to ensure successful antimicrobial 
stewardship practices. 
3. To identify areas of suboptimal antimicrobial use through prospective audits, antimicrobial order forms or 
surveillance and recommend appropriate intervention strategies. 
4. To provide regular feedback and reinforcement to prescribers regarding audit results and the appropriateness 
of their antimicrobial use with recommendations for improvement as necessary. 
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5. To develop and deliver educational programmes for RFM Health staff targeted at areas of weaknesses in 
antimicrobial prescribing. 
6. To work collaboratively with the provisional antimicrobial stewardship Group and the national antimicrobial 
stewardship committee in order to align with the provincial and the national wide antimicrobial stewardship 
initiatives. 
7. To plan action, including risk assessment, to improve the effectiveness of the AMS programme at RFM Hospital. 
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Organisational risks addressed by this committee: 
The key risks to the organisation that will be managed by this committee include: 
Risks associated with inappropriate use of antimicrobials (including antimicrobial resistance, toxicity and 
unnecessary costs); 
Conflict that may arise from formulary restrictions and/or performance measures based on concordance with 
clinical guidelines. 
 Membership and roles 
All members are expected to play an active role in the development, implementation and review of AMS 
strategies at RFM Hospital. Members represent their unit, department or discipline, and as such, may liaise with 
staff in their unit when broad input is needed e.g. development of a protocol for a specific infectious condition. 
Members are also expected to champion the AMS programme in their own unit, and demonstrate leadership for 
AMS in their prescribing practices, as well as in their knowledge and attitudes. 
Membership of the AMS committee will consist of: 
Senior Pharmacist (Executive Chair) 
Medical Officer (Deputy Chair) 
 Clinical microbiologist (AMS lead) 
AMS Pharmacy Technician (Secretary) 
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Patient Safety and Clinical Quality Manager 
 Nursing representatives 
Medical staff representatives (paeditrician, surgery, obs and gyane, casualty) 
Consumer representative 
 Infection Prevention Control representative 
Other personnel may be co-opted as required to assist the work of the committee. 
Head of AMS team 
Is an ID Physician/Paediatrician, senior physician or clinician, senior pharmacist deemed to be suitable by the 
Hospital Director? 
Represents the AMS team in the hospital infection control committee and gives feedback on AMS programme. 
Co‐opted into the DTC when considering changes of antimicrobials in the hospital formulary 
Prepares surveillance and audit reports for submission to state and national level 
Proposes annual AMS activities with the Hospital Director and various departments 
Infectious disease physician or paediatrician 
Leads the technical component of antimicrobial stewardship team. 
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Consults and advises on specific stewardship related cases and issues 
Antimicrobial pharmacist or clinical pharmacists 
Is preferably a dedicated full‐time Pharmacist trained in AMS 
Clinical role in conjunction with other members of the AMS Team 
Gives technical know-how on finer aspects of antimicrobials and newer agents. 
Works with and educates ward pharmacists to identify potential patients for stewardship interventions (e.g. de‐
escalation etc) 
Ensures dose optimisation is carried out especially for complex antimicrobials and complex clinical scenarios. 
Enforces the approval system of restricted antimicrobials 
Ensures safe and effective use of medication to reduce risk for errors and adverse events 
Surveillance of antimicrobial use 
Collection and analysis of local consumption and expenditure 
Provision of data to regional /national surveillance programmes 
Carries out and analyses point prevalence studies on antimicrobial usage 
Audit and feedback 
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Leads and conducts appropriate antimicrobial audits 
Provides timely feedback for future improvement 
Clinical microbiologist 
Provision of guidance on appropriate diagnostic tests in microbiology. 
Provision of timely and accurate reporting of culture and antimicrobial susceptibility data. 
Ensures selective reporting of antimicrobial susceptibilities and interpretative reporting of microbiology results. 
Provision of antimicrobial resistance patterns data in individual hospital on yearly basis. 
Ensure the appropriateness of microbiology request, sample collection (types, time, date taken and 
documentation) and sample quality. 
Work closely with the attending clinician, IDs specialist and antimicrobial pharmacist in the management of 
patients with infections 
Information technology officer 
Hospitals with existing IT systems may consider including an IT personnel into the AMS team to assist with : 
Creating localised electronic decision-making systems that can be available through the hospital network system. 
Providing AMS team access to microbiological data and antibiotic utilisation data. 
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Producing automated antimicrobial utilisation data and other programmed clinical data. 
Infection control nurse 
AMS teams frequently chance upon opportunities to tighten infection control practices during their course of 
the work. Having an Infection Control Nurse Practitioner within the team complements the efforts of the AMS 
team in bringing down resistance rates. 
Meeting frequency: 
Monthly 
Any additional meetings will be at the discretion of the antimicrobial stewardship committee chairperson. The 
meetings will be set at the beginning of each calendar year and circulated to members. 
Quorum 
A quorum will be half the members plus one. 
Agenda / minutes: 
An agenda will be established prior to each meeting and distributed to committee members. Following each 
meeting, a “Meeting Summary” will be distributed outlining action items and the individual responsible. 
 Communication: 
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All antimicrobial stewardship committee (ASC) members are responsible for obtaining regular input from their 
colleagues, whom they represent, and relaying this information to ASC to ensure thorough representation of all 
stakeholders. 
Members are required to keep their colleagues updated regarding ASC policies and protocols to ensure 
stakeholders remain informed. 
 ANTIMICROBIAL STEWARDSHIP PROGRAMME MEASUREMENT 
Successful antimicrobial stewardship program include all the elements of successful quality improvement 
programmes and measuring the effectiveness of programme activities is a key component. Monitoring and 
analysis of antimicrobial usage is critical to measure the effects of stewardship interventions. Process and 
outcome measures should be incorporated into the AMS plan. 
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A. Process measures 
Rate of clinician acceptance of AMS recommendations. 
Rate of adherence to documentation policy at time of antimicrobial initiation (dose, duration and indication 
explicitly written) 
Rate of review of Carbapenem and Polymyx in prescriptions by primary team at 72 hours 
Rate of appropriate empirical prescription according to antimicrobial guideline 
B. Outcome indicators 
Specific antibiotic DDDs over every 6 months 
Cost differences 
For intervention results in the antimicrobial being stopped or switched to a cheaper alternative or to oral dosage 
form. 
Formula of cost saving and days calculation ‐ 
C. Other Suggested Indicators (Where applicable) 
Readmission within 30 days. 
Percentage of patient with AMS recommendation accepted being re-admitted within 30 days. 
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Mortality within 30 days 
Rates of mortality within 30 days inpatient with AMS intervention. 
SWAZILAND NAZERINE HEALTH INSTITUTION - RESTRICTED ANTIBIOTICS DECLARATION FORM 
  Patient Details 
Name: Ward: 
File number: Age: Weight: Gender: 
Serum Creatinine: mg/dl 
Place of acquisition of the infection: Hospital{ } Community{ } 
Underlying diseases 1……………………………………………………. 2…………………………………………………………….. 
Site of infection: sepsis{ } gastrointestinal tract{ } bacteraemia{ } urinary tract{ } lung{ } 
  : Others, specify……………………………………………… 
Predicted / known causative organism 1…………………………………………………………………………… 
  2…………………………………………………………………………… 
Microbiology tests: Gram stain { } 
TURN OVER FOR LIST OF 
RESTRICTED ANTIBIOTICS 
AND USAGE GUIDELINES 
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  : Culture { } Not done 
  { } Done - Results pending { } 
  Results known { } as…………………………………………………….. 
 
{ } Empiric use: infecting organism (s) unknown, 3 day review of therapy required 
  OR 
{ } Directed therapy: infecting organism(s) known, 7 day review of therapy required 
INDICATION 
Please tick appropriate box on reverse side. Give details below if indication not listed: 
………………………………………………………………………………………………………………………………………… 
Note: The antimicrobial stewardship committee or clinical microbiology may be required for other indications 
CULTURE AND SENSITIVITY DATA 
Organism(s)………………………………………………. ……………………………………………………………….. ………………………………………………………….  
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Sensitive to………………………………………………. ……………………………………………………………….. ………………………………………………………….  
Resistant to………………………………………………. ……………………………………………………………….. …………………………………………………………. 
 
REQUESTING DOCTOR:………………………………………………………. 
PHARMACIST :…………………………………………………………. DATE:…………………………………………….. 
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Note: Doses may require modification based on renal function 
Antibiotic Usage Guidelines 
Ceftriaxone 1g Treatment of: LRTI( ), URTI( ), cholecystitis( ), ascending cholangitis( ) or pelvic inflammatory disease( 
), under the following circumstances: 
{ } in patients hypersensitive to penicillin (excluding immediate hypersensitivity or 
{ } due to susceptible organisms (resistant to earlier generations of cephalosporin) or 
{ } where the use of aminoglycosides are contraindicated due to a calculated creatinine clearance of 
less than 20Ml/min 
{ } Empirical treatment, with penicillin, of bacterial meningitis pending culture and sensitivity results 
{ } Acute epiglottis, orbital/ periorbital cellulitis, and gonococcal infections 
{ } Prophylaxis for meningococcal contacts 
{ } Spontaneous bacterial peritonitis pending culture and sensitivity results 
Ciprofloxacin { } Infections due to Pseudomonas aeruginosa or other gram-negative bacteria resistant to all other 
agents 
{ } Bacterial gastroenteritis in severely immunocompromised patients 
{ } Bone and Infections, epididymo-orchitis, prostatitis or perichondritis of the pinna, involving 
proven/ suspected gram-negative or gram-positive bacteria resistant to all other appropriate agents 
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Piperacillin 4g { } Treatment of Pseudomonas aeruginosa infections in combination with another anti-pseudomonal 
agent 
Meropenem { } Pathogen resistant to other antimicrobial agents except Meropenem 
{ } Documented ESBL producing organism 
Vancomycin { } For infection with methicillin-resistant S. aureus 
Clindamycin { } Susceptible gram-positive infections allergic to penicillin; sensitive staphylococcal and anaerobe 
infections 
{ } Severe soft tissue infections, lung abscesses, quinsy (not responding to penicillins) 
Tazobactam { } 
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Policy 
Clinical Guideline 
Principles for rational Antimicrobial Prescribing Clinical Guideline for children 
Policy developed by: Pharmacy department, Laboratory and infection Control department 
Approved by: Drugs and therapeutic committee 
Next review due: December 2016 
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Table of Contents 
Summary: 
The Antimicrobial Prescribing Clinical Guideline provides general principles that all RFMH Health prescribers 
should be aware of when prescribing antimicrobials for patients with, or at risk of, infection. 
It outlines processes for to ensure optimisation of prescribing of antimicrobials in all clinical settings, ensuring 
antimicrobials are prescribed and utilised according to principles of evidence-based medicine. 
Keywords: 
Antimicrobial, prescribing, guideline, AMS, antibiotic, MINDME, optimisation, evidence, Therapeutic Guidelines, 
Antibiotic, Antimicrobial Prescribing Clinical Guideline 
Policy history 
Is this a new policy? Y 
Does this policy amend or update an existing policy? N 
Does this policy replace an existing policy? N 
Staff impact 
All Clinical, Medical, Nursing, Allied Health, Emergency, Dental, Pathology 
Disclaimer 
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This document is provided as an information resource for all health care workers to assist in the appropriate 
prescribing of antibiotics. It attempts to summarise relevant information for clinicians from Swaziland and 
International guidelines as well as reference to textbooks, key publications and expert opinion. 
Recommendations change rapidly and opinion can be controversial. The authors do not warrant that the 
information contained in this booklet is complete. 
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Agents available at RFMH Medicine Formulary 
Antimicrobial Oral Parenteral Cost 
Benzyl penicillin 5.0MU Injection: E45.60/10’S 
Amikacin injection 1g/4ml, 
500mg/4ml 
Injection: E136.95/10’s-1g 
Injection: E113.11/10’s- 500mg 
Benzathine penicillin 2.4MU Injection: E70/10’s 
Procaine penicillin 300 000U 
/IU 
Injection: E54.20/10’s 
Phenoxymethyl penicillin 125mg/5ml, 250mg Tablets: 223.00/1000’s 
Suspension: E8.99/100ml 
Amoxicillin 250mg, 500mg,1g, 
125mg/ml 
250mg/ml 
500mg Tablets 250mg: E85.00/500’s 
Tablets 500mg: E164.00/500’s 
Suspension 125mg: E5.95/100ml 
Suspension 250mg: 8.50/100ml 
Injectable: E104.50/10’s 
Amoxicillin- clavulanic acid 125-31mg/5ml,
500-125mg
1.2g Tablets: E26.50/15’S 
Suspension: E13.09 
Injectable: E14.00/1’s 
Cloxacillin 125mg/5ml, 250mg, 
500mg 
500mg/5ml Capsules 250mg: E274.10 
Capsules 500mg: E260.00 
Suspension: E11.78/100ml 
Injectable: E43.40/10’s 
Flucloxacillin 125mg/5ml Suspension: E10.58/100ml 
Streptomycin 1g Injection: E150.70 
Erythromycin 125mg/5ml, 250mg 
500mg 
Tablets 250mg: E328.90/1000’s 
Tablets 500mg: E612.00/1000;s 
Suspension: E7.80/100ml 
Metronidazole 200mg/5ml, 200mg 
400mg 
500mg/100
ml 
Tablets 200mg: E75.64 
Tablets 400mg: E134.30/1000’S 
Suspension: E12.72/100ml 
Injectable: E10.95/100ml 
Cotrimoxazole 200-40mg/5ml, 400-
80mg, 800-160mg
80/400mg 
/5ml 
Tablets 480mg: E82.00 
Tablets 960mg: E259.00 
Suspension: E4.99/100ml 
Injectable: E349.90/10’s 
Cefazolin 1g Injection: E108.90/10’s 
Ceftriaxone 250mg, 1g Injection 250mg: E45.00/10’s 
Injection 1g: E70.00/10’s 
Cefuroxime 1.5g, Injection: E240/10’s 
Clindamycin 150mg 600mg Injection:E199.00/100’s 
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GENERAL PRINCIPLES OF PRESCRIBING ANTIMICROBIALS 
Diagnosis 
Consider the possible infecting pathogens and the severity of the condition to be treated. Specimens for 
microbiological examination should be taken before starting antimicrobial therapy. This is always important but 
especially in children with suspected infective endocarditis or urinary tract infections. Isolation of bacteria from 
a specimen does not automatically mean antibiotic treatment is required - treat the patient, not the culture 
result. 
Principles for rational antibiotic prescribing 
Decide if an antibiotic is indicated: does the patient have a bacterial infection? 
Ciprofloxacin 250mg, 500mg 2mg/ml Tablets 250mg: E5.50 
Tablets 500mg: E42.00 
Injection: E27.20/50ml 
Cefpodoxime 40mg/5ml Suspension: E 
Azithromycin 500mg Tablets: E5.95/3’s 
Cefaclor 375mg, 185mg/5ml Tablets:E69.99/15’s 
Suspension: E49.50/50ml 
Doxycycline 100mg Tablets E193.92/1000’s 
Nitrofurantoin 100mg Tablets E340.00/1000’s 
Dapsone 100mg Tablets: E 
Clarithromycin 125mg/5ml, 250mg, 
500mg 
Tablets 250mg: E207.72/100’s 
Tablets 500mg: 51.50/14’s 
Suspension: E69.99/50ml 
Chloramphenicol 1g Injection:E83.90/10’s 
Gentamycin 80mg/ml Injection:E270.00/100’S 
Spectinomycin 2g Injection: E78.00/1’s 
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
216 | P a g e
Targeted refers to specimen from site of infection e.g. urine for cystitis 
2. Perform cultures before administering antibiotics in hospitalised patients
This allows de-escalation to a narrow spectrum antibiotic once the antibiogram is available & is a cornerstone of 
antibiotic stewardship or in outpatients with recurrent infections. 
3. Choose an appropriate empiric antibiotic:
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a. Target the most likely pathogen(s) for the site of infection
This can be predicted by understanding the broad groups of pathogens that most commonly cause infections at 
various sites: 
- Skin and soft tissue: Gram-positive cocci
- Urinary tract: Gram-negative bacilli
- Intra-abdominal: Gram-negative, gram-positive and anaerobic organisms
- See chapters on specific infections for more details
An appropriate empiric antibiotic can then be selected by matching the narrowest spectrum antibiotic with the 
likely pathogens. Spectrums of activity of commonly used antibiotics are shown below: 
Gram-positive cocci 
Clusters Pairs/chains 
MSSA MRSA S. pneumoniae
Most other 
Streptococci 
E. faecalis E. faecium VRE 
Amoxicillin/ampicillin - - + +  - - 
Cloxacillin + - +/- - - - 
Clindamycin + +/- + - - - 
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Gram-positive cocci 
Clusters Pairs/chains 
Ceftriaxone + - + - - - 
Co-amoxiclav + - + / - - 
Vancomycin / + / / + - 
Moxifloxacin / +/- + / +/- - 
Linezolid / / / / / + 
Daptomycin / / / / / / 
Gram-negative 
Bacilli Cocci 
E. coli Klebsiella spp. Enterobacter 
spp. 
ESBL CRE Salmonella 
spp. 
Pseudomonas 
spp. 
Neisseria 
meningitidis 
Amoxicillin/ampicillin - - - - / - +/- 
Penicillin - - - - / - +/- 
Cotrimoxazole* +/- +/- +/- - +/- - - 
Ceftriaxone + - - - + - + 
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Gram-positive cocci 
Clusters Pairs/chains 
Co-amoxiclav + - - - / - / 
Ciprofloxacin + +  +/- +/- + +  / 
Aminoglycosides + +  +/- +/- - + - 
Cefepime / + - - / + / 
Imipenem / / / +/- / + / 
Meropenem / / / +/- / + / 
b. Assess likelihood of antibiotic resistance
Risk factors include known colonisation with a resistant pathogen, HCAI, recent antibiotic exposure. Local 
resistance patterns inform prescribing. 
c. Review potential contraindications
Allergy: 
Clinicians should differentiate an immediate Type 1 IgE mediated hypersensitivity reaction from other less 
dangerous types of hypersensitivity. Classical signs of Type 1 hypersensitivity are anaphylaxis, angioedema, 
urticarial rash, and bronchospasm. If a type I hypersensitivity reaction to penicillin has occurred, then all β-lactam 
antibiotics should be avoided, unless there is no alternative drug available when penicillin desensitisation can be 
attempted as an inpatient. 
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Patients with other types of hypersensitivity reactions, usually a maculopapular rash to amoxicillin, should avoid 
all penicillins but may tolerate other β-lactam antibiotics like Cephalosporins. The 1st generation Cephalosporins 
should be avoided as they have a higher risk of cross-reactivity with penicillin, but this risk is much lower for 
second- or third-generation Cephalosporins (reported to be only 0.1%). 
If the previous reaction to penicillin was a maculopapular rash, it is relatively safe to use 2nd/3rd generation 
Cephalosporins and use would depend on the patient’s social circumstances and access to follow-up. In patients 
with a remote history of a rash on penicillin it is often difficult to differentiate a maculopapular rash from an 
urticarial rash; all β-lactam antibiotics should be avoided if urticaria occurred on penicillins as this is a Type 1 
reaction. In this setting, skin testing before using a cephalosporin is recommended, as a positive reaction to 
penicillin indicates Type 1 hypersensitivity. 
Toxicity: 
Antibiotics can cause direct dose-dependent toxicity and should be avoided in patients at high-risk of developing 
organ damage with a specific agent. For example, do not use aminoglycosides in patients with renal impairment 
or hearing loss. 
d. Choose drug with adequate target tissue penetration
Drug CSF Lung Soft Tissue Urinary Tract 
Ampicillin Good *in higher 
doses 
Good Good Good 
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Cloxacillin Inadequate data Fair Good No data 
Clindamycin Poor No data Fair No data 
Amoxic-clav Poor Good Good Fair 
Ceftriaxone Good * in higher 
doses
Good Good Good 
Aminoglycosides Poor Poor Fair Good 
Ciprofloxacin Good *in higher doses Good Good Good 
Cotrimoxazole Good Good Good Good 
Imipenem Good Good Good Good 
vancomycin Poor Fair Poor Good 
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Linezolid Good Good Good Good 
Meropenem Good *in higher 
doses
Good Good Good 
e. Aim for a single drug with the desired spectrum of activity
Monotherapy is preferred unless combination therapy is required for synergy (e.g. endocarditis) or extended 
spectrum beyond what can be obtained with a single drug (e.g. atypical pathogens in severe CAP). 
f. Ensure correct dose and route of administration
Maximal doses do not always need to be given - the dose depends on the site and severity of infection as well as 
pharmacokinetics of the antibiotic. Dosing recommendations have been provided throughout the booklet. 
Infections that commonly require higher doses include infective endocarditis and meningitis, whilst 
uncomplicated urinary tract infections can be treated with lower doses since the drugs used are concentrated in 
the urine. The oral/enteral route is preferred whenever possible for patients with mild to moderate infections. 
Intravenous antibiotics should be reserved for severe infection or for certain sites such as the CSF, bacteraemia, 
endocarditis, bone and joint infections. Monitor the child’s response and consider changing from IV-to-oral 
therapy when possible. 
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g. Duration of therapy
Duration of therapy should be determined by clinical factors such as site of infection, severity of illness and 
response to treatment. As a general guide, antibiotics can be discontinued within 48-72 hours of the temperature 
returning to normal. Infections at certain sites (e.g. osteitis or endocarditis), with particular organisms or in 
immunocompromised individuals may require prolonged therapy. Guidelines are given in the text where this is 
relevant. With all antibiotics, an ongoing re-evaluation of the patient’s infection should occur with the aim of 
stopping the antibiotic as soon as it is no longer necessary. 
h. Cost
Choices often exist between antibiotics of equal efficacy and safety but differing cost. Where such a choice exists, 
the least expensive agent should be used whenever possible. This has been a guiding principle in the 
development of this document. If a more expensive agent is used empirically, a change to a cheaper, appropriate 
agent should be made as soon as the sensitivity report is available. 
i. Antibiotic levels
Measurement of serum antibiotic levels should be routinely performed when administering aminoglycosides. 
Trough levels are taken just before the next dose. Peak levels are taken one hour after a bolus IM or IV, or one 
hour after an IV infusion is commenced. A peak level should be established as soon as possible, after the first or 
second dose. Once an adequate peak level has been achieved only trough levels need be monitored (usually 
twice a week) provided the patient remains stable. Requests for levels should be submitted to the pharmacology 
laboratory indicating exact times of doses and samples. 
Routine measurement of vancomycin levels is indicated when treating serious infections, infections due to 
strains with raised MICs or when drug toxicity is a concern (“Vancomycin”21 below). Vancomycin levels should 
also be determined in patients with renal impairment to establish when the next dose is to be administered. The 
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level should be measured one to five days after the previous dose. The interval will depend on the degree of 
renal dysfunction. In patients with sensitive organisms, trough vancomycin levels should be maintained between 
5 and 10 mg/l, but higher concentrations are recommended for organisms with higher MICs (consult with 
microbiology or IDs and see “Vancomycin” below). Levels should also be monitored if patients are on a 
combination of a glycopeptide and an aminoglycoside. This combination should however be avoided if at all 
possible. 
5. Start the appropriate antibiotic rapidly in severe infections
Mortality increases by 8% for every hour antibiotic administration is delayed in septic shock 
6. Practice early and effective source control
Search for and remove any persistent foci of infection 
7. Evaluate antibiotic appropriateness every day
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Changing antibiotics 
Once antibiotics have been initiated the decision to change or stop therapy depends on the patient’s clinical 
response and culture results (algorithm). 
INDICATIONS FOR BLOOD CULTURES 
1. Child with fever (axillary T > 385°C) with no localising signs < 3 years of age.
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2. Fever with suspected: - meningitis - complicated pneumonia/effusion/lung abscess - pyelonephritis -
arthritis/osteomyelitis/cellulitis - endocarditis/pericarditis. 
3. Immunocompromised child (with fever/hypothermia) - severe protein-energy malnutrition
(kwashiorkor/marasmus) - immunologic deficiency (humoral/cellular) - neoplasia - HIV with suspected severe 
bacterial infection. 
4. Any neonate with fever (T > 384°C)/hypothermia.
5. Infant <1 month old with diarrhoea
6. No blood culture for uncomplicated tonsilitis/otitis media/pharyngitis or uncomplicated acute respiratory
infection including bronchiolitis / uncomplicated pneumonia 
7. No blood culture indicated in febrile seizures where a clear focus is identified
Please Remember:  always maintain strict aseptic technique and use a sterile pack when taking a blood culture 
 Cultures must be sent in the Paediatric Bactec bottles
 Take 1 -2 ml of blood in a neonate and 2-5ml in an older child
 Remember to get appropriate specimens for culture from other sources
sputum from a child old enough to cough, especially if has chronic lung disease, bronchiectasis 
urine and CSF in suspected neonatal sepsis 
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 urine dipstix screen in all children with gastroenteritis, severe PEM, unexplained source of fever. Sterile 
specimen subsequently taken and sent for culture if dipstix suggestive of UTI. 
RESTRICTED ANTIMICROBIALS AT RFMH 
The use of the antimicrobials listed below is restricted and requires clearance by either a microbiologist or IDs 
clinician. If the prescribing clinician is of the opinion that any of these agents are required for the management 
of a patient in their care, they should contact the microbiologist or IDs clinician on-call for details on how to 
obtain clearance. Motivation should be supported by relevant clinical details and preferably microbiological 
evidence. The Pharmacy is authorised to deny the release or continuation of restricted agents for which the 
necessary clearance has not been obtained. Vancomycin levels should also be determined in patients with renal 
impairment to establish when the next dose is to be administered. The level should be measured one to five days 
after the previous dose. The interval will depend on the degree of renal dysfunction. In patients with sensitive 
organisms, trough vancomycin levels should be maintained between 5 and 10 mg/l, but higher concentrations 
are recommended for organisms with higher MICs (consult with microbiology or IDs and see “Vancomycin” 
below). Levels should also be monitored if patients are on a combination of a glycopeptide and an 
aminoglycoside. This combination should however be avoided if at all possible. 
NOTES ON COMMONLY USED AGENTS 
Antibacterial Agents 
Aminoglycosides 
The aminoglycosides in use at RCCH/TCH are gentamicin, tobramycin and amikacin. Streptomycin is reserved for 
treating TB and tobramycin is currently used primarily for treating Acinetobacter infections. Aminoglycosides 
have activity primarily against aerobic gram-negative bacilli. They have no anaerobic cover. They are used most 
commonly where infection with a gram-negative bacillus is suspected or confirmed e.g. UTI, abdominal sepsis, 
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severe pneumonia. Aminoglycosides have some activity against staphylococci, but are not first-line agents for 
treating staphylococcal infections and should not be used alone for this purpose. They can also be used in 
combination with either penicillin (or rarely vancomycin) to treat streptococcal or enterococcal endocarditis. If 
used in combination, they are used at lower than normal doses, as their action is synergistic with the other agent. 
Aminoglycosides should not be used for longer than 14 days, unless unavoidable. Aminoglycosides demonstrate 
concentration-dependent killing - the higher the serum concentration, the better the killing activity. Peak levels 
are thus checked to ensure a high enough concentration. They also have a post-antibiotic effect - even at low 
concentrations in serum, they inhibit regrowth of bacteria. Aminoglycosides can thus be given as a single daily 
dose, with no loss of efficacy, and reduced potential for toxicity. As discussed earlier, trough levels should be 
measured just before the dose is given and peak levels measured one hour after a bolus IM or IV dose, or one 
hour after commencing an IV infusion. 
AMINOGLYCOSIDE DOSING SCHEDULE 
AMINOGLYCOSIDE DOSING SCHEDULE 
THE MOST IMPORTANT DOSE IS THE FIRST ONE - DO NOT UNDERDOSE 
Antibiotic Dose Interval Peak level Trough level 
Gram-negative infection - normal renal function 
Gentamycin 5-7.5mg/kg/dose daily >8 <1 
Amikacin 15mg/kg/dose daily >30 <1 
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Gram-negative infection - poor renal function 
Gentamycin 3-4mg/kg/dose
A peak of above 8mg/l must be achieved. Repeat dose 
when level <1mg/l but if interval required to achieve this 
is >48 hours consider alternative therapy 
Amikacin 10mg/kg/dose 
A peak of above 30mg/l must be achieved. Repeat dose 
when level <1mg/l but if interval required to achieve this 
is >48 hours consider alternative therapy 
Streptococcal or enterococcal endocarditis 
Gentamycin 1.5mg/kg/dose 12 hourly 3-8 <1 
Carbapenems 
The commonly used carbapenems are meropenem and imipenem. These are all very broad-spectrum agents, 
with activity against most gram-negative bacilli, Streptococci (poor enterococcal cover), cloxacillin susceptible S. 
aureus and anaerobes. These agents are reserved for infections with organisms resistant to other antibiotics and 
should be used very sparingly. 
Cephalosporins 
The available Cephalosporins at RFMH are Ceftriaxone, cefotaxime, Cefuroxime and cefepime. Cephalosporins 
are broad-spectrum agents, with activity against gram-positive and gram-negative organisms (but little effective 
anaerobic cover). 
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The use of Cephalosporins is strongly linked to the development of antibiotic resistance and should be used for 
specific indications only. They can be used where aminoglycosides may be inappropriate (e.g. due to intrinsic 
renal dysfunction) or for treating CNS infections. It is important to remember that Cephalosporins have NO 
activity against cloxacillin-resistant staphylococci as well as enterococci. 
• Ceftriaxone, which may be used as a once daily intravenous or intramuscular injection, is currently the most
cost-effective third-generation cephalosporin available. Roche recently released the following safety advice: 
“Rocephin and calcium-containing solutions, including continuous calcium-containing infusions such as 
parenteral nutrition, should not be mixed or co-administered to any patient irrespective of age, even via different 
infusion lines at different sites. As a further theoretical consideration and based on 5 half-lives of ceftriaxone, 
Rocephin and IV calcium-containing solutions should not be administered within 48 hours of each other in any 
patient”. This recommendation was made following reports of intravascular or pulmonary precipitations in 
neonates, treated with Ceftriaxone and calcium-containing IV solutions. 
• Cefotaxime is an alternative to Ceftriaxone.
• Cefuroxime is used orally to treat UTIs.
• Cefepime’s primary indication in children is for treating suspected or confirmed infections with P. aeruginosa.
Cotrimoxazole (trimethoprim + sulfamethoxazole) 
Traditionally regarded as an antibacterial agent and widely used as such, although widespread resistance has 
developed and few bacterial organisms remain susceptible. In instances where a pathogen is known to be 
susceptible to cotrimoxazole, it remains a useful and effective agent. Cotrimoxazole also has activity against 
other pathogens and its main current indication is for the prophylaxis and treatment of infections due to 
Pneumocystis jiroveci in immunocompromised patients. Also used in treating nocardiosis, prophylaxis and 
treatment of toxoplasmosis and Isospora belli diarrhoea. Well absorbed orally and widely distributed. Not 
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
231 | P a g e
recommended in infants under 4-6 weeks of age due to increased risk of hyper bilirubinaemia and kernicterus. 
There is a wide spectrum of potential side effects; sulfamethoxazole is more frequently implicated in 
hypersensitivity reactions and gastrointestinal disturbances. 
Macrolides / Lincosamides 
The macrolides (erythromycin, clarithromycin and azithromycin) and lincosamides (clindamycin) are not 
structurally related but are often linked together as they share very similar mechanisms of action, and thus cross-
resistance can exist. The spectrum of activity of the macrolides includes gram-positive organisms (staphylococci, 
Streptococci and some corynebacteria), atypical organisms (Legionella, Chlamydia and Mycoplasma) and 
Campylobacter spp. It must be remembered that amongst isolates of S. pneumoniae and S. aureus, resistance to 
these agents is well described. There is some (limited) evidence that azithromycin can be used to treat 
cryptosporidiosis; however, its efficacy is variable. The newer macrolides have a similar spectrum to 
erythromycin and do not have the same degree of GIT side effects as erythromycin; however, they are also more 
expensive. 
Clindamycin has activity mainly against staphylococci and Streptococci, as well as many anaerobic bacteria. 
Pneumococcal resistance to clindamycin is less common than to erythromycin, but staphylococcal resistance to 
clindamycin is unfortunately becoming more common amongst nosocomial isolates. However, for community-
acquired cellulitis / soft tissue infections clindamycin is still a very good agent, and some would consider it the 
drug of choice for necrotising fasciitis. 
Neither the macrolides nor lincosamides have any effective enterococcal activity. 
 Metronidazole 
Bactericidal and is indicated for treating anaerobic infections including peritonitis and necrotising enterocolitis 
(but excluding actinomycosis). It also has antiprotozoal activity 
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Penicillins 
Penicillin / amoxicillin / ampicillin effective against all S. pyogenes, most other Streptococci, enterococci and 
many anaerobes. Reduced susceptibility is an increasing concern amongst pneumococci, but these agents are 
still the best options for treating infections outside the CNS (e.g. pneumonia, otitis media) caused by S. 
pneumoniae with intermediate resistance to penicillin/ampicillin. Amoxicillin/ ampicillin are also effective 
against most H. influenzae isolates. 
Cloxacillin 
This agent is primarily used to treat staphylococcal infections, and if the isolate is sensitive to cloxacillin, 
cloxacillin is the best agent. It is worth remembering that cloxacillin susceptible staphylococci are susceptible to 
most other beta-lactams (except penicillin / amoxicillin / ampicillin). Thus, in cases of a mixed infection, co-
amoxiclav or a cephalosporin can be used to successfully treat a staphylococcal infection. However, the converse 
is also true - staphylococci that are resistant to cloxacillin are resistant to ALL beta-lactam agents. 
Amoxicillin-Clavulanic Acid 
This is a relatively broad-spectrum agent that is available in both oral and IV formulations (IV not available at 
RCCH). Its spectrum includes Streptococci, cloxacillin susceptible staphylococci, haemophili, gram-negative bacilli 
and anaerobes. Its main indications are for treating urinary tract infections, dental infections, bite wounds and 
as a second-line agent for otitis media (if amoxicillin alone has failed). Current paediatric oral preparations 
contain amoxicillin and clavulanic acid in a ratio of 4:1. When using higher dosage ranges (>15 mg/kg/dose), add 
amoxicillin separately to limit the clavulanic acid dose and minimise risk of gastrointestinal side effects. 
Piperacillin-tazobactam 
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This broad-spectrum agent is only available intravenously, and the spectrum is much the same as co-amoxiclav. 
However, it has a broader gram-negative spectrum than co-amoxiclav, and will provide cover against some 
Acinetobacter and Pseudomonas species as well as many of the enteric gram-negative bacilli. It should only be 
used for treating suspected or confirmed nosocomial infections, or if a community-acquired infection with 
Pseudomonas aeruginosa is suspected. 
Penicillin allergy 
There are usually alternatives to penicillin if there is a documented history of penicillin allergy. However, it is 
important to take a detailed history of the allergic reaction, as many supposed allergic reactions do not represent 
true allergy. 
Alternatives to penicillin include: 
• Erythromycin
• Clindamycin (especially for skin and soft tissue infection)
• Vancomycin (primarily for treating enterococcal infection)
• Cephalosporins (pneumonia and abdominal sepsis)
There is approximately a 5-10% chance of cross-reactivity with a cephalosporin. If there is a documented history 
of severe penicillin allergy (e.g. anaphylaxis), all Cephalosporins should be avoided. If a cephalosporin is 
considered, a cephalosporin with a different side-chain from the offending penicillin should be used. Cefuroxime 
has a unique side-chain and can be used in cases of side-chain allergy. If in doubt about suitable alternatives, 
please consult the microbiologist, IDs unit or allergy service. 
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Quinolones 
The fluoroquinolones, ciprofloxacin and ofloxacin, are all very effective agents for treating gram-negative 
infections. Nalidixic acid is only available orally, and is used to treat mild dysentery. Ciprofloxacin and ofloxacin 
also have very good activity against legionella, neisseria and haemophili, and some activity against staphylococci 
and chlamydia, although they are seldom used on their own for the latter two organisms. They provide no 
effective anaerobic cover and have unpredictable activity against gram-positive organisms. They are available 
orally or IV. Oral bioavailability is equivalent to IV, and they should thus be administered orally unless there are 
clinical reasons that the drug may not be absorbed (e.g. ileus, severe vomiting and/or diarrhoea etc.). 
Ciprofloxacin is used to treat various resistant gram-negative organisms, including P. aeruginosa. When used to 
treat Pseudomonas infections, a higher dose should be used. Ofloxacin is used primarily as part of combination 
therapy for MDR-TB. The use of ciprofloxacin should be limited to specific indications and primarily guided by 
antibiotic sensitivity results. Some of the newer fluoroquinolones (e.g. moxifloxacin) have better activity against 
gram-positive organisms, including Streptococci. These are not yet available at RCCH/TCH. 
Vancomycin 
Vancomycin is not an aminoglycoside, it is a glycopeptide, and only has activity against gram-positive organisms. 
If a Staphylococcus is sensitive to cloxacillin, cloxacillin is a more effective agent than vancomycin. Vancomycin 
must be given by slow intravenous infusion over at least 1 hour to avoid the “red man syndrome”, which is due 
to histamine release. As the dose of vancomycin appropriate for each patient is dependent on the MIC of the 
organism being treated, it is essential that every attempt be made to identify the suspected pathogen. Before 
vancomycin therapy is considered suitable specimens (including at least TWO blood cultures) must be submitted 
to the microbiology laboratory. Vancomycin levels remain a somewhat contentious issue - both with respect to 
whether they should be measured, and what constitutes the therapeutic range. Much of this debate revolves 
around the observations that clinical outcomes tend to be worse when treating strains with higher (although still 
sensitive) MICs of 1 or 2 mg/l. In these instances, some authors have recommended aiming for higher trough 
levels of 15 mg/l or administering as a continuous infusion. Routine measurement of vancomycin levels is not 
necessary when treating strains with low MICs (<1.0 mg/l), unless the patient has renal dysfunction, is on other 
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potentially nephrotoxic agents (e.g. aminoglycosides), is on unusually high doses of the antibiotic (e.g. obese 
patients) or is not responding to the treatment. Combinations of vancomycin and aminoglycosides should be 
avoided wherever possible. In cases of renal failure (especially in patients on dialysis), levels are measured to 
determine when to administer the next dose. 
Gastrointestinal infections 
Amoebiasis Metronidazole 15 mg/kg/dose 8 hourly x 10 days 
Bacterial dysentery Nalidixic acid 12.5 mg/kg/dose 6 hourly PO x 3-5 days. 
If ill and toxic or <3 months of age: Ceftriaxone 50 
mg/kg/dose once daily 
IV x 5 days 
Cholera Ciproflxacin 20 mg/kg/dose as a single dose PO 
Note: 
1. An alternative for children >8 years of age is
doxycycline 4 mg/kg/dose
as a single dose PO 
2. Antimicrobial susceptibilities of newly isolated
organisms should be
determined 
3. Oral or parenteral rehydration therapy to correct
dehydration and
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electrolyte abnormalities is the most important 
modality of treatment 
and should be initiated as early as possible 
Cryptosporidium No effective therapy 
Diarrhoeal disease 
Acute (<5 days) 
Persistent (>5 days) 
NIL 
Cholestyramine: <6 months of age 500 mg; >6 
months of age 1 g 6 hourly 
PO x 5 days + gentamicin 10 mg/kg/dose 4 hourly PO 
x 3 days (maximum 
dose 60mg) 
Giardiasis Metronidazole 7.5 mg/kg/dose 8 hourly PO x 5 days 
May also be used as a once daily dose according to 
age: 
1-3 years of age: 500 mg
3-7 years of age: 600-800 mg
7-10 years of age: 1 g
An alternative over the age of 2 years is albendazole 
400 mg once daily 
PO x 5 days 
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Giardiasis Peritonitis / 
necrotising 
enterocolitis 
Benzyl penicillin 50 000 U/kg/dose 6 hourly IV + 
gentamicin 7.5 mg/kg/ 
dose once daily IV + Metronidazole 7.5 mg/kg/dose 8 
hourly IV 
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ADMISSION & REFERRAL POLICY 
Rehydration room is an emergency room for the management of acute complications of diarrhoeal disease i.e. 
Hypovolaemia shock, Dehydration and Electrolyte imbalances. 
The room is not appropriate for admission of patients with the following problems: 
Those needing intensive care  
Neonates with diarrhoea 
Short bowel syndrome 
Persistent diarrhoea > 2 weeks who are not dehydrated and do not have nutritional issues -can be investigated 
and managed as outpatients 
The criteria for referral to L1 (general admission), L2 (Special admission) or L3 (Sub-special admission) is as 
follows: 
Level 1 PATIENT 
Common mild electrolyte disorders 
Lactose intolerance 
NG and IV Rehydration 
Uncomplicated dysentery 
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Step down care if >3 months. Stable children <3 months can be considered. 
Level 2 PATIENTS (Patients Who Require Specialist Care) 
Prolonged (>1 week)/recurrent diarrhoea 
Diarrhoeal disease with encephalopathy 
Diarrhoeal disease with seizures 
Diarrhoeal disease with extreme or persistent acid-base or electrolyte deviations 
Recurrence of shock 
<3 months (Only if unstable) 
Level 3 PATIENTS (Patients Who Require Subspecialist Care) 
Persistent diarrhoea (acute diarrhoea, of presumed infectious origin, lasting longer than 2 weeks) failing standard 
therapy 
Diarrhoea of duration longer than 4 weeks in any patient 
Malabsorption syndromes 
Level 2 Patients with exceptions 
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patients who should be seen by a doctor not less than three times a DAY (These are patients who have the 
highest diarrhoeal disease mortality) 
HIV-infected patients - particularly those who are not HAART 
Severe malnutrition 
HWZ <-3 
MVAC < 11mm 
Oedematous malnutrition 
Duration more than 2 weeks, not responding to standard treatment. 
Duration > 7 days in hospital - consult Paediatric Gastroenterology. 
Presence of severe comorbidity: Severe pneumonia or septicaemia. 
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PRINCIPLES OF MANAGEMENT OF DIARRHOEAL DISEASE 
Identify and treat shock first (triage) 
Do a thorough clinical assessment to determine 
Degree of dehydration (severe/some/none) 
Complications 
Dehydration 
Neurological sequelae 
Metabolic acidosis 
Electrolyte disturbances 
Hyper- and hyponatraemia, hypokalaemia 
Susceptibility to reinfection 
Malnutrition 
HUS 
Iatrogenic - complications fluid administration 
Death 
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Associated illnesses or Risk Factors 
small infant < 2 months 
malnutrition 
immune compromised 
pneumonia/sepsis/UTI etc. 
Decide on method of rehydration: enteral (ORT or NG) or intravenous (IV) 
Decide on type of fluid 
Decide on volume and rate of fluid 
Frequent reassessments of the hydration status of the child 
Decide level of care required (home/admit GG/refer) 
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IDENTIFY AND TREAT SHOCK FIRST (TRIAGE) 
Triage relates to the emergency signs 
A Airway 
B Breathing 
C Circulation 
 Coma (use AVPU) 
 Convulsion 
D Dehydration (severe) 
DEFG Do not Ever Forget Glucose…..check 
 
METHODS OF REHYDRATION 
 
ORS TRIAL 
Whilst being assessed/triaged in outpatient area the child should be given 10ml of ORS (by syringe, teaspoon or 
cup) every 5-10minutes and gradually increase the amount as tolerated, in the ORT corner. 
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Children should only be admitted if they have failed an adequate observed trial test of oral rehydration in the 
ORT corner and are >/=5% dehydrated/have “some/moderate dehydration”. 
Oral rehydration (“ad lib” ORS) can continue to be given throughout the subsequent admission unless they have 
shock, depressed level of consciousness or paralytic ileus. Breast feeding infants should continue to breastfeed. 
NASOGASTRIC REHYDRATION 
The method of choice of initial rehydration in all children with moderate dehydration (5%) and some children 
with severe dehydration (10%) i.e. those without associated shock (e.g. with malnutrition, not vomiting). 
In the following situations INTRAVENOUS REHYDRATION is indicated: 
circulatory shock 
paralytic ileus(abdominal distension, no bowel sounds, severe vomiting) 
severe/10% dehydration with profuse diarrhoea and vomiting fluids (an alert thirsty child with severe 
dehydration does not necessarily need a drip) 
depressed level of consciousness, severe hypotonia 
vomiting/not tolerating continuous Nasogastric ORS 
child <3months with severe dehydration and/or suspected sepsis 
failed Nasogastric rehydration(vomiting or not improving) 
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FLUID TO BE USED 
IVI ½ DD unless otherwise indicated (Electrolyte disturbances) 
ORS/Sorol -pre-packed 200ml containers for continuous NG 
 
 MANAGEMENT OF SHOCK DUE TO DEHYDRATION (INTRAVASCULAR DEHYDRATION) 
1. Assessment of Shock 
 
Shock Some/moderate dehydration 
Level of consciousness  Depressed ill/weak Normal 
Peripheral pulses  Absent or Palpable but weak Palpable 
Capillary refill time  > 3 secs < 3 secs 
Pulse rate  >120 / min Usually < 120 / min 
Clinical dehydration  Normal - > 10 % < 10 % 
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2. Shock management 
See shock management protocol 
Remember: 
If unable to get an iv line up rapidly, use intra-osseous infusion 
Investigations (after resuscitation or during if poor response) - blood gas, Na, K, urea/creat 
Keep the child nil per mouth for 4-6hours 
Monitor urine output 
A shocked child is critically ill and must always have a doctor or experienced member of nursing staff with them 
at any time 
Once the shock is corrected, proceed with rehydration 
If the shock is not corrected after 40-50ml/kg blouses of fluid, then the child must most likely be commenced on 
inotropes and discussed with the ICU 
There is no role for sodium bicarbonate in resuscitation for hypovolaemic shock 
There is no role for SHS as a volume expander in hypovolaemic dehydration from gastroenteritis 
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Intra-osseous needle insertion 
Needle inserted into the bone marrow of the tibia 
Effective and easy 
Use for emergencies and replace when an IV line can be set up preparing 
Flat surface of tibia runs on inner surface of the lower part of the leg 
There is a sharp blade of bone at the front of the shin 
Position leg with hips slightly open and some padding under the knee. 
position: 2cm below tibial tuberosity 
Prepare your equipment: 
Wear gloves 
Clean skin with antiseptic solution 
Hold leg firmly with left hand: DO NOT hold the leg BEHIND the site of insertion 
Hold base of needle in palm of right hand so you can push with the palm 
Keep fingers of right hand about 1cm behind the tip 
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Place needle through skin at right angles to bone until it rests on the bone 
Press firmly though the bone with palm of your hand, using the fingers to twist the needle so that it advances 
more easily 
Stop when you feel a sudden give and your fingers hit the skin! 
Make sure your own fingers are out the way! 
Remove stylet and aspirate marrow (can do dextrostix and blood culture if available) 
Needle remains upright without support 
Inject 10 ml of normal saline with ease 
Commence infusion: fluid flows quite easily without signs of subcutaneous infiltration 
Clamp a cord clamp at the base of the needle against the skin 
Strap the cord clamp (and attached needle) with strapping either in a spiral or around leg but leave a small gap 
at the back 
Strap the fluid tubing to the leg separately so that if someone pulls on the line it does not pull on the needle 
If you have a proper self-threading bone marrow needle this can be used and nor strapping is necessary 
Same principle and twisting and feeling a “give” 
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 REHYDRATION IN EXTRAVASCULAR DEHYDRATION 
A. Method - IV or Nasogastric - see before (II) 
B. See Management of sever dehydration protocol 
C. Fluid volume and rate. 
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(a) INITIAL FLUID VOLUME AND RATE (Flow Chart Appendix 3) 
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Rapid Nasogastric rehydration over 4 hours is given to all children with moderate or severe dehydration 
EXCEPT those with: 
1. Age under 3 months. 
2. Lung or cardiac disease e.g. pneumonia. 
3. Suspected or proven hypernatraemia (Na>150mmol/l). 
4. Overt malnutrition (NG slow over 24hrs). 
5. Meeting the criteria for intravenous (page before). 
NB Very important: 
These children 1-4 must not then have IV but have slower rehydration enterally 
The children needing Intravenous can also be rehydrated rapidly over 6-12 hours unless they meet the criteria 
1-4 above -then slow iv over 24hrs 
a) Calculate the rehydration volumes for the first FOUR (4) hours: 
“5%” dehydrated (i.e. IMCI “some dehydration”) -15-20 ml/kg/hour (give the higher volume to children with a 
history of profuse diarrhoea) 
 “10%” dehydrated (i.e. IMCI “severe dehydration”) 20-30 ml/kg/hour 
 NG - Set in-line manual controller to this rate in mls per hour  
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IVI - Set infusion pump to this rate in mls per hour 
b) Continue breast feeding and small volumes of ORS. Formula milks should not be given during the first 4 hours 
of rehydration but should be started after that. 
Note: These fluid rates incorporate maintenance, rehydration and ongoing losses for the first 4 hours (breast 
feeding to continue) 
 (b) ONGOING FLUID MANAGEMENT 
a) Review 1-2 hourly (e.g. is the child vomiting?). Full re-assessment at 4 hours: 
- Dehydrated to the same degree: As above, with higher infusion rate 
- Hydration worse: on NG, change to IV; on IV, increase the rate 
- Hydration better: reintroduce full feeds ((b) on p6 for volumes), give liberal ORS (≥50ml per loose stool), and 
reduce infusion to 10 ml/kg /hr 
b) Review every 6 hours thereafter till discharge:  
The infusion should be stopped if 
Weight is maintained, and the child is drinking 
If the child then maintains weight can be discharged 
(c) SLOWER Rehydration in Extravascular Dehydration in certain patients 
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Which patients require slower rehydration over 24 hours? 
1. Age under 3 months (if sepsis likely) 
2. Lung or cardiac disease e.g. pneumonia 
3. Suspected or proven hypernatraemia (VII Electrolyte disturbances) 
4. Overt malnutrition (never IV unless shocked) 
FLUID TO BE USED 
Nasogastric ORS in pre-packed 200ml containers 
IVI Give 1/2 DD unless otherwise indicated (VII Electrolyte disturbances) 
FLUID VOLUME AND RATE 
a) Calculate the maintenance volume 
Less than 1year 120 ml/kg/day 
 1-2 years 100 ml/kg/day  
 2-4 years 85 ml/kg/day  
 4 years and older 70 ml/kg/day 
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b) Calculate the rehydration volume. 
  “5%” dehydrated (IMCI “some dehydration”) 50 ml/kg 
  “10%” dehydrated (IMCI “severe dehydration”) 100 ml/kg 
c) Estimate ongoing losses (if history of large output diarrhoea) 
A child with severe diarrhoea loses at least 50ml/kg/24hrs or 10-20ml/kg/loose stool 
d) Add volumes b) and c) together as well as any part of the maintenance from a) that you have decided to 
give iv or NG together and divide by 24hrs to get mls per hour given iv/ continuous NG.  
(If choosing oral route can also divide volumes into 12 or 8 to be given 2 or 3 hourly but it must be ensured that 
this is communicated to the nurses and actually given. The continuous Nasogastric route with a volume per hour 
given through the rate controller is ideal for optimal absorption 
 Write the fluid and rate required in the fluid schedule in the notes and on the Fluid Chart. 
NB: This is only an ESTIMATE of fluid requirements and is a starting point.  
Repeated review and adjustment of fluid rates according to clinical assessment is essential. 
Many children require more fluid for ongoing losses. 
Children must be weighed and have their hydration status checked six hourly 
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D. In the acute setting there is no role for sodium bicarbonate to be used in dehydrated children with persistent 
acidosis, this is usually an indication that they are getting insufficient fluids, and fluid volumes must be increased. 
There are however times when it is given for correction of a persistent acidosis in children with suspected renal 
tubular dysfunction or bicarbonate depletion from excessive stool losses. The use of bicarbonate must be 
discussed with the consultant or senior registrar. If a transient renal tubular acidosis is suspected it can be 
replaced orally, otherwise half corrected over ½-1 hour intravenously. 
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V. GUIDELINES FOR INVESTIGATIONS 
1. Biochemical 
Biochemical tests should only be conducted in the following circumstances and only after rehydration has been 
commenced 
1. Shock - acid-base, Na, K, urea/creatinine (AFTER resuscitation) 
2. 10%/severe dehydration - Na, K, urea/creatinine +/- gas 
3. Altered level of consciousness - Acid-base, Na, K, glucose, urea/creat 
4. Convulsion - glucose, Na. K, Creatinine, (Ca, Mg, Pi if recurrent) 
5. Unexplained hypotonia/poor head control -Na, K, Urea,Creat 
6. Ileus/abdo distension - Na, K, Urea, Creat 
7. Protracted vomiting with little or no diarrhoea - acid-base, Na, K, Cl, Creat 
8. Anuria despite rehydration - Na, K, Urea/creat 
9. Kwashiorkor - see kwashi protocol for blood tests 
10. Chronic diarrhoea - Na, K, Urea/creat, Ca MgPi 
11. Dysentery - see protocol 
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12. Other: suspected hypernatraemia(e.g. incorrect SSS mix, clinical picture worse than apparent dehydration, 
rubbery skin, very irritable) Na, K, Urea,creat 
2. Stool Microscopy and Culture 
Most diarrhoea is caused by rotavirus or and E.coli which cannot be routinely cultured from the stool. Therefore 
MC&S should ONLY be conducted in the following circumstances: 
1. Dysentery 
2. Persistent diarrhoea (>2 weeks), especially if HIV positive 
3. Study of epidemic/outbreak (microbiology input) 
4. Severe malnutrition 
Note: Antibiotics are only routinely used in dysenteric forms of diarrhoea 
3. Urine Tests 
Dipstix testing of bag specimens commonly gives false positive results for possible infection. A negative result is 
very helpful in excluding infection. Dipstix is therefore not routine but should be conducted when there is a 
reasonable likelihood of a UTI: 
1. Suspected Sepsis with unexplained fever >38 degrees(protocol) 
2. Prolonged diarrhoea(>1 week) 
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3. Failure to thrive 
If dipsticks on a bag specimen is suspicious of a UTI(nitrites/leukocytes), the test must be repeated on a catheter 
specimen or Suprapubic specimen. (UTI protocol). Only if this specimen suggests infection should the sample be 
sent for microscopy and culture. Do not send bag specimens for MC&S. Note that most Suprapubic punctures 
will usually be dry in dehydrated children. 
Each test adds to the cost of the admission - it is a waste of resources (Dr time, parent’s and states money, child’s 
discomfort) to do a test that will not add to the child’s welfare. Remember the value of frequent clinical re-
assessment  
4. When to perform septic work-up in dehydrated child with gastro 
1. Child sicker than can be accounted for by dehydration alone: -urine dipstix (culture if abnornal dipstix), FBC, 
Blood culture (below), consider CSF(may need to be delayed) 
2. Infant under 3 months of age: urine dipstix, bld culture, FBC, CSF, CXR 
b. Note: CSF must be conducted in any child with gastro <1month and most <3months (but never perform LP in 
shocked/unstable child - delay and cover with antibiotics) 
3. Unexplained fever>38.5 degree celsis - dipstix, FBC, blood culture 
4. Persistent or recurrent circulatory shock: -dipstix, blood culture, FBC 
5. Kwashiorkor/severe protein-energy malnutrition (Kwashiorkor protocol) 
6. Unwell child with dysentery 
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Note:  
i) Children with HIV infection do not require investigations for infections unless they fulfil the above criteria 
ii) CRP is not helpful in decision making in these circumstances so must not be done please (give antibiotics if 
meet the indications below) 
 
Antibiotics are not routine but are indicated in: 
1. Suspected sepsis(meet criteria 1-5 above) 
a) ampi/genta if meningitis excluded/not suspected 
b) Ceftriaxone(100mg/kg/dose daily) if meningitis cannot be excluded and the child is too unwell to perform a 
lumbar puncture on or has renal impairment 
2. Blood in stool 
3. Pneumonia (ampi/amoxil, add genta if <6months) 
4. Kwashiorkor  
5. UTI 
6. Otitis media 
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7. In certain children with HIV infection(protocols/discuss with Reg/consultant) 
8. In chronic diarrhoea(> 5days) children should be put on the bowel cocktall 
Cholestyramine 1g po 6hrly for 5 days +  
gentamicin 50mg/kg/DAY 4hrly(max 60mg/dose or 360mg/day) 
Plus Metronidazole 7.5mg/kg/dose tds for 5 days 
OR if strongly suspect giardiasis(child>1 year, diarrhoea for 1-2weeks):give Metronidazole <15kg -500mg po daily 
for 5 days, 15-22kg - 800mg po dly for 5days, >22kg - 1g po daily X 5 days, adult 2g po daily for 5 days 
REMEMBER: to stop antibiotics if sepsis is proved unlikely or downscale from Ceftriaxone (to ampi/genta or 
appropriate oral antibiotic) if lumbar puncture is normal 
Taking a blood culture 
The younger and sicker the child, the more useful is a positive or negative blood culture result. However a blood 
culture is only indicated in gastroenteritis if: 
1. < 3months of age and pyrexial/ill 
2. <1 month old(by definition a neonate and diarrhoea could indicate parenteral sepsis) 
3. Suspected bacterial meningitis 
4. Kwashiorkor 
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5. Older “septic-looking” very unwell/pyrexial child e.g. with dysentery 
Blood cultures MUST be taken with aseptic technique, with a minimum volume of 1ml in a neonate and 3-5ml in 
older child to increase the yield. 
Always consider if the blood culture result might alter management and remember the dangers of false positives 
in terms of cost in lab, unnecessary exposure to antibiotics and prolonging hospital stay. 
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VI. ROUTINE MEDICATION 
1. Vitamin A. 
These dosages are given as on the road to health card. They should be given if there is no evidence/signature for 
a dose having been given in the last 3-6 months. Record the dose given on the RTHC 
2. Potassium chloride orally 
Potassium chloride 250 mg tds orally for 2 days(125mg/dose < 3 months of age). Omit in children who have been 
recently shocked or if there are renal concerns 
3. Zinc (elemental) 
Zinc supplementation shortens the duration of acute and persistent diarrhoea 
Dose: 20 mg po dly (10mg dly in children under 6 months of age) 
4. Immunisation 
Give measles immunisation to all children>6months if no proof of immunisation.  
Immunise all others on discharge if behind on schedule (check RTHC) 
ELECTROLYTE DISTURBANCES 
1. Hyponatraemia 
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If Na<125mmol/l 
a) If on ivi fluids: Normal Saline 200ml bag + 2ml 15% KCl+ 20ml 50% dextrose, at usual rate for rehydration (Do 
not correct rapidly with hypertonic(5%) saline) 
b) If NG fluids: continue with Sorol and recheck Na in 4 hours. If Na fallen further then change to ivi fluids as 
above 
c) Once Na>130 mmol/l change back to ½ DD 
2. Hypernatraemia 
If Na >150 mmol/l 
a) Use ½ DD (NOT 5% dextrose water) for rehydration. Treat shock with volume expanders as usual 
b) Calculate fluid administration rates as usual according to clinical dehydration, remembering that it is easy to 
underestimate dehydration in hypernatraemia. Rehydrate over 24hours (not 6hrs nor 48hrs) 
c) Check serum Na 4-6 hourly if Na>155mmol/l. The sodium level should drop by 1-2mmol/hr. Too rapid a fall 
leads to cerebral oedema and convulsions, whilst failure of the sodium level to drop means the patient needs 
more fluid per hour i.e. if not going down by 1-2mmol/hr increase fluid rate. Do not administer extra sodium 
bicarbonate. If Na>165mmol/l get ward bed for child 
d) Ensure hypovolaemia is corrected. Urine output should be > 2ml/kg/hr. Watch for rhadbomyolysis 
3. Hypokalaemia 
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If K< 3mmol/l OR K<4mmol/l and BE> -10 
i) KCl 100mg/kg/dose 6hrly orally X 2 days (maximum 750mg 6 hrly or 3g daily 
 
If K<2,0 mmol/l 
i) Oral KCl as above 
ii) Iv KCl: 2ml KCl(15% solution) added to 200ml 1/2DD. Do not exceed this dose 
iii) Check potassium level 4 hourly 
If K < 1,5mmol/l 
i) As for i) and ii) above 
ii) ECG monitor 
iii) Inform registrar and try to arrange high care /ICU bed for possible more rapid correction especially if child 
very symptomatic 
4. Hyperkalaemia 
If K>6,0 mmol/l in face of normal base deficit 
i) stop all K containing fluid including 1/2DD iv and orally, and check drug chart for any oral KCl 
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ii) correct any acidosis with sodium bicarbonate 
iii) if > 7 mmol/l or symptomatic, ECG monitor, treat with iv calcium gluconate(0,5ml/kg), oral/rectal kayexalate, 
salbutamol neb 
iv) ensure renal function has been checked and apply urine bag/insert catheter to monitor urine output 
v) inform registrar  
VIII. SPECIAL SITUATIONS 
1. When the Registrar Should Be Called for Admission to ward bed or ICU: 
1. Persistent shock 
2. Altered LOC despite correction of shock 
3. Bile-stained vomiting or marked abdominal distension 
4. Convulsions 
5. K+ <1,5 or >6 mmol/l 
6. Na+ <120 or >165 mmol/l 
7. pH <7,0 or >7,40 
8. pH <7,15 plus Na >150mmol/l 
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9. pa CO2>6,5kpa 
2. Blood in Stool/Dysentery 
1. Send stool MC&S 
2. Nalidixic acid(12,5mg/kg/dose 6 hrly po X 5 days) if reasonably well and able to take well orally 
3. Ceftriaxone 50mg/kg/dose daily ivi X 3-5days if toxic/ill/unable to take orally 
4. Follow-up in 3 days at local clinic to ensure recovery and mother/clinic Sr can phone in for stool culture results 
(Shigella dysenteriae can lead to HUS, or result in PLE or a more protracted course.) Parents must be told to 
return immediately if the child’s condition changes/deteriorates 
Keep the differential diagnosis of dysentery in mind especially intussuseption 
3. Abdominal Distension or Bile-Stained Vomiting 
Ileus is usually a result of intestinal infection or hypokalaemia BUT surgical causes must be excluded including: 
c. Malrotation 
d. Volvulus 
e. Intussusseption 
i) Keep NBM, ivi fluids only, NGT on open drainage 
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ii) Investigations: Abdominal X-ray, electrolytes 
iii) Discuss with registrar/consider surgical consult 
4. Nutritional Problems 
1. Kwashiorkor or marasmus - needs admission to a different cubicles 
2. UWFA, FTT owing to poverty or poor nutrition practices - refer complex issues to dietician 
5. Chronic diarrhoea 
Chronic diarrhoea is when the child has had loose stools for > 5days. 
Children should be put on the bowel cocktail 
Cholestyramine 1g po 6hrly for 5 days +  
gentamicin 50mg/kg/DAY 4hrly(max 60mg/dose or 360mg/day)  
Plus Metronidazole 7.5mg/kg/dose tds for 5 days as part of bowel cocktail 
OR if strongly suspect giardiasis(child>1 year, diarrhoea for 1-2weeks):give Metronidazole <15kg -500mg daily 
for 5 days, 15-22kg - 800mg daily for 5days, >22kg - 1g po daily X 5 days, adult 2g po daily for 5 days 
Consider sending stool reducing substances and changing the milk to low lactose containing (pellargon) or lactose 
free(infasoy) if reducing substances positive or acidic pH. If changed to infasoy needs secondary level bed as will 
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need to be challenged in hospital unless parents can afford soya for 2 weeks at home then to change back to 
normal milk after 2 weeks at home 
IX. ASSESSMENT FOR DISCHARGE 
The child is usually ready for discharge if: 
1. Discharge weight > admission weight 
2. Bright eyed and alert 
3. Drinking well 
4. No vomiting in recent hours 
5. Plans for other problems do not require inpatient care 
Patients who cannot be discharged after 2 nights in GGr should be admitted elsewhere as well as those who you 
anticipate will not meet these criteria within 48hrs 
Follow - up: 
i) Stools resolved: advice re an extra meal a day for a week. No follow-up required but encourage regular clinic 
attendance for weights, immunisations, vitamin A etc 
ii) Stools still loose or concerns re weight loss: refer for weight and hydration check at local clinic the following 
day 
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iii) Dysentery- as outlined above  
iv) Other problems present: follow-up at Primary Care service (e.g. nutrition clinic, local authority clinic unless 
specific issues requiring input at TBH required 
Always plot the discharge weight on the RTHC and make an entry on the RTHC about admission 
Always reinforce to the parents that should the child’s condition change/ deteriorate at home, including vomiting 
of all fluids, not taking in any fluids, becoming drowsy/less responsive/ etc to return to the local clinic 
immediately for re-evaluation 
  
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
276 | P a g e  
 
 
 
 
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
277 | P a g e  
 
 
 
PROTOCOL FOR THE Inpatient MANAGEMENT OF CHILDREN WITH SEVERE ACUTE MALNUTRITION AT RFMH 
“Severely malnourished children are different from other children so they need different treatment” 
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ASSESS SEVERITY OF RISK 
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1. Differentiate between complicated and uncomplicated SAM by using Document 1: Case definition of SAM, to 
refer patients appropriately and ensure optimal care. 
2. Uncomplicated SAM with low risk is suitable for Level 1 hospital care. 
3. Complicated SAM with high-risk and infants < 6 months with SAM will require Level 3 hospital care; whilst 
uncomplicated SAM with moderate risk will require level 2 hospital care. 
MEDICAL INVESTIGATIONS 
Perform Dextrostix test in outpatients/casualty and on admission on all patients. 
Bloods: blood glucose (glucostix test on admission), electrolytes & urea, total protein, albumin; FBC; blood 
culture, CMP, CRP 
Urine MCS (document urine dipsticks result in folder) and culture if UTI suspected; 
Chest X-ray-AP and lateral 
Mantoux and two gastric washings (if TB suspected), HIV test (all malnourished children). 
LP if clinically indicated 
STEP 1 
Hypoglycaemia (Low blood sugar), Hypoglycaemia is a blood glucose <3mmol/L 
PREVENTION 
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For children with normal blood glucose i.e. > 3 mmol 
1. Feed stabilising feeds /F75 straight away i.e. on arrival at hospital and within 30 minutes after admission (use 
feeding chart to find amount to give) and then every 2 hours for first 48 hours and then every 3 hours, day and 
night. 
2. Document time of first feed given. 
3. Encourage mothers to stay with very ill children to watch for any deterioration, help feed and keep child warm. 
 WARNING SIGNS 
1. Low temperature (hypothermia) noted on routine check. 
2. Child feels cold. 
3. Child becomes drowsy or lethargic. 
4. Signs of Shock. 
5. If blood sugar is low, monitor blood sugar every 30 minutes to 60 minutes and intervene accordingly. 
IMMEDIATE ACTION 
Check blood glucose immediately and record. 
1. If unable to drink, depressed level of consciousness, or convulsing and blood sugar is below 3mmol/L:- 
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Give 5ml/kg of sterile 10% dextrose IV or IO: prepare 1ml/kg 50% dextrose mixed with 4ml/kg sterile water or 
use 5ml/kg NNL. Follow with maintenance IV 1/2DD (if shocked) or NG feeds or dextrose containing fluid. 
Monitor response to treatment every 30 minutes 
If alert and able to drink and blood sugar is below 3mmol/L:- 
 Give oral/NG feed or give 10% glucose (50ml) orally or by NGT. To prepare 10% glucose solution: mix 10ml 50% 
dextrose with 40ml sterile water, or sugar solution (1 rounded teaspoon sugar in three tablespoons of plain 
water) If 10% glucose is not available, give sugar solution or stabilising feed/F75 rather than wait for glucose. 
Test again 30 minutes after treatment. If blood sugar is still low, repeat oral 50ml 10% glucose or sugar solution. 
Consider putting up a short IV line. 
 Recheck blood glucose after 30 minutes, monitor hourly until 3 consecutive values >3mmol/l then 3-4 hourly 
If blood sugar is persistently low, review feed and look for infections. 
Feed 2-hourly (12 feeds in 24 hours). Start straightaway. 
Commercial stabilising feed/F75 No or mild oedema 
 
With severe oedema 
130 ml/kg/d 100 ml/kg/day 
 
Give via Nasogastric tube (NGT) if oral intake is poor 
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The specialised commercial formula (F75), containing 75kcal/100ml and 0.9g protein/100ml is recommended. 
Where the commercial stabilising feed (F75) is not readily available, refer to Document 5: Feeding regimen for 
equivalent low protein products [See Point 7 Stabilisation feeding] 
Check blood glucose 3-4 hourly until stable for first 48 hours 
STEP 2 
Hypothermia (Low temperature) Hypothermia is a underarm/axillary temperature <35 degree celsius 
PREVENTION 
For all children:- 
1 Feed straight away and then every 2-3 hours, day and night. 
2. Keep warm. Let mother sleep with child to keep child warm. Cover with a blanket. 
3. Keep room warm, no draughts. 
4. Keep bedding/clothes dry. Dry carefully after bathing (do not bathe if very ill). Avoid early morning bathing in 
cold weather. 
5. Avoid exposure during examinations, bathing. 
6. Ensure temperature is monitored four hourly. 
WARNING SIGNS 
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1. Cold extremities 
2. Inactive, lethargic 
3. Poor appetite  
NOTE: Hypothermia in malnourished children often indicates coexisting hypoglycaemia and serious infection. 
IMMEDIATE ACTION 
 Take temperature on admission (Digital if available or ensure non-digital thermometer is well shaken down). 
Check temperature 3-4 hourly. 
If the temperature is below 36.5 degree celsius 
1. Feed straight away (or start rehydration if children have diarrhoea with dehydration). 
2. Active rewarming Re-warm. Put the child on the mother's bare chest (skin to skin contact) and cover them, OR 
clothe the child including the head, cover with a warmed blanket and place a heater or lamp nearby. 
3. Feed 2-hourly (12 feeds in 24 hours). 
Monitor during re-warming 
• Take temperature every two hours: stop re-warming when it rises above 36.50C 
• Take temperature every 30 minutes if heater is used because the child may become overheated. 
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STEP 3 
Some or Severe Dehydration (without shock) (too little fluid in the body) 
PREVENTION 
When a child has watery diarrhoea feed straightaway and give 10ml/kg ORS between feeds to replace stool 
losses. 
 As a guide: 
1. Give 50-100ml after each watery stool for children <2years; and 
2. Give 100-200ml to older children. 
Continue feeding, including breastfeeding. 
WARNING SIGNS 
Profuse watery diarrhoea, sunken eyes, slow skin pinch, absent tears, dry mouth, very thirsty, reduced urine 
output, sunken fontanelle, rapid pulse and respiration. 
IMMEDIATE ACTION 
DO NOT GIVE IV FLUIDS EXCEPT IN SHOCK 
See Emergency Treatment wall chart for treating shock 
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If child is shocked: 
Use shock protocol* (Addendum 1) Start with 10ml/kg normal saline or ringers lactate bolus 
If dehydrated (not in shock): 
1. Give ORS (orally or by Nasogastric tube) 5 ml/kg every 30 minutes for first 2 hours using frequent small sips. 
Show the caregiver how to give ORS with a cup and spoon. If child vomits wait 10 minutes and then continue 
more slowly. 
2. Continue with 10ml/kg/ hour up to 10 hours (remember to prescribe 2-hourly feeds in addition). 
3. Stop ORS if there are signs of over-hydration. 
4. Encourage caregiver to continue feeding the child, especially if breastfeeding. 
Monitor during rehydration for signs of over-hydration at least hourly. 
• increasing pulse and respiratory rate 
• increasing oedema and puffy eyelids 
Review at least hourly general condition, capillary filling time, level of consciousness, skin turgor, sunken eyes, 
respiratory rate, abdomen, if passing urine and number/quality of stools. 
If shock redevelops, then treat for shock (emergency wall chart) 
If dehydration is improving- continue for up to 10 hours 
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If there is no dehydration go to prevention 10ml/kg ORS orally after each loose stool. 
If dehydration is not improving consider IV fluids with great care. 
STEP 4 
Electrolyte imbalance (Too little potassium, magnesium, phosphate and too much sodium in body tissue) 
PREVENTION 
1. Do not add salt to food. 
2. Use standard low osmolarity ORS and stabilising FEED/F75 formula as these are low in sodium. 
3. Do not treat oedema with diuretics. Give extra potassium and magnesium (either as CMV in feeds or as 
a supplement. 
WARNING SIGNS 
Oedema develops or worsens, poor appetite and apathy 
IMMEDIATE ACTION 
Give daily: extra potassium, magnesium and phosphate 
For potassium: 4mmol/kg/day. KCl weight < 10 kg 250 mg; weight > 10kg: 500mg Give 8hrly orally until the 
oedema has resolved. 
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For magnesium: Mg 0.4 - 0.6 mmol/kg/day or Mg Cl 50mg/kg/ day 
For phosphate: Phosphate 1-2 mmol/kg/day if low (Phosphate Sandoz effervescent tablet per 16ml water gives 
1 mmol/ml); can however cause or exacerbate diarrhoea. 
STEP 5 
Infections 
1. Good nursing care. 
2. Reduce overcrowding if possible. 
3. Wash hands before preparing feeds and before and after dealing with any child. 
4. Give measles vaccine to unimmunised children over 6 months of age. 
5. If possible, protect these children from children admitted with severe infection by having a separate 
room/ward for SAM children. 
6. Follow guidelines for “safe preparation, storage and handling of feeds. 
PREVENTION 
NOTE: The usual signs of infection, such as fever, are often absent so assume all severely malnourished children 
have infection and treat with antibiotics. Hypothermia and hypoglycaemia are signs of severe infection. 
NOTE: ensure all doses are given. Give them on time. 
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IMMEDIATE ACTIONS 
Starting on the first day, give antibiotics to all children. 
1. If the child is severely ill (apathetic, lethargic) or has complications (hypoglycaemia, hypothermia, raw 
skin/fissures, meningitis, respiratory tract or urinary tract infection) give IV Ceftriaxone 100mg/kg/day for 5 days 
2. If the child has medical complications but not seriously ill, give IV Ampicillin: 50mg/kg IV 6-hourly for 5 days 
AND Gentamicin: 7.5mg/kg IV once daily for 5 days. If a child fails to improve after 48 hours, search for new 
infection, then change to Ceftriaxone 100mg/kg daily IM/IV for 5-7 days (or guided by local microbiological flora). 
 If the child does not improve after 48-72 hours, then change antibiotics and refer to higher level of care. 
3. If the child has no medical complications, give antibiotics orally Cefuroxime 15mg/kg/dose 12-hourly for 5 days 
or Augmentin 30mg/kg/dose 8 hourly(if no diarrhoea) or Amoxicillin 30mg/kg 8-hourly for 5 days 
NOTE: Avoid steroids as these depress immune function. Give measles vaccine if due. Continue use of 
cotrimoxazole to prevent PCP pneumonia if indicated. 
4. If the child has diarrhoea, add Metronidazole 7.5mg/kg/dose 8-hourly 
5. Treat for intestinal infestation (parasitic worms) once stable: 
  1-2 yrs old or < 10kg Mebendazole 100mg po bd for 3 days 
  > 2 yrs and > 10kg Mebendazole 500mg po single dose 
Investigate for TB. Do Tuberculin Skin Test and read it within 48 hours. Record the findings. 
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Counsel and Test for HIV. Record the findings. 
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STEP 6 
Micronutrient Deficiencies 
Vitamin  Schedule  Dose  
Folic acid Daily 
 
2.5mg 
On discharge  1 month supply sent home (if 
discharged on RuTF no need for 
additional Folic Acid) 
Vitamin A Day 1 to all malnourished 
children unless there is 
definitive evidence that a dose 
has been given during the past 
month. 
 
Repeat dose on Day 2 and day 14 
if there are any clinical signs of 
vitamin A deficiency (e.g. night 
blindness, conjunctival xerosis 
with Bitot’s spots, corneal 
xerosis or ulceration, or 
keratomalacia) 
Children with severe measles 
should receive Vitamin A on days 
1,2 and 14 
<6 months 50 000 IU 
6 - 11 months 100 000 IU 
12-59 months 200 000 IU 
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Multi-vitamin Give multivitamin syrup - 
without iron, daily. 
0-1months: multivit syrup e.g. 
Kiddy-vit 0.3 ml per day 
 
1-12 months: multivit syrup e.g. 
Kddy-vit 0.6 ml per day 
 
>1 year multivit syrup 5 ml daily 
(if stabilising FEED/F75 is used 
no need for multi-vit) 
Iron Do not give iron during the 
initial/stabilitation phase of 
treatment even if aenamic as it 
can have toxic effects and may 
reduce resistance to infection. 
 
 
 
In rehabilitation phase for 
children with anaemia start iron 
when oedema has resolved and 
the child is gaining weight 
Elemental iron 3mg/kg/day 
 Very severe anaemia 
Most children with SAM tolerate 
a low haemoglobin but if the Hb 
concentration is very low(less 
than 4-5g/dl) the child may be 
symptomatic with heart 
failure(tachycardia, gallop, 
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hepatogaly, respiratory 
distress). These children, and 
those with anaemia and severe 
pneumonia on oxygen will need 
a cautious blood transfusion. 
Give 10 ml/kg of packed red cells 
slowly over 4 hours. Give 
1mg/kg Lasix IV half way through 
or at the end of the transfusion. 
Another 10ml/kg can be given 
12-24 hours later if required. 
Monitor closely for fluid 
overload during transfusion 
Zinc  Daily (Zinc sulphate/Zinc 
picolinate) 
< 10kg:10 mg daily 
> 10kg:20 mg daily 
   
 
STEP 7 
7. Stabilisation feeding (stabilisation Phase) 
Re-establish breastfeeding OR feed with commercial stabilising feed/F75 as soon as possible after admission. The 
usual fluid requirement is F75 130ml/kg/day or 100 ml/kg/day if very oedematous (3+) or unstable (risk of re-
feeding syndrome and fluid shifts). Solids should not be given for at least the first 72 hours. Consult daily with 
dietician if available. 
If replacement fed, give orally or via NGT. 
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• Where the commercial stabilising feed (F75) is not readily available, refer to Document 5: Feeding 
regimen for equivalent low protein products 
• Aim for 100 kcal/kg/day and protein of 1-1.5 g/kg/day 
• Low osmolarity, low lactose feeds 
Those starting at lower volume can be increased by 10-20ml/kg/day if stable/no excessive weight gain 
3. Frequency of *feeds: Give 8-12 feeds over 24 hours. 
• Day 1-2: 2 hourly feeds; 12 feeds over 24 hours; 
• Day 3-5 and onwards: 3 hourly feeds; 8 feeds over 24 hours; 
• *See document five for feeding regimen 
4. Keep a 24-hour intake chart. Measure feeds carefully. Record leftovers. If the intake is <80% of the total 
prescribed intake for 2 to 3 consecutive feeds, insert Nasogastric tube for feeding. If in doubt check feeding chart 
for intakes. 
5. Weigh daily and plot weight on RtHB/WHO growth charts; calculate weight gain. 
6. A gradual transition helps to prevent re-feeding syndrome. 
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STEP 8 
8. Transition feeding and Catch-up growth rehabilitation phase 
1. If child is breastfed, encourage mother to continue breastfeeding. If replacement fed: Transfer to catch-up 
formula(F100) as soon as appetite has returned (usually within one week) and/or oedema is lost or is reduced, 
initiating at 150kcal//kg/day and 2-4gprotein/kg/day. 
• For 2 days, replace stabilising FEED/F75 with same amount of F100. (F100: 100 kcal, 2.9g protein per 100ml). 
• On day 3 increase each feed by 10ml until it reaches 150-180ml/kg/day until some feed remains. 
• Careful build up to 200 kcal/kg/day and protein 4-6 g/kg/day Monitor renal function carefully. 
Give 8 feeds over 24 hours(3-4 hourly). As the child is eager to eat, progress to five feeds of F 100 and 3 specially 
modified family meals, high in energy and protein. Ready-to-use Therapeutic Food(RuTF) may be introduced and 
given at discharge for catch-up growth. 
Consult daily with dietician if available 
2. To ensure rapid weight gain, encourage the child to eat as much as possible. If the child is finishing everything, 
offer more and increase subsequent feeds. Make sure that the child is actively fed. Involve the mother/caregiver 
in the feeding all the time. 
3. Weigh daily, plot weight and record intake daily: weight gain should exceed 10 g/kg/day Use daily weight chart 
for recording and monitoring weight changes. 
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4. Failure to maintain catch-up growth may indicate an undiagnosed infection (TB, HIV,UTI) or inadequate intake, 
re-investigate. 
STEP 9 
9. Loving care, play and stimulation 
1. Provide tender loving care and a stimulating environment 
2. Help and encourage mothers to comfort, feed, bathe and play with their children. 
3. Involve mother/caregiver in all the play/stimulation exercises. 
4. Give 15-30 minutes of structured play daily when the child is well enough. (Involve Occupational Therapist 
and/or physiotherapist for structured play, if available or organise in the ward.) 
STEP 10  
10. Preparation for follow-up after discharge 
Discharge Criteria: Discharge when there are signs of improvement: Good appetite, infection resolved, oedema 
resolved AND consecutive weight gain for 5 days Prior to Discharge ensure these are completed: 
1. Investigate for TB. Careful history for contacts. Repeat Tuberculin Skin Test if initial response was negative, 
and read it within 48 hours. Record the findings. Do CXR. 
2. Ensure counselling and Test for HIV was conducted. Record the findings. 
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3. Involve mother in the discharge process and follow-up plans. Obtain information on family background and 
socio-economic status. Refer all children to Social Services (SASSA, Social Development, Home Affairs) and/or 
hospital social workers. 
4. Give health and nutritional education. Issue mother/caregiver with the Family Booklet for Child Health. Share 
educational messages about the child and self or example, Family Practices booklet containing information on 
when to return urgently to clinic, hygiene, infant feeding and complementary feeding advice, stimulation, family 
planning, HIV, immunisation, role of male partner). Work with Dietician to counsel mothers/caregivers on how 
to modify family foods, how often to feed and how much to give. 
5. Register child on the Severe Acute Malnutrition Inpatient care register. Ensure the child is counted onto the 
provincial information system admissions, discharges and/or deaths tally sheet. 
6. Establish a link with local PHC clinic and family’s local Community Care Givers (CCGs) for home follow-up as 
they are a high-risk group. 
7. Prepare a Discharge Summary and write a brief clinical summary in RTHB. 
8. Send a NTP referral letter to the local PHC clinic. Ensure child is enrolled on nutrition therapeutic programme 
at local clinic or child returns to hospital outpatient in one week. 
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 PURPOSE 
This document describes the procedure followed by phlebotomists and technologists for proper 
specimen handling, i.e. collection and subsequent transport to the laboratory. 
APPLICATION SCOPE 
This procedure is to be used and followed by all sites and clinics which collect specimens to be sent to 
the laboratory for analysis. 
PERSONNEL RESPONSIBILITY 
It is the responsibility of the laboratory to ensure that staff at the sites and clinics are trained and are 
competent on this procedure. Adherence to this SOP is the responsibility of every person performing 
phlebotomy procedures or transporting specimens from clinics/sites to the laboratory. 
EQUIPMENT 
The following are needed for routine venipuncture: 
Evacuated collection tubes - The tubes are designed to fill with a predetermined volume of blood by 
vacuum. The rubber stoppers are colour-coded to the additive that the tube contains. Various sizes are 
available. Blood should NEVER be poured from one tube to another since the tubes can have different 
additives or coatings (refer to Appendix 1). 
Needles - The gauge number indicates the bore size: The smaller the gauge number, the larger the 
bore of the needle. 
Needles are available for evacuated systems and for use with a syringe, single draw or butterfly system. 
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Holder/adapter - use with the evacuated collection system. 
Tourniquet - Should be wiped off with alcohol and replace frequently. 
Alcohol wipes - saturated with 70% isopropyl alcohol. 
Povidine-iodine wipes/swabs - used if blood culture is to be drawn. 
Gauze sponges - for application on the site from which the needle is withdrawn. 
Adhesive bandages/tape - protects the venipuncture site after collection. 
Needle disposal unit - needles should be placed in a sharps container immediately after their use. They 
should never be broken, bent, or recapped. 
Gloves can be made of latex, rubber, vinyl, etc; worn to protect the patient and the phlebotomist. 
Syringes - may be used in-place of the evacuated collection tube system for special circumstances. 
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PROCEDURE 
Proper specimen collection and handling is an integral part of obtaining a valid and timely laboratory 
test results. Specimens must be obtained using proper phlebotomy techniques, collected in the proper 
container, correctly labelled and promptly transported to the laboratory. 
BLOOD COLLECTION 
Blood collection tubes with anticoagulant should be inverted several times as soon after collection as 
possible to prevent clotting. All blood collection tubes must be filled to the line in order to prevent dilution 
of blood components. Tubes with anticoagulant improperly filled will be rejected. 
Deliver samples to the laboratory promptly. Valid measurement of analytes in serum or plasma requires 
prompt separation from the blood cells and analysis in the laboratory. Estimates of the level of 
biochemical constituents in the serum or plasma are different from their levels in whole blood. This is 
because many of the chemical substances are present in different concentrations in the plasma and the 
blood cells. It is the concentration in plasma or serum which changes in disease and ca be used as an 
aid for diagnosis. 
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Venipuncture 
Several essential steps are required for every successful collection procedure: 
Identify the patient 
Assess the patient’s physical disposition (i.e. diet, exercise, stress, basal state) 
Check the requisition form for requested tests, patient information, and any other special requirements. 
Select a suitable site for venipuncture. 
Prepare the equipment, patient and venipuncture site. 
Perform the venipuncture. 
Collect the sample in the appropriate container. 
Assess the need for the sample recollection and/or rejection. 
Label the collection tubes at the drawing area. 
Promptly send the specimens with the requisition forms to the laboratory. 
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Patient identification 
To provide high quality patient care, it is the policy of CL to assure positive identification. Therefore it is 
important to identify the patient prior to sample collection. Greet the patient and identify yourself and 
indicate the procedure that will take place. Proper patient identification is MANDATORY. Verify patient’s 
initials and the patient identification (PID) number with that on the request form. DO NOT prelabel the 
specimen container with the patient information prior to sample collection. 
Requisition form 
A requisition form must accompany each sample that is submitted to the laboratory. This requisition 
form must contain the proper information in order to process the specimen. The essential elements of 
the requisition are: 
Patient’s initials 
Unique patient identification number (PID/BID) 
Date and time of collection 
Initials of the person collecting the sample (phlebotomist) 
Patient sex and date of birth 
Initials of the clinician requesting the test 
Billing information 
Test to be performed 
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Specimen container 
A properly labelled sample is essential so that the test results match the patient. The key elements in 
labelling are: 
Patient’s initials 
Unique patient identification number (PID/BID) 
Letter code of eth test requested 
Order of draw 
Blood collection tubes must be drawn in a specific order to avoid contamination by additives between 
tubes. The recommended order of draw is: 
1) Blood culture tube (yellow-black top) 
2) Non-additive tube (red-top or SST) 
3) Coagulation tube (light blue top). If a routine coagulation assay is the only test ordered, then a single 
light blue top tube may be drawn. If there is a concern regarding contamination by tissue fluids or 
thromboplastins, then one may drawn a non-additive tube first, and then the light blue top tube. 
Last - additive tubes in this order: 
a) SST (red-grey, or gold top). Contains a gel separator and clot activator. 
b) Sodium-heparin (dark green top). 
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c) Plasma separating tube (PST) (light green stopper). Contains lithium heparin anticoagulant and a gel 
separator. 
d) EDTA (lavender/purple top). 
e) ACDA or ACDB (pale yellow top). Contains acid-citrate-dextrose. 
f) Oxalate/fluoride (light grey top). 
Note: Tubes with additives must be thoroughly mixed. Erroneous test results amy be obtained when the 
blood is not thoroughly mixed with the additive. 
Note: For plastic tubes, order of draw for non-additive and coagulation tubes is reversed. 
Venipuncture site selection 
Although the larger and median cubital and cephalic veins of the arm are used most frequently, wrist 
and hand veins are also acceptable for venipuncture. 
Certain areas are to be avoided when choosing a site: 
Extensive scars from burns and surgery - it is difficult to puncture the scar tissue and obtain a specimen. 
The upper extremity on the side of a previous mastectomy - test results may be affected because of 
lymphedema. 
Hematoma - may cause erroneous test results. If another site is not available, collect the specimen 
distal from the hematoma. 
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Intravenous therapy (IV)/blood transfusions - fluid dilute the specimen, so collect from the opposite arm 
if possible. 
Otherwise, satisfactory samples may be drawn below the IV by the following procedures: 
Turn off the IV for at least 2 minutes before venipuncture. 
Apply tourniquet below the IV site. Select a vein other than the one with the IV. 
Perform the venipuncture. Draw 5ml of blood and discard before drawing the specimen tubes for testing. 
Cannula/fistula/heparin lock - hospitals have special policies regarding these devices. In general, blood 
should not be drawn from an arm with a fistula or cannula without consulting the attending physician. 
Oedematous extremities - tissue fluid accumulation alters test results. 
Procedure for vein selection 
Palpate and trace the path of veins with the index finger. Arteries pulsate, are more elastic, and have a 
thick wall. Thrombosed veins lack resilience, feel cord-like and roll easily. 
If superficial veins are not readily apparent, you can force blood into the vein by massaging the arm 
from the wrist to the elbow, tap the site with index and second finger, apply a warm, damp wash cloth 
to the site for 5 minutes, or lower the extremity to allow veins to fill. 
Performance of a venipuncture 
Approach the patient in a clam friendly manner. Provide for their comfort as much as possible, and gain 
the patient’s cooperation. 
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Identify the patient correctly. 
Properly complete the appropriate requisition forms 
Verify the patient’s condition. Fasting, dietary restrictions, medications, timing, and medical treatment 
are all of concern and should be noted on the lab requisition form. 
Position the patient. The patient should sit on a chair, lie down or sit up in bed 
 Hyperextend the patient’s arm and apply a tourniquet 3 - 4 inches above the selected puncture site. Do 
not place too tightly or leave on for more than 2 minutes. 
The patient should make a fist without pumping the hand. 
Select the venipuncture site. 
Prepare the site using an alcohol swab. Cleanse in a circular manner, beginning at the site and working 
outward. Allow to air-dry. 
Grasp the patient’s arm firmly using your thumb to draw the skin taut and anchor the vein. Swiftly insert 
the needle through the skin and into the lumen of the vein. Avoid trauma and excessive probing. 
When the last tube to be drawn is filling, remove the tourniquet. 
Remove the needle from the patient’s arm using a swift backwards motion. 
Press down on the gauze once the needle is out of the arm, applying adequate pressure to avoid 
formation of a hematoma. 
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Dispose of contaminated materials in designated containers. 
Label and mix all appropriate tubes immediately. 
Deliver specimens and requisition forms to the laboratory promptly. 
Performance of a finger stick 
Follow the procedure so outlined above for greeting and identifying the patient. As always, fill out the 
appropriate requisition forms. 
Verify the patient’s condition. Fasting, dietary restrictions, medications, timing, and medical treatment 
are all of concern and should be noted on the lab requisition form. 
Position the patient. The patient should sit on a chair, lie down or sit up in bed. Hyperextend the patient’s 
arm. 
The best locations for fingersticks are the 3rd and 4th fingers of the non-dominant hand. Do not use the 
tip or centre of the finger. Avoid the side of the finger where there is less soft tissue, where vessels and 
nerves are located, and where bone is closer to the surface. The index finger tends to have thicker, 
calloused skin. The fifth finger tends to have less soft tissue overlying the bone. Avoid puncturing a 
finger that is cold or cyanotic, swollen, scarred, or covered with a rash. 
Using a sterile lancet, make a skin puncture just off the centre of the finger pad. The puncture should 
be made perpendicular to the ridges of the fingerprint so that the drop of blood does not run down the 
ridges. 
Wipe away the first drop of blood, which tends to contain excess tissue fluid. 
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
313 | P a g e  
 
 
 
Collect drops of blood into a collection device by gently massaging the finger. Avoid excessive pressure 
that may squeeze tissue fluid into the drop of blood. 
Cap, rotate and invert the collection device to mix the blood collected. 
Have the patient hold a small gauze pad over the puncture site for a couple of minutes to stop the 
bleeding. 
Dispose of contaminated materials in designated containers. 
Label all appropriate tubes at the collection area. 
Deliver specimens promptly to the laboratory. 
Blood collection on babies 
The recommended location for blood collection on a newborn baby or infant is on the heel. 
Prewarming the infant’s heel (42C for 3-5 minutes) is important to obtain capillary blood gas samples. 
Warming also greatly increases the flow of blood for collection of other specimens. However, do not use 
too high a temperature warmer, because baby’s skin is thin and susceptible to thermal injury. 
Clean the site to be punctured with an alcohol sponge. Dry the cleaned area with a cotton sponge. Hold 
the baby’s foot firmly to avoid sudden movement. 
Using a sterile blood lancet, puncture the side of the heel. Do not use the central portion of the heel 
because the underlying bone, which is close to the skin surface, might be injured. Do not use a previous 
puncture site. Make the cut across the heel print lines so that a drop of blood can well up and not run 
along the lines. 
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
314 | P a g e  
 
 
 
Wipe away the first drop of blood with a piece of clean, dry cotton. Since newborns do not often bleed 
immediately, use gentle pressure or heavy massaging because the blood may become diluted with 
tissue fluid. 
Fill the capillary tube(s) or micro-collection device(s) as needed. 
When finished, elevate the heel, place a piece of clean, dry cotton to the puncture site, and hold it in-
place until the bleeding has stopped. 
Be sure to dispose of the lancet in the appropriate sharps’ container. 
Dispose of other contaminated materials in appropriate waste containers. 
Blood collection tubes 
Blood obtained by venipuncture may be collected directly into tubes that have been pretreated with 
coagulants. The vacutainer® evacuated blood collection system (Becton-Dickinson Co., New Jersey) 
consists of the following: 
An evacuated glass/plastic tube containing a premeasured vacuum to ensure that a specified volume if 
blood is drawn. 
A sterile single-use blood collection needle suitable for drawing either single or multiple samples after 
venipuncture. 
A specially designed holder which may be used optionally to secure the needle during venipuncture and 
insertion into the tube top. 
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The tubes are available in a variety of sizes and with a variety of additives. Tubes containing no 
anticoagulants are sued for tests requiring serum. The stopper colour coding for the tubes is listed in 
Table 1. Powdered anticoagulants are utilised in most vacutainer tubes because liquid anticoagulants 
may dilute blood and affect results. 
The recommended container should be used and transferring of specimen from one type of vacutainer 
to another is not allowed. Using the wrong container often leads to erroneous results 
It is important to draw the correct amount of blood (fill the tube) to obtain the proper ratio of anticoagulant 
to blood. 
01.6   GENERAL PRECAUTIONS 
01.6.1   Avoid hemolysis 
Red blood cells contain certain analytes in concentrations many times higher than in plasma. When red 
blood cells are hemolysed, there is s release of these analytes and dilution of the plasma results in 
erroneous laboratory values. Grossly hemolysed samples will be rejected for any analyte in the 
laboratory. A sample visibly hemolysed will be rejected for the following analytes: 
Acid phosphatase 
 ALP (Alkaline phosphatase) 
Amylase 
ALT (Alanine transferase) 
AST (aspartate aminotransferase) 
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Bilirubin 
CK-MB (Creatine Kinase - myocardial tissue specific) 
Glucose 
Lipase 
LDH (Lactate Dehydrogenase) 
Phosphorus 
Potassium 
RPR (Rapid Plastin Reagin) 
VDRL (Venereal Diseases Reference Laboratory) 
01.6.2  Hemolysis can be caused by: 
Mixing additive tubes too vigorously or using rough handling during transport. 
Drawing blood from a vein that has a hematoma. 
Pulling back the plunger on a syringe too quickly. 
Using a needle with too small a bore for the venipuncture. 
Using too large a tube when using a small diameter butterfly needle. 
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Frothing of the blood caused by improper fit of the needle on a syringe. 
Forcing blood from a syringe into an evacuated tube. 
 
01.6.3  Prevent hematoma 
 
Puncture only the uppermost wall of the vein. 
Remove the tourniquet before removing the needle. 
Use the major superficial veins. 
Make sure the needle fully penetrates the uppermost wall of the vein (Partial penetration may allow 
blood to leak into the soft tissue surrounding the vein by way of the needle bevel). 
Apply pressure to the venipuncture site. 
 
01.6.4  Avoid clotted samples 
Inadequate mixing of the vacutainer tube as soon as possible after phlebotomy will result in the blood 
not mixing with the anticoagulant. By gently inverting the vacutainer 5-10 times, the blood will mix and 
clotting will NOT occur. 
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01.6.5  Insufficient specimen quantity 
If the vacutainer is allowed to fill completely, there will be enough specimen to complete most tests. 
Vacutainer tubes half-filled or less than half filled may result in the lab requesting another sample to be 
drawn. 
01.6.6  Avoid prolonged tourniquet application 
Primary effect is hemoconcentration of non-filterable elements (i.e. proteins). The hydrostatic pressure 
causes some water and filterable elements to leave the extracellular space. 
Significant increases can be found in total protein, aspartate aminotransferase (AST), total lipids, 
cholesterol, and iron. 
Affects packed volume and other cellular elements 
01.6.7  Hemoconcentration is an increased concentration of larger molecules and formed 
elements in the blood and may be caused by: 
Prolonged tourniquet application (more than 2 minutes). 
Massaging, squeezing or probing a site. 
Long-term IV therapy. 
Sclerosed or occluded veins. 
01.6.8  Indwelling lines or catheters: 
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Potential source of test error. 
Most lines are flushed with a solution of heparin to reduce risk of thrombosis. 
Discard a sample at least three times the volume of the line before a specimen is obtained for analysis. 
SAFETY AND INFECTION CONTROL 
Because of contact with sick patients and their specimens, it is important to follow safety and infection 
control procedures. 
Protect yourself 
Practice universal precautions 
Wear gloves and a lab coat or gown when handling blood/body fluids. 
Change gloves between patients and whenever they are contaminated. 
Wash hands frequently. 
Dispose of items in appropriate containers. 
Dispose of needles immediately upon removal. Do not bend, break, recap or re sheath needles to avoid 
accidental needle puncture or splashing of contents. 
Clean up any blood spills with a disinfectant such as freshly made 0.5% bleach followed by 70% ethanol. 
If you stick yourself with a contaminated needle: 
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Remove gloves and dispose of them properly. 
Squeeze puncture site to promote bleeding. 
Wash the area well with soap and water. 
Record the patient’s name and PID. 
Follow the institution’s guidelines regarding treatment and follow-up (Post-exposure prophylaxis 
procedure). 
Protect the Patient 
Place blood collection equipment away from patients, especially children and psychiatric patients. 
Practice hygiene for the patient’s protection. When wearing gloves, change them between each patient 
and wash your hands frequently. Always wear a clean lab coat or gown. 
Hazardous conditions, practices, injuries or accidents must be immediate and always reported to a 
supervisor and/or safety officer for follow-up and assurance that appropriate medical attention is 
received if needed. Failure to do so could put other workers and patients in a potentially harmful 
situation. Reporting all unsafe conditions and accidents to the appropriate party is an ethical and moral 
job responsibility for all professionals. 
TROUBLESHOOTING GUIDELINES 
If An Incomplete Collection Or No Blood Is Obtained: 
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Change the position of the needle, move if forward (it may not be in the lumen), or move it backwards 
(it may have penetrated too far). 
Adjust the angle (The bevel may be against the vein wall). 
Loosen the tourniquet; it may be obstructing blood flow. 
Try another tube; there may be no vacuum in the one being used. 
Re-anchor the vein; veins sometimes roll away from the point of the needle and puncture site. 
 If Blood Stops Flowing Into the Tube 
The vein may have collapsed; re secure the tourniquet to increase venous filling. If this is not successful, 
remove the needle, take care of the puncture site and redraw. 
The needle may have pulled out of the vein when switching tubes. Hold equipment firmly and place 
fingers against patient’s arm, using the flange for leverage when withdrawing and inserting tubes. 
Problems Other Than Incomplete Collection A hematoma forms under the skin adjacent to the 
puncture site - release the tourniquet immediately and withdraw the needle. Apply firm pressure. 
The blood is bright-red (arterial), rather than venous - Apply firm pressure for than 5 minutes. 
TRANSPORT OF SPECIMENS TO THE LABORATORY 
All laboratory specimens should be treated as though infected with blood borne or other 
pathogens. 
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The clinical staff at the sites is responsible for the phlebotomy and the appropriate arrangement of 
samples onto a specimen rack. The clinical staff is also responsible for the transfer of samples into an 
appropriate cooler box which must be labelled ‘biohazard’. 
Specimen should be divided and put in different cooler boxes according to the required temperature for 
each test (Refer to Appendix 2 for guidance). 
 
The samples may only be handed over to the driver after they are securely placed in the cooler box and 
the cooler box is securely closed. 
 
The driver receiving the cooler box should ensure that he/she is wearing protective equipment; one hand 
should be gloved (to hold the cooler box) and the other ungloved to open doors. The glove should be 
removed during driving of the vehicle. However, on arrival at the lab, the driver should resume the one 
handed glove method as he/ she delivers the samples to the sample receiving area. 
Spills should be wiped up immediately with disposable towels, whilst wearing gloves, and then the 
surface wiped with disposable towels using a full strength disinfectant (3.5% bleach followed by 70% 
alcohol). Spill kits should be directly available for all drivers. 
All spills and exposures should be reported to the Safety Officers. 
CO-APPLICABLE QUALITY MANAGEMENT DOCUMENTS 
Procedure 002/PR-01 - Daily Specimen Reception and Processing Procedure 
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Procedure 009/PL-02 - Waste Disposal Policy 
Procedure 009/PL-01- Universal Precautions Policy 
Procedure 009/PR-02 - Decontamination of spills 
Procedure 009/PR-04 - Decontamination of Work surfaces and Biosafety Cabinets 
Procedure 009/PL-03 - BHP PEP Policy
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Appendix 1: Tube types and their recommended uses 
 
Top colour Additive Mode of action Uses 
Red None Blood clots and the serum 
is separated by 
centrifugation 
Chemistries, Immunology 
and serology, blood bank 
(cross match) 
Gold None SST contains a gel at the 
bottom to separate from 
serum on centrifugation 
Chemistries, Immunology 
and Serology  
Light green Lithium Heparin Anticoagulates with lithium 
heparin, plasma is 
separated with PST gel at 
the bottom of the tube 
Chemistries 
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Red-grey (tiger) Serum 
separating tube 
with clot activator  
Forms clot quickly and 
separates the serum with 
the SST gel at the bottom of 
the tube 
Chemistries 
Purple EDTA liquid Forms calcium salts to 
remove calcium 
Haematology (CBC) and 
blood bank (cross match); 
requires full draw- invert 
eight times to prevent clotting 
and platelet clumping 
Light blue Sodium citrate Forms calcium salts to 
remove calcium 
Coagulation tests (protime 
and prothrombin time), full 
draw required 
Dark Green Sodium-heparin 
or lithium heparin 
Inactivates thrombin and 
thromboplastin 
For lithium level, use sodium-
heparin. For ammonia level, 
use sodium or lithium 
heparin 
Dark Blue Sodium EDTA Tube designed to contain 
no contaminating metals 
Trace element testing (zinc, 
copper, lead, mercury) and 
toxicology 
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Light grey Sodium fluoride 
and potassium 
oxalate 
Antiglycolytic agent 
preserves glucose up to 5 
days 
For lithium level, use sodium-
heparin. Glucoses. Requires 
full draw (may cause 
hemolysis if short draw) 
Top Colour Additive Mode of action Uses 
Yellow ACD (acid-
citrate-dextrose) 
Complement inactivation HLA tissue typing, paternity 
testing, DNA studies 
Yellow-black Broth mixture Preserves viability of 
microorganisms 
Microbiology - aerobes, 
anaerobes, fungi 
Black  Sodium citrate 
(buffered) 
Forms calcium salts to 
remove calcium 
Westergren Sedimentation 
Rate. Requires full draw 
Orange  Thrombin Quickly clots blood STAT serum chemistries 
Brown  Sodium-Heparin Inactivates thrombin and 
thromboplastin 
Serum lead determination 
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Appendix 2: General Sample Criteria for CL 
 
 Requirements 
Test Tube Type Tube 
volume 
Specimen 
condition 
Maximum 
delivery time/ 
temperature 
Storage 
before 
Testing 
CD4 Cell Count Vacutainer with 
EDTA additive 
(purple top) 
 
Minimum 
0.5ml 
Neither clotted 
nor 
haemolysed 
24 hours/ 
room 
temperature 
48 hours/ 
room 
temperature 
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Hepatitis B/C 
Syphilis Serology 
Plain (red top with 
no additive) or 
yellow top with 
SST gel  
Minimum 
3.0ml 
Not 
haemolysed 
24 hours/ 4 0C  14 days/ 4 0C 
 or below -
200C 
 
 Requirements 
Test Tube Type Tube 
volume 
Specimen 
condition 
Maximum 
delivery 
time/ 
temperature 
 
Storage 
before 
Testing 
Haematology Vacutainer with 
EDTA additive 
(purple top) 
 
Minimum 
Infants 
0.5ml 
Adults 
1.0ml 
Not clotted 
Not 
haemolysed 
24 hours/ 4 
0C 
24 hours/ 4 
0C 
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Chemistry 
Liver function 
Cardiac 
Kidney 
U/E 
Blood in plain 
vacutainer; red top 
with no additive or 
yellow top with SST 
gel  
Minimum 
Infant 
0.5ml 
Adults 
3.0ml 
Not 
haemolysed 
24 hours/ 4 
0C 
24 hours/ 4 
0C 
Chemistry 
Lactate 
Blood in vacutainer 
with Potassium 
oxalate or sodium 
fluoride as additive 
(grey/ green top) 
 
Minimum 
3.0ml 
Not clotted 
Not 
haemolysed 
15 min/ ice 
or 
2 hours/ 
room 
temperature 
if separated 
into plasma 
or 
2 days/4-80C 
None 
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Chemistry 
Glucose 
Blood in vacutainer 
with potassium 
oxalate or sodium 
fluoride as 
additive(grey top) 
 
Minimum 
3.0ml 
Not clotted 
Not 
haemolysed 
24 hours/ 4 
0C 
24 hours/ 4 
0C 
 
Immunology 
Storage 
Vacutainer 
with EDTA 
additive 
(purple top)  
Minimum 
5.0ml 
Neither clotted 
nor 
haemolysed 
6 hours/ 4 0C  -70 0C until 
tested 
Viral Load Storage Vacutainer 
with EDTA 
additive 
(purple top)  
Minimum 
5.0ml 
Neither clotted 
nor 
haemolysed 
6 hours/ 4 0C  -70 0C until 
tested 
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Appendix 3: SOP Attestation Form 
Attestation Record (general staff SOP Review At least annually) 
{Please ensure that you have read and understood before signing} 
Names Signature Date 
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Purpose 
For inoculating specimens onto culture media and sub-culturing from one medium to another in 
microbiological investigations 
 
Responsible personnel 
Technologist, Technician or Student Technologist 
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Safety 
Personal protective equipment must be worn at all times. 
Decontamination of the working area must be carried out per SOP 
Any spillage occurring during sample receiving should be dealt with according to the laboratory 
health and safety guidelines. 
 
Materials and equipment 
Sterilised loops 
Media plates 
Bunsen burner/ Flame 
Biosafety Cabinet 
Permanent Marker 
Pasteur pipettes 
Sterile swabs 
Paper Towel 
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Instrument for seeding media 
This is selected according to the nature of the medium and inoculum. Platinum or nichrome wires of 
different gauges are used. Nichrome has oxidising properties and hence in some of the tests where 
this property of bacterium is to be tested (e.g. oxidase test), platinum wire, instead of nichrome 
should be used. This wire is sterilised by holding it vertically in the flame of the burner so that the 
whole length of wire becomes red hot. It is allowed to cool down before it touches any material 
suspected to be having bacteria to avoid the heat killing the organisms. Presterilized disposable 
loops are now available commercially. The wire can be used as a: 
➢ Straight wire to stab the culture, picking of single colonies as well as for inoculating the liquid 
media, 
➢ Thick wire which is useful for lifting the viscid material such as sputum, and 
➢ Wire loop which is usually of 2 mm diameter is most useful of all inoculating wires. These are 
preferred to seed a plate of medium as the straight wire usually cuts the agar. 
 
Process of seeding a culture plate 
Whole plates, half plates or quarter plates can be used depending on the circumstances. 
Flame wire loops by holding them loop end down in a Bunsen flame until the loop and entire wire 
reaches red heat. Place on a rack to cool before use. This should be conducted before and after use 
and between agar plates. It is usual to use two loops, to allow adequate cooling of one after flaming 
whilst the other is in use. Different disposable loops should be used for each plate. For semi 
quantitative analysis of urine the loop should not be flamed. 
The inoculum from the clinical material or another plate is first spread out in the form of a primary 
inoculum which is also called as ‘well-inoculum’ or only ‘well’. The successive series of strokes are 
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made with the loop sterilised between each sequence. At each step the inoculum is derived from the 
most distal part of the immediately preceding strokes so as to gradually reduce the number of 
bacteria. This helps in obtaining isolated colonies. 
In an alternative plating procedure, one edge of a large loop is used to make a secondary well. The 
other edge is then used to make succession of strokes across the remaining unseeded area. 
When the inoculum is small or the medium is selective it can be more heavily inoculated. Several 
loop-fulls of the specimen are used to spread the primary inoculum. After sterilising the loop, it is 
recharged by rubbing it over inoculum area and the plate is seeded in parallel strokes. 
 
Seeding a liquid medium 
If the tubes have got cotton plugs, the mouth of the tubes should be heated in flame before and after 
any handling of tube to prevent contamination from the rims of tubes getting into the medium. It is 
not required when metal caps and screw-capped tubes are handled. Incline the tube containing the 
liquid medium to 45º and deposit the inoculum on its wall above the surface of the liquid at its lower 
end. Return the tube to a vertical position. Now the inoculum shall be below the surface of the liquid. 
 
Sub-culture from a solid medium to solid medium 
Using a sterile wire or loop, a representative colony is touched and sub-cultured onto appropriate 
solid medium by touching the wire or loop onto the surface of the medium. 
Important points about inoculation of culture media 
➢ Aseptic technique is important to avoid contamination. 
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Aseptic technique 
With the exception of urine specimens, caps and lids from containers should not be placed on the 
workbench, but retained in the hand whilst the sample is being processed, taking care not to 
contaminate the hand or cap. Caps and lids should be replaced as soon as possible. 
If the work is carried out on the open bench, a Bunsen burner should be in close proximity to flame 
loops or wires. 
When opening culture containers keep samples away from the face. 
Aerosol production should be minimised by: 
Opening the caps slowly as the contents are sometimes under pressure 
Avoiding vigorous swirling or shaking of the sample prior to opening 
Cooling loops that have been heated before use 
Avoid expelling the last drop from a pipette 
If forceps or scissors are used when handling specimens, they should be heated in a Bunsen flame 
and allowed to cool before use. 
 
Specimen Processing 
Primary Culture Methods 
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Swabs- plate culture 
Initial inoculum should cover between a quarter and a third of the plate to be used. The swab should 
be rolled over the inoculation area to maximise transfer of organisms, taking care to avoid the edges 
of the plate. Inoculation of samples on to selective media such as Sabourauds agar when usually a 
quarter plates only will be used may not require spreading with a loop. 
 
Swabs- liquid culture 
Using an aseptic technique, remove the broth container cap, place the swab in the broth, break off 
or cut the swab- stick and replace the cap. The swab may be placed in the broth directly, or after 
inoculating solid culture media. 
 
Fluid specimens and pus 
Resuspend the centrifuged deposit of any fluid in approximately 0.5mL supernatant, then transferto 
appropriate culture media using a sterile pipette. Thick pus may require inoculation with the aid of a 
swab or swabstick. 
 
Urine- calibrated loop, surface streak method 
Mix the urine gently to avoid foaming. Dip the end of a sterile calibrated loop ( e. g. 1µL, 2µL or 10µL) 
to just below the surface of the urine and remove vertically, taking care not to carry over any urine 
on the shank. 
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Urine- Filter paper method 
Dip the commercially prepared sterile filter paper strip into the urine up to the mark indicated. 
Remove excess urine by touching the side of the strip against the side of the container and allow the 
urine time to absorb into the strip before inoculating a CLED agar plate. Bend the inoculated end of 
the strip and press it flat against the agar for a few seconds. Several specimens may be inoculated 
on to one CLED agar plate using this technique, but it is important to ensure adequate spacing to 
minimise the potential risk of any antibacterial effect. 
 
Tissue and Biopsy specimens 
Homogenise tissue using using a sterile tissue grinder or a pestle and mortar, and inoculate 1 or 2 
drops of the homogenate on to appropriate media. Tissue may also be cut or sliced with a sterile 
scalpel, or preferably, sterile scissors. Using sterile forceps smear the sliced portion directly on to 
the culture medium. If enrichment culture is performed, this should be inoculated with pieces of 
specimen that have not been spread over the surface of solid media to avoid possible contamination. 
All homogenisation and grinding procedures must be performed in a biosafety cabinet. 
 
Sub-culture methods 
Sub-culture of liquid media to solid or liquid medium 
Obtain samples for sub-culture using a sterile loop (1µL, 10µL, etc) or a plastic pipette. Immerse the 
loop into the fluid to be sub-culture, and remove carefully without allowing excess fluid to remain on 
the shank of the shank of the loop. Either inoculate the loopful of fluid on to an appropriate agar 
plate, streaking out for individual colonies. The use of a pipette is particularly recommended when 
sub-culturing organisms to multiple culture media. 
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Sub-culture from a solid medium to a liquid medium 
Select a representative colony or colonies of the organism to sub-culture using a sterile wire or loop 
to transfer to an appropriate broth. Gently agitate before incubation to distribute the organisms 
throughout the broth. 
 
Sub-culture from a solid medium to a solid medium 
It is recommended that a sterile wire be used when dealing with mixed cultures to ensure the 
sampling of the single colonies. Select a representative colony or colonies of the organism to be sub-
cultured using a sterile wire or loop, and sub-culture on to the appropriate medium by touching the 
wire or loop on to the surface of the agar and then plate out. The use of a densitometer or McFarland 
standards may be required to adjust inoculum density. 
 
References 
www.evaluations-standards.org.uk 
Sudarshan K. and R.L. Ichhpujani, 2000. Guidelines on Standard Operating Procedures for 
Microbiology, New Delhi. 
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Annex 1: SOP ATTESTATION FORM 
 
Attestation Record (general staff SOP Review At least annually) 
{Please ensure that you have read and understood before signing} 
Names Signature Date 
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Purpose: 
To test the sensitivity of bacterial isolates to antimicrobial agents so as to guide patient therapy 
 
Principle 
Susceptibility testing is conducted for organisms whose response to antimicrobial agents cannot be predicted 
from knowledge of the organism identity. 
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Disc diffusion is the most commonly used method for determining antimicrobial susceptibility. It predicts 
susceptibility based on break points that correlate zones of inhibition with the minimum inhibitory 
concentrations. 
 
The methods described here are based on those of Kirby-Bauer. They must be explicitly followed in order to 
obtain reliable and reproducible results.  
 
Responsibilities: 
Setting and reading of the tests shall be performed by a trained technician 
The overall process shall be under the supervision of a microbiologist 
 
Safety issues: 
Observe standard precautions. 
 
Equipment and materials: 
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Equipment 
Incubator at 35 - 37oC 
Inoculating loops (10µl) 
Test tubes 
Sterile cotton tipped swabs 
Calibrated ruler (in mm) 
Forceps 
Bunsen burner 
Refrigerator (2 - 8oC) 
Comparator card 
Culture media 
Muller-Hinton agar 
Muller-Hinton Broth 
Haemophilus test medium (for Haemophilus spp) 
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GC agar (for Neisseria gonorrhoeae) 
Muller-Hinton agar supplemented with 5% sheep blood (for S. pneumoniae and other Streptococci) 
 
Reagents/supplies 
0.5 McFarland standard 
Antimicrobial discs (potency summarised in tables for the various categories of organisms) 
Sterile normal saline 
Control strains: 
E.coli 25922 
E.coli 35218 (for β-lactam-inhibitor combinations) 
S. aureus ATCC 25923 
E. faecalis 29212 (for HLAR testing for Enterococcus) 
H.influenzae 49247 (Ampicillin resistant β-lactamase negative) 
H.influenzae 49766 (Ampicillin sensitive for control of β-lactam) 
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Klebsiella pneumoniae 700603 (Control for ESBL tests) 
Neisseria gonorrhoeae 49226 
Pseudomonas aeruginosa 27853 
Streptococcus pneumoniae 49619 
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Procedure: 
Preparation of inoculum: 
Pick 3 - 5 discrete colonies from an 18 - 24 hour old culture using a loop 
Transfer into a tube containing 4 - 5 ml of sterile normal saline and emulsify. 
Adjust the turbidity of the suspension so that it matches that of the 0.5 McFarland standard by adding 
more sterile saline or more of the growth. 
(To do this, compare the suspension with the McFarland standard against a card with a white 
background and contrasting black lines in the presence of adequate light) 
Note 
Always use well isolated/discrete colonies. 
(In case the colonies are not discrete, first prepare a purity plate on a non-inhibitory medium before 
performing susceptibility testing) 
Use Cultures that are not more than 18 - 24 hours old. Sub-culture for fresh growth if the cultures 
are too old. 
Use the suspension within 15 minutes of adjusting the turbidity standard 
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Inoculation of plates: 
Label well dried plates of Muller-Hinton agar with the number of the specimen and identification of 
the isolate 
Dip a sterile cotton tipped swab into the adjusted suspension of the isolate 
Rotate the swab several times, pressing it firmly against the inside wall of the tube above the fluid 
level to drain excess inoculum from the swab 
Streak the swab over the entire surface of the agar. 
Rotate the plate through about 60o and repeat the streaking. Do this twice. 
Swab the rim of the agar as the final step in streaking 
In case the surface of the plate appears wet after the streaking, leave the plate on the bench (agar 
side down) with the lid slightly ajar for 3 - 5 minutes. (In any case not more than 15 minutes) 
 
Application of discs: 
Place the appropriate discs on to the agar surface using a pair of forceps 
(tables 6.5 - 6.16 for selection of antimicrobial agents for various organisms) 
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Space the discs so that they are at least 24 mm from each other. No more than five discs should be 
placed on each 100mm plate or 12 discs on 150mm plates. 
Press the disc down to ensure complete contact with the agar 
Incubate the plates inverted in an incubator at 35oC within 15 minutes of placing the discs on to the 
plate. 
(Do not incubate in CO2 except for Haemophilus, N.gonorrhoeae, Streptococci)  
 
Reading plates and interpreting results: 
Examine the plates after 16 - 18 hours of incubation 
In case of testing of Staphylococcus for oxacillin and Enterococcus for vancomycin, incubate 
the plates for 24 hours before reading (other disks on the same plate may be read at 16 -18 
hours and the plate re-incubated). 
 
Check for confluence of the growth: 
There should be a confluent lawn of growth and zones of inhibition should be uniformly circular if the 
plate was satisfactorily streaked 
If individual colonies are seen, the inoculum was too light and the test should be repeated 
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Measure the diameters of the zones of inhibition (to the nearest whole number) as observed with the 
naked eye using a ruler held at the back of the Petri dish.  
If the media is opaque (as in the case of blood agar), measure the media from the surface of the 
agar illuminated with reflected light. 
The zone margins are taken as the areas showing no obvious growth as seen with a naked eye. 
Faint growth of tiny colonies seen only with the aid of a hand lens at the edge of the zone of inhibited 
growth should be ignored 
If discrete colonies are seen within the clear zone of inhibition, repeat the test with a single colony 
from the primary culture or a purity plate. If the growth of discrete colonies within the zone of inhibition 
continues upon repeating the test, measure the colony free inner zone. 
In case of Proteus, a thin veil of swarming growth may be seen within an otherwise clear zone of 
inhibition. Ignore the swarming and measure the zone of inhibition. 
On plates supplemented with blood agar, measure the zones of inhibition and NOT zones of 
haemolysis 
For sulfonamides/trimethorpim (e.g. cotrimoxazole), antagonists in the medium may allow some light 
growth within the zone of inhibition. Ignore the light growth and measure the more obvious zone. 
In testing susceptibility of Staphylococcus spp for oxacillin and Enterococcus spp for vancomycin, 
examine the plate with transmitted light for any growth within the zone of inhibition. Any discernable 
growth within the zone of inhibition is indicative of methicillin or vancomycin resistance respectively. 
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Record the zone diameters in a table on the work sheet and use the relevant interpretative tables for 
each organism to record whether the organism is susceptible, intermediate or resistant. 
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Antibiotic list and Interpretative diameters for Enterobacteriaceae (other than Salmonella/Shigella) 
Media: Muller-Hinton agar 
 
 
 Zone diameter (mm) Setting and 
Reporting guidelines 
Special considerations 
 Antibiotic R I S   
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 Ampicillin 10µg ≤ 13 14-16 ≥ 17 Always set 
Always report 
 
 Cefazolin 30µg or 
Cephalothin 30µg (1st 
generation) 
≤ 14 15 - 17  ≥ 18 Always set 
Always report 
Do not test for CSF isolates. Instead use 
Ceftriaxone 
 Cefuroxime axetil (30µg) ≤ 14 15 - 22  ≥ 23 Always set If resistant test for ESBL 
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(2nd generation) Always report Do not test for CSF isolates. Instead use 
Ceftriaxone 
 Amoxycillin-clavulanic 
acid (Augmentin) 
(20/10µg) 
≤ 13 14 -17 ≥ 18 Always set 
Always report 
If resistant screen for inducible AmpC (If present 
recommend combination of cephalosporin and 
aminoglycoside) 
 Gentamicin (10µg) ≤ 12 13 - 14 ≥ 15 Always set 
Always report 
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 Cotrimoxazole 
(Trimethoprim-
sulfamethoxazole) 
(1.25/23.5µg) 
≤ 10 11 - 15 ≥ 16 Always set 
Always report 
Ignore any light growth that may be seen within 
the clear zone of inhibition (measure the outer 
zone) 
 Chloramphenicol (5µg) ≤ 12 13 - 17  ≥ 18 Always set 
Always report 
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 Ciprofloxacin (5µg)  ≤ 15 16 - 20 ≥ 21 Always set 
Always report 
 
 Ceftriaxone (30µg) ≤ 13 14 - 20  ≥ 21 Always set 
Report if requested/if other 
agents are resistant 
Set ESBL confirmatory test for zones of 
Klebsiella spp, E.coli and Proteus mirabilis 
that are ≤ 25mm  
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 10. Ceftazidime 30µg) ≤ 13 14 - 20  ≥ 21 Always set 
Report if requested/if other 
agents are resistant 
Set ESBL confirmatory test for zone of 
Klebsiella spp, E.coli and Proteus mirabilis 
that are ≤ 22mm  
 
 
 Zone diameter (mm) Setting and 
Reporting guidelines 
Special considerations 
 Antibiotic R I S   
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 11. Cefotaxime (30µg) ≤ 14 15 - 22 ≥ 23 Set as an alternative to 
Ceftriaxone. Always set for 
Proteus spp 
Set ESBL confirmatory test for zone of 
Klebsiella spp, E.coli and Proteus mirabilis 
that are ≤ 27mm 
 12. Imipenem(10µg)/ 
Meropenem (10µg) 
≤ 13 14 - 15 ≥ 16 Set in case of resistance to 
Ceftriaxone or demonstration 
of ESBL 
 
13. Nalidixic acid (30µg) ≤ 13 14 - 18 ≥ 19 Always set and report for 
urine isolates only 
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14. Nitrofurantoin 300 µg ≤ 13 15 - 16 ≥17 Always set for urine isolates 
Always report for urine 
isolates 
 
For Salmonella and Shigella: 
Faecal isolates: 
Set Ampicillin, ciprofloxacin, nalidixic acid, cotrimoxazole (Report all routinely) 
Extra-intestinal isolates of Salmonella spp: Add chloramphenicol and Ceftriaxone. Exclude nalidixic acid. 
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Antibiotic list and Interpretative diameters for Vibrio cholerae 
Media: Muller-Hinton agar   QC strain: ATCC 25922 
 
 
 Zone diameter (mm) Setting and 
Reporting guidelines 
Special considerations 
 Antibiotic R I S   
 Ampicillin 10µg ≤ 13 14-16 ≥ 17 Always set  
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Always report 
 Trimethoprim-sulfamethoxazole 
(1.25/23.5µg) 
≤ 10 11 - 15 ≥ 16 Always set 
Always report 
Ignore the light growth that may 
be seen within the clear zone of 
inhibition (measure the outer 
zone) 
 Sulfixazole (250µg) ≤ 12 13 - 16 ≥ 17 Always set 
Always report 
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 Tetracycline (30µg) ≤ 14 15 - 18 ≥ 19 Always set 
Always report 
 
 Chloramphenicol (5µg) ≤ 12 13 - 17  ≥ 18 Always set 
Always report 
Test sometimes miss classifies 
some strains 
Disc diffusion should not be conducted for erythromycin as it correlates poorly with MIC results. 
 
  
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
RFMHL SBP 08                                                                              SUSCEPTIBILITY TESTING                                                                        SHLS 
 
Effective Date: 08/09/2014              Page 375 of 468 
                                                                          RFMHL Confidential Controlled Document 
 
 
Antibiotic list and Interpretative diameters for Pseudomonas aeruginosa 
Media: Muller-Hinton agar 
 
 
 Zone diameter (mm) Setting and 
Reporting guidelines 
Special considerations 
 Antibiotic R I S   
1. Piperacillin 100µg ≤ 17 - ≥ 18 Always set  
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Always report 
2. Piperacillin-tazobactam 
(100µg/10µg) 
≤ 17 -  ≥ 18 Always set 
Always report 
 
3. Ceftazidime(30µg) ≤ 14 15 - 17  ≥ 18 Always set 
Always report 
Heavy inoculum gives 
erroneous resistance 
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4. Cefepime(30µg) ≤ 14 15 - 17  ≥ 18 Set when Ceftazidime is resistant Heavy inoculum gives 
erroneous resistance 
5. Gentamicin (10µg) ≤ 12 13 - 14 ≥ 15 Always set 
Always report 
 
7. Ciprofloxacin (5µg)  ≤ 15 16 - 20 ≥ 21 Always set 
Always report  
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8. Tetracycline(30µg)  ≤ 14 15 - 18 ≥ 19 Always set 
Always report 
 
  9. Imipenem(10µg)/ 
 
≤ 13 14 - 15 ≥ 16 Set in case of resistance to 
Ceftazidime or demonstration of ESBL 
or AmpC 
 
10. Amikacin(30µg) ≤ 14 15 - 16 ≥ 17 Always set 
Report in case of resistance to 
gentamicin. In report, mention that 
 
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
RFMHL SBP 08                                                                              SUSCEPTIBILITY TESTING                                                                        SHLS 
 
Effective Date: 08/09/2014              Page 379 of 468 
                                                                          RFMHL Confidential Controlled Document 
 
 
tobramycin and netilimicin are 
alternatives 
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Antibiotic list and Interpretative diameters for Acinetobacter spp 
Media: Muller-Hinton agar 
 
 
 Zone diameter (mm) Setting and 
Reporting guidelines 
Special considerations 
 Antibiotic R I S   
1. Piperacillin 100µg ≤ 17 18 - 20 ≥ 21 Always set  
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Always report 
2. Piperacillin-tazobactam 
(100µg/10µg) 
≤ 17 18 - 20 ≥ 21 Always set 
Always report 
 
3. Ceftazidime(30µg) ≤ 14 15 - 17  ≥ 18 Always set 
Always report 
Heavy inoculum gives 
erroneous resistance 
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4. Cefepime(30µg) ≤ 14 15 - 17  ≥ 18 Sethen Ceftazidime is resistant Heavy inoculum gives 
erroneous resistance 
5. Trimethoprim-
sulfamethoxazole (1.25/23.5µg) 
≤ 10 11 - 15 ≥ 16 Always set 
Always report 
 
5. Gentamicin (10µg) ≤ 12 13 - 14 ≥ 15 Always set 
Always report 
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8. Ciprofloxacin (5µg)  ≤ 15 16 - 20 ≥ 21 Always set 
Always report  
 
9. Tetracycline(30µg)  ≤ 14 15 - 18 ≥ 19 Always set 
Always report 
Represent Minocycline and 
Doxycycline but some strains 
that are I or R to tetracycline 
may be susceptible to the two 
drugs 
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10. Imipenem(10µg) 
 
≤ 13 14 - 15 ≥ 16 Set in case of resistance to 
Ceftazidime or demonstration of ESBL 
or AmpC 
 
11. Amikacin(30µg) ≤ 14 15 - 16 ≥ 17 Always set 
Report in case of resistance to 
gentamicin. In report, mention that 
tobramycin and netilimicin are 
alternatives 
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Antibiotic list and Interpretative diameters for Burkholderia cepacia 
Media: Muller-Hinton agar 
 
 
 Zone diameter (mm) Setting and 
Reporting guidelines 
Special considerations 
 Antibiotic R I S   
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1. Ceftazidime(30µg) ≤ 17 18 - 22  ≥ 21 Always set 
Always report 
Heavy inoculum gives 
erroneous resistance 
2. Minocycline (30µg) ≤ 14 15 - 18  ≥ 19 Always set 
Always report 
Heavy inoculum gives 
erroneous resistance 
3. Trimethoprim-
sulfamethoxazole (1.25/23.5µg) 
≤ 10 11 - 15 ≥ 16 Always set 
Always report 
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Antibiotic list and Interpretative diameters for Stenotrophomonas maltophilia 
Media: Muller-Hinton agar 
 
 
 Zone diameter (mm) Setting and 
Reporting guidelines 
Special considerations 
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 Antibiotic R I S   
1. Minocycline (30µg) ≤ 14 15 - 18  ≥ 19 Always set 
Always report 
Heavy inoculum gives 
erroneous resistance 
2. Levofloxacin (5µg) ≤ 13 14 - 16 ≥ 17 Always set 
Always report 
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3. Trimethoprim-
sulfamethoxazole (1.25/23.5µg) 
≤ 10 11 - 15 ≥ 16 Always set 
Always report 
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Antibiotic list and Interpretative diameters for Staphylococcus spp 
 Media: Muller-Hinton agar 
 
 
 Zone diameter (mm) Setting and 
Reporting guidelines 
Special considerations 
 Antibiotic R I S   
1. Penicillin G (10 units) ≤ 28 - ≥ 29 Always set 
Always report 
If oxacillin is resistant, always report as 
resistant 
2. Cefoxitin (30 µg) ≤ 19 
 
- ≥ 20 
 
Always set Used as a screen for oxacillin resistance. 
Report as oxacillin resistant or sensitive 
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≤ 24 
(for CoNS) 
≥ 25 
(for CoNS) 
Always report (as oxacillin resistant or 
sensitive) 
 
Incubate a full 24 hours 
3. Erythromycin (15µg) ≤ 13 14 - 22  ≥ 23 Always set 
Always report 
  (Do not report for urinary tract) 
 
4. Clindamycin (2µg) ≤ 14 15 -20 ≥ 21 Always set 
Report if erythromycin is resistant 
Place next to erythromycin disc to text for 
inducible resistance (erm) (Appendix I) 
5. Vancomycin -  -  ≥ 15 Always set 
Report if other agents are resistant 
Resistant isolates may not be detectable by 
disc diffusion. For isolates with zone 
diameters ≤14mm should do MICs  
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6. Tetracycline ≤ 14 15 - 18 ≥ 19 Always set 
Always report 
  (except for paediatrics) 
 
6. Trimethoprim-sulfamethoxazole 
(1.25/23.5µg) 
≤ 10 11 - 15 ≥ 16 Always set 
Always report 
Ignore the light growth that may be seen 
within the clear zone of inhibition (measure 
the outer zone) 
7. Chloramphenicol (5µg) ≤ 12 13 - 17  ≥ 18 Always set 
Always report 
 
8. Ciprofloxacin (5µg)  ≤ 15 16 - 20 ≥ 21 Always set 
Report if requested/if other agents are 
resistant 
Indicate warning that Staphylococcus spp 
may develop resistance to quinolones during 
the course of treatment 
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  9. Gentamicin (10µg) ≤ 12 13 - 14 ≥ 15 Always set 
Report if requested/if other agents are 
resistant 
 
  10. Nitrofurantoin (300µg) ≤ 14 15 - 16  ≥ 17 Always set for urine only  
  11. Rifampicin (5µg) ≤ 16 17 - 19 ≥ 20 Set in case of oxacillin resistance Always used in combination with another 
agent in case of treatment 
12. Linezolid (30µg) - - ≥ 20 Set in case of oxacillin resistance  
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Antibiotic list and Interpretative diameters for Enterococcus spp 
Media used: Muller-Hinton Agar QC strain: S. aureus ATCC 25923. For HLAR test with Gentamicin use E. faecalis 29212 
 
 
 Zone diameter (mm) Setting and 
Reporting guidelines 
Special considerations 
 Antibiotic R I S   
1. Ampicillin 10µg ≤ 16 - ≥ 17 Always set 
Always report 
Always test blood & CSF isolates for β-
lactamase using nitrocefin test. A 
positive test indicates resistance 
2. Vancomycin 30µg ≤ 14 15 - 17  ≥ 18 Always set 
Report if ampicillin resistant 
Always incubate for a full 24 hours. 
Examine plate with transmitted light. Any 
haze or any growth within zone of 
inhibition indicates resistance 
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 Zone diameter (mm) Setting and 
Reporting guidelines 
Special considerations 
3. Erythromycin 10µg ≤ 13 14- 22  ≥ 23 Always set 
Report if ampicillin and vancomycin are 
resistant  
Do not report for urine isolates 
 
4. Tetracycline 30µg ≤ 14 15 -18 ≥ 19 Always set 
Report if resistant to ampicillin and 
vancomycin  
 
5. Gentamicin (120µg) ≤ 6 7 - 9 ≥ 10 Always set A screen for high-level resistance to 
aminoglycosides. Resistance precludes 
synergy with β-lactams/vancomycin 
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 Zone diameter (mm) Setting and 
Reporting guidelines 
Special considerations 
(HLAR test) Always report 
6. Chloramphenicol (30µg) ≤ 12 13 - 17  ≥ 18 Always set 
Report if resistant to vancomycin 
 
7. Ciprofloxacin (5µg)  ≤ 15 16 - 20 ≥ 21 Set for urine isolates only 
Report if ampicillin resistant 
 
8. Nitrofurantoin (300µg) ≤ 14 15 - 16 ≥ 17 Set and report for urine only  
9. Rifampicin (5µg) ≤ 16 17 - 19 ≥ 20 Set in case of vancomycin resistance  
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 Zone diameter (mm) Setting and 
Reporting guidelines 
Special considerations 
Report if resistant to vancomycin 
  10. Linezolid (30µg) ≤ 20 21 - 22 ≥ 23 Set in case of vancomycin resistance 
Report if resistant to vancomycin 
 
Do not test Cephalosporins, clindamycin, cotrimoxazole (SXT) and aminoglycosides (Except HLAR) because they may appear active in vitro 
but are ineffective clinically 
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Antibiotic list and Interpretative diameters for Haemophilus spp 
Media used: Haemophilus test agar 
QC strain: H. influenzae ATCC 49247, H. influenzae ATCC 49766, E.coli ATCC 35218 (For Augmentin testing) 
 
 
 Zone diameter (mm) Setting and 
Reporting guidelines 
Special considerations 
 Antibiotic R I S   
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
RFMHL SBP 08                                                                     SUSCEPTIBILITY TESTING                                                                   SHLS 
 
Effective Date: 08/09/2014              Page 399 of 468 
                                                                          RFMHL Confidential Controlled Document 
 
 
1. Ampicillin 10µg ≤ 16 - ≥ 17 Always set 
Always report (base initial report on 
nitrocefin disc) 
Do Nitrocefin β-lactamase test as 
initial screen for ampicillin 
susceptibility 
2. Augmentin (20/10µg) ≤ 19 - ≥ 20 Always set 
Report if ampicillin resistant 
Do not report for CSF 
Used empirically in treating 
respiratory tract infections. 
Susceptibility testing mainly for 
surveillance purposes 
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3. Tetracycline 30µg ≤ 25 26 -28 ≥ 29 Always set 
Report only for ampicillin resistant 
isolates 
Do not report for CSF/children  
 
6. Chloramphenicol (30µg) ≤ 25 26 -28 ≥ 29 Always set 
Report if ampicillin resistant 
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7. Trimethoprim-
sulfamethoxazole 
(1.25/23.5µg) 
≤ 10 11 - 15 ≥ 16 Always set 
Always report 
Do not report for CSF 
 
8. Ciprofloxacin (5µg)  - - ≥ 21 Always set 
Report if ampicillin resistant 
Do not report for CSF 
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9. Cefuroxime (30µg) 
(For both oral and parenteral 
preparations) 
≤ 16 17 - 19 ≥ 20 Always set 
Do not report 
Do not report for CSF 
Used empirically in treating 
respiratory tract infections. 
Susceptibility testing mainly for 
surveillance purposes 
10. Ceftriaxone - - ≥ 26 Always set 
Report only for CSF and blood 
In case of diameters ≤26 set MICs 
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11. Rifampicin (5µg) ≤ 16 17 - 19 ≥ 20 Set in case of all other drugs are 
resistant 
Report if resistant to other drugs 
 
12. Meropenem - - ≥ 20 Set in case of all other drugs are 
resistant 
Report if resistant to other drugs 
 
For Ceftriaxone, ciprofloxacin and meropenem, resistance has not been defined. If zones smaller than the susceptible category are seen, 
reconfirm identification and susceptibility then keep isolate for further study.  
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Antibiotic list and Interpretative diameters for Neisseria gonorrhoeae 
Media used: GC agar base (with 1% defined supplement) 
Incubation: 35-37oC in CO2  
Susceptibility testing for N. gonorrhoeae is only for research and epidemiological purposes. 
 
 
 Zone diameter (mm) Setting and 
Reporting guidelines 
Special considerations 
 Antibiotic R I S   
1. Penicillin G 10 units ≤ 26 27 - 46  ≥ 47 Always set nitrocefin β-lactamase test should 
be conducted.  
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Always report 
2. Ceftriaxone (30µg) - - ≥ 34 Always set 
Always report 
In case zone <34mm, confirm the 
identification and the susceptibility 
result. Save the isolate for 
confirmation by a reference lab. 
3 Cefuroxime (30µg) (parenteral) ≤ 25 26 - 30  ≥ 31 Always set 
Report upon request 
 
3. Cefoxitin (30µg) ≤ 23 24 -27 ≥ 28  Always set 
Report upon request 
 
6. Cefpodoxime (30µg) - - ≥ 29 Always set 
Report upon request  
In case zone <29mm, confirm the 
identification and the susceptibility 
result. Save the isolate for 
confirmation by a reference lab. 
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7. Tetracycline (30µg) ≤ 30 31 - 37 ≥ 38 Always set 
Report upon request 
 
8. Ciprofloxacin (5µg)  ≤ 27 28 - 40  ≥ 41 Always set 
Always report 
 
9. Spectinomycin (100µg) ≤ 14 15 - 17 ≥ 18 Always set 
Report upon request 
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Antibiotic list and Interpretative diameters for Streptococcus pneumoniae 
Media used: Muller-Hinton agar with 5% sheep blood 
Incubation: 35-37oC in CO2  for 20 - 24 hours 
 
 
 Zone diameter (mm) Setting and 
Reporting guidelines 
Special considerations 
 Antibiotic R I S   
1. Oxacillin (1µg) - -  ≥ 20 Always set 
Always report (as penicillin and 
cephalosporin susceptibility 
All isolates with zone diameters ≥ 
20mm are reported as susceptible to 
all penicillins and Cephalosporins. If 
zone diameters are < 19mm, set 
MICs for penicillin, and Ceftriaxone  
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2. Erythromycin (15µg) ≤15 16 - 20  ≥ 20 Always set 
Always report (Except for CSF) 
 
3. Clindamycin (2µg) ≤ 15 16 - 18 ≥ 19 Always set 
Report if other antibiotics are 
resistant 
Do not report for CSF & UTI 
 
4. Trimethoprim-sulfamethoxazole 
(1.25/23.5µg) 
≤ 15 16 - 18 ≥ 19 Always set 
Always report (except for CSF) 
 
 
5. Chloramphenicol (30µg) ≤ 20 - ≥ 21 Always set  
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Always report (Except for urine) 
6. Tetracycline (30µg) ≤ 18 19 - 22 ≥ 23 Always set 
Always report (Except for 
children and CSF) 
 
7. Sparfloxacin (5µg)  ≤ 15 16 - 18  ≥19 Always set 
Report if other antibiotics are 
resistant 
Do not report for CSF 
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Antibiotic list and Interpretative diameters for Streptococcus spp other than S. pneumoniae 
Media used: Muller-Hinton agar with 5% sheep blood 
Incubation: 35-37oC in CO2  for 20 - 24 hours 
In this protocol the term β-haemolytic Streptococci refers to large colony forming strains (i.e. S.pyogenes, S. agalactiae and group C and G 
strains with large colonies)  
The term viridans Streptococci refers to the viridans group but also includes small colony forming β-haemolytic Streptococci 
Testing should not be conducted routinely for S. pyogenes and S. agalactiae as these are known to be susceptible to penicillin, other β-
lactams and vancomycin. Testing is only for research purposes. Any strain found not to be susceptible to these antibiotics should be re-
identified and retested 
Freeze isolates of S.pyogenes for subsequent study 
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 Zone diameter (mm) Setting and 
Reporting guidelines 
Special considerations 
 Antibiotic R I S   
1. Penicillin G(10IU) - -  ≥ 24 Set only for research purposes 
Do not set for viridans Streptococci  
Test has been standardised only for 
β-haemolytic Streptococci 
(S.pyogenes, S. agalactiae and 
group C & G with large colonies) 
2. Ceftriaxone 30 µg 
(for β-haemolytic Streptococci) 
 
- 
 
 
- 
 
 
≥ 24 
 
 
In case of S.pyogenes and S. agalactiae set only 
for research 
 
Zones diameters differ between β-
haemolytic Streptococci and viridans 
Streptococci 
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(for viridans Streptococci) <24 
 
25 -26 ≥ 27 Always Report for the viridans group 
3. Erythromycin (15µg) ≤15 16 - 20  ≥ 20 Set for viridans or allergic patients 
Always report when set 
Result is particularly important in 
patients with allergy to penicillin 
4. Clindamycin (2µg) ≤ 15 16 - 18 ≥ 19 Set for viridans 
Report if other antibiotics are resistant 
Place next to erythromycin disc to 
test for inducible resistance (erm) 
(appendix I) 
5. Chloramphenicol (30µg) ≤ 17 18 - 20  ≥ 21 Always set for viridans 
Report in case resistant to β-lactams 
 
6. Vancomycin (30µg) - - ≥17 Set for viridans  
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Report if other antibiotics are resistant 
7. Tetracycline (30µg) ≤ 18 19 - 22 ≥ 23 Always set for viridans 
Report in case resistant to β-lactams 
Do not report in children) 
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Quality control 
Control tests will be conducted on a schedule summarised in Table 7.1 
 
Schedule for quality controls for the Kirby-Bauer antimicrobial susceptibility testing 
Reason for QC Frequency Comments 
Routine Once weekly At beginning of this protocol QC shall be 
conducted daily until 20 consecutive days of 
satisfactory results are achieved.  
When a new batch of susceptibility testing media 
is prepared 
Once for each batch  
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When a new lot number or shipment of discs is 
used 
Once for each lot number/shipment  
When any change in the SOP is implemented Test daily until satisfactory results are obtained 
on 20 consecutive days  
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Antibiotics and Q.C strains to test for Muller-Hinton agar without Blood and the acceptable limits of zone diameters(in mm) 
Antimicrobial agent E.coli 
(ATCC25922) 
S. aureus 
(ATCC25923) 
Pseudomonas 
aeruginosa 
(ATCC27853) 
E.coli 
(ATCC35218) 
For testing β-lactamase 
inhibitors 
Klebsiella 
pneumoniae 
(ATCC 700603) 
For ESBL 
Amikacin (30µg) 19 - 26 20 - 26 18 - 26 Not tested Not tested 
Ampicillin (10µg) 16 - 22  27 - 35  Not tested 6 Not tested 
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Augmentin(20/10µg) 18 - 24 28 - 36 Not tested 17 - 22  Not tested 
Cefotaxime (30µg) 29 - 35 25 - 31  18 - 22 Not tested 17 - 25  
Ceftriaxone (30µg) 29 - 35  22 - 28  17 - 23  Not tested 16 - 24  
Ceftazidime (30µg) 25 - 32  16 - 20 22 - 29 Not tested 10 - 18  
Cefuroxime (30µg) 20 - 26  27 - 35  Not tested Not tested Not tested 
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Cephalothin (30µg) 15 - 21 29 - 37 Not tested Not tested Not tested 
Chloramphenicol (30µg) 21 - 27  19 - 26  Not tested Not tested Not tested 
Ciprofloxacin (5µg) 30 - 40  22 - 30  25 - 33  Not tested Not tested 
Erythromycin (15µg) Not tested 22 - 30 Not tested Not tested Not tested 
Gentamicin (10µg) 19 - 26 19 - 27 16 - 21  Not tested Not tested 
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Imipenem (10µg) 26 - 32 Not tested 20 - 28  Not tested Not tested 
Linezolid (30µg) Not tested 25 - 32 Not tested Not tested Not tested 
Meropenem (10µg) 28 - 34 29 - 37 27 - 33  Not tested Not tested 
Nalidixic acid (30µg) 22 - 28 Not tested Not tested Not tested Not tested 
Nitrofurantoin (300µg) 20 - 25 18 - 22 Not tested Not tested Not tested 
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Oxacillin (1µg) Not tested 18 - 24 Not tested Not tested Not tested 
Penicillin (10units) - 26 - 37  Not tested Not tested Not tested 
Piperacillin (100µg) 24 - 30 Not tested 25 - 33 Not tested Not tested 
Rifampicin (5µg) 8 - 10 26 - 34 Not tested Not tested Not tested 
Sparfloxacin (5µg) 30 - 38 27 - 33 21 - 29 Not tested Not tested 
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Sulfisoxazole (250 or 
300µg) 
15 - 23 24 - 34 Not tested Not tested Not tested 
Tetracycline (30µg) 18 - 25 24 - 30 Not tested Not tested Not tested 
Trimethoprim-
Sulfamethoxazole 
(1.25/23.75µg) 
23 - 29 24 - 32  Not tested Not tested Not tested 
Vancomycin (30µg) Not tested 17 - 21  Not tested Not tested Not tested 
Highlighted antimicrobial agents need not be tested routinely 
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Antibiotics and Q.C strains to test for fastidious organisms and the acceptable limits of zone diameters(in mm) 
Antimicrobial agent H.influenzae 
(ATCC49247) 
Haemophilus test 
medium 
H.influenzae 
(ATCC49766) 
Haemophilus test 
medium 
Neisseria gonorrhoeae 
(ATCC49226) 
Supplemented G.C agar  
Streptococcus 
pneumoniae 
(ATCC49619) 
Muller-Hinton agar 
supplemented with 5% 
sheep blood  
Ampicillin (10µg) 13 - 21  Not tested Not tested 30 - 36 
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Augmentin(20/10µg) 15 - 23  Not tested Not tested Not tested 
Ceftriaxone (30µg) 31 - 39  Not tested 39 - 51  30 -35 
Cefuroxime (30µg) Not tested 28 - 36  33 - 41 Not tested 
Chloramphenicol (30µg) 31 - 40 Not tested Not tested 23 - 27  
Ciprofloxacin (5µg) 34 - 42  Not tested  48 - 58 Not tested 
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Erythromycin (15µg) Not tested Not tested Not tested 25 - 30  
Linezolid (30µg) Not tested 25 - 32 Not tested 25 - 34 
Meropenem (10µg) 20 - 28 Not tested Not tested 28 - 35  
Oxacillin (1µg) Not tested Not tested Not tested < 12 
Penicillin (10units) Not tested Not tested 26 - 34  24 - 3 
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Rifampicin (5µg) 22 - 30 Not tested Not tested 25 - 30 
Sparfloxacin (5µg) 32 - 40 Not tested 43 - 51 21 - 27 
Tetracycline (30µg) 14 - 22 Not tested 30 - 42  27 - 31 
Trimethoprim-
Sulfamethoxazole 
(1.25/23.75µg) 
24 - 32 Not tested Not tested 20 - 28  
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Vancomycin (30µg) Not tested Not tested Not tested 20 - 27  
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Disc diffusion Q.C trouble shooting when using Muller-Hinton agar 
Repeat out of range tests 
If issue is unresolved after repeating, troubleshoot using the table below 
Inform suppliers of any suspected manufacturing problem 
QC organisms should be well maintained: Avoid repeated subcultures. Retrieve new Q.C strains from stock. Maintain the Q.C strains at -
80oC and prepare working stock cultures weekly. Avoid repeated subcultures 
Antimicrobial agent QC strain Observation Probable cause Comments/Action 
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Aminoglycosides Any Zone too small pH of media too low Acceptable pH range is 
7.2 - 7.4 
Avoid incubation in CO2 
(it lowers pH) 
Aminoglycosides Any Zone too large pH of media too high Acceptable pH range is 
7.2 - 7.4 
(check media pH) 
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Aminoglycosides Pseudomonas 
aeruginosa (ATCC 
27853) 
Zone too small Ca2+ or Mg2+ content 
too high 
Use alternative lot of 
media 
Aminoglycosides Pseudomonas 
aeruginosa (ATCC 
27853) 
Zone too large Ca2+ or Mg2+ content 
too low 
Use alternative lot of 
media 
Augmentin E.coli ATCC 35218 Zone too small  Disc has lost potency 
(clavulanic acid is labile 
Use alternative lot of disc 
check storage conditions 
and package integrity 
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Ampicillin E.coli ATCC 35218 Zone too large (should be 
no zone-resistant) 
Spontaneous loss of the 
β-lactamase plasmid 
Store organisms as 
mentioned above and 
avoid repeated 
subcultures 
β-lactams Any Zone initially acceptable 
but decreases and goes 
out of range over time 
Disc has lost potency Use alternative lot of disc 
check storage conditions 
and package integrity 
Imipenem and clavulanic 
acid are particularly labile 
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Antimicrobial agent QC strain Observation Probable cause Comments/Action 
Azetroenam, Cefotaxime, 
Cefpodoxime, 
Ceftazidime, Ceftriaxone 
Klebsiella pneumoniae 
(ATCC700603) 
Zone too large Spontaneous loss of the 
β-lactamase plasmid 
Store organisms as 
mentioned above and 
avoid repeated 
subcultures 
ESBL confirmatory test Klebsiella pneumoniae 
(ATCC700603) 
Negative ESBL 
confirmatory test 
Spontaneous loss of the 
β-lactamase plasmid 
Store organisms as 
mentioned above and 
avoid repeated 
subcultures 
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Penicillin Any Zone too large pH of media too low  Acceptable pH range is 
7.2 - 7.4. Avoid 
incubation in CO2 (it 
lowers pH) 
Penicillin Any Zone too small pH of media too high Acceptable pH range is 
7.2 - 7.4 
(check media pH) 
Clindamycin S. aureus(ATCC25923) Zone too small pH of media too low  Acceptable pH range is 
7.2 - 7.4. Avoid 
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incubation in CO2 (it 
lowers pH) 
Clindamycin S. aureus(ATCC25923) Zone too large pH of media too high Acceptable pH range is 
7.2 - 7.4 
(check media pH) 
Macrolides S. aureus(ATCC25923) Zone too small pH of media too low Acceptable pH range is 
7.2 - 7.4. Avoid 
incubation in CO2 (it 
lowers pH) 
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Macrolides S. aureus(ATCC25923) Zone too large pH of media too high Acceptable pH range is 
7.2 - 7.4 
(check media pH) 
Quinolones Any Zone too small pH of media too low Acceptable pH range is 
7.2 - 7.4. Avoid 
incubation in CO2 (it 
lowers pH) 
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Antimicrobial agent QC strain Observation Probable cause Comments/Action 
Quinolones Any Zone too large pH of media too high Acceptable pH range is 
7.2 - 7.4 
(check media pH) 
Tetracyclines Any Zone too large pH of media too low Acceptable pH range is 
7.2 - 7.4. Avoid 
incubation in CO2 (it 
lowers pH) 
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Tetracyclines Any Zone too small pH of media too high Acceptable pH range is 
7.2 - 7.4 
(check media pH) 
Tetracyclines Any Zone too small Ca2+/Mg2+ too high Use alternative lot of 
media 
Tetracyclines Any Zone too large Ca2+/Mg2+ too low Use alternative lot of 
media 
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Sulfonamides, 
Cotrimoxazole 
E.faecalis (ATCC 29212) Zone ≤20 mm  Media too high in 
thymidine content 
Use alternative lot of 
media 
Various Any Many zones too large Inoculum too light, error 
in inoculum preparations, 
media too thin, MHA 
nutritionally unacceptable 
Repeat inoculum 
preparation 
Check expiry date and 
storage of the barium 
sulphate turbidity 
standard 
Use correct agar depth 
(about 4mm) 
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Recheck with another lot 
of MHA 
Various Any Many zones too small Inoculum too heavy, error 
in inoculum preparations, 
media too thick, MHA 
nutritionally unacceptable 
Repeat inoculum 
preparation 
Check expiry date and 
storage of the barium 
sulphate turbidity 
standard 
Use correct agar depth 
(about 4mm) 
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Recheck with another lot 
of MHA 
Antimicrobial agent QC strain Observation Probable cause Comments/Action 
Various Any One or more zones too 
small or too large 
Measurement error, 
transcription error, 
Random defective disc, 
disc not pressed firmly 
against the agar  
Check reading for 
measurement or 
transcription errors 
Retest. If retest results 
are out of range and no 
error has been detected 
initiate corrective action 
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Various S.pneumoniae (ATCC 
49619) 
Zones too large 
Lawn of growth scanty 
Inoculum source plate is 
too old with too many 
non-viable cells 
Plate used to prepare 
inoculum should be 18 - 
24 hours 
Sub-culture QC strain 
and repeat the test 
 
Or retrieve new QC strain 
Various Any One QC strain is out of 
range but others are in 
range with the same 
antibiotic 
One Q.C organism may 
be a better indicator of the 
QC problem 
Retest the strain for 
reproducibility of 
acceptable results 
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Evaluate the alternative 
strains with known MICs 
Initiate corrective action 
with the problem QC 
strain/antimicrobial 
agents 
Various Any 2 QC strains out of range 
with the same 
antimicrobial agent 
Indicative of a problem of 
the disc 
Use alternative lot of 
discs 
Check storage conditions 
and Package integrity 
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Various Any Zones overlap Too many discs per plate Place no more than 12 
discs on 150mm plates 
and five discs on 100mm 
plates; for some 
fastidious bacteria that 
produce large zones use 
fewer discs 
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Annex 1: SOP ATTESTATION FORM 
Attestation Record (general staff SOP Review At least annually) 
{Please ensure that you have read and understood before signing} 
Names Signature Date 
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